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This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
Highly Selective Vagotomy: Forward or Backward 
in the Surgical Treatment of Duodenal Ulcer?
v- -
How many major advances have been 
r made in gastrointestinal surgery since the 
introduction of vagotomy by Dragstedt? 
-* * Regrettably, the answer is dismally few.
The great increase in our understanding 
| A and knowledge of the pathophysiology of 
many diseases unfortunately has not been 
* ‘ translated into many important new 
operations. Surgical results have certain­
ly improved, but this can be attributed to 
better selection of patients and more 
sophisticated care pre- and postoperative- 
v-». ly. Gastrointestinal surgeons today are 
doing essentially the same operations as 
► the surgeons of the previous generation.
When Johnston and Wilkinson1 and 
v f Amdrup and Jensen2 independently sug­
gested an entirely new approach to 
vagotomy, based on the physiologic ex- 
v periments of Griffith and Harkins,3 
there was considerable excitement. Highly 
_ r  selective vagotomy, by preserving the 
vagal branches to the antrum, allowed the 
r ysurgeon to dispense with the drainage
procedure that appears to be an essential 
addition to complete gastric vagotomy. 
The advantages were recognized im­
mediately. Because the gastrointestinal 
tract is not entered, the operation is much 
safer. As no drainage procedure is per­
formed, there are fewer long-term side ef­
fects. The only apparent disadvantage is 
that the operation, if done properly, takes 
longer to perform than a standard 
vagotomy with a drainage procedure. The 
one remaining question, therefore, was 
the rate of recurrent ulceration.
The initial recurrence rate following 
highly selective vagotomy was not only as 
low as but even lower than after 
vagotomy and drainage.4 These results 
were treated with skepticism by some, 
who wondered how fewer recurrences 
could be achieved with the same degree 
of acid reduction. There was anxiety 
about the conversion of almost all pa­
tients from insulin-test negative results to 
insulin-test positive. There was concern
about the possibility of reinnervation 
from the antrum. However, many sur­
geons and the majority of gastroentero­
logists, particularly in Europe, hailed this 
new operation as a major advance in the 
treatment of duodenal ulcer. Enthusiasts 
advocated its use not only for un­
complicated duodenal ulcer but also for 
duodenal ulcers complicated by pyloric 
obstruction, perforation or hemorrhage, 
for gastric ulcer, hiatus hernia and other 
conditions. An operation with so little at­
tendant morbidity was hard to eschew. 
Has it stood the test of time? As recently 
as 1980, no less an authority than the late 
Dr. Morton Grossman was warmly en­
dorsing it and advocating its wider use in 
the United States.5
In this issue (pages 340 and 341) Mr. 
Terence Kennedy reports on 512 highly 
selective vagotomies performed over 15 
years by a number of surgeons. There was 
only one operative death and a proven 
recurrence rate of 13% in those followed
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up for more than 5 years. That record is 
impressive and is more convincing than 
the reports of spectacular results obtain­
ed by a single surgeon. What we need to 
know is whether highly selective 
vagotomy should be recommended as the 
best elective surgical treatment for all pa­
tients with duodenal ulcer.
It is ironic that the strongest claim for 
this operation (unsupported by any con­
trol data) comes from the surgical depart­
ment that so elegantly demonstrated the 
feasibility and value of the prospective, 
randomized, controlled surgical trial.6 It 
is also worth recalling that the proven 
recurrent ulcer rate after vagotomy and 
drainage in that trial, involving many 
surgeons, was only 2.5%. Kennedy states 
that there are no published randomized 
controlled data comparing highly selec­
tive vagotomy with truncal vagotomy and 
drainage, with a follow-up of 5 years or 
more. To the shame of the surgical com­
munity, this is strictly true. But we are not 
entirely without good data. There have 
been several controlled trials. Madsen and 
Kronborg7 compared the results of 
highly selective vagotomy with selective 
vagotomy and pyloroplasty after 5 'h to 
8 years and found ulcer recurrence rates 
of 26% and 14%, respectively. Elder and 
colleagues8 in this Journal reported a 
randomized trial of highly selective 
vagotomy versus truncal vagotomy and 
pyloroplasty in which the mean follow­
up was 4 years. The rate of recurrent ulcer 
following highly selective vagotomy was 
21.4% compared with 7.5% following 
vagotomy and pyloroplasty. Surprising­
ly, there was no difference in the in­
cidence of any side effect other than diar­
rhea. Koo and associates9 compared 
highly selective vagotomy with truncal 
vagotomy and drainage after a median 
follow-up of 4 years. Recurrence after 
highly selective vagotomy was 18% and 
after vagotomy and drainage was 12%. 
Christiansen and associates10 reported a 
2- to 5-year follow-up of highly selective 
vagotomy compared with truncal vago­
tomy and drainage and selective vago­
tomy and drainage. The risk of ulcer 
recurrence calculated by an actuarial 
method was significantly higher after 
highly selective vagotomy than after trun­
cal vagotomy and drainage but not after 
selective vagotomy and drainage. One of 
the most worrisome features is that recur­
rent ulceration after vagotomy and 
drainage occurs within 2 years or pro­
bably not at all, whereas after highly 
selective vagotomy it is apparent that the
longer the patients are followed the more 
recurrent ulcers are detected. The Leeds 
group" has progressively increased its 
reported recurrence rate after highly selec­
tive vagotomy from 0% to 11%. At what 
point will recurrent ulcers stop appearing? 
The true recurrence rate of 35% after 
gastroenterostomy alone was not recog­
nized for more than 20 years.
None the less, some surgeons, armed 
even with these facts, strongly advocate 
highly selective vagotomy as the primary 
operation for duodenal ulcer for two 
reasons. First, recurrent ulcer can now be 
treated successfully with powerful H2 
blocking agents and second, if worse 
comes to worst, the patient can be offered 
another operation. The reason the patient 
was offered an operation in the first place 
was because we do not accept that lifetime 
treatment with H2 blocking agents is ap­
propriate for duodenal ulcer disease. How 
safe and effective vagotomy and antrec­
tomy (the operation generally recom­
mended) will prove to be for failed highly 
selective vagotomy is not yet known. But 
is it reasonable to offer an operation that 
even one of its originators predicts will 
fail within 10 years 23% of the time?12 
The ultimate defence of highly selective 
vagotomy, of course, is the claim that if 
the operation is done properly, the recur­
rence rate will not be 23% but 2% to 6%. 
If the operation is so difficult to do cor­
rectly, should it be advocated for general 
use? Why has there been no report of 
long-term, independent, objective follow­
up with such respectable recurrence rates? 
Why have several interim reports13-15 of 
controlled trials of highly selective 
vagotomy, including one by Kennedy and 
associates, not been followed by the 
publication of detailed long-term results?
Those who stubbornly promote the 
concept that highly selective vagotomy is 
not only safer but is followed by fewer 
sequelae and a similar number of recur­
rent ulcers as vagotomy and drainage 
must face the facts. Facts come only from 
properly controlled prospective trials with 
lengthy follow-up.
M a x  M . C o h e n , m b , c h  b , f r c s (Ed in >,
FRCS[C], FACS
Member,
Editorial Board.
Professor of Surgery,
University of Toronto,
Ste. 440,
Mount Sinai Hospital,
600 University Ave.,
Toronto, Ont. M5G 1X5
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► Accuracy of Noninvasive Peripheral Arterial Testing
Evaluation of peripheral arterial disease 
*" by noninvasive methods has played an in- 
v creasingly important role in patient 
management as noted by Symes and col- 
, ^ leagues in this issue (pages 345 to 347).
The clinical impression of arterial status 
4 -*■ is complemented by the objective, quan­
titative evaluation of noninvasive testing. 
•" Scientific evaluation of peripheral arterial 
disease or procedures requires laboratory 
* confirmation and noninvasive studies 
. may be able to provide information not 
available even by arteriography, thus in- 
M * creasing the accuracy of diagnosis.
The accuracy of a noninvasive tech- 
4 nique (true positive plus true negative 
results divided by the total number of ex­
aminations) varies depending on the pa­
tient population studied. Accuracy also 
v v depends on the threshold level chosen for 
a positive test, which can vary according 
to whether one is more concerned with 
■y y detection of patients with disease (sen­
sitivity) or excluding those without disease 
r (specificity). Assessment of accuracy also 
requires a proper “ gold” standard for 
V v comparison.
With respect to peripheral arterial 
" r disease, the accuracy of clinical diagnosis 
^alone may be very high. Baker and 
associates1 compared clinical evaluation 
y. by attending surgeons with noninvasive 
laboratory testing (segmental pressures, 
y y femoral Doppler recordings without spec­
trum analysis and treadmill exercise) of
► 102 patients. A similar, high degree of ac­
curacy was obtained from both the nonin-
' Vasive studies and the attending surgeon, 
who was correct in 98 patients and at least 
partially correct in the other 4. The Jess­
ys y experienced clinicians (surgical house- 
staff), however, did not fare as well, with
► only 62% totally correct anatomic diag­
noses. The high degree of accuracy of the
-  ^attending surgeon in this study may have 
been influenced by the patient population 
selected since all 102 patients were admit- 
k ted to hospital for arteriography and thus 
likely had severe disease which often 
,  ^ facilitates clinical accuracy. The patients 
in whom diagnosis is more difficult are 
> *those who have disease in both iliac and 
femoral systems. Several different 
\  methods have been used to detect com­
bined segment disease. The technique of
combined segmental pressure measure­
ments and pulse-volume recordings was 
developed by Raines and associates.2 
Segmental pressures at the common 
femoral level are difficult to measure 
since it is not possible to place the thigh 
pressure cuff high enough. Combined 
segmental pressure measurement and 
pulse-volume recording may not accurate­
ly predict the major contributing lesion 
in combined segment disease.3 A study is 
currently in progress at the Miami Heart 
Institute to define the accuracy and 
limitations of this method in combined 
segment arterial disease.3
The other technique of noninvasive 
testing evaluated by Symes and associates 
was Doppler waveform analysis using 
continuous wave Doppler ultrasound and 
a spectrum analyser with calculation of 
pulsatility index. This may help in dif­
ficult cases, where the patient has com­
bined disease. Johnston and associates,4 
using a pulsatility index of 5.5 as a 
threshold level, found 95% sensitivity and 
specificity in detecting hemodynamically 
important aortoiliac disease (correspond­
ing to a resting aortofemoral pressure gra­
dient of 10 mm Hg). Other investigators 
have been less optimistic regarding the ac­
curacy of the pulsatility index in diagnos­
ing iliac disease,5,6 but their techniques 
differed in a major fashion from that of 
Johnston and colleagues.
The lack of a definite “ gold” standard 
makes comparison of various techniques 
difficult. The inadequacy of single-plane 
arteriography to define hemodynamical­
ly important aortoiliac disease has long 
been appreciated.7 Some have used 
aortofemoral pressure gradients as the 
“ gold” standard of iliac disease at rest4 
and after vasodilatation by papaverine.8
Noninvasive studies play a major role 
in the management of the vascular pa­
tient. Either combined segmental pressure 
measurement and pulse-volume recording 
or Doppler waveform analysis may be 
adequate in the majority of patients. In 
more complicated cases where there is 
combined iliac and femoral disease, 
evidence that combined segmental 
pressure measurement and pulse-volume 
recording allows precise anatomic 
diagnosis is not available. While con­
troversial, preliminary evidence suggests 
that Doppler waveform analysis may 
facilitate diagnosis of combined segment 
disease and give information in addition 
to  th a t supplied by single-plane 
arteriography.4 In the occasional dif­
ficult case of multilevel disease, even a 
combination of clinical, noninvasive and 
arteriographic methods may not give an 
accurate hemodynamic diagnosis and 
direct aortofemoral pressure measure­
ments may be required. The comparison 
of accuracy of noninvasive techniques in 
vascular disease is difficult because of the 
variability of patient populations and lack 
of a suitable “ gold” standard.
Peter Brown, md, frcs[C]
Department of Surgery,
Queen’s University,
Kingston, Ont.
K7L 3N6
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Simplified Dressing for the Drained Empyema
* i 
i
Any empyema, complicated or not by a 
bronchopleural fistula, must be drained 
by a closed or open technique. Care of 
the wound imposes a heavy burden on 
medical and paramedical staff and dis­
comfort to the patient is severe. The 
pleural abscess releases a large volume of 
infected secretions that not only irritate 
the skin around the drain site but are a 
constant source of reinfection. Frequent 
dressing changes, costly in time and 
material, are required and cannot be done 
on an outpatient basis. Moreover, pro­
longed bed rest and inactivity delay the 
recovery of these patients, who are 
already severely debilitated, and increase 
the risks of additional complications. Our 
experience with enterostomy therapy gave 
us the opportunity to design a closed 
system technique that eliminates most of 
these inconveniences.
FIG. 1—Material required: A = pleural 
drain, 3 = skin barrier washer and square, 
4 = bag, 6 = vent.
FIG. 2—Drain with its anchor line and skin 
barrier washer.
Technique
The purpose is to assure the total col­
lection of the purulent secretions into a 
bag without spillage, skin irritation or air 
trapping (Fig. 1). First, the skin around 
the drain or the edges of the window is 
cleaned and covered with a layer of water­
proof protective coating (United Skin 
Prep., United, Division of Howmedica 
Inc., Guelph, Ont.) that will enhance the 
holding power of the dressing. If the 
pleural drain must be kept in place, stitch-
FIG. 3—Skin barrier square.
FIG. 4—Final set up: sealed vented bag
ing must be avoided since it is painful and * 
will eventually cut through the skin. 
Therefore, the drain is cut 4 cm from the  ^
thoracic wall and a heavy silk is tied 
around it; then its free end is glued to the 
skin with a thin layer of Karaya paste -* 
(Hollister Inc., Willowdale, Ont.). Next, 
a round washer of skin barrier (Hollister -* 1 
Inc.) is applied around the edges of the 
wound (Fig. 2) and is covered with an 
adhesive blanket (10 x 10 cm) of the  ^
same material (Fig. 3). The inside edge of *" 
the wound is sealed with additional A 
Karaya paste to assure a watertight bar­
rier. A urinary diversion bag (Hollister * * 
Inc.) is glued to the skin barrier patch. 
Further adhesion of the bag is guaranteed v 
by a layer of Micropore Surgical Tape j 
(3M Canada Inc., London, Ont.) applied 
to its external base. In the presence of a 
bronchial fistula, venting of the bag is 
assumed by a no. 14 French rubber drain 
(Robi-Nel Catheter, Argyle, Division of j 
Sherwood Medical Industries Ltd., St. y „ 
Louis, Mo.) introduced through its up­
per part and sealed with some tape (Fig.
4). The only care needed will then be the j 
emptying of the bag as required. Inspec- ’ V 
tion of the wound, irrigation or bacterial ; 
culture can be done through the fundus  ^
of the bag. On an outpatient basis, 
periodic controls may be extended to 10 
to 15 days. H
In our experience, this method has ! 
simplified the treatment of drained em- ■< U 
pyema. By eliminating the constant pain 
and the anguish of a dirty weeping wound 4 
and by permitting the patient an early 
return home to normal activities, it has * v 
brought about the essential elements of l 
a quick recovery and cut down con­
siderably on hospital costs. .,
G illes Laroche, m d , frcsic], facs
Section of Thoracic and < -
Cardiovascular Surgery,
G illes Dumais, et ,
Enterostomy Therapist, * A.
Serge Latouche, et , 
Enterostomy Therapist,
V
♦ 4
Hotel-Dieu de Quebec, 
11 C6te du Palais, 
Quebec, PQ 
G1R 2V6
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Operative Myocardial Protection
To the editors.—I would like to compli­
ment Brown and Chiu on their excellent 
paper “Operative myocardial protection: 
does an elevated level of creatine 
phosphokinase-MB isoenzyme always in­
dicate myocardial necrosis?” (Can JSurg  
1984; 27: 80-3). Their answer in the 
negative and their careful documentation 
of methods used, with myocardial needle 
biopsy confirming the lack of extensive 
infarction, puts the routine measurement 
of creatine phosphokinase-MB isoenzyme 
postoperatively into its proper perspective 
as a quality control factor. Their myocar­
dial temperature threshold of 25°C is cer­
tainly higher than I would accept,1 but 
their excellent clinical results cannot be 
faulted. Eight years ago I also reported 
a minimal effect of the duration of cross­
clamping on creatine phosphokinase-MB 
isoenzyme peak values,2 but we did not 
perform the frequent analyses that make 
Brown and Chiu’s study superior. I think 
the explanation for why patients who 
undergo valve replacement have higher 
levels of enzyme release than those who 
undergo coronary artery grafting is 
covered by the authors’ formula on page 
82. Certainly, in most patients with aor­
tic valve disease and in many patients with 
mitral insufficiency, the myocardial mass 
at risk is markedly increased, compared 
with that in the average patient with cor­
onary artery disease.
G. F rank O. T yers, m d , frcsic], facs
Professor and Head,
Division of Cardiovascular 
and Thoracic Surgery,
Vancouver General Hospital,
855 West 12th Ave.,
Vancouver, BC 
V5Z 1M9
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Small-Bowel Varices
To the editors.—Drs. Ostrow and Blan­
chard, in the discussion of their most in­
teresting paper on bleeding small-bowel 
varices (Can J  Surg 1984; 27: 88-9), in­
dicate that only a few similar cases have 
been reported. I should like to report 
briefly another patient with a bleeding 
small-bowel varix.
A 16-year-old girl had had a ruptured ap­
pendix with peritonitis when she was 1 year old. 
It was satisfactorily treated and she had no fur­
ther complications for 4 years when she was 
discovered to have Banti’s syndrome and 
underwent splenectomy. Apparently the caver­
nous transformation of the portal vein was 
unrecognized.
When the patient was admitted, she gave a 
history of passing tarry stools for several days 
but without hematemesis. A nasogastric tube 
introduced into the stomach did not produce 
blood and subsequently an upper gastro­
intestinal series was reported as “ unremark­
able” . She continued to pass blood and re­
quired transfusion, so abdominal exploration 
was elected. The stomach, duodenum and liver 
appeared normal. On examination of the small 
bowel, a loop was found adhering to the back 
of the previous laparotomy incision. A large 
vein could be seen running through the 
mesentery across one side of the small intestine, 
entering the abdominal wall near the umbilicus. 
The rest of the small intestine did not appear 
abnormal but distally was distended with 
blood.
The varix was ligated in the mesentery and 
the small intestine dissected from the ab­
dominal wall. The vein entering the abdominal 
wall was suture-ligated and the wound closed.
Subsequently, the patient did well and in the 
2 years of follow-up had no further bleeding 
episodes. She was subsequently lost to follow­
up so her ultimate fate is unknown.
At operation there was no evidence of 
multiple intramural jejunal varices but 
only one large varix. The previous 
splenectomy with the resultant small- 
bowel adhesion to the abdominal wall ap­
parently established a vascular connection
between the portal and systemic venous 
system that resulted in variceal hemor- ., 
rhage at the jejunal level. It therefore ap­
pears possible that in any patient with un- -* i 
corrected portal hypertension, whether 
due to hepatic or prehepatic obstruction, ” 
varices may develop at anomalous sites,  ^
with hemorrhage, particularly if there has 
been previous peritonitis or abdominal  ^
surgery and adhesions are present.
4 A
P.A. Sa lm o n , m d , frcsic], facs
¥
Professor,
Department of Surgery,
University of Alberta,
Edmonton, Alta.
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Lymphoscintigraphy for 
Staging Breast Cancer j
* y
To the editors.—In his editorial, “ Lym- j 
phoscintigraphy in the staging of breast " * 
cancer” (Can J  Surg 1983; 26: 487-8), 
Shibata has obscured the simple facts we 
presented. Our study (Can J  Surg 1983;
26: 507-9) demonstrated that axillary 
lymphoscintigraphy in its present state of -y 
development is not a reliable indicator of 1 
axillary lymph-node metastases. It is, < 
however, worth further study. We also 
prospectively tested the specificity of * '  
preoperative internal mammary lympho- j 
scintigraphy because of the possibility | 
that postoperative surgical artefact had < 
confounded the data on which Ege and ] 
Clark based their original conclusions.1 , 
Only one false-positive result was obtain­
ed in the preoperative examination of 76 < - 
patients with breast masses that were 
subsequently proven to be noncancerous. 
There is no doubt that the test is remark- 
ably specific for nonmalignant disease.
The suggestive correlation of the abnor-  ^
mal preoperative internal mammary scan 
with the most sensitive biologic marker  ^ i_ 
presently in use (involved axillary nodes) 
and with recognized anatomical lym- A 
phatic drainage pathways (medial and
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central location of the primary tumour in 
the breast) may be purely coincidental, 
k ^ Surgical excision of the whole internal 
^  mammary lymph-node chain should be 
4 performed to settle the question. Unfor­
tunately, this is not ethically justifiable. 
y l  Alternatively, we need large numbers of 
patients and long-term follow-up. We do
► not believe we have enough evidence to 
start adjuvant therapy on the basis of an
*■ abnormal internal mammary lymphoscin- 
tigram in patients with negative axillary 
nodes. We do believe this part of the 
^ h study is worth continuing.
► Norman S. H ill, md, frcsic]
Leo J. Mahoney, md, ms, frcsic], facs 
♦ >- Dennis W. J irsch, md, m sc, ph d , 
FRCS[C] 
y
Department of Surgery,
 ^ St. Michael’s Hospital.
N. David Greyson, md, frcpicj
Department of Nuclear Medicine,
A 4. St. Michael’s Hospital,
30 Bond St.,
, Toronto, Ont.
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Esophagopericardial Fistula 
*• > Producing Purulent Pericarditis
r
To the editors.—In a recent review, 
vv Cyrlak and associates' reported what 
they thought was the 50th documented 
' * case of esophagopericardial fistula. They 
noted that such fistulas are uncommonly
* related to operation and when they occur 
postoperatively they are recognized 
clinically within 2 years. We report a pa-
v ► tient who had esophagopericardial fistula, 
documented radiologically, and presented 
► 22 years after repair of a lower esophageal 
stricture.
► ►
An 81-year-old woman was admitted suffer­
ing retrosternal chest pain, which had been pre­
sent for 12 hours. Twenty-two years earlier she 
’ * had undergone excision of a benign lower 
esophageal stricture with interposition of a je- 
*” junal loop between the distal esophagus and 
stomach (Merendino procedure2). Her heart
* rate was 115 beats/min, temperature was 37°C 
and blood pressure 90/70 mm Hg with a 
paradoxical pulse pressure of 30 mm Hg;
^ Kussmaul’s sign was present. The heart sounds 
■ were soft and no pericardial rub was audible. 
The findings on abdominal examination were 
*  unremarkable. The leukocyte count was 30 x 
109/L . There was elevation of the ST-segment 
'  in the lateral leads. Chest roentgenogram 
revealed an enlarged, globular cardiac 
*'• silhouette. A two-dimensional echocardiogram 
showed a large pericardial effusion.
Pericardiocentesis was performed and an in­
dwelling catheter left for pericardial drainage. 
The leukocyte count in the pericardial fluid was 
74 x 109/L ; there was a predominance of 
neutrophils. Gram-positive cocci and gram­
negative bacilli were present on the smear. 
Cultures subsequently grew Staphylococcus 
aureus, a-hemolytic Streptococcus and 
Clostridium perfringens. Roentgenogram after 
a swallow of dilute meglumine diatrizoate 
demonstrated a free passage from the jejunal 
interposition graft to the pericardial space. 
Esophagogastroduodenoscopy demonstrated a 
stomal ulcer at the gastrojejunal anastomosis. 
The fistula was not visualized.
After 2 weeks of pericardial drainage, 
parenteral feeding and intravenously ad­
m inistered penicillin, netilm icin and 
metronidazole, her clinical status was unim­
proved. Excision of the interposition graft and 
fistula was performed. Wide pericardial to 
pleural cavity drainage was achieved and 
esophagogastric reconstruction was performed. 
Her postoperative course was complicated by 
septicemia and acute renal failure. The patient 
died 7 weeks after admission. Autopsy revealed 
evidence of extensive pericarditis and Candida 
albicans was isolated from the pericardial sac.
Development of esophagopericardial 
fistula as late as 22 years after operation 
has not been reported before. Purulent 
pericarditis in our elderly patient is typical 
in many ways of the changed spectrum 
of purulent pericarditis in the antibiotic 
era. The general incidence of purulent 
pericarditis has declined since 1944 and 
its occurrence has become relatively more 
common in adults, in women and follow­
ing thoracic surgery.3 Fever is seldom 
absent; in the series of Rubin and 
Moellering4 only 4% of patients had no 
fever. Anaerobic and aerobic gram­
negative bacteria are being recognized 
more frequently in this infection.5
The overall mortality for patients with 
purulent pericarditis who are treated is 
about 40% and when unrecognized the 
disease is almost always fatal.3 Although 
the diagnosis of purulent pericarditis is 
undoubtedly facilitated by the use of two- 
dimensional echocardiography, the unex­
pected, fatal, late postoperative complica­
tion in our patient underscores the need 
for acute awareness of the condition.
Robert J. Burns, md, frcp[C] 
Robert S. Nitkin, md 
David Martin, md 
T imothy G. Prieur, md
Division of Cardiology,
Department of Medicine,
Toronto Western Hospital.
Paul F. Waters, md, frcsic]
Division of General Surgery, 
Department of Surgery,
Toronto Western Hospital,
399 Bathurst St.,
Toronto, Ont.
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Perforated Duodenal Ulcer
To the editors.—In response to the let­
ters of Cohen and Fong (Can J  Surg 1984; 
27: 7), I wish to make the following com­
ments. Perforation is a complication of 
duodenal ulcer. Fortunately, with specific 
drugs, peptic ulcer disease is not as com­
mon as it was. Once they have undergone 
plication, 30% to 50% of patients con­
tinue to enjoy a trouble-free life. Surgery 
for perforation should be safe, simple, 
soon and just sufficient for the immediate 
problem.
Definitive surgical treatment for pep­
tic ulcer disease should be offered after 
a medical regimen has failed, after biop­
sy of the ulcer has been obtained, after 
basal acid output and maximal acid out­
put have been studied, after the gastrin 
level has been ascertained and associated 
disease has been ruled out. The patient 
should be informed of the recurrence rate 
of 5% to 7% after vagotomy and 
drainage and of the crippling long-term 
effects on nutrition and quality of life of 
adding hemigastrectomy.
Dr. Jordan of Baylor University ad­
vocates a drastic solution to a simple pro­
blem — a “ no mortality” treatment is 
preferable to “ accepted mortality” — by 
being overly aggressive.
In socioeconomically backward areas 
where patient compliance is not ensured, 
definitive treatment as the initial treat­
ment for perforation is not to my mind 
academic or catholic in the case of a 
disease whose etiology is still not known.
M.P. CHATURVEDI, md, FRCS[C], 
FRCS(EDIN)
180 Tulip Ave.,
Floral Park, NY 11001 
USA
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17. The procedure depicted above
(A) is frequently required for optimal results in patients with 
gastroesophageal reflux
.(B) has no place in the management of peptic ulcer disease complicated 
by hemorrhage, obstruction, or perforation
(C) has been shown to be associated with substantially lower rates of 
recurrent peptic ulcer disease than antrectomy and truncal 
vagotomy
(D) diminishes the postoperative effects of destruction or bypass of 
the pylorus that complicate other operations for peptic ulcer
(E) is based on anatomic discoveries made during the past two decades
For the incomplete statement above select the one answer that is best of the 
five given. For the critique of Item 17 see page 406.
(Reproduced by permission from SESAP IV  Syllabus: Surgical Education and 
Self-Assessment Program No. 4. For enrolment in the Surgical Education and 
Self-Assessment Program No. 4, please apply to the American College of 
Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Concern for the late formation of stric­
tures at the site of an endoscopic 
sphincterotomy has delayed the accep­
tance of this procedure as treatment for 
choledocholithiasis in otherwise healthy 
patients. The authors addressed this 
issue by comparing the biochemical and 
histologic sequelae of sphincterotomy in 
23 dogs with those in 10 sham-operated 
controls.
Twenty-four hours after sphincter­
otomy, hemorrhagic, edematous mucosa 
surrounded the incision. Microscopically, 
there was an acute inflammatory ex­
udate bridging the mucosal surfaces. 
Mucosal regeneration was sufficient after 
1 week to cover the defect caused by 
the cautery, although some inflammatory 
changes were still evident.
A widely patent sphincterotomy orifice 
was seen in 15 dogs followed up for 10 
weeks. In three dogs, the fibres of the 
papilla had reunited below the incision, 
resulting in a choledochoduodenal fistula. 
Histologically, complete healing of the 
mucosal surface had occurred with no 
evidence of scar formation or chronic in­
flammation. Serum bilirubin and liver en­
zyme measurements did not show 
evidence of biliary obstruction due to the 
sphincterotomy.
From the results of our study, there is 
no evidence to suggest that an en­
doscopic sphincterotomy is predisposed 
to late stenosis.
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La crainte de voir apparattre tardivement 
un retrecissement au niveau d'une 
sphincterotomie endoscopique a retard^ 
('acceptation generate de cette interven­
tion comme traitement de la choledocho- 
lithiase chez des patients par ailleurs en 
bonne sant6. Les auteurs ont abordg ce 
sujet par la comparaison des sequelles 
biochimiques et histologiques de la 
sphincterotomie chez 23 chiens par rap­
port a 10 chiens t£moins soumis a une 
operation simulee.
Vingt-quatre heures apres la sphincte­
rotomie une muqueuse hemorragique et 
oedemateuse entoure I'incision. Au 
microscope on constate un exsudat 
inflammatoire aigu recouvrant les surfa­
ces muqueuses. Apres 1 semaine, la 
regeneration de la muqueuse est suffi- 
sante pour couvrir les marques de caute­
risation meme si des changements 
inflammatoires sont encore evidents.
Un orifice de sphincterotomie bien per­
meable a ete observe chez 15 chiens qui 
ont ete gardes sous surveillance pour 
jusqu'e 10 semaines. Chez trois chiens, 
les fibres de ia grande caroncule 
s'etaient reunies sous I'incision entrat- 
nant la formation d’une fistule 
choledocho-duodenale. A I'histologie, on 
observait une guerison complete de la 
surface muqueuse sans signe de cica­
trice ou d'inflammation chronique. Le 
dosage de la bilirubinemie et des enzy­
mes hepatiques n'a pas reveie de signe 
d'obstruction biliaire attribuable a ia 
sphincterotomie.
Les resultats de notre etude n'indi 
quent pas que la sphincterotomie 
endoscopique puisse predisposer & une 
stenose tardive.
Endoscopic sphincterotomy is now the 
preferred method for treating retained or 
recurrent biliary calculi.1 Although its 
application is unchallenged in the high- 
risk surgical patient, many surgeons 
prefer the classic operative approach to 
common-bile-duct calculi in otherwise 
healthy patients, because of concern that
strictures will form later at the site o f the 
sphincterotom y.1'4 We attempted to 
resolve this issue by examining the 
histologic sequelae of electrosurgical 
sphincterotomy, using a canine model.
Material and Methods
A cholecystectomy was performed at 
the time of laparotomy in 33 anesthetiz­
ed mongrel dogs. Through a longitudinal 
duodenotomy, the papilla o f Vater was 
identified and cannulated with a sphinc- 
terotome designed for endoscopic use.
In 23 dogs (group 1), a sphincterotomy 
1 to 1.5 cm long was performed by ap­
plying blended electrocautery current to 
the raised cutting wire. The duodenotomy 
and laparotomy incisions were then clos­
ed and the animals were allowed to 
recover.Ten control dogs (group 2) under­
went cholecystectomy and duodenotomy, 
but a sphincterotomy was not performed.
All group 2 dogs and 15 group 1 dogs 
had serum bilirubin and liver enzyme 
levels measured daily for the first week 
postoperatively and thereafter at weekly 
intervals for 10 weeks. The remaining 
eight dogs in group 1 were sacrificed at 
varying intervals from 24 hours to 1 week 
postoperatively to investigate the early 
changes caused by the electrocautery 
incision.
At the time of sacrifice, the duodeno­
tomy was reopened and the sphincter­
otomy orifice examined. After excision 
o f the choledochoduodenal junction, 
histologic sections across the sphincter­
otomy were examined to ascertain the 
changes and the degree o f healing at the 
incision site.
Results
The postoperative course was similar in 
both groups, with no complications that 
we could attribute to the sphincterotomy. 
Two dogs in group 2 died as a result o f  
viral epidemics in the animal storage area, 
one 4 weeks and the other 6 weeks 
postoperatively.
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Fig. la  Fig. lb
FIG. 1—(a) Duodenal papilla (arrow) in control dog. (b) Intramural portion of common bile duct. Lumen of common bile duct is filled 
with papillary projections of bile-duct mucosa, separated from lumen of duodenum by roof of smooth muscle and duodenal mucosa (hematoxylin- -•* 
phloxine-saffron stain, reduced by 51% from x 80).
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Fig. 2a Fig. 2b
FIG. 2—(a) Sphincterotomy after 24 hours. Incision surrounded by hemorrhagic and edematous mucosa, (b) Histologic section taken 
across sphincterotomy after 24 hours. Acute inflammatory exudate lining incision, with hemorrhage and edema in surrounding tissue (hematoxylin- 
phloxine-saffron stain, reduced by 51% from x 80).
Fig. 3a Fig. 3b (- j<
FIG. 3—(a) After 10 weeks, sphincterotomy fully healed. Divided fibres of papilla visible (arrow), with patent sphincterotomy extending 
proximally. (b) Histologic section shows incision lined by mature mucosal epithelium without evidence of inflammation or scar tissue at mucosal k 
interface (hematoxylin-phloxine-saffron stain, reduced by 51% from x 80).
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The serum bilirubin and liver enzyme 
(alkaline phosphatase, glutamic oxalo­
acetic transaminase and glutamic pyruvic 
transaminase) levels were moderately 
elevated after the first postoperative 
week, then rapidly returned to normal 
in both groups and remained normal 
for the duration of the study. No persis­
tent or increasing biliary obstruction was 
evident, and there was no notable dif­
ference between the two groups.
The duodenal papilla in normal dogs 
(group 2) (Fig. la) consisted of a small 
mucosal elevation with a central opening 
for the common bile duct. From this 
point, the common duct ascended in- 
tramurally in the duodenal wall for a 
variable distance before emerging as the 
common bile duct proper. A microscopic 
section across the intramural portion of 
the common bile duct (Fig. lb) showed 
that its lumen was filled with papillary 
projections of bile-duct mucosa and was 
separated from the duodenal lumen by a 
septum of smooth muscle and duodenal 
mucosa.
At 24 hours postsphincterotomy, gross 
inspection revealed hem orrhagic, 
edematous mucosa surrounding the 
sphincterotomy site (Fig. 2a). A histologic 
section taken across the sphincterotomy 
(Fig. 2b) showed the base of the incision 
lined by an acute inflammatory exudate, 
with hemorrhage and edema in the sur­
rounding tissue. Despite this surprising 
degree of early local reaction, healing pro­
gressed rapidly and was nearly complete 
in the group 1 dogs examined at 1 week 
postoperatively.
At 10 weeks, all 15 dogs had a widely 
patent sphincterotomy orifice (Fig. 3a) 
with no gross signs of scarring or ongo­
ing inflammation. In three dogs, the 
papillary fibres had reunited below the 
sphincterotomy, creating, in effect, a pro­
ximal choledochoduodenal fistula. 
Histologic examination of the healed 
sphincterotomy at 10 weeks (Fig. 3b) 
demonstrated a lining of mature duodenal 
and common-bile-duct mucosa with ac­
curate mucosal healing in all areas. There 
was no evidence of scar tissue or chronic 
inflammatory changes at the mucosal in­
terface or in the surrounding tissues that 
might predispose to late stenosis.
Discussion
> s
Endoscopic sphincterotomy successful­
ly clears the common bile duct in 90.5% 
to 93.8% of patients with choledocholi- 
thiasis, and is associated with a mortali­
ty of less than 1.5% in large series.2,5'7 
Late stenosis at the sphincterotomy site 
is uncommon, occurring in only 1.0% of 
patients followed up from 1 to 5 years.3,5
In early animal experiments, Kawai and 
associates8 studied the feasibility of elec- 
trosurgical sphincterotomy in five dogs.
They found no visible evidence of fibrosis 
or stenosis 2 to 4 weeks postoperatively. 
Tanaka and associates9 studied three 
monkeys 10 to 12 months following 
sphincterotomy. They found that ac­
curate mucosal healing had occurred in 
all cases, but failed to show convincing 
histologic proof of these claims. Other 
investigators10 have demonstrated the 
safety of electrosurgical sphincterotomy 
in animals, but have not examined the in­
cision to assess its potential for late 
scarring.
In our study, we found no evidence to 
suspect that an electrosurgical sphinc­
terotomy is prone to late stenosis. The 
sphincterotomy remained widely patent 
throughout the study period, with no 
visual evidence of scarring or chronic in­
flammation. Moreover, histologic ex­
amination of the incision 10 weeks after 
sphincterotomy confirmed the presence of 
accurate mucosal healing with a remark­
able absence of scar tissue formation and 
chronic inflammation at the mucosal 
interface.
Conclusions
From our study on the healing of an 
endoscopic sphincterotomy in a canine 
model, we found that within 24 hours an 
appreciable inflammatory response sur­
rounded the incision. Healing progress­
ed rapidly, however, so that after 10 
weeks the incision was lined by mature 
mucosal epithelium without evidence of 
ongoing inflammation. We could find no 
evidence to suggest that an endoscopic 
sphincterotomy is predisposed to late 
stenosis.
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Blunt Splenic Trauma: Diagnosis and Management
■*
* *
- i
To examine the morbidity and mortality 
associated with blunt splenic injuries, the 
authors reviewed the results in 106 such 
patients treated in the Sunnybrook 
Regional Trauma Unit between June 1, 
1976 and June 30, 1983.
Initial assessment included peritoneal 
lavage in 86 patients. No patient with 
known or suspected splenic injury was 
treated nonoperatively nor were any pa­
tients found to have had splenic injuries 
missed at the initial assessment. 
Seventy-one splenectomies and 35 
splenorrhaphies were performed. The 
overall mortality was 25% and 10 sur­
viving patients had serious complica­
tions. The splenic injury itself was never 
the cause of death. Only one patient 
who initially underwent splenorrhaphy 
later required splenectomy.
It is concluded that blunt splenic injury 
is rarely the cause of death or serious 
morbidity when a policy of immediate 
diagnosis and operative treatment is 
carried out. Furthermore, in selected 
patients, splenorrhaphy is a safe and 
effective treatment.
Dans le but d'evaluer la morbidity et la 
mortality rattachees aux traumatismes 
fermes de la rate, les auteurs passent en 
revue les rgsultats obtenus chez 106 
patients victimes de telles blessures qui 
ont ete traites au Sunnybrook Regional 
Trauma Unit entre le 1er juin 1976 et le 
30 juin 1983.
Chez 86 patients, I'examen initial com- 
prenait un lavage peritoneal. Aucun 
patient ayant un traumatisme splenique 
diagnostique ou soupconne n'a ete traite 
de fagon non chirurgicale; de meme
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aucun patient chez qui on a confirme 
une lesion de la rate n'a echapp£ a I'exa­
men initial. Soixante-et-onze splenecto­
mies et 35 splenorraphies ont ete prati- 
quees, Le taux de mortaiite globale a 
ete de 25% et 10 survivants ont eu 
des complications serieuses. En soi, le 
traumatisme splenique n'a jamais ete la 
cause du deces. Des patients qui ont 
subi une spienorraphie, un seul a par la 
suite necessite une spienectomie.
On conclut qu'un traumatisme splenique 
ferme est rarement mortel ou la cause 
d'une morbidite serieuse quand on 
recourt systematiquement a un diagnos­
tic immediat et a la chirurgie. De plus, 
chez des patients choisis, la spienorra­
phie s'avdre un traitement sur et 
efficace.
The management of splenic injury in 
adults continues to be controversial. The 
methods of diagnosis, treatment and con­
sequences of splenectomy have not yet 
been fully agreed upon. Splenic rupture 
can be spontaneous or caused by pene­
trating, blunt or operative trauma.
At the Sunnybrook Regional Trauma 
Unit all adult patients with splenic injury 
due to blunt trauma have been managed 
uniformly and this paper reviews the 
results of their management.
Patients and Methods
Only patients aged 16 years and older 
with splenic injuries caused by blunt 
trauma were included. Excluded were all 
patients with penetrating trauma, those 
initially operated upon elsewhere and 
transferred to Sunnybrook Medical Cen­
tre for postoperative care and all patients 
who died in the Emergency Department 
and were found at autopsy to have splenic 
trauma.
Of 1378 patients admitted to the 
Regional Trauma Unit at Sunnybrook 
Medical Centre between June 1, 1976 and 
June 30, 1983, 136 had splenic injuries. 
In 106 patients the splenic injury was due 
to blunt trauma and they were cared for 
entirely at Sunnybrook Medical Centre; 
22 were operated upon elsewhere, 7 died
before receiving definitive care and 1 suf- 
fered penetrating splenic trauma. The 106 
patients are the subject of this report. 
There were 29 women and 77 men and ,  
they were predominantly young (Fig. 1).
When the trauma unit is notified that-t -* 
a patient is being transported to Sun­
nybrook, residents of the appropriate ser- ’• 
vices are called to the trauma room in the 
Emergency Department. They include a 
trauma team leader and residents in . 
general surgery, anesthesia, orthopedics 
and neurosurgery. As soon as the patient« v 
arrives, resuscitation and evaluation are 
carried out. Indications for operation for F 
an intra-abdominal injury may be clear.
If not, or if the abdomen cannot be 
evaluated because of coma, alcoholic in­
toxication or spinal cord injury, open 
peritoneal lavage is carried out in 
the trauma room. If the lavage fluid is 
grossly bloody or if its erythrocyte < 
count is greater than 0.02 x 1012/L  
(20 000/mm3), its leukocyte count more 4 
than 0.5 x 109/L  or its amylase level is 
more than 1750 U/L, laparotomy is done. •' s 
Until Jan. 1, 1979, all splenic injuries 
were managed by splenectomy. Since '* 1 
then, splenorrhaphy has been performed 
if possible. Antibiotics are not given ’ 
prophylactically. ^
An abbreviated injury severity score 
(1980 version) was calculated for each pa- < - 
tient according to the rules of the 
American Association for Automotive < 
Medicine.1 This system of scoring was 
introduced in 1974 by the Maryland In- * * 
stitute for Emergency Medicine.2 Each 
organ system injured is assigned a number 
from 1 (minor injury) to 5 (critical in- „ - 
jury). The overall injury severity score is 
the sum of the squares of the individual < 
organ system scores.
330 VOLUME 27, NO. 4, JU LY 1984 /  THE CANADIAN JOURNAL OF SURGERY
Statistical comparisons of injuries sus­
tained by surviving patients and nonsur- 
viving patients were carried out, using the 
X2 test in a 2 x 2 contingency table. 
► Comparisons of injury severity scores 
were carried out with an unpaired /-test.
^ ^Results were considered significant if p 
. was less than 0.05.
 ^Findings
► Motor vehicle accidents accounted for 
91 % of the injuries in the 106 patients and 
K the remainder were primarily due to falls.
A positive result from peritoneal lavage 
k was the main indication for laparotomy 
in 82% of the patients. Ten percent, 
however, had obvious intra-abdominal 
r injury — usually indicated by a ruptured 
hemidiaphragm on chest roentgenogram. 
r' fThe others underwent surgery on the basis 
of a clinical diagnosis of intra-abdominal 
injury. In 102 of the 106 patients, other 
injuries were present (Tables I and II).
’ 1 Surviving patients had an average of 2.3 
 ^while nonsurviving patients had an 
average of 2.9 other organ systems in- 
j, *jured (Fig. 2). The severe nature of these 
injuries is reflected in the distribution of 
A injury severity scores (Figs. 3 and 4).
All patients with evidence of, or with 
a possibility of, intra-abdominal injury 
were operated upon immediately. No pa- 
tient with negative findings on peritoneal 
lavage or thought clinically to have no 
intra-abdominal injury had signs or 
..symptoms suggestive of splenic injury 
subsequently. Seventy-one patients under- 
► went splenectomy and 35 splenorrhaphy 
(Table III).
->■ No splenorrhaphies were performed 
before Jan. 1, 1979. Since then, this form 
‘ of management has become increasingly 
popular (Fig. 5). Complications of the in­
juries and their management have been
surprisingly few. In 10 patients (13% of 
survivors) there were 12 complications. 
These included subphrenic abscess, pan­
creatic injury, pulmonary embolism and 
upper gastrointestinal bleeding. All but 
one had had a splenectomy. The mean ( ± 
SEM) injury severity score for those pa­
tients who had complications was 38.6 ± 
11.0. Seventy-nine of the 106 patients sur­
vived their injuries and were discharged 
from hospital. The mean injury severity 
score of the 79 survivors was 34.5 ± 11.3 
and of the 27 nonsurvivors 52.4 ± 10.4 
(Table IV and Fig. 4). The mean injury 
severity score of all survivors was
FIG. 2—Number of organ systems injured 
other than gastrointestinal tract. White bars = 
survivors, black bars = nonsurvivors.
T a b le  I l l - O p e r a t i v e  M a n a g e m e n t
P ro c e d u re N o . |% )
S p le n e c to m y 7 1  ( 6 7 )
P a r t ia l  s p le n e c to m y 0
S p le n ic  s u tu re 8 ( 8 )
H e m o s t a t ic  a g e n t 2 2 ( 2 1 )
N o n e 5 ( 5 )
T a b le  1-- A s s o c ia t e d  In ju r ie s
In ju ry
S u rv iv o rs ,  
n o . (% ) (n  -  7 9 )
N o n s u rv iv o rs ,  
n o . ( % )  (n  -  2 7 )
C e n t r a l n e rv o u s  s y s te m  o r s p in a l c o rd 3 3 ( 4 2 ) * 2 0  ( 7 4 )
F a c e 1 8 ( 2 3 ) * 3 ( 1 1 )
B lu n t  c h e s t 3 8  ( 4 8 ) 1 5 ( 5 6 )
O th e r  in t r a  a b d o m in a l 3 2  ( 4 1 ) * 2 0  ( 7 4 )
G e n ito u r in a r y 1 4 ( 1 8 ) 6 ( 2 2 )
M u lt ip le  s y s te m s 4 9 ( 6 2 ) 1 7  ( 6 3 )
‘ D if f e r e n c e  s ig n if ic a n t  as  d e te r m in e d  b y  x 2 t e s t  a t  th e  5 %  le v e l.
T a b le  I I — In tr a -a b d o m in a l In ju r ie s  A s s o c ia te d  w i t h  S p le n ic  T r a u m a
S u r v iv o r s , N o n s u rv iv o r s ,
In ju ry n o . ( % )  (n =  7 9 ) n o . ( % )  (n =  2 7 )
R u p tu re d  d ia p h r a g m 6 ( 8 ) 6 ( 2 2 )
L iv e r 2 2 ( 2 8 ) 1 4 ( 5 2 )
H o l lo w  v is c u s  ( in c lu d in g  s e ro s a l te a r s ) 1 4 ( 1 8 ) 4 ( 1 5 )
R e t r o p e r ito n e a l (e x c lu d in g  g e n ito u r in a ry ) 1 6 ( 2 0 ) 9 ( 3 3 )
significantly (p < 0.005) different from 
the score of those who died. Fifteen 
(56%) of the 27 nonsurvivors died of 
closed head injuries, 7 (26%) died of un­
controllable hemorrhage from severe 
hepatic injuries and retroperitoneal 
bleeding, 4 (15%) survived their prolong­
ed hypovolemic shock only to succumb 
to multiple organ system failure. One pa­
tient with multiple fractures and a flail 
chest died of pulmonary embolism.
D iscussion
The diagnosis and management of
FIG. 3—Splenectomy (white bars) or 
splenorrhaphy (shaded bars) and injury severity 
score.
FIG. 4—Survivors (white bars), nonsur­
vivors (black bars) and injury severity score.
FIG. 5—Splenectomy (white bars), splenor­
rhaphy (shaded bars) and date of admission.
VOLUME 27, NO. 4, JULY 1984 /  THE CANADIAN JOURNAL OF SURGERY 331
blunt splenic injury has undergone a 
marked change in the last 10 years. 
Diagnosis made on the basis of physical 
examination and clinical suggestion is dif­
ficult in patients with multiple injuries. 
Peritoneal lavage, when carried out 
through a mini-laparotomy incision, is a 
safe and rapid method of detecting the 
presence of intra-abdominal blood in the 
patient who has received blunt trauma. 
False-negative results are extremely rare 
and false-positive findings can be avoid­
ed by careful insertion of the catheter.3 
Peritoneal lavage provides a rapid method 
of determining the necessity for laparo­
tomy while the patient is still in the 
emergency department and eliminates the 
need for time-consuming radiologic or 
nuclear medical tests. We believe that the 
policy of observation of adult patients 
with possible splenic injuries is to be con­
demned. To wait for generalized peri­
tonitis or hypotension secondary to 
hypovolemia to develop is to invite 
complications.
Although the diagnosis of blunt splenic 
injury has been greatly simplified and ex­
pedited in the last 10 years, its manage­
ment has become more complex. Two 
factors account for this complexity. First, 
the Hospital for Sick Children in Toron­
to has amply demonstrated the efficacy 
of conservative management of splenic in­
juries in children.4 This has occasional­
ly been tried in adults, but no results have 
been published. Over 90% of the patients 
in this series had injuries to other organs, 
many of which required one or more 
operative procedures. In particular, 41%
c our surviving patients and 74% of 
those who died had other intra-abdominal 
injuries. In this group it would be difficult 
to select those with splenic injury as their 
only intra-abdominal injury. Further­
more, it would be hazardous to subject 
even patients with isolated splenic injury 
to prolonged anesthesia for orthopedic 
procedures, as it would be difficult to 
determine the cause of any hypotensive 
episodes. Thus, we believe that it is 
simpler and safer to treat all splenic in­
juries by immediate operation.
The second factor that has increased 
the complexity of treatment is the sugges­
tion that splenectomy can have adverse 
effects on host-defence mechanisms. 
Total splenectomy in childhood has 
definitely been shown to result in an in­
creased incidence of overwhelming sep­
ticemia leading to rapid death.5 In 
adults, however, it has been very difficult 
to prove that overwhelming postsplenec­
tomy sepsis even exists. One study in 
adults suggested an incidence of 
postsplenectomy sepsis of 2.2.% in 45 
months of follow-up of healthy adult pa­
tients who underwent splenectomy for a 
variety of reasons.6 A matched group of 
patients who underwent other operations
had no deaths due to sepsis in this period. 
Although this study suffers from the 
usual problems of a retrospective chart 
review, it does appear to indicate a small 
but definite risk associated with asplenia 
in the adult. The pathophysiology of this 
state has recently been reviewed.5 This 
has led to numerous attempts to salvage 
splenic tissue. Suggested methods have 
ranged from a nonoperative approach 
(already condemned) to operative salvage 
of the spleen to implantation of splenic 
tissue into the peritoneal cavity7 or por­
tal vein.8 The only form of splenic con­
servation we have experience with is a 
direct attack on the bleeding site. This in­
cludes partial splenectomy,9 splenic 
suture, splenic artery ligation,10 the ap­
plication of a hemostatic agent and no 
treatment (Table III). In our series, no 
partial splenectomies or splenic artery 
ligations were carried out. It is our belief 
that if the spleen has been so damaged 
that only a partial splenectomy can 
salvage a portion of it, it is better to pro­
ceed with total splenectomy to save time 
and reduce blood loss in these multiply 
injured patients. The splenic vessels pass 
out radially from the hilum of the spleen, 
dividing the spleen into several poorly 
defined segments.11 This anatomical ar­
rangement makes partial splenectomy 
technically possible. It also allows the 
spleen to be sutured by passing the sutures 
at right angles to the vessels. Of our 35 
patients who underwent splenorrhaphy, 
8 required sutures to control bleeding. 
However, we have not had success in at­
tempting to suture disrupted hilar vessels. 
Patients with this injury should undergo 
a total splenectomy. Most patients (22 of 
35) required simply the application of 
hemostatic agents (e.g., Avitene, Oxycel) 
and laparotomy sponges to the bleeding 
site to obtain hemostasis. Usually 5 to 10 
minutes of such packing is all that is re­
quired. Five patients had small capsular
tears which had stopped bleeding by the 
time the spleen could be observed at 
laparotomy. It is interesting that whereas 
most splenic injuries in childhood will 
stop bleeding spontaneously, in our adult * 
series, at least 30 of 35 did not. ^
Special mention should be made of one 
patient. At the time of operation, this pa- 4 
tient was in severe hypovolemic shock due 
to multiple injuries resulting from an -> 1 
automobile accident. The splenic injury 
was repaired with hemostatic materials * 
and sutured and other injuries were at­
tended to. Twelve hours later, the patient7 M 
was operated upon again because of con­
tinued intra-abdominal bleeding. At 
laparotomy, there was a blood clot about T 4 
the spleen, and a previously repaired blad­
der injury was actively bleeding. The 
spleen was removed and the bladder ■ 
repaired a second time. However, the pa-"* + 
tient died later the same day from irrever­
sible hypovolemic shock. This case il- 7 
lustrates the principle that hemodynami- A , 
cally unstable patients who require large * 
quantities of blood with the subsequent, * 
almost inevitable, coagulopathy are not 
candidates for splenic repair. * j.
A retrospective chart review is a poor 
method of determining complication * 
rates. Only complications noted in the 
chart are tabulated. Nevertheless, it is 
clear that the complication rate associated 
with the operative management of splenic 
injuries is reasonably low. Only 13% of „ 
our surviving patients had complications 
that could possibly be attributed to the v  ^
splenic injury. All but one had undergone 
total splenectomy. Two pancreatic fis- 4 
tulas were noted, at least one of which j 
was likely an iatrogenic injury. Six pa- 7 ■> 
tients had sepsis — one had a wound in- 1 
fection, four had intra-abdominal 7 
abscesses and one had severe pneumonia. j 
Patients who had abscesses had other j 
intra-abdominal injuries — usually liver ^ 
lacerations or bowel perforations — that
Table IV--Mean Injury Severity Scores
No. of Score,
Group patients mean ±  SEM
All survivors 79 34.5 +  11.3
Survivors with complications 10 38 .6  ±  11.0
Survivors without complications 68 33.8 +  11.1
Survivors with splenectomy 50 35 .8  +  11.4
Survivors with splenorrhaphy 28 32.1 +  11.0
Nonsurvivors 27 52.4 ±  10.4
Table V—Morbidity and Mortality in Patients 
_______________________ Who Underwent Splenectomy and Splenorrhaphy
Splenectomy Splenorrhaphy
Group___________________________________________ In = 71)_______________________ (n -  35)
Survivors 50 29
Survivors with complications 9 1
. u
u
332 VOLUME 27, NO. 4, JULY 1984 /  THE CANADIAN JOURNAL OF SURGERY
clearly contributed to the onset o f  sepsis. 
Four patients had miscellaneous com- 
plications — jaundice, pulmonary em­
bolism and stress upper gastrointestinal 
^ bleeding — that were at least partially a 
result o f the splenic injury and its treat- 
► kment. Most noteworthy is that the 35 pa­
tients who underwent splenorrhaphy had 
^ only one complication associated with this 
treatment (stress gastrointestinal bleed- 
r ing). On the other hand, patients treated 
 ^by splenorrhaphy had less severe injuries 
than those who required splenectomy, 
.although the difference in injury severity 
score was not substantial.
*- O f the 106 patients operated upon at 
Sunnybrook Medical Centre, 27 died — 
'  r a mortality o f 25%. This contrasts with 
a mortality o f 18.6% in a large series o f 
* patients at the University o f Texas.12 
v fOur slightly higher mortality likely 
reflects the fact that 85% o f  our trauma 
► patients are referred from other centres 
and hence tend to have more serious in- 
I* * juries. As might be expected, most o f our 
patients who died had severe head injuries 
k (56%). Uncontrollable hemorrhage and 
 ^ ^prolonged shock accounted for only 11 
i deaths. In the large Texas series, shock 
k was the commonest cause o f death.
Again, we believe that the difference is 
due to the contrasting patient popula­
tions. Our mortality could only be im­
proved by the more rapid transportation 
o f critically injured patients to well- 
equipped and well-staffed emergency 
departments.
In Table V, we compare morbidity and 
mortality o f patients who underwent 
splenectomy or splenorrhaphy. However, 
as noted above, this does not indicate that 
splenorrhaphy is a safer operation than 
splenectomy; rather, patients treated by 
splenorrhaphy tended to be less severely 
injured than those treated by 
splenectomy.
Conclusions
Splenic injuries due to blunt trauma 
can now be diagnosed and treated in a 
prompt and straightforward fashion. 
Splenorrhaphy is a safe and effective 
form o f treatment in the stable patient 
with an easily repairable splenic injury.
Our thanks to Miss Lilli Boctor for assisting 
in the chart review and Miss Malca Kates for 
typing the manuscript.
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Value of High-Resolution Computerized Tomography in 
Localizing Diseased Parathyroid Glands
Eighteen patients w ith  hyperpara­
thyro id ism  underw ent high-resolution 
computerized tom ography o f the neck 
and superior m ediastinum  to  assess the 
accuracy o f the m ethod in localizing 
diseased parathyroid glands preoperative- 
ly. The tom ogram s were correlated w ith  
surgical and pathologica l find ings. Four 
scans were technica lly  unsatisfactory. Of 
the remaining 14 scans, 8 showed an 
enlarged parathyroid gland; in 7 cases, 
the scan correctly  identified  the location 
o f the diseased gland w h ile  in 1 case, 
the side o f the lesion was incorrect. The 
other six scans did not show  an abnor­
mal parathyroid. These glands varied in 
size from  0 .0 5  to  5 .0  cm 3 at the tim e of 
pathological exam ination. Three patients 
were undergoing re-exploration fo r per­
s istent disease; technica lly acceptable 
scans w ere obtained in tw o  and, in both, 
the location o f the adenoma was correct­
ly identified. Excluding patients w ith  
technically unsa tis facto ry scans, th is 
technique has a sens itiv ity  o f 50%
(7/14) and a fa lse-negative rate o f 43%  
(6/14) independent o f gland size. 
However, in the e ight scans interpreted 
as positive, the correct side o f the lesion 
was localized in 7 (88% ).
This technique is not recommended for 
routine preoperative localization but may 
be o f value in re-exploration fo r persis­
ten t disease.
D ix-huit pa tients sou ffran t d ’hyperpa- 
rathyroi'die on t subi une tom odensitom 6- 
trie  a haute resolution du cou et du 
mediastin superieur afin d 'eva luer la pre-
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cision de ce tte  methode quand il s 'ag it 
de localiser des parathyroides pathologi- 
ques en preoperatoire. Les tomogrammes 
on t 6t6 mis en parall&le avec les consta- 
ta tions chirurgicales et les resultats de 
pathologic. Quatre scintigraphies etaient 
techniquem ent insatisfaisantes. Sur les 
14 autres tom ographies, 8 revelaient des 
parathyroides h yp e rtro p h ie s ; dans 7 
cas, la scintigraphie iden tifia it correcte- 
m ent la localisation de la glande malade 
alors que dans le dernier cas, le cote de 
la is io n  e ta it erronee. Les six autres 
tom ographies n ’ont revele aucune 
parathyroide anormale. La taille de ces 
glandes varia it de 0 .0 5  e 5 .0  cm 3 au 
m om ent de I'exam en pathologique. Trois 
patients subissaient une seconde in ter­
vention explorato ire pour la persistance 
de la maladie; une tom ographie techni­
quement acceptable a ete obtenue dans 
deux cas perm ettan t les deux fo is de 
localiser correctem ent I'adenome. Si I'on 
exclu t les patients don t la scintigraphie a 
ete techniquem ent insatisfaisante, la sen­
s ib ility  de la technique a ete de 50%  
(7 /14) et le taux de faux n£gatifs de 
43 %  (6/14), independam ment de la taille 
de la glande. Toute fo is , sur les huit 
tom ographies positives, le cote patholo­
gique a et6 localise correctem ent 7 fois 
( 88 % ) .
Cette technique n 'es t pas recomman- 
dee comme m oyen systematique de loca­
lisation prgoperatoire. Elle peut toutefo is 
etre u tile  lo rsqu 'il s 'ag it de rgevaluer une 
maladie persistante.
Once considered rare, primary hyper­
parathyroidism is now being diagnosed 
more frequently and at an earlier stage. 
The widespread availability of the 
multichannel autoanalyser for routine 
determination of serum calcium concen­
tration and highly sensitive assays for 
parathyroid hormone facilitate diagnosis 
and treatment. Surgery for primary 
hyperparathyroidism, especially when 
performed infrequently, can be difficult 
because the parathyroid glands are small 
and their location is variable. Numerous 
preoperative localization techniques have
been tried in an effort to aid the surgeon "" 
at the time of exploration.
The purpose of this study was to assess 
the accuracy and value of computerized ,  
tomography of the neck and medias­
tinum, using a high-resolution techniques •> 
for preoperative localization of diseased 
parathyroid glands. *
Materials and Methods
4
Eight men and 10 women (age range 
from 19 to 75 years, mean 55 years) with* *• 
hyperparathyroidism were studied in a 
consecutive, prospective manner. The A 
diagnosis was primary hyperparathyroid­
ism in 17 patients and tertiary hyper­
parathyroidism in 1 patient. Fifteen pa­
tients underwent primary neck explora- H 
tion and 3 patients had reoperation for ^ 
persistent disease following neck explora­
tion elsewhere. All had abnormally/ / 
elevated serum calcium and plasma ! 
parathormone levels preoperatively. 4
Our surgical technique and philosophy i 
have been described in detail previously.1 y ' 
Both sides of the neck are carefully ex­
plored and an attempt is made to iden- " 
tify all parathyroid glands. All normal-^ 
appearing glands are biopsied for 
histologic confirmation and all grossly 
abnormal-appearing glands are excised.
Computerized tomography was per-* v 
formed immediately preoperatively at the j! 
Montreal Neurological Institute by a *  
high-resolution technique used to in­
vestigate carotid and cerebral abnor* ^  
malities. This technique employs high v 
voltage (140 kV) and a high-resolution 
comb that produces an enlarged image. < , 
The patients were scanned from the hyoid j 
bone to the superior mediastinum every -< i 
13 mm. Scan interpretations were based j 
upon a final retrospective, but blinded,'' - 
reading by a skilled tomographer. All 
findings were correlated with the intra- * 
operative findings and the final patho- y 
logical description of the gland, including 
gross size, weight and histologic findings. f
Results f M
In four patients the scans were un- f  
satisfactory for interpretation; in three the ;
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presence of surgical clips created artefacts 
and in one the scan was technically poor. 
^  In the remaining 14 patients, an abnor­
mality was identified in eight scans, but 
^ no abnormality was seen in six.
In the eight patients whose scan show- 
t  Fed an abnormality, the scanning tech­
nique correctly identified the location of 
► the diseased gland in seven. All of these 
patients had single adenomas, which were 
► more than twice normal gland size (Figs. 
1 and 2). In the one patient in whom 
tomography incorrectly identified a 
^ .diseased gland, the scan unequivocally 
suggested a right-sided lesion instead of 
F the left-sided adenom a found at 
operation.
1 > In six patients, the scan failed to iden­
tify any enlarged abnormal parathyroid 
 ^ tissue. Of these, four patients had single 
^adenomas while two had multigland 
^hyperplasia (Fig. 3).
Three patients underwent reoperation 
for persistent hypercalcemia following 
* k. neck exploration at other institutions. AH 
were found to have parathyroid adeno- 
► mas in the superior mediastinum. In one 
the scan was technically unacceptable. In 
A Athe two others the lesion was correctly 
k identified by computerized tomography 
(Fig. 4).
In patients whose scan was positive, the 
glands ranged in size from 0.1 to 3.0 
cm3. In the six patients with a negative 
scan, the abnormal parathyroid glands 
*- were of similar size, ranging from normal 
to grossly enlarged (Table I).
v Discussion
^ ” Many techniques have been described 
for preoperative identification and 
[ v localization o f diseased parathyroid 
^glands. Radionuclide scanning with 
selenomethionine has been advocated.2 
y. This modality has not become popular 
because the false-positive rate is greater 
~  r than 50%. Cine-esophagography has a 
reported accuracy of only 25%3 and is 
► reliably positive only if the abnormal 
gland is located adjacent to the esophagus 
V *and is associated with markedly elevated 
 ^ levels o f serum calcium and plasma 
parathyroid hormone. Thyroid lympho- 
y , graphy, originally described by Kato and 
associates,4 has been reported to be 
r- highly accurate but only in a small series 
of four patients. Thermography, with an 
> ►accuracy of less than 40%,5 cannot 
| detect mediastinal glands or identify the 
r exact number of diseased glands. Arteri­
ography provides accurate localization in 
3 50% to 77% o f cases.6,7 However, this 
, technique carries serious risks of arterial 
occlusion and neurologic sequelae.
A 4 Venous catheterization with serial 
i sampling for parathyroid hormone levels 
* can be sensitive and accurate in experi­
enced hands. Arteriography with demon­
stration o f the venous phase should be 
carried out before the venous sampling 
for accurate localization and interpre­
tation.8 The patients are therefore sub­
jected to the described risks of arterio­
graphy as well. The combined procedure 
has an accuracy o f greater than 90% in 
some series but requires considerable time
FIG. 1—Computerized tomogram of neck 
in 53-year-old man with primary hyper­
parathyroidism demonstrates large, well- 
defined, rounded mass (arrow) 1.5 cm in 
diameter to left of esophagus, indenting left 
posterolateral wall of trachea at T l.
FIG. 3—Five hyperplastic glands found at 
operation on 60-year-old woman with primary 
hyperparathyroidism. Computerized 
tomogram had failed to demonstrate any ab­
normality despite several grossly enlarged 
glands.
FIG. 2—Same patient as in Fig. 1. Large 
adenoma was found in superior pole of left 
lobe of thymus at operation.
FIG. 4—Computerized tomogram of 
mediastinum in 53-year-old woman with per­
sistent primary hyperparathyroidism following 
neck exploration reveals lesion above arch of 
aorta, 2 cm anterior to trachea. Parathyroid 
adenoma was identified at operation at this 
location.
Table 1 -P a t ie n t  D ata
Scan
Patient
no. Diagnosis
Gland
volum e, cm 3
Positive (n =  81 i A 0 .1
2 A 0 .5
3 A 1 .2
4 A 1 .3
5 A 1 .5
6 A 2 .0
7 A 3 .0
8 A 3 .0
N egative In =  6) 9 H -
10 H 0 . 0 5 - 0 . 1 3
11 A 1 .5
12 A 1 .5
13 A 1 .8
14 A 5 .0
U nsatis factory 15 A 0 .6
In =  4) 16 A 1 .0
17 A 3 .0
18 A -
A -  single adenoma, H -  hyperplasia.
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and expertise. It is generally reserved for 
complicated cases when the patient must 
undergo re-exploration. Ultrasonography, 
using sensitive, small probes, has an ac­
curacy of greater than 70% when the 
glands are more than 1 cm in diameter or 
weigh more than 1 g.9
In the present study, 18 consecutive pa­
tients underwent preoperative com ­
puterized tomography of the neck and 
mediastinum using a sensitive high- 
resolution technique. In four (22%) pa­
tients, the scans were unacceptable. In the 
remaining 14, scanning resulted in correct 
localization o f the site o f diseased glands 
in 7 for a true-positive ratio or sensitivi­
ty o f 50% (7 o f 14). There was a false­
positive result in 7% (1 of 14). The false­
negative rate was 43% (6 o f 14). Despite 
the poor sensitivity and a high rate of 
negative scans associated with this tech­
nique, it is noteworthy that when an ab­
normality was detected (eight patients) it 
was correct in 88% (seven). Moreover, 
when the abnormal parathyroid gland 
was located in the mediastinum (three pa­
tients), the high-resolution technique cor­
rectly localized the abnormality in both 
patients in whom an acceptable scan was 
obtained. The low density o f mediastinal 
fat may render enlarged parathyroid 
glands more visible in this location.
Similar results have been reported in a 
small series by Doppman and colleagues.10
Many factors may be responsible for 
the high number of negative neck scans. 
As can be seen in Table I, both greatly 
and minimally enlarged glands were miss­
ed. Therefore, size alone is not critical for 
detection by this technique. The slice 
thickness of 13 mm may play a role. The 
close proximity of a major artery and 
veins with their branches viewed in cross- 
section and the proximity to the thyroid 
gland with similar density and frequent 
irregular outline may present further 
difficulties.
In patients with hyperparathyroidism, 
surgery is successful in over 90% of cases 
if performed by a competent, experienced 
surgeon. Invasive, costly and potentially 
hazardous procedures are not required 
preoperatively. All noninvasive pro­
cedures described to date have poor sen­
sitivity, including computerized tomo­
graphy, despite the use of a high-resolu- 
tion technique as described here. Com­
puterized tomography o f the neck and 
mediastinum therefore appears to be of 
limited value for routine preoperative 
localization of diseased parathyroid 
glands. The need for reader expertise, the 
high cost and exposure to radiation are 
all factors to be considered, in addition
to the low yield independent of gland size. 
However, this technique may be valuable 
in those patients who undergo re-explo­
ration for persistent disease, particularly 
if it is located in the mediastinum.
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prescribed and administered with the same degree of caution appropriate 
to the use of other oral medication containing narcotics.
Usage in ambulatory patients: Oxycodone may impair the mental and/or 
physical abilities required for the performance of potentially hazardous 
tasks such as driving a car or operating machinery. The patient using 
PERC0CET should be cautioned accordingly.
Interaction with other central nervous system depressants: Patients 
receiving other narcotic analgesics, general anesthetics, monoamine 
oxidase inhibitors, tricyclic antidepressants, phenothiazines, other 
tranquilizers, sedative-hypnotics or other CNS depressants (including 
alcohol), concomitantly with PERC0CET may exhibit an additive CNS 
depression. When such combined therapy is contemplated, the dose of 
one or both agents should be reduced.
Usage in pregnancy: Safe use in pregnancy has not been established 
relative to possible adverse effects on fetal development. Therefore, 
PERC0CET should not be used in pregnant women unless, in the 
judgment of the physician, the potential benefits outweigh the possible 
hazards. The administration of PERC0CET to obstetrical patients in labour 
may be associated w ith respiratory depression of the newborn.
Usage in children: The more potent formula, PERC0CET, should not be 
administered to infants or children. However, PERC0CET-DEMI, containing 
half the amount of oxycodone, can be considered for children of six years 
or older.
PRECAUTIONS: Head injury and increased intracranial pressure: The 
respiratory depressant effects of narcotics and their capacity to elevate 
cerebrospinal fluid pressure may be markedly exaggerated in the 
presence of head injury, other intracranial lesions or a pre-existing 
elevated intracranial pressure. Furthermore, narcotics may produce 
adverse reactions which can obscure the clinical course of patients with 
head injuries.
Acute abdominal conditions: The administration of PERC0CET or other 
narcotics may obscure the diagnosis or clinical course in patients with 
acute abdominal conditions.
Special risk patients: PERC0CET should be given with caution to certain
patients such as the elderly or debilitated, because of the danger of 
cardiac or respiratory depression, as well as to those patients with 
hemorrhage, severe impairment of hepatic, respiratory or renal function, 
hypothyroidism, Addisons' disease, prostatic hypertrophy or urethral 
stricture.
Headache: Because headache often involves a significant psychological 
component, a narcotic analgesic should only be employed for the 
treatment of headache when no other treatment is effective, in order to 
minimize the risk of psychological and physical dependence.
Drug interactions: The CNS depressant effects of PERC0CET may be 
additive with those of other CNS depressants. See WARNINGS.
Other: Patients should be instructed to store PERC0CET, as for any 
medication, safely out of the reach of children. >
ADVERSE REACTIONS: The most frequently observed adverse reactions 
include light-headedness, dizziness, sedation, nausea and vomiting. 
These effects seen* to be more prominent in ambulatory than in non­
ambulatory patients, and some of these adverse reactions may be 
alleviated if the patient lies down.
Other adverse reactions include euphoria, dysphoria, constipation and 
pruritus.
SYMPTOMS AND TREATMENT OF 0VER00SAGE: Signs and symptoms: 
Serious overdosage with PERC0CET is characterized by respiratory 
depression (a decrease in respiratory rate and/or tidal volume. Cheyne- 
Stokes respiration, cyanosis), extreme somnolence progressing to stupor 
or coma, skeletal muscle flaccidity, cold and clammy skin, and 
sometimes bradycardia and hypotension. In severe overdosage, apnea, 
circulatory collapse, cardiac arrest and death may occur. The ingestion 
of very large amounts of PERC0CET may, in addition, result in acute 
acetaminophen intoxication, characterized by anorexia, nausea, vomiting 
and sweating within two or three hours of ingestion, and possibly cyanosis 
with methemoglobinemia. Within 48 hours, liver function tests rise 
abnormally, and the liver becomes enlarged and tender. Within three to 
five days jaundice, coagulation defects, myocardiopathy, encephalopathy, 
and renal failure occur, followed by death due to hepatic necrosis. The 
ingestion of 10 g of acetaminophen is considered to result in intoxication, 
with the possibility of a fatal outcome if the amount exceeds 15 g. 
Hepatotoxicity occurs when plasma levels of 300 jig/m l are observed 
within four hours of ingestion.
Treatment: Primary attention should be given to the re-establishment of 
adequate respiratory exchange through provision of a patent airway and 
the institution of assisted or controlled ventilation. The narcotic antagonist 
naloxone is a specific antidote against the respiratory depression which 
may result from overdosage or unusual sensitivity to narcotics, including
- i
oxycodone. Therefore, an appropriate dose of this antagonist should be 
administered, preferably by the intravenous route, simultaneously w jttK  
efforts at respiratory resuscitation. Since the duration of action of 
oxycodone may exceed that of the antagonist, the patient should be kept 
under continued surveillance and repeated doses of the antagonist shoatd * 
be administered as needed to maintain adequate respiration. The 
instructions contained in the package insert provided by the manufacturer. 
should be carefully observed.
An antagonist should not be administered in the absence of clinically 
significant respiratory or cardiovascular depression.
Oxygen, intravenous fluids, vasopressors and other supportive J 
measures should be employed as indicated. 1
Gastric emptying by emesis or lavage may be useful in removing v  
unabsorbed drug, and should be carried out at an early stage of 
treatment. Plasma levels of acetaminophen should be determined* If 
hemodialysis is carried out within ten hours of ingestion, it may be of 
some value. |
The drug PARV0LEX® (N-acetylcysteine, Allen & Hanburys) is a spe# fic*V 
antidote for acetaminophen intoxication. For directions for use, refer to 
the manufacturer's Product Monograph or the CPS. ^
DOSAGE AND ADMINISTRATION: Dosage should be adjusted according 
to the severity of the pain and the response of the patient. It may 
occasionally be necessary to exceed the usual dosage recommended 
below in cases of more severe pain or in those patients who have become 
tolerant to the analgesic effect of narcotics. The usual adult dose is one 
tablet every six hours as needed for pain.
DOSAGE FORMS: PERC0CET, supplied as white, scored tablets each 
containing oxycodone hydrochloride, 5.0 mg and acetominophen 325^ng.* 
in bottles of 100 and 500 tablets. Also available as PERC0CET-DEMI, 
containing half the amount of oxycodone, and with the same amount of 
acetaminophen, in bottles of 100 tablets.
Precaution: This product has the 
potential for being abused.______
Full product monograph available on request
Du Pont Pharmaceuticals
Mississauga,
Ontario L5M 2J4 <w o i m
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Acetaminophen +
Oxycodone
One tablet usually relieves pain w ithin 15 minutes
And pain stays away for up to 6 hours 
With less risk of constipation than codeine 
Or gastrointestinal disorders like ASA
Du Pont P h arm aceu tica ls (\ D f l w T )
Mississauga, Ontario L5M 2J4 \ !U I Ul *T '
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sPIPRACIL piperacillinsodium
An Extended Spectrum of Activity
Pipracil is an effective advanced agent for 
gram negative, gram positive and 
anaerobic infections.
Pipracil (piperacillin sodium) is a major 
advance in presumptive antibiotic therapy. 
The bactericidal spectrum of Pipracil is 
broader than other antibiotics, such as the 
aminoglycosides, cephalosporins, penicillins 
and clindamycin. Yet Pipracil has an excel­
lent clinical safety profile, with a low sodium 
content and with no reported nephrotoxicity, 
ototoxicity or pseudomembranous colitis.
In addition, Pipracil achieves excellent 
concentrations in body tissues and fluids.
By providing a high degree of efficacy
in a wide range of mixed infections, Pipracil 
is a logical therapeutic alternative for pre­
sumptive therapy in surgery, urology and 
gynecology, including patients with 
impaired host defences.
| ) |  A /^ *¥ ¥  The Spectrum of a
■ I ■  l i / l l .  >11 v Combination in 
One Advanced Agent
Cyanamid Canada Inc. 
Toronto PAAB
[ . M A C | CCPP•Pipracil is a trade mark of Ledcrle Piperacillin, Inc.
PIPRACIL
efacillin sodium
tertbAntibiotic for Intravenous and Intramuscular Use
*TI0N$ AND CLINICAL USES: Treatment of serious infections caused by susceptible strains of the designated 
•Isms in the conditions listed below.
fra-Abdominal Infections including hepatobiliary and surgical infections caused by Escherichia coli. Pseudo- 
s aeruginosa, enterococci. Clostridium sp„ anaerobic cocci, and Bacteroides sp., including B. fragilis.
Uruary Tract Infections (complicated and uncomplicated) caused by Escherichia coli, Klebsiella sp., Pseudomonas 
lirrcsa, Proteus mirabilis and enterococci. Also uncomplicated urethritis caused by Neisseria gonorrhoeae. 
Gynecological Infections including endometritis and pelvic inflammatory disease caused by Bacteroides sp.,
JingB. fragilis, anaerobic cocci, Neisseria gonorrhoeae, and enterococci (Streptococcus faecalis).
Septicemia caused by Escherichia coli, Klebsiella sp., Serratia sp., Proteus mirabilis, S. pneumoniae, enterococci, 
jomonas aeruginosa, Bacteroides sp., and anaerobic cocci.
Lowgr Respiratory Tract Infections caused by Escherichia coli, Klebsiella sp., Enterobacter sp., Pseudomonas 
jinosa, Serratia sp., Haemophilus influenzae, Bacteroides species and anaerobic cocci. Although improvement 
leen noted in patients with cystic fibrosis, lasting bacterial eradication may not be achieved.
^ n  a ad Skin Structure Infections caused by Escherichia coli, Klebsiella sp., Serratia sp., Acinetobacter sp, 
jbacter sp., Pseudomonas aeruginosa, indole-positive Proteus sp., Proteus mirabilis, Bacteroides sp., including 
igilis, anaerobic cocci and enterococci.
Bo#s and Joint Infections caused by Pseudomonas aeruginosa, enterococci, Bacteroides sp.. and anaerobic cocci. 
PIPRACIL* is useful for the treatment of mixed infections and presumptive therapy prior to the identification 
causative organisms; infections produced by organisms resistant to other penicillins, some aminoglycosides 
leptaiosporins; and infections at various sites caused by streptococcus species including Group A beta-hemo- 
Streptococcus and Streptococcus pneumoniae.
PIPRACIL* may be administered as single drug therapy in some situations where normally two antibiotics 
t bffemployed. In vitro synergism has been shown between Piperacillin and some aminoglycosides in some 
jrial strains. PIPRACIL* has been used clinically with aminoglycosides, especially in patients with impaired host 
ices. Both drugs were used in full therapeutic closes.
PfPRfiCIL* can be used safely in combination with a penicillinase-resistant penicillin, e.g. oxacillin, in mixed 
tions when beta-lactamase-positive Staphyloccus aureus is isolated along with piperacillin-susceptible 
niqpis. It may be administered concomitantly with a cephalosporin, provided that an additive or synergistic 
acterial action of the two antibiotics is ascertained through in vitro tests. Based on in vitro data, cefoxitin should 
le given with piperacillin when Pseudomonas infections are suspected or confirmed.
I^eciiiise PIPRACIL* is excreted not only renally, but also by the biliary route, it can be used in patients with 
tobiliary infections, or severely restricted kidney function, and in patients who have had nephrotoxic reactions 
her drugs, with appropriate adjustment of dosage (See DOSAGE).
Api&opriate cultures should be made for susceptibility testing before initiating therapy and therapy adjusted, 
propriate, once the results are known.
RAINDICATIONS: A history of allergic reactions to any of the penicillins and/or cephalosporins, 
ttftssfSerious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients 
lying therapy with pencillins. These reactions are more apt to occur in persons with a history of sensitivity to 
iple allergens.
Cross-sensitivity of patients to penicillins and cephalosporins has been reported. Before initiating therapy with 
ACILT careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalospo- 
and other allergens.
If an allergic reaction occurs, the antibiotic should be discontinued.
SERIOUS ANAPHYLACTOID REACTIONS REQUIRE IMMEDIATE EMERGENCY TREATMENT WITH EPINEPHRINE, 
i p i *  INTRAVENOUS STEROIDS, AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINIS- 
*D AS NECESSARY.
IUTI0NS: Bleeding manifestations have occurred in some patients receiving beta-lactam antibiotics including 
iciliin. These reactions have sometimes been associated with abnormalities of coagulation tests such as 
lg time, platelet aggregation and prothrombin time and are more likely to occur in patients with renal failure, 
f bleeding manifestations or significant leukopenia occur. PIPRACIL* should be discontinued and appropriate 
bpy instituted.
The possibility of the emergence of resistant organisms and the development of superinfections should be 
in mind, particularly during prolonged treatment.
Aswith other penicillins, patients may experience neuromuscular excitability or convulsions if higher than 
mmended doses are given intravenously.
Dosage adjustment should be made in renal insufficiency.
PIPRACIL* is a monosodium compound containing 1.98 milliequivalents (45.5 mg) of Na+per gram based on 
;ontent which includes the U.S.P. allowed average. The calculated value, based on molecular weight is 1.85 
Jq (42 55 mg.). Periodic electrolyte determinations should be made in patients with low potassium reserves 
the possibility of hypokalemia should be kept in mind with patients who have potentially low potassium 
ves, receiving cytotoxic therapy or diuretics. Electrolyte and cardiac status should also be monitored during 
ngecMreatment in patients with impaired cardiac function.
Prior to treatment, patients with gonorrhea should also be evaluated for syphilis. Specimens for darkfield 
| ination should be obtained from patients with any suspected primary lesions, and serologic tests should be 
irlired. In all cases where concomitant syphilis is suspected, monthly serological tests should be made for a 
mum of 4 months.
I The use of some penicillins (ampicillin, amoxicillin) has been associated with morbilliform rashes in some 
&  oPTnfectious mononucleosis. PIPRACIL* should be used with caution in the treatment of patients with infec- 
s mononucleosis.
Interactions:The mixing of PIPRACIL* with an aminoglycoside in vitro can result in substantial inactivation of the 
noglycosides.
je During Pregancy or Lactation: Safety of PIPRACIL* use in pregnant women has not been determined. Because 
aal reproduction studies are not always predictive of human response, this drug should be used during pregnancy 
n f clrarly needed. It has been found to cross the placenta in rats. Caution should be exercised when PIPRACIL* 
Jministered to nursing mothers. It is excreted in low concentrations in milk. 
itr,ic Use: Dosages for children under the age of 12 have not been established.
ERSE REACTIONS: PIPRACIL* is generally well tolerated. The most common adverse reactions have been local in 
ire, following intravenous or intramuscular injection. The following adverse reactions may occur:
J-ocg! Reactions -  In clinical trials thrombophlebitis was noted in 3.8%of patients. Pain, erythema, and/or indura- 
fat the injection site in 1.9% of patients. Less frequent reactions: ecchymosis, deep vein thrombosis and 
atomas.
Hypersensitivity Reactions-Rash was noted in 1.9% of patients. Drug fever 2.1%. Less frequent findings: pruitis, 
icuiar eruptions, positive Coombs tests.
Gastrointestinal -  Diarrhea and loose stools were noted in 2.8% of patients. Less frequent reactions: vomiting, 
•fca, tftoody diarrhea.
| Hepatic -  Increases in liver enzymes (LDH, SGOT, SGPT), hyperbilirubinemia. Rarely, cholestatic hepatitis.
I Penal-Elevations of creatinine or BUN.
Central Nervous System -  Headache, dizziness, fatigue.
Hemic and Lymphatic-Reversible leukopenia, neutropenia, thrombocytopenia and/or eosinophilia, bleeding and 
teases in prothrombin time have been reported. Reversible leukopenia (neutropenia) is more apt to occur in 
fcntsVeceiving prolonged therapy at high dosages or in association with drugs known to cause this reaction. 
Serum Electrolytes -  Individuals with liver disease or individuals receiving cytotoxic therapy or diuretics, were 
irteArarely to demonstrate a decrease in serum potassium concentrations with high doses of PIPRACIL* 
Musculo-Skeletal- Rarely, prolonged muscle relaxation. 
l Other-Superinfection, including candidiasis.
bGt ,$D ADMINISTRATION: PIPRACIL* may be administered by the intramuscular route or intravenously by injec­
tor infusion. Dosage and route of administration should be determined by the severity of the infection and 
iJition of the patient. The usual dosage for serious infections is 3 to 4 grams given every 4 to 6 hours as a 20 to 30 
kittt infusion administered intravenously.
rThe maximum daily dose usually administered to adults is 24 g/day, although higher doses have been used.
Usual Total Frequency of
Type of Infection Daily Dosage Administration
Serious infections such as septicemia, nosocomial pneumonia, intra- 12-18 gl.V. Every 4 to
abdominal infections, aerobic and anaerobic gynecologic infections, (200-300 mg/kg) 6 hours
and skin soft-tissue infections.
Every 6 to 
8 hours
Complicated urinary tract infections. 8-16 gl.V. 
(125-200 mg/kg)
Uncomplicated urinary tract infections and most community-acquired 6-8 g I.M. orl.V. Every 6 to
pneumonia. (100-125 mg/kg) 12 hours
Uncomplicated gonococcal urethritis. 2 g I.M* Single dose
*One gram of probenecid given orally 1/2 hour prior to injection.
Dosage In Renal Impairment
Creatinine
Clearance
mL/min.
Urinary Tract
Infection
(uncomplicated)
Urinary Tract
Infection
(complicated)
Serious Systemic 
Infection
>40 No dosage adjustment necessary
20-40 No dosage adjustment necessary 9 g/day 3 g every 8 hrs. 12 g/day 4 g every 8 hrs.
<20 6 g/day 3 g every 12 hrs. 6 g/day 3 g every 12hrs. 8 g/day 4 g every 12 hrs.
Patients on 
Hemodialysis*
Hemodialysis removes 30-50% of piperacillin in 4 hours; 6 g/day 2 g every 8 hrs. 
1 g additional dose should be administered following each dialysis period.
For patients with renal failure and hepatic insufficiency, measurement of serum levels of PIPRACIL* will provide 
additional guidance for adjusting dosage.
Infants and Children -  Dosages in infants and children under 12 years of age have not been established.
The average duration of PIPRACIL* treatment is from 7 to 10 days, except for gynecologic infections, in which 
it is from 3 to 10 days; the duration should be guided by the patient’s clinical and bacteriological progress. For most 
acute infections, treatment should be continued for at least 48 to 72 hours after the patient becomes asympto­
matic. Therapy for Group A beta-hemolytic streptococcal infections should be maintained for at least 10 days to 
reduce the risk of rheumatic fever of glomerulonephritis.
ADMINISTRATION
Intramuscular: When indicated by clinical and bacteriological findings, intramuscular administration of 6 to 8 g. daily 
of PIPRACIL* in divided doses, may be utilized for initiation of therapy and this route may be considered for mainte­
nance therapy after clinical and bacteriologic improvement has been obtained with intravenous piperacillin sodium 
treatment. Administration should not exceed 2 g. per injection at any one site.This route has been used primarily in 
the treatment of patients with uncomplicated gonorrhea and urinary tract infections.
Adults and Children MoreThan 12 Years of Age: The reconstituted solution is given by deep intramuscular injection. The 
preferred site of injection is the upper outer quadrant of the buttock (i.e. gluteus maximus). Also may be given in the 
mid-lateral muscles of the thigh. The deltoid area should be used only if well developed, and then only with caution 
to avoid radial nerve injury. Intramuscular injection should not be made into the lower or mid-third of the upper arm. 
Intravenous: The intravenous route should be used in the treatment of serious infections.
Direct Intravenous (Bolus) Injection:The vials should be reconstituted with 5 mL of suitable diluent listed below 
and the resulting solution should be injected slowly over a period of 3 to 5 minutes to help avoid vein irritation.
Intravenous Infusion: A dilution of at least 15 mL per gram is recommended to reduce potential for vein irritation. 
The reconstituted and diluted solution may be administered by intermittent or continuous drip. Intermittent infusion 
should be administered over a period of about 30 minutes. During intermittent infusion it is desirable to discontinue 
the primary intravenous solution. Any unused portion must be discarded. For continuous infusion the solution may 
be administered over a longer period of time.
RECONSTITUTION
For Intramuscular Use: Solutions for Reconstitution: Sterile Water for Injection, or if required 
*Bacteriostatic Water for Injection,
**Lidocaine HC1 0.5 or 1% (without epinephrine)-For Intramuscular Use Only.
For Intravenous Use: Solutions for Reconstitution: Sterile Water for Injection, or if required,
‘ Bacteriostatic Water for Injection.
•Either parabens or benzyl alcohol.
**Lidocaine HC1 is contraindicated in patients with a known history of hypersensitivity to local anesthetics of 
the amide type.
RECONSTITUTION TABLE
Product
Size
VOLUME OF 
Diluent to be added
Approximate 
Available Volume
Approximate 
Average Concentration
Vials 2 g 4.0 mL 5.0 mL 1 g/2.5 mL
3 g 6.0 mL 7.5 mL 1 g/2.5 mL
4 g 7.8 mL 10.0 mL 1 g/2.5 mL
Infusion Bottles
3g 15 mL 17 mL
4g 20 mL 23 mL
Intravenous Admixtures:
Normal Saline (+KCL 40 mEq).
5% Dextrose/Water [D5W] (-H<CL 40 mEq).
5% Dextrose/Normal Saline [D5NS] (+KCL 40 mEq). 
Ringer’s Injection, U.S.P. (+KCL 40 mEq).
Lactated Ringer’s Injection, U.S.P. (+KCL 40 mEq).
The prepared solution may be further diluted to the desired volume with any of the solutions for intravenous 
infusion listed below.
The contents of the 3 and 4 g infusion bottles should be diluted to at least 15 mL per gram.
The appropriate quantity of reconstituted solution may be added to an intravenous bottle or bag containing 
any of the solutions for intravenous infusion listed below.
Solutions for Intravenous Infusion:
Intravenous Solutions:
5% Dextrose in Water [D5W]
0.9% Sodium Chloride (Normal Saline) [NS].
Dextrose 5% and 0.9% Sodium Chloride [D5NS].
Lactated Ringer's Injection, U.S.P.
Dextran 6% in 0.9% Sodium Chloride.
STABILITY OF SOLUTIONS: PIPRACIL* is stable in both glass and plastic containers when reconstituted with recom 
mended diluents and further diluted with the indicated intravenous solution and intravenous admixtures.
Stability studies have demonstrated chemical stability (pH, potency and clarity) through 24 hours at room 
temperature and up to 72 hours refrigerated. Appropriate consideration of aseptic technique, however, recom­
mends discarding unused portions after storage for 24 hours at room temperature or 48 hours refrigerated. If used 
as a multi-dose container, the vials must be reconstituted only with the bacteriostatic diluents noted above. 
INCOMPATIBILITY: Because of chemical instability, PIPRACIL* should not be used for intravenous administration with 
solutions containing sodium bicarbonate
PIPRACIL* should not be added to blood products, protein hydrolysates or amino acids.
When PIPRACIL* is given concurrently with aminoglycosides, it is recommended that both drugs be used in full 
therapeutic doses, but administered separately. PIPRACIL* should not be mixed with an aminoglycoside in a 
syringe or infusion bottle, since this can result in inactivation of the aminoglycoside.
DOSAGE FORMS: PIPRACIL* (sterile, lyophilized piperacillin sodium) is available in vials containing amounts of pipera­
cillin sodium equivalent to 2 ,3  and 4 grams of piperacillin. Available in boxes of 12 vials.
Product Numbers: 2 g /v ia l-3879-48 3 g/vial-3882-49 4 g/vial-38 8 0 -5 0
Available in 100 mL size infusion ("piggyback") bottles, containing sterile, freeze-dried piperacillin sodium 
powder equivalent to 3 and 4 grams of piperacillin. Boxes of 12 infusion bottles.
Product Numbers: 3 g /bo ttles-3882-41 4 g /bo ttles-3880-42
Piperacillin Sensitivity Discs impregnated with 100 ug of piperacillin are also available.
Storage:
PIPRACIL* vials and infusion bottles should be stored at controlled room temperatures of 15-30°C (59-86°F). 
Piperacillin Sensitivity Discs should be refrigerated upon receipt. Product Monograph available on request.
•PIPRACIL is a trade mark of Lederle Piperacillin, Inc.
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Long-Term Results of Proximal Gastric Vagotomy
- o -
*
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Proximal gastric vagotomy without 
drainage for duodenal ulcer was perform­
ed in 304 patients between 1969 and 
1977. There was one operative death 
(0.3%) and two patients required secon­
dary drainage (0.6%). Eleven patients 
died subsequently of unrelated causes. 
Follow-up 5 to 13 years after operation 
was conducted on 242 patients (80%). 
Of these, 141 were asymptomatic and 
48 had only trivial symptoms, a success 
rate of 78% . Thirty-two patients had 
recurrent ulcer and 2 of them had 
Zollinger-Ellison syndrome. When these 
two were excluded, the recurrence rate 
was 12.4%. Two patients had 
duodenitis.
Seven patients had unexplained pain 
and some of them may ultimately be 
shown to have recurrence. Appreciable 
esophageal reflux was seen in eight pa­
tients. Other symptoms, nearly all mild, 
were dumping in one, diarrhea in seven 
and bile reflux in six.
Recurrent ulcer was treated by 
cimetidine initially in all 32 cases but 
ultimately by repeat vagotomy and an­
trectomy in 27, with no deaths and only 
one further recurrence (Zollinger-Ellison 
syndrome). After operative correction, 
the ultimate success rate (Visick grades I 
and II) was 90%.
Entre 1969 et 1977, une vagotomie 
gastrique proximate sans drainage a ete 
pratiquee chez 304 patients. Un patient 
est decede peroperativement (0.3%) et 
deux patients (0.6%) ont necessity un 
drainage secondaire. Onze patients sont 
decedes par la suite, de causes n'ayant 
aucun rapport avec ('intervention. Un 
examen de controle a 6t6 effectue de 5 a
From the Department o f Surgery, the Royal Victoria Hospital, Belfast, Northern Ireland
Presented at the 6th annual meeting o f  the Canadian Association o f General Surgeons, Calgary, Alta., Sept. 21, 1983
Accepted fo r  publication Oct. 24, 1983
Correspondence to: Mr. T. Kennedy, Royal Victoria Hospital, Grosvenor Rd., Belfast BT12 6BA, Northern Ireland
13 ans apres I'operation chez 242 pa­
tients (80%). De ceux-ci, 141 etaient 
asymptomatiques et 48 n'avaient que 
des symptomes banals, pour 78% de 
bons resultats. Trente-deux patients 
avaient eu une recidive ulcereuse et 2 
souffraient du syndrome de Zollinger- 
Ellison. En excluant ces deux derniers le 
taux de recidive s'etablit a 12.4%. Deux 
patients souffraient de duod6nite.
Sept patients se plaignaient de 
douleurs inexpliquees et il est possible 
que, dans le futur, on constate chez eux 
une recidive. Un reflux gastrique ap­
preciable a ete observe chez huit pa­
tients. Les autres symptomes, presque 
tous benins, comprennent "dumping" 
chez un, diarrhee chez sept et reflux 
biliaire chez six.
Les 32 cas de recidive ulcereuse ont 
6te traites initialement a la cimetidine 
mais 27 d'entre-eux ont finalement eu 
une deuxi&me vagotomie avec antrec- 
tomie; il n'y eut aucun autre d£c£s et 
une seule autre rechute (un syndrome de 
Zollinger-Ellison). Apres correction 
operatoire le taux final de bons resultats 
(les grades I et II & I'echelle de Visick) 
s'etablit h 90% .
operative death (0.2%). Primary drainage 
was required in 25 patients with stenosis 
of the gastric outlet. Of these operations, v 
304 were performed more than 5 years 
ago; 11 patients have died o f various ,, 
unrelated causes and 242 patients (80%) 
have now been followed up for between-*
5 and 13 years.
Recurrence
*  *
Ulceration recurred
Sixty-two years ago, Andre Latarjet1 
described the principal nerves of the lesser 
curve and 14 years ago, Amdrup and 
Jensen2 and Johnston and Wilkinson3 
independently introduced the operation 
of parietal cell, highly selective or prox­
imal gastric vagotomy without drainage. 
This operation has gradually been ac­
cepted in many countries; in many parts 
of the United Kingdom and Scandinavia 
it is now regarded as the operation of 
choice for chronic uncomplicated 
duodenal ulcer. The results, in terms of 
eliminating side effects, have been
in 32 patients 4 
(13.2%), but 2 of these were shown to 
have Zollinger-Ellison syndrome and* * 
should probably be excluded, leaving a 
corrected recurrence rate of 12.4%. In * 
published follow-up data, exceeding 5 
years, of 1370 patients from seven dif­
ferent countries, the mean recurrence rate 
was 13.1% ,soour experience appears to 
be average. Much lower recurrence rates 
have been reported by individual 
surgeons, giving their personal experi- v 
ence.7 There are no published random­
ized, controlled data comparing recur- -y 
rences after proximal gastric vagotomy 
with those 5 or more years after truncal -* - 
vagotomy and drainage.
The clinical results were expressed as * 
modified Visick gradings, in which grades 
I and II are regarded as successful, and" 
are shown in Table I. The success rate was 4 
78.1%, but it should be noted that 58% 
were graded Visick I, indicating that the , 
patients had no symptoms of any kind. 
The Visick II patients had various vague -< 
symptoms, including a feeling of fullness 
in many cases. This was due to loss o f’* 
receptive relaxation of the gastric fundus.
Side E ffects
The objective when proximal gastric
excellent4 but over the long term, recur­
rence rates o f about 20% have been Table 1—Clinical Results ofreported.5’6
Visick
Proximal Gastric Vagotomy 
No. of patients Success A ->P atien ts and F indings grade (n > 242) (failure), %
I performed my first proximal gastric 1II 14148 78.1
f
vagotomy in 1969 and in my unit this III 17 (21.9)
L i
operation has now been performed by IV 36
various surgeons in 512 patients, with one
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vagotomy was introduced was to elim­
inate troublesome side effects — namely 
dumping, bile reflux and vomiting and, 
*..► in particular, postvagotomy diarrhea. The 
number of side effects is shown in Table
► II; in only one patient were the symptoms 
sufficiently severe to warrant a Visick
► ^grading other than II, which indicates 
. qualified success. Of the seven who had 
^ diarrhea, this symptom followed chole-
 ^ cystectomy in two; the combination of 
cholecystectomy and vagotomy is known 
». to be diarrheogenic. It should be 
remembered that many healthy patients 
>-with neither ulcer nor operation ex­
perience similar symptoms from time to 
*• time.4
'  v Failures
The failures are analysed in Table III. 
y *.The absolute failures (Visick grade IV) in­
clude the 32 patients with recurrence
► already noted and 2 patients with 
duodenitis but no ulceration. Two other
* * patients had gastric retention in the early 
postoperative period and required drain- 
k age; they subsequently did well.
A i  The qualified failures (Visick grade III)
I were a heterogeneous group. In seven 
k there was abdominal pain but no en­
doscopic or other evidence of recurrence. 
Some of these patients as well as the two 
with duodenitis may ultimately be found 
■ to have a recurrent ulcer. One patient had 
moderate diarrhea, but it was probably 
* due to the irritable bowel syndrome. The 
most important problem has been eso­
phageal reflux. It is scarcely surprising 
y that hiatus hernia or reflux may occur 
after the manipulation required to bare
>  *-
r  ► Table II—Late Side Effects after
Proximal Gastric Vagotomy in 242 Patients
r Followed up for 5 to 13 Years
Side effect No. (%)
y  r
Dumping 1 (0.4) 
Diarrhea 7* (2.9)
Bile reflux 6 (2.5)
*Two followed cholecystectomy.
at least 5 cm of esophagus. It is tempting, 
and indeed easy, to add a Nissen fund- 
oplication8 but we found three instances 
of lesser curvature necrosis, in patients 
operated on after this series was com­
pleted, when proximal gastric vagotomy 
and fundoplication were combined.9 
This may have been due to the “bloat syn­
drome” and could perhaps have been 
avoided by ensuring that the wrap around 
was “ floppy” . Another alternative is the 
Hill procedure as modified by Oster and 
colleagues.10
Comments
What can be done for the failures? 
Most experienced surgeons recognize that 
dumping, diarrhea and bile reflux can be 
extremely difficult to treat, but in this 
series the major problem was the manage­
ment of recurrent ulcer. We have had on­
ly limited success with cimetidine and 
ranitidine and more than half of our pa­
tients have eventually required a second 
operation. The Nashville school11 has 
shown that vagotomy with antrectomy as 
a primary procedure has a very low recur­
rence rate so it is rational to treat recur­
rent ulcer by repeat vagotomy and 
antrectomy.12 We used this procedure in 
104 patients after all types of vagotomy; 
there was one operative death, in an 
emergency procedure, and only two fur­
ther recurrences. Thus, recurrent ulcer 
can be well controlled by adequate fur­
ther surgery. After correction of the 
failures by medical or surgical treatment, 
the ultimate clinical grading shows a 90% 
success rate (Table IV).
The somewhat high recurrence rate that
Table IV—Corrected Clinical Grading 
(after Treatment of Failures),
5- to 13-Year Follow-up
Visick
grade
No. of 
patients
Success 
(failure), %
I
II
III
IV
162 i
55 J
21 1 
4 J
90
(10)
r ►
Table Ill-Causes of Failure
r Visick grade
Ill IVy ►
Cause (n - 17) In - 36)
r Unexplained abdominal pain 7 -
Esophageal reflux 8 -
s  ^ Diarrhea 1 -
Psychogenic 1 -
i Recurrent ulcer — 32*
Duodenitis - 2
>  d Retention - 2
)
*2 with Zollinger-Ellison syndrome.
we have experienced leads us to ask 
whether there are any technical modifica­
tions that should be applied. We did not 
employ intraoperative tests o f com­
pleteness of vagotomy, although evidence 
supporting the use of Burge13 or Grassi 
tests14 appears convincing.
We have not used proximal gastric 
vagotomy for gastric ulcer and perforated 
or bleeding ulcer often enough to make 
any worthwhile comment. For pyloric 
stenosis, we initially added pyloroplasty 
but we have now combined proximal 
gastric vagotomy with duodenoplasty15 
in 44 patients; in 5 of these, the ulcer 
ultimately recurred but only 1 had further 
obstructive symptoms.
From this experience we conclude that 
proximal gastric vagotomy is a safe pro­
cedure and the undesirable side effects of 
truncal vagotomy with drainage are vir­
tually eliminated. Esophageal reflux may 
be a problem and its management is still 
not clearly defined. The great problem is 
recurrent ulcer but this can be controlled 
by either medical or surgical treatment so 
that the ultimate failure rate is only 10%. 
Proximal gastric vagotomy is surely here 
to stay.
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NEW VI VON EX* TEN.
TOTAL ENTERAL N UTRITIO N  “
« 4
Introducing a new formula for patients who 
need more than maintenance nutrition. 
Vivonex T .E .N . is total nutrition via the 
enteral route. It reverses catabolism by 
producing a positive nitrogen balance to 
aid wound repair...restore lean 
body mass...speed recovery... 
and shorten hospital stay.
New Vivonex T.E .N . is the 
only enteral formula that 
combines:
Enhanced Nitrogen Utilization
A high essential: nonessential .,
amino acid and branched-chain 
amino acid content, together 
with a calorie: nitrogen ratio 
of 175:1 provide enhanced 
nitrogen utilization.
Improved Gl Tolerance 4
An osmolality comparable to that of peptide - , 
diets provides better Gl tolerance. As for
fat content, the low (but adequate) fat 
| level does not alter gastric empty- " 4 
ing, thereby reducing the danger of - 
aspiration, and making feeding ^  t  
through a small bore tube possible.
4
Complete Nutrition ^
Vivonex T.E .N . provides complete 
nutrition including trace !
elements in an elemental form, a •* 
This means there is little or „
no digestion required by the 
already stressed patient.
k
VIVONEX T.E.N.
Total Enteral Nutrition.
To reverse catabolism 
speed recovery 
shorten hospital stay.
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' h  *-
Arterial Injuries
f  * . . ... ............... - ..... I --------
► The authors review arterial injuries in 68  
patients treated at Maisonneuve-
y ^Rosemont Hospital in Montreal between 
1975 and 1982. Penetrating trauma 
^  caused 54.4% of these injuries, which 
consisted of either laceration or intimal 
tear with thrombosis. Arterial injuries of 
k the extremities were predominant 
(58.8%). Associated injuries were fre- 
4 *quent. Surgical repair was effected in 60 
l patients. End-to-end anastomosis,
* angioplasty and venous or prosthetic 
bypass grafting were the techniques 
used. Postoperative complications occur-
. _ red in 37% of the patients. Overall mor­
tality was 19% and was related mainly
► to aortic injury. The amputation rate for 
arterial injuries of the extremities was
b *15%. Prompt recognition and treatment 
of arterial injuries are important in order
*  to achieve the best results.
y Durant la periode de 1975 h 1982, 68 
 ^patients furent traites pour traumatisme 
arteriel a I'hopital Maisonneuve- 
, tftosemont. Les plaies penetrantes 
causerent 54.4% de ces traumatismes. 
v La laceration partielle ou complete et la 
rupture intimale avec thrombose furent 
y r  les deux types de lesions rencontrees. La 
proportion de traumatisme arteriel des 
^extremites fut de 58.8%. Les 
^traumatismes associes furent frequents. 
Une correction chirurgicale fut pratiquee 
r chez 60 patients. Les techniques 
utilisees furent: I'anastomose termino- 
- * terminate, I'angioplastie et le bypass 
veineux ou synthetique. Le taux de com­
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plications postoperatives fut de 37% . La 
mortality .totale fut de 19% et en relation 
avec les traumatismes aortiques. Le taux 
d'amputation pour les traumatismes 
arteriels des extremites fut de 15% . Le 
diagnostic e» le traitement des 
traumatismes arteriels doivent etre des 
plus precoces si I'on veut obtenir des 
rgsultats favorables.
This study reviews 68 cases of arterial 
trauma treated at the Maisonneuve- 
Rosemont Hospital in Montreal from 
1975 to 1982. Most patients were less than 
50 years old. The anatomical distribution 
of the injuries is illustrated in Fig. 1. 
Arterial injuries of the extremities were 
predominant (58.8%) followed by those 
of the abdomen, neck and thorax.
The two main types of arterial injury 
encountered were partial or complete 
laceration (64.7%) and intimal tear with 
thrombosis (33.8%). Penetrating injuries 
resulting from gunshot and stab wounds 
and motor vehicle accidents were respon­
sible for 54.4% of the cases.
Hypovolemic shock was frequently 
present. Injuries to the central nervous 
system, abdominal contents and bones 
were common. The clinical presentation 
was acute in all patients but one who had 
a chronic pseudoaneurysm of the right il­
FIG. 1—Anatomical distribution of arterial 
injuries.
iac artery caused by blunt abdominal 
trauma. Trauma to arteries of the trunk 
was characterized by hypovolemic shock 
associated with multiple organ injuries. 
Varying degrees of acute ischemia and 
hemorrhage were the two classic accom­
paniments of arterial injuries to the 
extremities.
Surgical repair was carried out in 60 pa­
tients; in the other 8, the clinical situation 
precluded any arterial reconstruction. The 
surgical techniques used were debride­
ment and end-to-end anastomosis (16 pa­
tients), angioplasty (8), saphenous bypass 
grafting (16), prosthetic bypass grafting 
(13), ligation (3), nephrectomy (2) and ex­
ploration (2). All arterial injuries in the 
limbs were treated with the first two 
techniques. Prosthetic material was usual­
ly required to repair aortic injuries.
There were 25 (37%) postoperative 
complications and 13 deaths (19%) (Table 
I). These high rates well reflect the severi­
ty and the magnitude of these injuries. 
The mortality of 19% was related main­
ly to aortic injuries. Arterial injuries of 
the extremities were associated with a 
15% amputation rate.
To some extent, each anatomical region 
had its own features, and accordingly they 
will be reviewed separately.1
Carotid Arteries
A direct blow to the neck and severe 
hyperextension of the cervical spine were
Table 1—Complications and Mortality
Complication/death No.
Death 13
Neurologic sequelae
Central 4
Peripheral 7
Major amputation 6
Compartment syndrome 3
Causalgia 2
Crush syndrome 1
Pulmonary embolism 1
Pancreatic fistula 1
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responsible for carotid (common and in­
ternal) artery injuries in eight patients. 
These injuries produced intimal tears with 
secondary thrombosis. When first seen, 
the majority o f these patients already had 
a neurologic deficit, indicating the 
presence o f  the lesion. In the presence of 
a recent deficit, surgery was carried out 
only in one patient with a circumferen­
tial intimal tear of the carotid bifurcation 
and partial thrombosis. One patient had a 
stab wound of the common carotid 
artery. Surgical treatment in this case in­
cluded lateral suture of the carotid artery. 
Important neurologic sequelae ensued in 
three patients (33%).
Thoracic Aorta
In a group of seven patients with 
deceleration injury, four who were in 
stable condition with contained rupture 
of the thoracic aorta had a successful 
operation. In contrast, three patients with 
free aortic rupture died of hypovolemic 
shock despite aggressive resuscitation and 
attempted surgical repair. Early diagnosis 
and treatment are most important if this 
situation is to be avoided. Surgical treat­
ment included grafting the defect; a tem­
porary shunt was used in most patients. 
One patient with a stab wound of the aor­
tic arch is also reported.
Abdominal Arteries
Penetrating injuries predominated 
(56.5%) in these 11 patients with ab­
dominal arterial trauma. Associated in­
juries occurred in all cases and involved 
the majority o f intra-abdominal organs. 
Hypovolemic shock was frequent (63.6%). 
Surgical treatment included aortic repair 
in two patients, nephrectomy in two and 
angioplasty in one patient. Iliac artery 
bypass was performed in three patients. 
Two patients with gunshot wounds of the 
aorta died during the operation. Mortality 
was 45.4% and was related to prolonged 
and severe preoperative shock associated 
with aortoiliac injuries.
Arterial Injuries to the Extremities
The mechanism of injury and the types 
of arterial trauma were identical in the up­
per and lower extremities in 40 patients. 
Arterial laceration occurred in 66.7% of 
the cases and intimal injury with throm­
bosis in 33.3%. A high incidence of frac­
tures and soft-tissue trauma was noted in 
association with arterial injuries o f the 
extremities.2 This combination had a 
negative impact on the outcome in these 
patients. Soft-tissue injury and associated 
fractures carried, respectively, 23.5% and 
33% amputation rates while in isolated 
arterial trauma the amputation rate was 
only 11%. Surgical treatment consisted of
debridement and either end-to-end 
anastomosis or saphenous vein grafting. 
Peripheral nerve injuries occurred in 40% 
of the patients with arterial injuries of the 
upper extremities leading to chronic 
disability in 26% of them.
Angiography was done in 48.5% of the 
patients. Acute ischemia and signs of 
vascular involvement were the usual in­
dications. The overall accuracy of the 
technique was 97%. Indications for 
angiography are relative as in patients 
with a single injury and acute arterial in­
sufficiency. In contrast, the indication is 
strong in multiple injuries o f one limb 
combined with arterial insufficiency and 
in patients with preexisting atherosclerotic 
disease and possible arterial injury. 
Suspected thoracic aortic rupture is an ab­
solute indication for angiography and a 
positive angiogram is essential before em­
barking on a thoracotomy. Angiography 
may be detrimental to those patients with 
active bleeding and obvious arterial 
injury.
Peripheral arterial injury associated 
with limb fractures has been a subject of 
controversy in regard to which injury 
should be treated first. Eleven such cases 
occurred in our series. In five patients, the 
vascular repair was carried out before and 
in six patients after the orthopedic pro­
cedure. Complication and amputation 
rates were comparable. The amputation 
rate was 20% in patients whose vascular 
injury was repaired first and 33% in the 
others; this is not statistically significant. 
Despite the small numbers, these results 
tend to support the concept that the order 
of repair must be chosen for each in­
dividual case. The duration of ischemia 
remains the important factor in this selec­
tion. In the first 2 hours after arterial 
trauma, the orthopedic procedure can be 
carried out first, but after 4 to 5 hours 
of ischemic time, revascularization 
becomes imperative to avoid the sequelae 
and complications of prolonged acute 
ischemia. Close cooperation between the 
orthopedic and vascular teams is essen­
tial to achieve the best results. The Roger 
Anderson or the Hoffman device was us­
ed in all these patients.3
Associated peripheral nerve injuries 
were found in 40% of patients with 
arterial trauma to the upper extremities 
and in 12% with arterial injury in the 
lower extremities. Long-term neurologic
sequelae were present in at least 12.5% 
of the patients with arterial injuries to the 
limbs.4 Treatment o f these injuries 
should be carried out at the same time if 
feasible. Proximal nerve injuries usually ^ 
carry a poor prognosis, while distal le­
sions offer the best chance of recovery..« ^
Of 40 patients with arterial injuries of 
the limbs, 6 had associated venous in- -4 
juries with a predilection for the popliteal 
segment. Repair was carried out in four < 
patients and extensive damage precluded 
any reconstruction in the other two pa­
tients. The amputation rate for this group ^  
o f six patients was 33%. In one patient, 
who was in the ligation group, the am- ., 
putation was directly related to venous 
outflow occlusion and massive edema. < < 
Although these numbers are too small to 
draw any firm conclusion, major vein * 
ligation seems to carry a substantial am­
putation rate. Venous repair is probably-* 'f 
as important as arterial repair at least in 
critical locations such as the popliteal ^  
area.
Crushing injuries, more than 6 hours 
of ischemia and associated venous injuries * 
are the usual indications for fasciotomy 
at the time of the arterial repair. Three4 * 
patients were in this category. In four 
others without these predisposing factors, * 
a compartment syndrome developed 
within 48 hours of revascularization. i
Fasciotomy through small skin incisions_^
offers good decompression and has a 
minimal effect on soft tissues, which are < 
often severely traumatized. Fibulectomy, 
although theoretically sound, may be ill-' - 
advised in these circumstances.
The overall amputation rate in arterial 4 
injury of the limbs was 15%. The lower 
limbs were involved in all but one am- * r  
putation. Analysis o f the causes of am-  ^
putation underlines some important fac­
tors such as delay in diagnosis, wound,* , 
sepsis and graft failure (Table II). Delay 
in diagnosis occurred twice and led to am --*  
putation in both cases. These two patients 
were transferred to our institution 3 days ' 4 
and 22 hours, respectively, after injury. |
Wound sepsis was usually secondary to 
severe soft-tissue trauma associated with^  ^
multiple fractures. Due to heavy con­
tamination, local edema and devitalized 
tissues, infection supervened. This 
necessitated amputation in two patients. < 1
Graft failure was responsible for one j 
amputation despite early re-exploration4
T a b le  I I — C a u s e s  o f  M a j o r  A m p u t a t io n
S i t e N o . C a u s e
A x i l l a r y 1 D e la y  in  d ia g n o s is  ( 3  d )
F e m o r a l 1 E x t e n s iv e  d a m a g e  p r e c lu d in g  r e p a i r ,  p r im a r y  a m p u t a t i o n
P o p l i t e a l 4 C r u s h  s y n d r o m e  
W o u n d  s e p s is
D e la y  in  d ia g n o s is ,  v e n o u s  in ju r y ,  w o u n d  s e p s is  
G r a f t  f a i l u r e ,  w o u n d  s e p s is
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of the arterial repair. One of the most dif­
ficult decisions and one that requires ex- 
perience is when to amputate rather than 
revascularize the limb,5 particularly in 
► the case of extensively injured limbs with 
loss of soft tissue and skin and with 
’ v neurovascular damage. When in doubt, 
^ a primary reconstruction should be at­
tempted. Amputation may be done as a 
h. secondary procedure if necessary.
The treatment of vascular trauma con­
tinues to be an exciting challenge and re­
quires much ingenuity. Application of the 
modern principles of treatment has great­
ly reduced the morbidity and mortality 
associated with this condition.
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\  Doppler Waveform Analysis versus Segmental Pressure and
> .Pulse-Volume Recording: Assessment of Occlusive Disease
► in the Lower Extremity
k
In a prospective study, the accuracy of 
A 4 combined segmental pressure 
1 j  measurements and pulse-volume recor­
dings was compared with Doppler 
waveform analysis in evaluating 
peripheral arterial occlusive disease. 
r - - Before arteriography, 50 patients (100 
limbs) underwent vascular assessment 
► which included measurement of the 
segmental pressure and pulse volume at 
' ’ the thigh, calf and ankle. Analogue 
Doppler waveform tracings were 
obtained from the femoral, popliteal and 
tibial arteries and used to calculate the
y r
pulsatility index and inverse damping 
, r  factor. Results of each method were 
assessed by independent observers and 
r .compared with the arteriographic data.
No appreciable difference was 
y  demonstrated between the two methods, 
both giving an overall accuracy in the 
r 90%  to 95%  range. Both accurately 
predicted the severity of iliac and super­
ficial femoral artery obstruction and 
„ ^distinguished iliac from proximal disease 
of the superficial femoral artery. Outflow 
*- disease (tibial arteries) was better
assessed by measurement of segmental 
f pressures than by Doppler waveform
analysis or pulse-volume recording alone.
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Dans une etude prospective, la precision 
obtenue en associant la mesure de la 
pression segmentaire et I'enregistrement 
du volume systolique a ete comparee a 
celle de I'analyse des ondes Doppler 
comme methode d evaluation des oblite­
rations des arteres peripheriques.
Avant I'arteriographie, 50 patients 
(100 membres) ont ete soumis a une 
evaluation du systeme vasculaire com- 
prenant la mesure de la pression seg­
mentaire et du volume systolique au 
niveau de la cuisse, du mollet et de la 
cheville. Les traces correspondants des 
ondes Doppler obtenus des arteres femo- 
rales, poplitees et tibiales ont ete utili- 
sees pour calculer I'indice de pulsatilite 
et le facteur de modulation inverse. Les 
resultats de chaque methode ont ete 
apprgcies par un observateur indepen­
dant qui les a compares aux donnees 
arteriographiques.
La precision globale rattachee a I'une 
ou I'autre des deux methodes variait de 
90%  a 9 5 %  et ne differait pas de facon 
appreciable. Les deux methodes sont 
capables de predire avec precision la gra- 
vite des obliterations des arteres iliaques 
et femorales superficielles et de distin- 
guer entre les foyers iliaques et femo- 
raux superficiels d'obstruction. L'obs- 
truction de I'artere tibiale s'evalue mieux 
par la mesure de la pression segmentaire 
que par I'analyse des ondes Doppler ou 
de I'enregistrement du volume systolique 
seul.
Noninvasive evaluation has recently 
assumed an increasing role in the manage­
ment of patients with peripheral vascular 
disease. In the 20 years since the advent 
of the first Doppler velocity detector,
many types of equipment for noninvasive 
investigation of vascular problems have 
been developed. If the vascular surgeon 
is to utilize data obtained from these in­
struments to make critical clinical deci­
sions, it is essential that he know the limits 
of their reliability. The combination of 
segmental pressure measurements and 
pulse-volume recordings is perhaps the 
most common approach used at present 
to evaluate the arterial circulation to the 
lower limbs. Various authors13 have 
reported excellent results with this tech­
nique. Others, 4’5 using frequency analysis 
of Doppler signals, have also claimed 
that the method will reliably assess arte­
rial occlusive disease in the peripheral 
vessels.
We have recently concluded a prospec­
tive study, comparing the accuracy of 
segmental pressure and pulse-volume 
recording with that of Doppler waveform 
analysis in a group of patients who sub­
sequently underw ent angiographic 
evaluation.
Methods
Before arteriography, 50 patients (100 
limbs) underwent assessment in the 
vascular laboratory. The assessment con­
sisted of: (a) measurement of the segmen­
tal pressures and pulse volume at the 
thigh, calf and ankle, using a Life 
Sciences pulse-volume recorder (Life 
Sciences Inc., Greenwich, Conn.), and an 
exercise test; (b) Doppler waveform 
analysis of the femoral, popliteal and 
tibial arteries using a Bach-Simpson 
DFA-10 frequency analyser (Bach-Simp­
son Ltd., London, Ont.). Single-plane 
arteriography was then performed using 
standard methods.
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The interpretations of the segmental 
pressure and pulse-volume recordings and 
Doppler waveform analysis were carried 
out by different individuals independent­
ly, who had no knowledge of the results 
of the other procedure. The findings 
were then compared to those from 
arteriography with respect to specificity, 
sensitivity and accuracy.
Segmental Pressure Measurement
Segmental pressures were recorded con­
ventionally with a Doppler flow probe at 
the ankle and appropriate cuffs at the 
brachial, thigh, calf and ankle levels. 
After 1 minute of treadmill exercise, the 
ankle pressure measurements were re­
peated at 1-minute intervals until baseline 
pressures were restored. Our criterion for 
the presence of significant stenosis was a 
pressure gradient of 20 mm Hg between 
segments or an ankle-brachial index less 
than 0.8. An ankle-brachial index less 
than 0.5 was considered indicative of 
multisegment disease. Postexercise 
recovery time at the ankle level was also 
used to indicate the degree of ischemia 
present.
Pulse- Volume Recordings
The criteria for the presence of oc­
clusive disease with this technique are 
related to waveform contour and ampli­
tude. The presence of notable proximal 
obstruction is signalled by flattening of 
the anacrotic limb, rounding of the crest 
and loss of the dicrotic notch or a 
decrease in amplitude, or both. Further, 
the fact that the calf pulse-volume record­
ing has a greater amplitude than that of 
the thigh, except in the presence of super­
ficial femoral obstruction, was used to 
distinguish iliac from proximal disease of 
the superficial femoral artery.
Doppler Waveform Analysis
Criteria for the presence of occlusive 
disease by this method were based on the 
waveform contour, the pulsatility index 
and the inverse damping factor (D F 1). 
As with pulse-volume recording, the 
velocity waveform will have a lower, flat­
tened peak, a decreased upstroke and no 
reversed flow over a diseased vessel. A 
pulsatility index of 6 or more at the 
femoral level was considered indicative of 
a normal iliac segment, while a value less 
than 5 implied substantial iliac stenosis. 
A DF’1 of less than 1 was considered in­
dicative of significant disease in that seg­
ment (superficial femoral or tibial).
Specificity, Sensitivity, Accuracy
outflow (tibial arteries) segments of the 
arteriograms were classified as (a) no 
significant stenosis, (b) less than 50% 
stenosis, (c) 50% to 99% stenosis and (d) 
occlusion.
The result of the combined segmental 
pressure and pulse-volume recordings and 
that of the Doppler waveform data for 
each segment were analysed and com­
pared with the arteriographic findings for 
specificity, sensitivity and accuracy. 
Specificity was defined as the number of 
negative noninvasive tests divided by the 
number of arteriograms that appeared 
normal or showed less than 50% stenosis. 
Sensitivity was defined as the number of 
positive noninvasive tests divided by the 
number of arteriograms showing 50% to
100% stenosis. Accuracy was defined as 
the total number of positives plus 
negatives divided by the total number of 4 
limbs examined.
*  <
The patient illustrated in Figs. 1 to 3 
with an isolated unilateral iliac lesion is ’ 
cited as an example of the findings on 
segmental pressure and pulse-volume 
recording and on Doppler waveform 
analysis. Fig. 1 demonstrates an impor­
tant segmental pressure gradient at the-i a  
thigh level and the pulse-volume record­
ing shows the typical changes of an oc- ■» 
elusive iliac lesion (decreased amplitude 
and abnormal contour of the thigh and <
FIG. I—Isolated iliac artery occlusion. Typical segmental pressure and pulse-volume 
recording.
The iliac, superficial femoral and FIG. 2—Doppler waveform analysis on same patient as Fig. 1.
346 VOLUME 27, NO. 4, JU LY 1984 /  THE CANADIAN JOURNAL OF SURGERY
►\  V 
►
calf tracings, calf showing greater 
amplitude than thigh). Fig. 2 demon­
strates the Doppler waveform changes in 
the same patient. The waveform is 
markedly altered, compared with the 
other leg, the pulsatility index is dimin­
ished at the femoral level while the DF"1 
distally is normal (greater than 1).
The results in the 100 limbs we ana­
lysed are summarized in Table I. They in­
dicate that both techniques are accurate 
in identifying obstructive lesions greater 
than 50% when compared to our “gold 
standard” of arteriography. Both 
methods reliably distinguished iliac 
disease from superficial disease. In fact, 
the lower specificity at the iliac level may 
imply the detection of so-called occult il­
iac stenosis not adequately seen on single­
plane angiograms. We did find that Dop­
pler waveform analysis was not as ac- 
' curate in assessing the outflow but the dif­
ferences were not significant.
Discussion
•. Over the past 6 years we have used the 
combination of segmental pressure 
* * measurements and pulse-volume record­
ings to evaluate arterial occlusive disease 
4 in the lower limb. With the advent of
FIG. 3—Arteriogram of same patient, with 
unilateral iliac artery occlusion. Distal vessels
Doppler waveform analysis as an alter­
native method, we elected to evaluate pro­
spectively both approaches and thus 
determine the limits of reliability of each 
and whether or not one was superior to 
the other in delineating the presence of 
obstruction of the iliac, superficial 
femoral and tibial vessels.
The criteria and methods for measur­
ing segmental pressure and pulse volume 
have been well documented. However, 
the terminology of pulsatility index and 
inverse damping factor (D F 1) deserves 
further clarification. Waveform analysis 
is the best method for processing Doppler 
signals. A normal Doppler waveform is 
triphasic (forward flow, reversed flow 
and then again forward flow). If  an oc­
clusive lesion is present, then the 
waveform distal to it will be diminished. 
In order to eliminate variations of the 
waveform caused by technical factors, 
several investigators4-6 have devised the 
pulsatility index to quantify the Doppler 
waveform. The pulsatility index is the 
peak height of a wave divided by the 
mean height. The DFA-10 frequency 
analyser calculates these numbers 
automatically and prints them as the 
waveforms are recorded. Hemodynamic- 
ally important stenosis at the femoral 
level is indicated if the pulsatility index 
is 5.0 or less. Normally, the index in­
creases with progression distally in the leg. 
This has been quantified by a second 
numerical index, the damping factor, 
which is the proximal pulsatility index 
divided by the distal pulsatility index.7 
To conform to the convention of decreas­
ing indices with increasing disease severi­
ty, the term is expressed as the inverse 
damping factor (DF-1). If the DF'1 is less 
than 1, then disease is present in that 
arterial segment. Therefore, with Doppler 
waveform analysis, the diagnosis of oc­
clusive vascular disease can be ascertain­
ed by inspecting the analogue waveform 
at the femoral, popliteal and tibial vessels 
and by calculating the pulsatility index
► t
(not shown) were patent. and D F 1. In this study, all procedures
T a b le  1— R es u lts  O b ta in ed  w ith  C om bined S e g m e n ta l P ressu re  and  
P u lse-V o lu m e R ecording (S P /P V R ) and D o p p le r W a v e fo rm  A n a lys is  (D W A ) 
C o m p ared  w ith  th e  A rte rio g rap h ic  D a ta  fo r  E ach  S eg m e n t
S eg m e n t S P /P V R , % DW A, %
Iliac
S e n s itiv ity 9 5 .1 9 4 .9
S p e c ific ity 8 3 .3 8 8 .8
A cc u rac y 9 1 .5 9 2 .9
S u p e rfic ia l fe m o ra l a r te ry
S e n s itiv ity 9 3 .3 9 2 .8
S p e c ific ity 8 5 .2 9 6 .2
A ccu racy 8 9 .5 9 4 .4
O u tflo w
S e n s itiv ity 1 0 0 .0 8 0 .0
S p e c ific ity 6 6 .0 5 0 .0
A ccu racy 9 6 .4 7 8 .8
- A
4
*> 4 
t
were carried out by the same tecbnician 
on each patient at the same examination. 
The data were then interpreted indepen­
dently by different evaluators before the 
angiograms were studied for comparison.
The results of the study clearly 
demonstrate that both approaches offer 
a high degree of accuracy at the iliac and 
superficial femoral levels. Both pulse- 
volume recording and Doppler waveform 
analysis distinguished accurately iliac 
from proximal obstruction of the super­
ficial femoral artery even when both were 
present in the same limb. Evaluation of 
the tibial outflow segment appeared bet­
ter with segmental pressure and pulse- 
volume recording, primarily because 
severe proximal disease tended to damp 
both the pulse-volume recording and 
Doppler waveform tracings alone whereas 
segmental pressure measurements could 
still show a gradient between the calf and 
ankle, and an ankle-brachial index below 
0.3 generally indicated poor outflow 
below the knee.
In most instances, single-plane films 
only were taken and only occasionally 
were oblique films used to assess the il­
iac vessels. The lim itations of 
arteriography in assessing aortoiliac 
disease have been documented and many 
surgeons believe that stenoses in these 
segments are routinely underestimated. In 
1971, Moore and Hall8 outlined some of 
the physiologic problems in interpreting 
aortoiliac disease from arteriography. 
Despite these limitations, we still rely on 
arteriography in planning the therapeutic 
approach and because it is the current 
“ gold standard” , we felt justified in us­
ing it for comparison with our data. Some 
of the false-positive results obtained from 
both methods at the iliac level may in fact 
reflect a greater sensitivity of these nonin- 
vasive tests to so-called occult iliac 
disease.
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^. Ventricular Function following Mitral Valve Surgery: 
w k Assessment Using Radionuclide Ventriculography
rr>
The effects of mitral valve replacement 
or commissurotomy on cardiac function 
 ^  ^were studied using radionuclide ventri­
culography in 13 patients with chronic 
x  mitral stenosis and in 8 with chronic 
mitral regurgitation, before and after 
4 mitral valve surgery. The stenosis
resulted from rheumatic heart disease in
* * all instances while regurgitation was due
 ^to mitral valve prolapse in three patients 
and rheumatic heart disease in five. 
Fourteen patients had a Carpentier- 
Edwards valve inserted and 4  a Lillehei- 
» Raster disc valve. Three patients with 
mitral stenosis had an open 
«- commissurotomy.
All patients underwent supine-rest and 
*■ * symptom-limited exercise radionuclide 
ventriculography shortly before and 6 to
*  12 months after operation. The data ob­
tained showed that left ventricular func-
** tion remained unchanged postoperatively 
,. in patients with mitral stenosis but 
deteriorated in those with mitral 
►t *■ regurgitation. Right ventricular function 
improved postoperatively in those with 
V- •'mitral stenosis but remained unchanged 
in patients who had regurgitation.
Les effets sur la fonction cardiaque d'un 
remplacement de valvule mitrale ou 
t  y d'une commissurotomie ont ete etudies 
chez 13 patients souffrant de stenose 
r  »mitrale chronique et chez 8 patients
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ayant une regurgitation mitrale chronique 
au moyen d'une ventriculographie 
isotopique pratiquee avant et aprfes 
chirurgie valvulaire. La stenose etait le 
resultat d'une cardite rhumatismale dans 
tous les cas alors que les regurgitations 
6taient dues £ un prolapsus de la valvule 
mitrale dans trois cas et a une cardite 
rhumatismale dans cinq cas. Quatorze 
patients ont recu une proth&se 
Carpentier-Edwards et 4 une valvule & 
disque Lillehei-Kaster. Trois patients 
porteurs d'une stenose mitrale ont subi 
une commissurotomie ouverte.
Tous les patients ont subi une ven­
triculographie isotopique au repos, en 
position couchee, et & I'effort limits par 
les symptomes, avant, et de 6 & 12 mois 
apres I'operation. Les resultats obtenus 
montrent que la fonction ventriculaire 
gauche est demeuree inchangee en 
postoperatoire chez les patients qui 
avaient une stenose mitrale alors qu'elle 
s'est deterioree chez ceux qui avaient 
une regurgitation mitrale. La fonction 
ventriculaire droite s'est amelior6e en 
postoperatoire chez ceux qui avaient une 
stenose mais elle est demeuree in­
changee chez les patients souffrant de 
regurgitation.
The left ventricular ejection fraction at 
rest may be either normal or decreased in 
the presence of mitral stenosis.1-8 Studies 
examining exercise left ventricular func­
tion usually demonstrate hemodynamic 
abnormalities.9-12 Whether reduced left 
ventricular function is due to a decrease 
in diastolic filling or to intrinsic myocar­
dial dysfunction has not been firmly 
established.2-4’6’8’13-17 Left ventricular 
ejection fraction at rest is usually main­
tained in mitral regurgitation due to ad­
justments in left ventricular and left atrial 
mechanics18-22 so that a depressed value 
in such patients indicates a markedly ab­
normal ventricle. Mitral valve replace­
ment at this stage may be associated with 
further deterioration in left ventricular
function or a decrease in operative 
survival.7’23-26 Right ventricular function 
has not been extensively evaluated for 
either mitral stenosis or regurgitation.
The purpose of this study was to com­
pare the effects of mitral valve replace­
ment or commissurotomy in patients with 
mitral stenosis and those with mitral 
regurgitation. Equilibrium radionuclide 
ventriculography provides an excellent 
noninvasive tool to examine rest and max­
imal exercise biventricular function.27-28
Patients and Methods
Included in the study were 21 patients, 
13 (11 women, 2 men, group 1) in whom 
mitral stenosis was the predominant 
valvular lesion and 8 (4 women, 4 men, 
group 2) in whom mitral regurgitation 
was predominant. The mean age for 
group 1 patients was 58 years (range from 
40 to 73 years) and for group 2, 54 years 
(range from 39 to 68 years).
The cause of the condition was 
established in all patients by cardiac 
catheterization and M-mode or two- 
dimensional echocardiography. The 
mitral stenosis in all group 1 patients was 
due to rheumatic cardiac disease. The 
mitral regurgitation in group 2 patients 
was due to rheumatic cardiac disease in 
five patients and to mitral valve prolapse 
in three.
In both groups the patients’ hemo­
dynamic condition was severe — luminal 
diameter of 1 cm2 or less in all group 1 
patients as determined by the Gorlin 
method and regurgitation demonstrated 
angiographically in group 2. No patient 
had significant coronary artery disease 
(25% or more narrowing of one or more 
coronary arteries).
In group 1, 10 patients received new 
m itral valves (C arpentier-Edw ards 
bioprosthetic porcine valve in 8, Lillehei- 
Kaster eccentric monocuspid disc valve in 
2) and 3 patients had an open mitral com­
missurotomy. In group 2, all patients
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underwent mitral valve replacement 
(Carpentier-Edwards in six and Lillehei- 
Kaster in two).
Mitral valve disease had been present 
in all patients for at least 5 years and in 
most for many years. Patients underwent 
preoperative assessment within the 3 
months before operation. Postoperative 
assessment was conducted 6 to 12 months 
after the surgical procedure. Diuretic 
therapy was reduced at the time of 
postoperative assessment in 10 of 13 pa­
tients with mitral stenosis and 4 of 8 with 
mitral regurgitation. All patients were re­
quired to undergo at least one 3-minute 
stage of supine bicycle exercise at a 
workload of 25 watts.
Twenty-eight healthy men with a mean 
age of 54 years (range from 34 to 65 years) 
served as controls. No one was taking 
regular medication. In all, the findings of 
functional inquiry, physical examination, 
exercise stress electrocardiogram and 
thallium-201 scintigraphy were normal. 
Wall motion was normal during exercise 
radionuclide ventriculography.
In all group 1 patients, the left ven­
tricular ejection fraction, derived from a 
single right anterior oblique projection at 
the time of cardiac catheterization, was 
more than 50%; it was less than 50% in 
four group 2 patients, as determined at 
the time of ventriculography.
Radionuclide Ventriculography
Electrocardiographically multigated 
equilibrium radionuclide ventriculogra­
phy was carried out with the patient 
supine at rest and during symptom- 
limited exercise. After in-vivo labelling of 
erythrocytes with 20 mCi of techne- 
tium-99m pertechnetate, cardiac scinti­
graphy was performed in the left anterior 
oblique position that best isolated the left
ventricle. All images were collected for 2 
minutes using a conventional Anger scin­
tillation camera equipped with a high- 
sensitivity parallel-hole collimator inter­
faced to a dedicated medical computer 
system (Ohio Nuclear model 460; Tech- 
nicare International, Cleveland, Ohio).29 
Data were collected in a continuous elec­
trocardiographic synchronized mode with 
16 frames spanning the cardiac cycle. Pa­
tients began supine exercise with an in­
itial workload of 25 W, which was in­
creased by 25 W every 3 minutes until 
symptoms were produced. Data were 
analysed using a mobile medical com­
puter (Ohio Nuclear model 550). As 
previously described,30 the left ven­
tricular ejection fraction was derived by 
first identifying a background region of 
interest, approximately 50 to 100 pixels 
along the inferolateral left ventricular free 
wall of the end-systolic frame. After 
smoothing and background subtraction, 
a region of interest was then drawn 
manually around the left ventricle at end- 
systole and end-diastole (previously iden­
tified from the left ventricular time- 
activity curve), using an endless-loop cine 
display to improve edge detection. This 
was performed on three separate occa­
sions and an average of the three counts 
for each of the frames was used to 
calculate the ejection fraction.
Determination of the right ventricular 
ejection fraction was based on a previous­
ly described technique.28 After subtrac­
tion of background activity previously 
identified along the left ventricular free 
wall, right ventricular end-systolic and 
end-diastolic regions of interest were 
manually outlined. The superior right 
ventricular edge was considered to border 
on a parallel line drawn from the mitral 
valve plane in both diastole and systole.
Analysis of variance shows that for the
left ventricle a change in ejection fraction 
of 5% (absolute value! or more was 
significant. For the right ventricle, a 
change of 11 % (absolute value) or more 
in ejection fraction was considered 
significant.
The percentage change in radioactive . 
counts from rest to exercise at end-systole 
and end-diastole was used to determine-* 
changes in cardiac volume.31
Statistical Analysis
Student’s /-test for paired and unpaired ' 
samples was used to determine significant 
changes in hemodynamic parameters. *  
Two-way analysis of variance was used 
to determine intraobserver and in­
terobserver variance for left and right 
ventricular ejection fractions from 25 
previously obtained resting studies in pa- ■ 
tients with coronary artery disease. 
Variance was defined as the error due to i 
observer bias plus the random error of the 
method. The largest variance obtained 
from intraobserver and interobserver 
sampling was used to define a significant 
change upon introduction of an interven- , 
tion. Probability of 5% or less was con­
sidered significant. ■*
Results
Atrial fibrillation was present in 9 of 
the 13 group 1 patients preoperatively and 
it developed postoperatively in 2 others. 
In group 2, six of the eight patients had 
atrial fibrillation preoperatively and there 
was no change postoperatively.
All patients were taking digoxin at the 
time of preoperative assessment. Post­
operatively, all but two patients were tak­
ing digoxin. No patient was taking a 13- 
receptor blocking agent.
■ *
FIG. 1—Mitral stenosis. Rest (R) and exercise (Ex) left ventricular 
ejection fraction (EF) and percentage change (% A) in end-systolic 
volume (ESV) and end-diastolic volume (EDV) with exercise. Compared 
with normal (triangles) increase (p <  0.001), exercise EF failed to rise 
preoperatively (open circles) or postoperatively (closed circles) owing 
to decrease (p <  0.01) in exercise EDV. Values are mean ± standard 
error. NS = not significant.
FIG. 2—Mitral stenosis. Rest and exercise right ventricular ejection 
fractions increased (p < 0.05) postoperatively (closed circles). Com­
pared with normal (triangles) increase (p <  0.001), exercise EF failed , 
to rise preoperatively (open circles) or postoperatively owing to increase 
(p <  0.001) in exercise ESV.
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Group 1 (Figs. 1 and 2)
^  Preoperatively, all patients with mitral 
stenosis were in New York Heart Associa- 
y tion class III for dyspnea or fatigue. At 
the time of follow-up, 11 patients were 
► in class I and 2 in class II. Rest and exer­
cise heart rate and systolic blood pressure 
► *■ were unchanged postoperatively from 
preoperative values (Table I). Changes 
from rest to exercise were significant 
^ (p < 0.001) and no differences occurred 
postoperatively.
y. K The results for left and right ventricular 
function are set forth in Tables II and III 
k > respectively. The significant (p < 0.001) 
rise from rest to exercise of the left ven- 
r tricular ejection fraction in healthy peo­
ple did not occur in patients with mitral 
K stenosis preoperatively or postoperative- 
y ly, although three patients did have an in­
creased ejection fraction postoperatively, 
at rest, while five had a substantial 
decrease (5% or more). Likewise, the 
significant (p < 0.001) rise in right ven­
tricular ejection fraction from rest to ex­
ercise in healthy subjects did not occur in 
those with mitral stenosis.
None of the patients had evidence of 
mitral stenosis at follow-up.
Group 2 (Figs. 3 and 4)
All patients in this group were in New 
York Heart Association class III for 
dyspnea or fatigue preoperatively. At 
follow-up, five patients were class I and 
three were class II. Rest and exercise heart 
rates and systolic blood pressures post­
operatively did not differ substantially 
from the preoperative values (Table I).
y y
k - A
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Table 1-Preoperative and Postoperative Heart Rate and 
Systolic Blood Pressure at Rest and Exercise in Groups 1 and 2*
Heart rate, beatslmin Systolic blood pressure, mm Hg
Group Rest Exercise Rest Exercise
Control 65 ±  11 129 ±  20 129 ±  16 198 ±  28
1, mitral stenosis
Preop 78 ±  14 131 ±  36 114 ±  12 141 ±  17
Postop 76 ±  12 130 +  42 117 ±  17 153 ±  24
2, mitral regurgitation
Preop 85 ±  15 129 ±  30 124 ±  11 155 ±  27
Postop 80 ±  14 130 ±  31 137 ±  26 176 ±  24
'Values are mean ±  standard deviation.
*- >
Y- *
y y 
r *
Table II—Group 1, Mitral Stenosis. Left Ventricular Function Pre- and Postoperatively
Ejection fraction, %
End-systolic 
volume, % '
End-diastolic 
volume, % 'Rest Exercise
Control 67 ±  5 i 76 ±  6 -1 6  ±  24 +10 ±  18 “1
t J * J  NS 1 t
Preop 56 +  11 n 55 ±  17 -1 9  ±  24 -11 ± 2 0 §
NS 1 NS 1 NS NS
Postop 55 ±  15 J 52 ±  15 J + 2 ±  28 J -  8 ±  10 J
'Percentage change in volume with exercise from resting value, 
tp <  0.01.
4p <  0.001.
§p <  0.05.
k
S
A
4
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Table Ill-Group 1, Mitral Stenosis. Right Ventricular Function Pre- and Postoperatively
Ejection fraction, % .
------------------------------------------  End-systolic End-diastolic
__________ Rest___________Exercise volume, % *  volume, % *
Control 51 ±  8 64 ±  11 -21 ±  28 + 5 ±  19
J t I * ] * NS
Preop 37 ±  15 32 ±  15 + 15 ±  30 4 + 9 ±  33
] t 1 t I n s NS
Postop 48 ±  10 J 45 ±  12 + 24 ± 2 8 J +12 +  35 J
'Percentage change in volume with exercise from resting value, 
tp <  0.05.
4p <  0.001.
All changes from rest to exercise were 
significant (p < 0.001).
Tables IV and V show the results of left 
and right ventricular function at rest and 
after exercise. As in group 1, there was 
no significant change in either left or right 
ventricular ejection fraction from rest to 
exercise pre- or postoperatively. Four pa­
tients had a decrease and three patients 
an increase in rest ejection fraction (5% 
or more).
Discussion
Left Ventricular Function
The etiology of the impaired response 
of the left ventricular ejection fraction in 
patients with mitral stenosis surprisingly 
remains controversial. Gash and asso­
ciates8 found that of five patients with a 
left ventricular ejection fraction of less 
than 50%, four had normal intrinsic mus­
cle function. Reduced systolic function 
was the result of an increased afterload 
without adequate Frank-Starling com­
pensation. In contrast, other studies have 
suggested that impaired muscle function, 
which may have been due to chronic 
rheumatic myocarditis, results in a re­
duction in ejection fraction.2'6,9'1417 
Others32'33 have suggested that the 
presence of right ventricular dysfunction 
may depress left ventricular function. 
Although the mechanism of left ven­
tricular dysfunction at rest was not ex­
amined in this study, both systolic and 
diastolic left ventricular impairment could 
have contributed to the diminished ejec­
tion fraction. Lack of improvement post­
operatively in the left ventricular ejection 
fraction at rest suggested that impaired 
diastolic filling from mitral valve stenosis 
was not the sole cause of the reduced ejec­
tion fraction. Due to chronic rheumatic 
fibrosis, preoperative systolic function 
may have been impaired and so con­
tributed to the decreased ejection fraction 
at rest. It is possible that the ejection frac­
tion was falsely depressed by the use of 
equilibrium radionuclide ventriculography 
in the presence of atrial fibrillation. But 
this is unlikely since the value of ra­
dionuclide ventriculography in this situa­
tion has been either documented or com­
mended by others.34,35
By determining volume changes with 
mitral stenosis, we were able to assess 
ejection fraction responses to exercise in 
greater detail. Preoperatively, a signifi­
cant decrease occurred in exercise end- 
diastolic volume. Coupled with a normal 
decrease in end-systolic volume, the left 
ventricular ejection fraction failed to rise, 
suggesting that impaired diastolic filling 
was responsible for the abnormal ejection 
fraction response to exercise. Since the 
heart rate did not increase beyond the 
normal exercise heart rate, reduced 
diastolic filling time was not responsible.
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Postoperatively, impaired diastolic filling 
persisted. Moreover, there was a slight 
rise in end-systolic volume. Thus, mitral 
valve surgery did not improve exercise left 
ventricular function as measured by these 
parameters. Possibly, diastolic filling re­
mained abnormal because of prosthetic 
valve narrowing, a consistent finding 
following mitral valve replacement.36 In 
addition, the presence postoperatively of 
atrial fibrillation may have reduced end- 
diastolic filling. The slight rise in end- 
systolic volume indicates a reduction in 
exercise systolic function. This may have 
occurred during the perioperative period 
but more likely paradoxical septal motion 
contributed to this finding.37
In contrast to mitral stenosis, mitral 
regurgitation is associated with major 
hemodynamic left ventricular stress. The 
left ventricle compensates by several 
mechanisms. Wall thickness increases in 
relation to the increase in chamber size 
and the chamber becomes spherical.22 
Major increases in left ventricular and left 
atrial compliance permit a reduction in 
end-diastolic pressure.18'22 The enlarged 
left atrium can accept very large volumes 
of blood at the onset of systole and in do­
ing so, markedly reduces resistance to left 
ventricular outflow. These adaptive 
mechanisms permit mitral regurgitation 
to be present for prolonged periods 
without a reduction in left ventricular 
ejection fraction. In this study, a slight 
reduction in left ventricular ejection frac­
tion postoperatively at rest and a signifi­
cant decline in exercise ejection fraction 
suggest that mitral valve replacement may 
have been undertaken relatively late in the 
course of the disease. Normally, a decline 
in regurgitant volume combined with an 
increase in afterload (obstruction to the 
low impedance leak) results in a decrease 
in end-diastolic volume, little change in 
end-systolic volume and a slight fall in left 
ventricular ejection fraction. In the 
presence of preoperative left ventricular 
dysfunction, a greater fall in ejection frac­
tion is likely after mitral valve replace­
ment.7,23'26
Right Ventricular Function
In this study, the right ventricular ejec­
tion fraction preoperatively was depress­
ed at rest with both mitral stenosis and 
regurgitation. Winzelberg and asso­
ciates38 noted a relation between 
pulmonary artery pressure and right ven­
tricular ejection fraction in patients with 
aortic and mitral valve disease. The ejec­
tion fraction was decreased in over half 
the patients with right ventricular peak 
systolic pressures greater than 50 mm Hg. 
However, this decrease may not relate to
a decline in intrinsic muscle function. 
Wroblewski and associates39 found that 
in the presence of moderate pulmonary 
hypertension, removal of pulmonary -i ' 
artery pressure from the calculation of 
right ventricular performance showed 1 
that contractility was not impaired. In­
deed, in patients with mitral stenosis, 1  
right ventricular ejection fraction improv-^ 
ed postoperatively in the present study, 
probably owing to a reduction in _. 
pulmonary artery pressure.
During exercise, pulmonary artery -* 
pressure may increase further because in­
creased forward flow is obstructed.9 " 
Thus, as our preoperative study^, 
demonstrated with mitral stenosis and ^
Table IV—Group 2, Mitral Regurgitation. Left Ventricular Function Pre- and Postoperatively
Ejection fraction, %
Rest Exercise
End-systolic 
volume, %*
End-diastolic 
volume, %*
Control 67 ±  5-1 76 ± 6 n -1 6  ±  24 -]
J t J + J NS
Preop 54 ±  11 57 ± 9 , -  9 ±  19
NS 1 t I t
Postop 49 ±  12 J 46 ± 8 J +11 +  37 J
+
+ 1 0 ±  18 -j —
J NS
§ -  4 ±  20 NS
1 NS ►
0 ±  25 J J
4 A"Percentage change in volume with exercise from resting value, 
tp <  0.05. 
fp  <  0.001.
§p <  0.01.
A  X
Table V—Group 2, Mitral Regurgitation. Right Ventricular Function Pre- and Postoperatively 
Ejection fraction, %
Rest Exercise
End-systolic 
volume, %*
End-diastolic 
volume, %*
Control 51 ±  8 i 64 ±  11 -21  ±  28 + 5 ±  19 “1
t I + NS
Preop
.
30 ±  17 24 ±  17 +29 ±  14 4 + 19 ±  8
NS NS NS 1 NS
Postop 38 ±  15 J 31 ±  17 + 39 ±  38 J + 19 ±  26 J
NS
"Percentage change in volume with exercise from resting value, 
tp <  0.01. 
tp  <  0.001.
X -t
J 
« v
1 -<
FIG. 3—Mitral regurgitation. Exercise EF decreased (p <  0.05) 
postoperatively (closed circles). Compared with normal (triangles) in­
crease (p <  0.001), exercise EF failed to rise postoperatively owing to 
increase (p <  0.01) in exercise ESV. Open circles = preoperative values.
FIG. 4—Mitral regurgitation. Compared with normal (triangles) in- * 
crease (p < 0.001), exercise EF failed to rise preoperatively (open circles) 
or postoperatively (closed circles) owing to increase (p <  0.001) in ex-* *- 
ercise ESV.
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mitral regurgitation, exercise may be 
associated with an abnormal response of 
the right ventricular ejection fraction. 
Surprisingly, right ventricular ejection 
fraction also declined postoperatively.
* Although the exercise ejection fraction
* improved significantly in patients with
* mitral stenosis compared with the
► ►preoperative value, it failed to increase
from the rest value because o f a rise in 
-  c end-systolic volume. Similarly, the exer­
cise ejection fraction failed to rise from 
*■ rest in patients with mitral regurgitation 
owing to an increase in end-systolic 
" volume. These hemodynamic alterations,
. k comparable in magnitude to those found 
preoperatively, implied depressed systolic 
r y function. Exercise systolic function may 
have been impaired postoperatively for 
v several reasons. First, a significant gra­
dient across the prosthetic mitral valve 
•*" v during exercise could cause an increase in 
right ventricular afterload. Although pros- 
y * thetic valves vary in their flow gradients, 
k k a mild gradient usually exists.36 Second, 
irreversible damage to the right ven- 
4 tricular myocardium may have occurred 
i because of the hemodynamic stress o f a
► k chronically elevated pulmonary artery
pressure. Improvement in contractility
* * postoperatively would be unexpected.
Third, tissue may have been damaged 
during the perioperative period. Con­
ceivably, gradual improvement in 
myocardial function with an increase in 
w ejection fraction could occur beyond our 
follow-up of 6 to 12 months. 
y »- In summary, left ventricular ejection 
fraction remained unchanged after opera- 
► > tion for mitral stenosis but was reduced 
after operation for mitral regurgitation.
► ' Right ventricular function improved after
operation for mitral stenosis; it remain­
ed unchanged after opr-ation for mitral 
regurgitation.
y  y  We thank Michelle Darragh, Pam Mickle, 
Ashok Patel and Paul Purves for their technical 
■ assistance and Marlene Gillis for her secretarial 
assistance.
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Transluminal Dilatation for Takayasu’s Arteritis
^  ^ Takayasu's arteritis, pulseless disease or 
occlusive thromboaortopathy, is a pro- 
y ► gressive disease usually of young
women. Early morbidity and death result 
f  *■ from ischemia of vital organs. The
results of surgical revascularization have 
*" been disappointing.
Two women with Takayasu's arteritis 
are reported. They underwent 
y  transluminal dilatation of serious symp­
tomatic stenoses of the origins of the 
k left carotid, left subclavian, renal and 
superior mesenteric arteries. Four repeat 
4 dilatations were required. There was one 
complication.
* Clinical syndromes of transient cerebral 
 ^ k ischemia, upper limb claudication, renal 
failure and intestinal angina have been 
reversed by transluminal dilatation.
Percutaneous transluminal dilatation is 
.. a suggested alternative to surgical 
revascularization in selected patients 
y  with Takayasu's arteritis.
'  L'arterite de Takayasu est une maladie 
qui se distingue par I'absence de pouls 
r  * ou par ('obliteration de I’aorte et de ses 
branches. La maladie progressive affecte
r
d'une mani&re prddominante les jeunes 
femmes. La morbidity precoce et la mort 
peuvent etre les consequences causees 
> r par I'ischemie des organes vitaux. Les 
resultats de la revascularisation 
v- + chirurgicale ont ete decourageants.
La dilatation des arteres par la techni- 
v * que de I'entree d'un catheter a ete faite 
aux endroits ou les symptdmes de la 
stenose etaient les plus considerables, 
r Y c'est-e-dire a I'origine de la carotide
gauche, sous-claviere gauche, renale et 
r  ► I'artere mesenterique superieure. Le pro- 
ced6 a du etre repete quatre fois; une 
>- '  complication s'est presentee.
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Les syndrdmes medicaux des attaques 
transitoires de I’ischemie cerebrale, la 
claudication des extremites sup6rieures, 
la defaillance renale et I'angine intesti- 
nale ont ete corrigees par la technique 
de la dilatation des arteres.
Cette technique a ete suggeree comme 
une alternative e la revascularisation 
chirurgicale chez les sujets choisis at- 
teints de l'arterite de Takayasu.
Takayasu’s arteritis is a progressive in­
flammatory arteriopathy whose cause is 
unknown. It results in thickening of the 
arterial wall, leading to constriction or oc­
clusion, occasionally aneurysmal dilata­
tion and, rarely, thrombus formation in 
the aorta and its major branches.1
The clinical history o f Takayasu’s 
arteritis is often one of slow progression 
interspersed with acute morbid episodes 
due to inadequate blood supply to vital 
organs such as brain, kidneys or 
intestine.2
The success o f percutaneous translu­
minal angioplasty as a new therapeutic 
modality for atherosclerotic obstructive 
disease has prompted its use for the treat­
ment o f Takayasu’s arteritis. This report 
is to update our experience3 and docu­
ment further expansion of the technique 
to include stenoses of the renal4 and 
superior mesenteric artery origins involv­
ed in Takayasu’s arteritis.
Case Reports
Case 1
A 34-year-old woman had a history of severe 
left-sided headaches, episodes of blindness of 
the left eye lasting up to 3 minutes, vertigo and 
weakness of the left arm manifested by an in­
ability to hang up cups or wash dishes.
No blood pressure could be recorded in the 
left arm, which was markedly cooler than the 
right and showed slow capillary filling. Bruits 
were heard over the entire anterior precordium 
including the left infraclavicular region.
Arch aortography demonstrated typical fin­
dings of Takayasu’s arteritis with severe 
stenoses at the origins of the left common 
carotid and subclavian arteries (Fig. 1). There 
was retrograde filling of the left vertebral artery 
in later phases of the injection.
Transluminal dilatation was undertaken. A 
guide wire was passed across the left subclavian 
ostial stenoses and a no. 7 French dilatation 
catheter with a balloon 6 mm in diameter was
advanced over it. Four balloon inflations were 
accomplished without complication. Follow­
ing dilatation, there was marked improvement 
in the left arm pulse and diminution of the 
systolic gradient across the stenosis from 90 
mm Fig to 10 mm Hg. Postdilatation aor­
tography showed angiographic improvement 
as well as antegrade opacification of the left 
vertebral artery.
Over the next 2 days, the patient experienc­
ed quite marked hyperesthesia of the left arm, 
thought to be due to the increased blood flow 
to that arm.
Eight days later a retrograde left carotid 
angioplasty was performed through a left com­
mon carotid arteriotomy. A no. 7 French 
Gruntzig balloon catheter with guide was in­
serted through the arteriotomy and advanced 
under fluoroscopic control across the left com­
mon carotid ostial stenosis. Three dilatations 
were performed. Following each deflation of 
the balloon, blood was allowed through the 
arteriotomy. No embolic debris was seen. An 
increase in systolic pressure of 40 mm Hg was 
recorded distally after dilatation.
In traoperative arteriography  showed 
satisfactory dilatation. The patient recovered 
without complication.
Fifteen months later, repeat arteriography 
showed increased stenosis of the origins of the 
left subclavian (gradient 60 mm Hg) and left 
carotid (gradient 65 mm Hg) arteries. Repeat 
percutaneous transluminal dilatation was per­
formed. Gradients were reduced to 25 mm Hg 
at the origin of the left subclavian artery and 
20 mm Hg at the origin of the left carotid
FIG. 1—Case 1. Arch aortogram  
demonstrates stenoses at origins of left subcla­
vian and left carotid arteries (arrows). Systolic 
pressures were 140 mm Hg proximally and 50 
mm Hg distally.
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Table I—Case 1. Systolic Pressure Gradients (mm Hg) before and after Percutaneous* 
Transluminal Angioplasty
Date of angioplasty
Oct.1981 Feb. 1983 Apr. 1983 June 1983
Pressure gradient Pre Post Pre Post Pre Post Pre Post Sept. I
Aorta to left carotid artery 80 40* 65 20 — — — - 20
Aorta to left
subclavian artery 90 10 60 25 - — — — 10
Aorta to superior
mesenteric artery - - — 130 75 105 35 30
'First dilatation through left common carotid arteriotomy.
artery. Repeat pressure studies done 6 months 
later demonstrated no change in the degree of 
stenosis (Table I) (Fig. 2).
During the patient’s period of observation, 
she began to complain of postprandial midab­
dominal colicky pain. No diarrhea or weight 
loss was noted. The only new physical finding 
was a loud midabdominal bruit.
Biplane arteriography documented a com­
plex stenosis of the celiac axis not suitable for 
dilatation. A severe stenosis of the superior 
mesenteric artery (gradient 130 mm Hg) was 
found (Fig. 3). Transluminal dilatation of this 
vessel was accomplished successfully to a 
residual gradient of 75 mm Hg.
Symptoms and increased stenosis (gradient 
105 mm Hg) of the superior mesenteric artery 
occurred within 3 months. Repeat transluminal 
dilatation reduced the gradient to 35 mm Hg 
(Fig. 4). This gradient has remained stable for 
6 months (Table I).
Case 2
A 34-year-old woman was admitted with 
severe nausea, vomiting and azotemia. Her 
serum creatinine level was 707 /tmol/L.
Twelve years previously, she had been in­
vestigated for severe hypertension, and 
Takayasu’s arteritis type II (Kimoto variety) 
had been diagnosed.5 Aortography docu-
FIG. 2—Case 1. Follow-up aortogram after 
15 months. Origins of left subclavian and left 
carotid arteries well dilated. 110, 120, 130 = 
systolic blood pressures in mm Hg.
mented severe left renal ostial stenosis, celiac 
and superior mesenteric artery occlusions and 
stenosis of the left common iliac artery. Aor- 
torenal and aortosuperior mesenteric artery 
bypasses were performed. The renal bypass 
failed early and left nephrectomy was done to 
control recurrent hypertension.
Repeat aortography 3 years later docu­
mented occlusion of the superior mesenteric 
artery graft and 95% ostial stenosis of the re­
maining right renal artery. Further surgery was 
not considered because the previous grafts had 
failed to remain patent. Hypertension recur­
red and was difficult to control despite ag­
gressive medical management.
Renal failure occurred 8 years later, resulting 
in the present admission. Rehydration and tem-
APR 11 ' 83  
PRE P T A
20
FIG. 3—Case 1. Lateral abdominal aor­
togram shows stenosis of celiac axis (left ar­
row) and superior mesenteric artery (right ar­
row). Numbers indicate systolic pressures in 
mm Hg proximally and distally to superior 
mesenteric artery stenosis. Gradient is 130 mm 
Hg.
FIG. 4—Case 1. Lateral aortogram follow­
ing second transluminal dilatation. Arrow = 
site of previous stenosis of superior mesenteric 
artery; 120 is systolic pressure in mm Hg distal 
to previous stenosis.
porary transvenous dialysis were undertaken.
She rem ained anuric. Angiography 
docum ented a 161 mm Hg gradient 
(165/90-4/4 mm Hg) across the ostial stenosis ^ , 
of the right renal artery (Fig. 5). Retrograde 
transluminal dilatation using a no. 7 French ^ 
Gruntzig catheter successfully reduced the 
arterial gradient to 45 mm Hg (Fig. 6). Urine ^  . 
production resumed and the serum creatinine ” 
level stabilized at 159.6 /rmol/L. A ^
Over a 9-month period, hypertension 
became severe and repeat aortography .
documented recurrent stenosis with a gradient 
of 170 mm Hg. A repeat dilatation was only ^  
partially successful. A 95 mm Hg gradient re­
mained and dissection of the distal renal artery  ^ ^ 
was seen. Over the next 48 hours renal failure 
recurred. Repeat aortography documented a ^ A 
thrombus in the right renal artery. Strep­
tokinase therapy at 15 000 U /h was given. „ 
Dissolution did not result and the clot was 
thought to be subintimal. Repeat dilatation of ,, 
the area of the subintimal hemorrhage suc­
cessfully re-established adequate renal blood v 
flow (resulting in a residual gradient of 60 mm ’ 
Hg) and renal function returned. Her serum 
creatinine level remained stable at 159.6 to 
212 jitmol/L over an 8-month period but her K M 
hypertension persisted. \
Discussion ^
4 4
The course of the individual afflicted 
with Takayasu’s arteritis is difficult to 4 * 
predict. An initial delay in diagnosis is 
common.2 Of those with documented \
FIG. 5—Case 2. Abdominal aortogram. Ar- < , 
row shows ostial stenosis of right renal artery. 
Systolic blood pressures are 165 mm Hg prox- 
imal and 4 mm Hg distal to stenosis. !
FTG. 6—Case 2. Abdominal aortogram 
following successful transluminal angioplasty 
of right renal artery. Systolic pressure gradient *■ 
is now 45 mm Hg.
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disease, morbidity is usually related to 
unrelieved renovascular hypertension, or 
visual and cerebral events thought to be 
■-»- secondary to ischemic episodes.
Medical therapy, particularly during
► the active phase o f the disease, is directed 
towards preventing progression of the
r  * underlying inflammatory process of the 
^  ^arterial wall.
Revascularization is undertaken to pre- 
vent ischemic damage to end organs 
whose arterial supply is severely com- 
promised by the disease, or to correct 
renovascular hypertension. 
y  *- Surgical revascularization, however, 
has a higher morbidity and mortality in 
v “Takayasu’s arteritis than in equivalent 
obstructive arteriopathy due to athero­
sclerosis.6,7 In a review of the literature 
y by Ishikawa,6 26.9% of the surgically 
treated patients died. Lupi-Herrera and 
r y associates8 reported that four of five 
aortorenal grafts occluded in patients
► 'with Takayasu’s arteritis and they have
abandoned the procedure. Graft occlu- 
f 4 sion or anastomotic failure is thought to 
 ^ be related to active disease at the site of 
arterial anastomosis.
A „ The use of percutaneous transluminal 
dilatation as the initial form o f
A »
revascularization in Takayasu’s arteritis 
has been reported.9
During our first attempt at dilatation 
at the origin o f the left carotid artery, we 
used left common carotid arteriotomy 
through the neck10 to prevent emboliza­
tion. Cerebral blood flow was interrupted 
at the time of dilatation and blood and 
possible embolic debris were allowed 
through the arteriotomy. No debris was 
seen. As a result, subsequent per­
cutaneous transluminal dilatation was 
performed using the femoral approach.
Castaneda-Zuniga and associates4 
have stressed the need to repeat trans­
luminal dilatation should clinical signs or 
follow-up angiography document recur­
rent stenosis. Our experience with two pa­
tients requiring nine dilatations of four 
major vascular lesions supports the ef­
ficacy of repeated dilatation should it be 
required. Close follow-up, including the 
use o f the noninvasive techniques and 
repeat angiography, have been useful in 
documenting recurrent stenosis before 
end-organ ischemia occurs.
While the long-term results o f  this form 
of therapy remain uncertain, percutane­
ous transluminal angioplasty appears to 
be a safe and logical initial technique for
revascularizing severely stenotic arteries 
in patients with Takayasu’s arteritis.
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Results of percutaneous transluminal 
>- angioplasty of 60 Iliac arteries are 
presented, with a follow-up of 3 to 12
* *" months. The patency rate at 1 year was
95% using the thigh-brachial index as 
4 the criterion and 86% with the ankle- 
 ^ brachial index. Study of the patients 
with an exercise test component im- 
4  4, proved the sensitivity of the evaluation, 
demonstrating that both indices tend to
* *• underestimate the functional improve­
ment. The authors propose a simple, 
cost-effective way for practitioners to 
follow-up their patients after per- 
'  cutaneous transluminal angioplasty.
Les auteurs presentent une sdrie de 60 
f angioplasties transluminaies percutanees 
de I'art&re iliaque avec une post- 
r  » observation de 3 S 12 mois. Le taux de 
succes a 1 an est 95% en utilisant 
»- I'index cuisse-bras comme crit&re et 
86% avec I'index cheville-bras. En plus 
r  de ces mesures au repos, ils ont inclus 
une composante fonctionnelle dans 
v revaluation par le laboratoire vasculaire 
^  y ex ont ainsi amdliore la sensibilite de
leurs evaluation, demontrant que les in- 
. y dices ont tendance 6 sous-estimer 
■ 'amelioration apres la dilatation par 
r angioplastie. Les auteurs proposent aux 
praticiens une methode simple et peu 
*  coOteuse de suivre leurs patients apres 
angioplastie percutande.
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The introduction of noninvasive vascular 
testing has made it possible to document 
accurately the natural history of disease 
and to assess and compare the results of 
treatment.1 In many centres, noninvasive 
evaluation has now become an essential 
component of the clinical assessment of 
patients with known or suspected vascular 
disease before and after treatment.2 We 
have followed up a group of patients with 
iliac artery disease before and after per­
cutaneous transluminal angioplasty by 
measuring their performance at rest and 
after exercise with resting segmental 
pressure studies and functional evalua­
tion. These studies were used to document 
the success of angioplasty, comparing the 
results of resting segmental studies with 
the functional evaluation during the 
follow-up period.
Patients and Methods
From October 1980 to April 1983, 142 
percutaneous transluminal angioplasties 
were performed in our institution. Eighty- 
one involved the iliac arteries; in 60 of 
tnese the patients were followed up for 
3 to 12 months and are included in this 
study. All angioplasties were performed 
by the same radiologist (M.H.) and 
evaluated by the same vascular laboratory 
technician (D.L.). All lesions were 
segmental (less than 4 cm long) and in­
completely occluded.3
The following angioplasty technique 
was used: after local intradermal 
anesthesia with lidocaine 2%, a per­
cutaneous puncture ipsilateral to the 
stenosis was performed at the level of the 
common femoral artery (few patients 
underwent contralateral puncture) and 
catheterization was carried out through 
the stenosis, using a leading guide wire. 
A balloon-tip catheter was then inserted 
over the guide wire (the balloon size was 
chosen according to the vessel diameter 
measured directly on the angiogram) and 
the ballon was manually inflated with a
10-mL syringe filled with Renografin-30. 
The balloon was inflated to full capacity 
and the dilatation repeated as necessary 
to increase the vessel diameter to normal 
size. Before inflation of the balloon, 5000 
U of heparin were injected through the 
catheter. After removing the catheter and 
applying hand pressure, we applied a 
pressure dressing. All patients were nurs­
ed flat in bed overnight.
Evaluations were made before angio­
plasty, on the following day and at 3 and 
12 months after. Each assessment includ­
ed measurements of the ankle-brachial 
pressure index before and after exercise 
and the thigh-brachial pressure index, 
and an exercise tolerance test. The exer­
cise tolerance test consisted of the walk­
ing time performance on a treadmill set 
at 2.4 kph with a 10° grade.4 The exer­
cise test was concluded after 5 minutes of 
walking or at the appearance of claudica­
tion when the time was noted and the 
ankle-brachial pressure measured. The 
walking distance is calculated by multiply­
ing the walking time by the treadmill 
speed.
To assess the reproducibility of our 
results, the mean contralateral ankle- 
brachial pressure index was calculated 
before and after angioplasty. No signifi-
1.00 -
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FIG. 1—Mean (±  SEM) ankle-brachial 
pressure index (A /B ) before and after 
angioplasty in contralateral limb.
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cant difference was found (p > 0.05, Stu­
dent’s 7-test), indicating that our method 
of measuring the indices is reliable 
(Fig. 1).
We define patency as any improvement 
over the preangioplasty index; our paten­
cy rates at 1 year were 95% (thigh- 
brachial) and 86% (ankle-brachial).
Results
Table I represents the group’s perfor­
mance in terms of indices. The results of 
the exercise tolerance test are expressed 
in Table II. To compare the sensitivity of 
each category of measurements, we ex­
pressed our data as percent improvement 
(Figs. 2 and 3).
Improvement after Angioplasty
Immediately after angioplasty (Fig.
2) .—There was no significant difference 
between the improvement in the ankle- 
brachial pressure index and that for the 
thigh-brachial index. However, the dif­
ferences in improvement between the 
ankle-brachial index and exercise 
tolerance and between the thigh-brachial 
index and exercise tolerance were signifi­
cant (p < 0.001). There was no signifi­
cant difference between the postexercise 
ankle-brachial index and the exercise 
tolerance test results.
Three months after angioplasty (Fig.
3) .—This group includes 60 procedures; 
55 patients were tested and 5 were lost to 
follow-up. There was a significant (p < 
0.01) difference after angioplasty between 
the improvement in the ankle-brachial 
pressure index and in exercise tolerance 
and the thigh-brachial index and exercise 
tolerance. As before, improvement of the 
postexercise ankle-brachial index and ex­
ercise tolerance did not differ signifi­
cantly.
Twelve months after angioplasty (Fig.
4).—In this group, 37 procedures were 
performed; 23 patients had examinations 
and 14 were lost to follow-up. There was 
a significant difference between the im­
provement in the thigh-brachial index 
and exercise tolerance (p < 0.05) and in 
the thigh-brachial index and postexercise 
ankle-brachial index (p < 0.01), as well 
as in the pre- and postexercise ankle- 
brachial indices (p < 0.02). However, 
there was no significant difference be­
tween the ankle-brachial pressure index 
and the results of the exercise tolerance 
test (0.1 > p > 0.05).
Using the vascular laboratory data and 
the recurrence of symptoms as criteria, we
FIG. 2—Mean ( ± SEM) percent improve­
ment of indices after angioplasty. A /B  =  
ankle-brachial pressure index, T /B = thigh- 
brachial pressure index, PEI = postexercise 
ankle-brachial pressure index, ET = exercise 
tolerance test.
Table 1—Indices before and after Percutaneous Transluminal Angioplasty'
Index
Before
angioplasty
Day after 
angioplasty 3 mo 12 mo
Ankle-brachial pressure 0.56 ±  0.02 0.73 ±  0 .03t 0.78 ±  0 .02t 0.82 ±  0 .0 3 t
Thigh-brachial pressure 
Postexercise ankle-brachial
0.62 ±  0.02 0.83 ±  0 .02 t 0.83 ±  0 .02t 0.87 ±  0.14 t
pressure 0.43 ±  0.04 0.62 ±  0.094 0.79 ±  0 .03t 0.78 ±  0 .05 t
'Figures are mean ±  standard error, 
tp <  0.001.
+p -  0.05.
Table II—Exercise Tolerance Test: Improvement before and after Angioplasty'
Exercise
Before
angioplasty
Day after 
angioplasty 3 mo 12 mo
Time, min 
Distance, m
1.72 ±  0.22 
45.3 ±  5.7
2.83 ±  0 .58t 
74.7 ±  15.3
3.90 ±  0.254 4.33 ±  0.204  
102.9 +  6.6 114.3 ± 5 . 1
'Figures are 
tp <  0.05. 
4p <  0.001
mean ±  standard error.
had eight failures in our series of common 
iliac artery angioplasties. One procedure 
involved a dilatation of a distal anasto- ^  
mosis of an aortoiliac graft (the only pro­
cedure on a graft in our series). Three 
were performed on patients with disease 
of the superficial femoral artery and tibial t- 
artery, two on patients with tibial artery 1  
disease alone and two patients with no -4 ^  
distal disease. Looking at the successful 
group, 1 year after angioplasty, we found 
that all but one had two- or three-vessel M 
run-off.
◄
Discussion
•* <
Our patency rates (95% with thigh-
FIG. 3—Mean (+  SEM) percent improve­
ment of indices at 3 months after angioplasty. '
FIG. 4—Mean ( ± SEM) percent improve­
ment of indices at 12 months after angioplasty.
360 VOLUME 27, NO. 4, JU LY 1984 /  THE CANADIAN JOURNAL OF SURGERY
brachial and 86% with ankle-brachial 
pressure measurements) were comparable 
to those noted by Neiman and associates5 
->- in their review of more than 4000 cases 
of peripheral vascular disease treated by 
percutaneous transluminal angioplasty. 
We found no significant difference be- 
^ * tween the improvement in ankle-brachial 
i  ^.and thigh-brachial indices immediately 
after angioplasty, probably because most 
, w of our patients had two- and three-vessel 
run-off in the calf. Incorporating an ex- 
► ercise tolerance test increased the sensitivi­
ty of our evaluation, indicating that 
thigh-brachial and ankle-brachial 
^pressure m easurem ents tend to 
underestimate the functional improve- 
u_ ment in these patients. This is also true 
at 3 months; however, at 12 months, the 
y difference between the ankle-brachial 
pressure index and results of the exercise 
f  y tolerance test was not statistically signifi­
cant (0.1 > p > 0.05). We think that this 
r is due to a smaller sample number (23 
procedures). Still, the exercise tolerance 
‘ test seems to be a more sensitive indicator 
, of patient performance.
Our early results suggest that per- 
k k cutaneous transluminal angioplasty offers 
results comparable to those of aortoiliac
* k
bypass grafting6 if patients are carefully 
selected.3,7'10 None of our patients had 
complete obstruction and all lesions in­
volved short segments (less than 4 cm). 
Four of the eight failures had severe distal 
disease, including occlusion of the super­
ficial femoral artery and poor run-off. 
One patient had a distal graft dilated. On­
ly one successful patient had poor run­
off in the calf, emphasizing the impor­
tance of patient selection for angioplas­
ty. As noted in 1975 by Malone and 
associates6 in the case of aortofemoral 
bypass grafting, the postoperative symp­
toms of patients after angioplasty cor­
relate well with patency.
Conclusions
This study indicates that with proper 
patient selection and technique, trans­
luminal angioplasty of the iliac arteries is 
an effective treatment, with patency rates 
comparable to those of bypass pro­
cedures. The inclusion of a functional 
component in follow-up evaluations more 
closely mimics clinical conditions and is 
more sensitive than resting studies alone. 
Thus, the referring doctor can successful­
ly follow up patients after angioplasty by
noting the walking distance and time 
before the onset of claudication in addi­
tion to routine physical examination. 
Deterioration of symptoms or signs is an 
indication for vascular laboratory testing 
and, if necessary, angiographic reap­
praisal.
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Etude comparative des angioplasties transluminales 
percutanees iliaques et femoro-poplitees dans 
I’arteriopathie des membres inferieurs
A la Iumi6re d'une serie de 100 
. angioplasties transluminales percutanees 
(ATP) consecutives, les auteurs com- 
. r  parent les donnees anatomo-
radiologiques et les r£sultats immediats 
r  * et tardifs en fonction de I'etage lesionnel 
iliaque et f6moro-poplite. A I'etage sus-
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crural 57 ATP concernent I'iliaque 
primitive (36) et I'iliaque externe (21). A 
I'etage sous-crural 43 ATP concernent 
I'artere poplitee haute (9) et I'art6re 
femorale superficielle (34). L'ATP de la 
lesion iliaque primitive est dominante 
avant I'age de 60 ans par rapport a 
I'ATP femoro-poplitee (p <  0.05). A 
I'etage iliaque 89% des patients ont un 
stade de claudication severe; e I'etage 
femoro-poplite les troubles trophiques 
sont retrouves dans 39% des cas. Le 
caractdre "dominant" ou "accessoire" 
de la lesion n'intervient pas de facon dif- 
ferente dans ('indication selon le niveau. 
La thrombose segmentaire repermeabili- 
see represente 44.2%  des indications 
d'ATP femoro-poplite contre 7% a 
I'etage iliaque (p <  0.04). Le taux 
d'echec est moindre a I'etage iliaque que 
femoro-poplite. La surveillance des suites
therapeutiques concerne 86 .6%  des 
patients avec un recul de 22 mois en 
moyenne. Les indices systoliques de la 
cuisse apres ATP iliaque et de la cheville 
apres ATP femoro-poplite sont majores 
de facon significative (p <  0.01). A 
I'etage femoro-poplite, dans 74%  des 
cas, le patient est totalement asymp- 
tomatique. Un seul 6chec est note 
(3.8%); amputation de cuisse au 12e 
mois apres ATP. A I'etage iliaque. dans 
91%  des cas, une amelioration est 
observee et 70%  des patients sont 
asymptomatiques. Globalement, le taux 
de succes (permeabilite et amelioration 
clinique) actuariel est de 92%  ± 0.09% .
The authors compared the anatomo- 
radiologic data from a series of 100 con­
secutive percutaneous transluminal 
angioplasties (PTA), as well as the im-
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mediate and long-term results as a func­
tion of the level of the lesion — iliac or 
femoropopliteal. Proximal to the thigh, 
there were 57 PTAs, 36 of the common 
iliac and 21 of the external iliac. In the 
lower thigh, there were 43 PTAs, 9 of 
the upper part of the popliteal artery and 
34 of the external femoral artery. Per­
cutaneous transluminal angioplasty of 
the common iliac lesion was dominant in 
patients under 60 years of age (p <  
0.05). At the iliac level, 89%  of the pa­
tients had severe claudication; at the 
femoropopliteal level. 39%  had trophic 
problems. The "dominant” or "ac­
cessory" character of the lesion did not 
modify the indication for the procedure, 
regardless of the level. Segmental throm­
bosis accounted for 44.2%  of the 
femoropopliteal PTA indications, com­
pared with 7%  at the iliac level (p <  
0.04). The failure rate was less at the 
iliac than at the femoropopliteal level. 
Follow-up was available for 86.6% of the 
patients for an average of 22 months. 
The systolic indices at the thigh after 
iliac PTA and at the ankle after 
femoropopliteal PTA were significantly 
increased (p <  0.01). At the 
femoropopliteal level, 74%  of the pa­
tients were totally asymptomatic. There 
was one failure (3.8%); amputation at 
thigh level was carried out 12 months 
after the PTA. At the iliac level, improve­
ment was observed in 91%  of the pa­
tients and 70%  became asymptomatic. 
The overall success rate (clinical patency 
and improvement) was 92%  ± 0.09% , 
based on the life-table method.
Depuis le rapport preliminaire sur l’an- 
gioplastie transluminale percutanee 
(APT) de Dotter et Judkins,1 cette tech­
nique, standardisee par Gruntzig et 
Hopff2 et Gruntzig et Kumpe,3 peut etre 
consideree comme l’une des plus impor- 
tantes acquisitions de l’angiographie the- 
rapeutique. Elegante car peu agressive, 
elle permet sans geste chirurgical direct 
une recanalisation ou dilatation des 
thromboses et stenoses arterielles segmen- 
taires; l’elargissement endoluminal est le 
fruit d’une fragmentation avec clivage de 
la plaque atheromateuse intimale, la 
media et l’adventice se laissant distendre 
du fait de leur elasticite.4 Nous mettons 
en correlation les indications anatomo- 
cliniques et les resultats des ATP a l’etage 
sus-crural et femoro-poplite.
Etude de la serie
De 1979 a 1983 nous avons etudie 100 
ATP consecutives. C’est apres un bilan 
fonctionnel clinique, des explorations vas- 
culaires debimetriques non penetrantes et 
une analyse des lesions radiologiques que 
les indications des ATP ont ete posees au 
terme de reunions conjointes entre mede-
cins angiologiques, radiologues et chirur- 
giens vasculaires. Les ATP ont ete reali­
ses  par les radiologues vasculaires. Les 
comparaisons statistiques ont utilise les 
tests du chi carre, de l’ecart type, du t de 
Student ainsi que les calculs actuariels de 
succes.
Repartition topographiques des A TP
A 1’etage sous-crural 43 ATP se repar- 
tissent en deux groupes — 9 ATP popli- 
tes hautes et 34 ATP de l’artere femorale 
superficielle. Nous n’avons pas pose d e ­
dication d’ATP des arteres femorales pro- 
fondes ou poplitees basses.
A 1’etage sus-crural 57 ATP se repar- 
tissent en 36 cas concernant l’artere ilia- 
que primitive et 21 cas de l’artere iliaque 
externe. Nous n’avons pas retrouve de cas 
d’ATP de 1’hypogastrique.
Age et sexe des patients (fig. 1)
Reflet de l’epidemiologie de la maladie 
atherosclereuse, la preponderance des
ATP est au sexe masculin (3:1). La femme 
est touchee par l’atherome, et par conse­
quent justiciable d’ATP, a un age signi- 
ficativement plus eleve que 1’homme (69 4- 
ans contre 58.4 annees en moyenne). La 
comparaison du niveau cfe l’ATP en fonc- 
tion de Page des patients (tableau I) mon- 
tre qu’au dela de 60 ans, 1’ATP femoro- * 
poplitee est le plus frequemment rencon-^ * 
tree. L’axe de l’artere iliaque externe est 
concerne de fa?on identique quelle que - 
soit Page; par contre l’ATP d’une lesion 
cible de l’artere iliaque primitive est domi- -t 
nante avant 60 ans (p < 0.001).
*  <
Globalement, 74% des patients sont au 
stade de claudication intermittente severe 
et 3% des patients ont une lesion asymp- 
tomatique dilatee en complement de 
lesions plus importantes. Les ATP pour -< , 
sauvetage de membre concernent 23% des ;* 
cas: douleurs de decubitus (15%) ou trou-4 r 
bles trophiques (8%). La correlation des I 
stades cliniques en fonction du niveau de x ' 
l’ATP (tableau II) montre qu’a l’etage A
Stade clinique
Tableau 1—Niveau de I'ATP et age
Age, ans
Niveau <  60 > 6 0 Total
ATP femoropoplitee 7 33 40
ATP iliaque externe 9 8 17
ATP iliaque primitive 26 6 32
Total 42 47 89
X2 -  29.26, degres de liberte -  2, p <  0.01.
Tableau II—Niveau de I'ATP et stade clinique
Niveau
Stade clinique Iliaque
Troubles trophiques ou douleurs de decubitus 6
Claudication intermittente 51
Femoro-poplite Total
17
26
23
77
Total 57 43 100
Ecart reduit -  3.4, p <  0.001.
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iiiaque, dans 89% des cas (51 sur 57), l’in- 
dication est motivee par un stade de clau­
dication intermittente severe. Par contre, 
*■ dans 11% (6 sur 57) seulement des cas, 
il existe un stade de sauvetage de mem-
* bre. A l’etage femoro-poplite on constate 
 ^ ^ une dominance significative (p < 0.001)
de l’indication de 1’ATP pour sauvetage 
K39.5%) (17 sur 43) par rapport a l’ATP 
iiiaque.
Resultats
Lesions anatomiques
V  ►
La lesion cible concernee par l’ATP 
, peut s’integrer dans un tableau d’atteinte 
etagee polystenosante; elle est alors acces- 
y soire (38%) ou bien dominante, determi- 
nante dans la symptomatologie fonctio-
Y r nelle (59%). Dans ce dernier cas l’ATP
^se veut curative. II apparait que ce carac- 
f tere “ accessoire” ou “ dominant” n’in- 
A tervient pas dans l’indication selon le 
niveau sus- ou sous-crural; la lesion est 
t  determinante dans 64.3% (27 sur 42) des 
ATP femoro-poplitees et dans 58.2% (32 
* *> sur 55) des ATP iliaques. A l’etage 
femoro-poplite, les thromboses segmen-
* k taires a repermeabiliser representent
44.2% (19 sur 43) des indications contre 
7% (4 sur 57) a l’etage iiiaque (p < 0.04); 
1’indication des ATP sus-crurales est dans 
plus de 9 cas sur 10 une stenose. Ces don- 
v nees anatomiques correspondent a l’ob- 
servation faite cliniquement de lesions 
j- - femoro-poplitees dilatees a un stade de 
sauvetage de membre. La longueur 
^  r  moyenne des thromboses repermeabilisees
A FIG. 2—Evaluation hemodynamique des 14 
ATP iliaques (indice systolique a la cuisse). 
Recul moyen de 13.3 mois (extremes: 1 a 28 
'  mois). Ecart type de la moyenne. Difference 
moyenne (7X) = 0.223 ± 0.14, t de Student 
' 7 (t) = 5.9, degres de liberty (ddl) = 13, p < 
0.001.
est de 3.5 ± 2.5 cm (ecart type) et celles 
des stenoses de 1.8 ± 1.5 cm. La longueur 
moyenne de la thrombose est significati- 
vement plus importante que celle de la ste­
nose (p < 0.01). II n ’existe pas de diffe­
rence significative entre les longueurs 
moyennes des thromboses repermeabili­
sees selon le niveau sus- ou sous-crural de 
meme qu’entre les stenoses a ces niveaux.
Resultats immediats des A  TP 
selon le niveau sus- ou sous-crural
Le taux d ’echec radio-clinique lie a la 
methode est de 18% (18 sur 100); la com- 
paraison des echecs radio-cliniques selon 
le niveau iiiaque (14%) (8 sur 59) et 
femoro-poplite (23%) (10 sur 43) est en 
faveur d ’un moindre taux a l’etage iiia­
que a la limite de la signification statisti- 
que (p < 0.06). L’analyse des 10 echecs 
d’ATP sous-crurales montre que sur huit 
lesions de l’artere femorale superficielle 
la lesion n’a pu etre franchie dans cinq 
cas (quatre thromboses segmentaires et 
une stenose pre-occlusive); dans les trois 
autres cas, la dilatation n’a pas ete suffi- 
sante (absence d ’amelioration clinique 
dans un cas et thrombose secondaires 
dans les autres suivies d’une amputation 
de cuisse pour l’une et d’une sympathec- 
tomie lombaire pour l’autre). Les deux 
echecs d’ATP poplitee pour des lesions 
pre-occlusives et thrombotiques ont 
entraine une amputation et une sympa- 
thectomie lombaire.
Au niveau sus-crural, les echecs (huit 
cas) sont le fait de lesions non franchies, 
pre-occlusives deux fois et non dilatables 
trois fois. Dans trois cas, malgre une dila­
tation radiologique correcte de lesions 
“ accessoires” , il existe un echec clinique. 
La morbidite liee a l’abord percutane 
femoral est la meme quelque soit le niveau 
de l’ATP: sept hematomes au point de 
ponction, non chirurgicaux.
FIG. 3—Evaluation hemodynamique des 10 
ATP femoro-poplitees (indice systolique jam- 
bier). Recul moyen de 12 mois (extremes: 1 a 
30 mois). S  = 0.191 ± 0.09, (t) = 6.6, ddl 
= 9, p < 0.001.
Resultats tardifs compares 
entre A  TP iliaques et f&morales
La surveillance des suites therapeuti- 
ques, d ’une duree moyenne de 22 mois (3 
a 38 mois), concerne 86.6% des ATP 
reussies. Les indices systoliques a la cuisse 
apres ATP iiiaque sont significativement 
majores: l’indice moyen avant ATP, 
de 0.88% ± 0.03%, est augmente a 
1.1% ± 0.04% (p <  0.001). Les memes 
constatations sont faites au niveau de la 
cheville apres ATP femoro-poplitee: 
de 0.71% ± 0.03% l’indice passe a 
0.90% ± 0.04% (p < 0.001) (figs. 2 et 3).
Sur le plan fonctionnel a l’etage 
femoro-poplite, sur 27 ATP suivies, une 
amelioration est acquise dans 96.3% (26 
sur 27) des cas et, dans 74% (20 sur 27) 
des cas, le patient est totalement asymp- 
tomatique (fig. 4a). Le cas d ’amputation 
de cuisse observe (3.8%) a ete secondaire 
a une gangrene que l’ATP a stabilise pen­
dant 12 mois. La lesion etait pre-occlusive 
et “ accessoire” .
A l’etage iiiaque, 44 patients soumis a 
une ATP ont ete suivis. Dans 70% (31 sur 
44) des cas, les patients sont asymptoma- 
tiques et dans 91% (40 sur 44) des cas une 
amelioration est observee. Quatre patients 
ont ete operes pour stenose recidivante, 
soit sur la zone anterieurement dilatee 
(trois fois a 10 et 12 mois), soit dans un 
segment arteriel sus-jacent a l’ATP (fig. 
4b).
Globalement, sur 71 patients suivis 
apres ATP, le taux de succes actuariel 
(asymptomatique ou perimetre de marche 
augmente) a 3 ans est de 92% ± 0.09%.
Discussion
Sur un plan technique, l’ATP a tou- 
jours ete realisee sous heparinate de 
sodium intraveineux. L’anticoagulation a
FIG. 4—Comparaison des resultats fonc- 
tionnels tardifs selon le niveau de I’ATP. (a) 
27 femoro-poplitee suivies, (b) 44 iliaques 
suivies.
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ete poursuivie pendant 48 heures avec 
relais aux anti-aggregants plaquettaires 
(dipyridamole-Aspirine). L’appreciation 
de l’efficacite hemodynamique de la dila­
tation ou de la recanalisation a ete faite 
par les mesures des gradients trans- 
stenotiques. Ceux-ci sont plus fiables a 
l’etage iliaque que femoro-poplite du fait 
de la taille des arteres.
Les verification anatomo-pathologi- 
ques4 ont permis de visualiser l’indefor- 
mabilite de la plaque d’atherome; sous 
l’effet de la pression, elle se rompt sur la 
media et l’adventice qui, par leur elasti­
city, se pretent sans rupture a la dilata­
tion. La cicatrisation intimale secondaire 
se fait sans retraction fibreuse ce qui 
explique la persistance du “ recalibrage” 
La cicatrice retractile explique peut-etre 
les recidives observees. Dans un quart des 
cas, apres ATP, il persiste un aspect 
radiologique de dissection s’expliquant 
par ces ruptures sous-intimales. En aucun 
cas la realisation d’une ATP n’a entrave 
secondairement un geste de chirurgie. Les 
complications chirurgicales sont appre- 
ciees a 3.5% par Roberts et Ring,5 domi- 
nees dans 1% a 2% des cas par des 
hemorragies au point de ponction et, dans 
1 % des cas, par une migration embolique 
deteriorant le lit d’aval. Dans un cas (1%) 
de notre serie, une desobstruction par 
catheter de Fogarty a ete necessaire. 
Schneider et collaborateurs6 rapportent, 
sur 882 cas d ’ATP, un taux de complica­
tions chirurgicales de 2.5% (2% de sutu­
res arterielles et 0.5% d’emboles). Le taux 
d’echecs de notre serie lie directement a 
la methode est de 10%; il s’agit soit d ’une 
stenose franchie non dilatee ou d ’une 
thrombose secondaire. Le taux d’echec de 
l’etude collective rapportee par Zeitler et 
collaborateurs7 sur 2942 cas d ’ATP est 
aussi de 10%. Schneider et collabora­
teurs6 evaluent le taux de succes initial 
entre 93% pour les ATP iliaques et 88.3% 
pour les atteintes femoro^poplitees. 
Levade et collaborateurs8 rapportant les 
resultats de l’etude multicentriques fran- 
faise sur 647 cas d’ATP, observent 6% 
de complications (dont 2% chirurgicales) 
et un taux de succes de 96% a l’etage 
iliaque et 92% a l’etage sous-crural. 
Rieger et collaborateurs,9 sur 306 steno­
ses iliaques, observent 88.3% de succes 
immediat.
Tardivement 1’evaluation des resultats 
repose sur l’amelioration clinique et 
hemodynamique ainsi que sur d’eventuels 
controles radiologiques. La mesure des 
indices systoliques a la cuisse et a la che- 
ville permet d ’authentifier un bon resul- 
tat ainsi que les epreuves de marche avec 
etude de la recuperation des valeurs de 
repos.10,11 Samson et collaborateurs12 
decrivent une possible dissociation ana- 
tomoclinique: dans 9 cas sur 12 d’ATP 
iliaques et 3 sur 12 ATP femoro-poplitees 
sans amelioration objective des chiffres 
hemodynamiques malgre un succes radio­
logique, les membres ont ete sauves. Ana- 
tomiquement, le controle est possible par 
les methodes semi-effractives que sont les 
angiographies intraveineuses photogra- 
phiques avec soustraction13 ou les angio­
graphies veineuses digitalisees.14
La fiabilite a long terme de l’ATP est 
grande. Schneider et collaborateurs6 
retrouvent un taux actuariel de permea­
bility a 1 et 5 ans de 89.4% et 84.6% a 
l’etage iliaque et de 74% a 68% au niveau 
sous-crural. Sur 5000 cas recenses par 
Zeitler et collaborateurs,7 le taux de per­
meability a 3 ans a l’etage iliaque est de 
84% et, a 5 ans a l’etage femoro-poplite, 
de 69%. Rieger et collaborateurs9 ont 
retrouve un taux de permeability a 6 ans 
de 80% sur 164 stenoses iliaques con- 
trolees.
Ainsi Tindication ideale de l’ATP est- 
elle representee par le stenose courte, con- 
centrique et non calcifiee de 1’artere ilia­
que primitive ou de 1’artere iliaque 
externe.5’15 A Petage femoral c’est sur- 
tout 1’artere femorale superficielle qui est 
l’objet de la dilatation. Ces indications 
sont elargies aux arteres iliaques internes, 
femorales profondes et au stenoses 
anastomotiques.5
Conclusions
Le taux important de succes initial et 
a long terme de cette technique peu agres- 
sive et non chirurgicale lui reserve une 
place de choix dans le traitement de cette 
maladie chronique qu’est l’arteriopathie 
des membes inferieurs. Les limites tech­
niques de l’ATP, progressivement recu- 
lees, permettent d’elargir les indications. 
Loin d’etre une therapeutique concuren- 
tielle de la chirurgie, l’ATP en est un com­
plement. Peut-etre la decennie a venir 
elargira-t-elle les possibility de l’angio- 
graphie therapeutique par l’application 
du rayon laser sur la plaque d ’atherome.
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Duodenal Obstruction Secondary to Congenital Web
in an Adult
- 'Congenital duodenal web, although rare, 
may be more common than presently ap- 
r predated. The possibility of this condi­
tion should be considered in the differen­
tial diagnosis of duodenal obstruction in 
y the adult. It should be treated 
surgically either by duodenotomy with
► excision of the web or by duodenoje­
junostomy. The results are excellent, as
*- illustrated by the authors in their report 
of a 58-year-old man with this condition, 
* who was treated by duodenojejunostomy.
x
Bien que rare, la presence d'un 
diaphragme duodenal congenital est 
peut-etre plus frequente qu'on ne le croit 
presentement. Cette possibility doit etre 
, y envisagee chaque fois que I'on procede 
au diagnostic differential d'une obstruc-
► tion duodenale chez I'adulte. Cette affec­
tion est une indication de chirurgie.
r L'operation consiste en une duodeno- 
tomie avec incision de la membrane ou 
*en une duodeno-jejunostomie. Les 
resultats sont excellents comme I'illustre 
le cas decrit par les auteurs d'un homme 
de 58 ans qui a ete traite par duodeno- 
jejunostomie.
^Congenital duodenal diaphragm or web 
is a rare anomaly, reported to occur in 1
► in 9000 to 40 000 births.1 The majority 
become apparent in infancy. Its occur-
r rence in adults has been considered a rari­
ty, but recent reports suggest that this en- 
y tity may be more common than previous­
ly appreciated.13 Appropriate investiga­
tions include plain films of the abdomen,
► upper gastrointestinal series and 
gastroduodenoscopy. Once the diagnosis
r is made, operation is indicated.
We report a case of congenital web
► which presented with acute duodenal 
obstruction in an adult and was diagnos-
_ f From the Department o f  Surgery,
St. Joseph’s Health Centre and University 
K o f  Toronto, Toronto, Ont.
Accepted fo r  publication Dec. 22, 1983
 ^ Reprint requests to: Dr. M. Deitel,
St. Joseph’s Health Centre Research 
\ dFoundation, 30 The Queensway, Toronto, 
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ed preoperatively. Excellent results were 
obtained with a duodenojejunostomy.
Case Report
A 16-hour history of progressive abdominal 
distension, epigastric fullness and one episode 
of vomiting led to the admission of a 58-year- 
old man. He denied a history of peptic ulcer 
disease, weight loss or malaise. He admitted 
that he had suffered intermittently for many 
years from epigastric fullness and mild discom­
fort following the ingestion of high residue 
foods, particularly raw fruits and vegetables, 
but because this occurred infrequently he had 
never sought medical attention. He was a well- 
nourished, mildly obese, afebrile man who 
complained of mild discomfort and had mark­
ed upper abdominal distension. There were no 
signs of peritoneal irritation and bowel sounds 
were normal. His hemoglobin, serum elec­
trolyte and blood urea nitrogen levels were nor­
mal. The leukocyte count was slightly elevated. 
Abdominal films showed a markedly distended 
stomach (Fig. 1). Following insertion of a 
nasogastric tube, 1.5 L of bile-stained fluid 
were aspirated.
Roentgenography after barium meal show­
ed that the first and second portions of the 
duodenum were distended (Fig. 2a) and there 
was partial obstruction at the third portion 
(Fig. 2b). A septum was outlined at the point 
of obstruction, with the contrast medium trick­
ling through a centrally located aperture.
FIG. 1—Plain film shows stomach distend­
ed with fluid.
Ultrasonography revealed a normal gallblad­
der, biliary tree and pancreas.
Endoscopy, using the 11-mm Q-gastroscope, 
revealed a normal esophagus, a large stomach 
containing bile-stained material, a dilated 
pylorus and first, second and proximal third 
parts of the duodenum. There was no duodenal 
ulcer. At the proximal third part of the 
duodenum, approximately 7 cm beyond the 
ampulla of Vater, was a circumferential, soft, 
mucosa-lined diaphragm with a central open­
ing. The endoscope could be passed wrlh dif­
ficulty through the centrally located aperture, 
the margins of which hugged the instrument.
At laparotomy on the day of admission, a
Fig. 2b
FIG. 2—(a) Markedly distended first and se­
cond portions of duodenum, (b) Almost com­
plete obstruction of proximal third part of 
duodenum due to septum with tiny central 
opening.
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normal gallbladder and pancreas were noted. 
The first, second and proximal part o f the third 
portions o f the duodenum were dilated and 
mobilized by the Kocher maneuver. There was 
no evidence o f compression of the duodenum 
by the superior mesenteric artery, the obstruc­
tion being to the right o f this vessel. The 
duodenum was marked externally by a slight 
ring-like constriction at the site o f obstruction.
A side-to-side antecolic duodenojejunostomy 
was performed. The postoperative recovery 
was uncomplicated. At the 6-month follow-up, 
the patient was asymptomatic, experiencing no 
epigastric fullness or discomfort with high- 
residue foods. An upper gastrointestinal series 
showed that the duodenojejunostomy emptied 
promptly.
Discussion
Forty-three cases of congenital 
duodenal web presenting in adults have 
been reported,1 5 in the past 2 years.2,3 
Some patients had moderate to severe 
symptoms of upper gastrointestinal tract 
obstruction intermittently for several 
months to a few years. Outlet obstruction 
attributed directly to peptic ulcer disease 
was the most common preoperative 
diagnosis in these cases.1-4 In the three 
patients described by Cooperman and 
associates1 and in two of three patients 
reported by Killebrew and Kukora,3 con­
servative therapy resulted in marked pro­
longation of obstructive symptoms with 
resulting malnutrition.
The embryologic defect producing the 
duodenal web is probably best explained 
by Tandler’s theory, proposed in 1900.5 
Tandler examined the developing gut in 
embryos and found that during its 
development the intestinal lumen is fill­
ed with proliferating epithelium. A pro­
cess of vacuolization results in a lumen. 
If vacuolization is incomplete, a duodenal 
web may result. Atresia of the intestinal 
lumen also occurs as a result of in­
complete vacuolization. A complete web 
becomes manifest in the neonate. When 
apertures are present, they may be single 
or multiple. One patient, reported by 
Bilton and Yap,6 had a single 2-mm 
aperture that did not become clinically ap­
parent until age 61.
It is not clearly understood why pa­
tients with small apertures may live for 
many years asymptomatically, in a nor­
mal nutritional state, and then the con­
dition may progress to obstruction. In at 
least six reported cases the obstruction oc­
curred concomitantly with pyloroduo- 
denal ulceration. Subsequent medical 
ulcer therapy resulted in only temporary 
relief of the obstruction.1-3 Mucosal 
edema associated with the ulcer with 
resultant narrowing of the aperture distal- 
ly may have caused the condition to pro­
gress to obstruction in these patients. In­
termittent partial duodenal obstruction by 
debris following high-residue meals and 
mucosal edema are likely an important
cause. We believe this explains the de­
velopment of obstruction in our patient.
The diagnosis of duodenal web in an 
adult requires an awareness of the enti­
ty, in order to distinguish it from the 
other uncommon causes of high small- 
bowel obstruction, such as superior 
mesenteric artery syndrome7,8 and an­
nular pancreas.9 Plain abdominal roent­
genograms may show dilated stomach 
and proximal duodenum. The upper 
gastrointestinal series will demonstrate the 
dilated stomach and duodenum proximal 
to the web and may show a windsock­
shaped obstruction (Fig. 2b). Gastroscopy 
was used in seven other cases,1-3,10 but 
was carried through the duodenum far 
enough to give the diagnosis preoperative- 
ly in only three; the diagnosis was con­
firmed by gastroduodenoscopy in our 
patient.
Intraoperatively, the presence of a 
slight circumferential indentation of the 
duodenum externally indicated the site of 
the web. Histologically, the web consists 
of a lining of thickened mucosa, including 
muscularis mucosae, on both sides of a 
normal submucosa.5 Of these duodenal 
webs, 75% are within 2 cm of the ampulla 
of Vater;1,5 approximately 60% are 
located proximal to the ampulla.3
Initial therapy consists of gastric de­
compression with a nasogastric tube and 
replacement of fluid and electrolytes. The 
surgical procedures that have been per­
formed include duodenotomy with exci­
sion of the web and duodenoplasty,1,3,6,10 
duodenojejunostomy,8 gastrojejunosto­
my3,6 and duodenoduodenostomy.2,11 
Most patients have been treated by duo­
denotomy with excision of the web and 
suturing the mucosal edges together, with 
either a transverse or longitudinal closure 
of the duodenotomy or Finney pyloro­
plasty.1-3,6,10 This gives excellent results. 
Gastrojejunostomy may be inadequate, 
as it fails to relieve the duodenal obstruc­
tion and symptoms often persist post- 
operatively.4 Furthermore, bile gastritis 
may recur subsequently. We preferred 
duodenojejunostomy in our patient, be­
cause the web was approximately 7 cm 
beyond the ampulla and quite close to the 
superior mesenteric artery. Technically, 
this was easily performed.
Our patient differed in that he had a 
brief history of obstructive symptoms. 
The normal electrolyte levels, fluid 
balance and nutritional status of the pa­
tient support this. However, the fact that 
he had a markedly distended stomach and 
duodenum and yet had vomited only once 
and was not in severe distress indicated 
that there was a degree of chronic 
obstruction.
The congenital duodenal web, although 
rare, is likely more common than has 
been appreciated, with three papers be­
ing published recently, reporting on eight
adult patients.1-3 This entity should be 
considered in the differential diagnosis of 
subacute or acute duodenal obstruction 
in the adult. Once the diagnosis is made, T- 
surgical correction either by duodeno­
tomy with excision of the web or a * 
duodenojejunostomy provides excellent.- 
results.
4 A
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Activity comparable to doxorubicin 
Effective as first and second line therapy 
Responses at all major sites of metastases 
Long duration of response
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Less than 6% severe alopecia 
Little or no severe nausea and vomiting 
No tissue necrosis on extravasation reported 
Low potential for cardiotoxicity
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NOVANTRONE*
mitoxantrone hydrochloride 
intravenous injection
ANTINEOPLASTIC
AGENT
CAUTION
NOVANTRONE* ISA POTENT DRUG AND SHOULD BE USED ONLY 
BY PHYSICIANS EXPERIENCED WITH CANCER CHEMO­
THERAPEUTIC DRUGS (SEE WARNINGS AND PRECAUTIONS). 
BLOOD COUNTS SHOULD BE TAKEN AT FREQUENT INTER 
VALS PRIOR. DURING AND POST THERAPY. CARDIAC MONI­
TORING IS ADVISED IN THOSE PATIENTS WHO HAVE RE­
CEIVED PRIOR ANTHRACYCLINES. PRIOR MEDIASTINAL 
RADIOTHERAPY OR WITH PRE-EXISTING CARDIAC DISEASE.
PHARM ACOLOGICAL ACTION 
Although its mechanism of action has not been determined, mitoxantrone 
is a DNA-reactive agent. It induces nuclear aberrations with chromo­
some scattering in cell cultures (human colon carcinoma line) and is a 
potent inhibitor o f RNA and DNA synthesis. Compared on an equimo­
lar basis, mitoxantrone is seven times more potent than doxorubicin in 
inhibiting the uptake of 3H-uridine and four times more potent in inhibiting 
the uptake o f ’H-thymidine by mouse lymphoma L5178Y cells in vitro. 
INDICATIONS
NOVANTRONE* is indicated for chemotherapy in patients with carci­
noma of the breast, including locally advanced and metastatic disease. 
CONTRAINDICATIONS
NOVANTRONE* is contraindicated in patients who have demonstrated 
prior hyper- sensitivity to anthracyclines.
WARNINGS
Since NOVANTRONE* produces m yelosuppression (see ADVERSE 
EFFECTS), it should be used with caution in patients in poor general 
condition or with pre-existing myelosuppression.
Cases o f functional cardiac changes, including congestive heart failure 
and decreases in left ventricular ejection fraction have been reported. 
These cardiac events have occurred almost exclusively in patients who 
have had prior treatment with anthracyclines, prior mediastinal radio­
therapy or with pre-existing heart disease. Cardiac monitoring is advisable 
in such patients. It is suggested that cardiac monitoring also be per­
formed in other patients during therapy exceeding 12 courses of NOVAN­
TRONE*. as experience during prolonged treatment is limited. 
NOVANTRONE* may impart a blue-green colouration to the urine for 24 
hours after administration, and patients should be advised to expect this 
during active therapy. Safe use o f NOVANTRONE* in pregnancy has not 
been established. No information is available concerning the presence 
o f NOVANTRONE* in the milk o f nursing mothers.
PRECAUTIONS
Full blood counts should be undertaken serially during a course of 
treatment. Dosage adjustments may be necessary based on these counts 
(see DOSAGE section).
It is recommended that NOVANTRONE* not be mixed in the same infu­
sion with other drugs.
ADVERSE EFFECTS
NOVANTRONE* is clinically well tolerated, demonstrating a low overall 
incidence o f adverse events, particularly those of a severe, irreversible 
or life-threatening nature.
Some degree o f  leukopenia is to be expected following recommended 
doses o f NOVANTRONE*. However, suppression of WBC counts below 
1000/mm3 is infrequent. With dosing every 2 1 days, leukopenia is usu­
ally transient, reaching its nadir at about 10 days after dosing, with 
recovery usually occurring by the 21 st day. Thrombocytopenia can occur, 
and anaemia occurs less frequently. Myelosuppression may be more 
severe and prolonged in patients having had extensive prior chemother 
apy or radiotherapy or in debilitated patients.
The most commonly encountered side effects are nausea and vomiting, 
although in the majority of cases these are mild (WHO Grade I) and 
transient. Alopecia may occur, but is most frequently o f minimal sever­
ity and reversible on cessation o f therapy.
Other side effects which have occasionally been reported include 
anorexia, diarrhoea, dyspnoea, fatigue and weakness, fever, gastroin­
testinal bleeding, stomatitis/ mucositis, and non-specific neurological 
side effects.
Changes in laboratory test values have been observed infrequently, e.g.. 
increased liver enzyme levels, elevated serum creatinine and blood urea 
nitrogen levels.
Cardiovascular effects, which have only occasionally been of clinical 
significance, include decreased left ventricular ejection fraction (de­
termined by ECHO or MUGA scan), EKG changes and acute arrhythmia. 
Congestive heart failure has been reported. Such cases generally re­
sponded well to treatment with digitalis and/or diuretics.
CLINICAL RESULTS
Introduction
Clinical trials experience has established the dosage range, efficacy and 
safety profile o f  NOVANTRONE*.
A single dose can be given intermittently every three or four weeks. 
The recommended initial treatment dose in good risk patients is 14 
mg/m2.
Efficacy
Efficacy data are available on 349 patients with locally advanced or 
metastatic breast carcinoma. Results are dependent on many predispos­
ing factors including prior chemotherapy and/or radiotherapy, the health 
o f the patients, sites of metastases, and dose of the agent employed. In a 
European multi-centre first- line single-agent trial using an initial dose 
o f 14 m g/m 2. the overall response rate was 39% . which compared 
favourably to doxorubicin therapy at a dose o f60-75 mg/m2 when given 
to patients with similar stage disease. In an ongoing study of a direct 
comparison with doxorubicin, given as second-line therapy to breast 
cancer patients who failed a standard first-line combination, response 
rates are 27% for NOVANTRONE* and 23% for doxorubicin. The mean 
duration of response observed after NOVANTRONE* was greater than 
those reported after doxorubicin. Responses have been seen in all major 
sites of metastases including lymph nodes, lung, bone, skin and viscera, in 
patients both with and without prior hormonal therapy. Available data
suggest that NOVANTRONE* is comparable in efficacy with doxorubicin 
in the treatment of advanced breast cancer. Myelosuppression with 2 1 -day 
treatment intervals is comparable with that observed with doxorubicin. 
Multiple courses of single-agent NOVANTRONE* therapy, in some cases 
for longer than twelve cycles, have been administered with excellent 
tolerance and a good response. NOVANTRONE* showed incomplete cross- 
resistance with doxorubicin since responses have been observed in pa­
tients in whom doxorubicin had failed or who relapsed after response to 
that drug. A continuing large-scale clinical trials program with combi­
nation therapy also demonstrated early positive results for efficacy and 
safety. In seven studies, over 100 cycles o f combination therapy have 
been given to 77 patients.
Safety
Data on the overall safety profile of NOVANTRONE * (based on 989 patients) 
demonstrated advantages o f NOVANTRONE* compared to the anthracy­
clines with respect to both the quality of life and tne long-term safety of 
patients. The majority o f side effects with NOVANTRONE* are mild in 
nature. Removal of patients from NOVANTRONE* treatment for reasons 
of toxicity has been rare in clinical studies. A number o f patients have 
reported no side effects at all. In addition, the relatively low risk of 
serious side effects has permitted treatment of patients on an out-patient 
basis. The most common acute effects were nausea and/or vomiting 
(only 3.5% severe or very severe with NOVANTRONE*. compared to 
10-15% reported with doxorubicin), stomatitis/mucositis (only 0.3% 
severe or very severe with NOVANTRONE*) and alopecia (only 0.9% 
severe or very severe, and 15% overall with NOVANlRONE* compared 
with 85% severe or very severe and 100% overall reported with 
doxorubicin). Serious local reactions have not been reported following 
extravasation of NOVANTRONE* at the infusion site.
With respect to myelosuppression, initial NOVANTRONE* doses of 14 
mg/m2 every three weeks are well-tolerated in good-risk patients. Se­
vere degrees of myelosuppression have been rare. The median white 
cell nadir in a European second-line study was 2 .5x l03; in a European 
first-line study only 4.8% (2/42) o f patients experienced a nadir of less 
than 1.000. The nadir usually occurs around day 10 or 11 and returns to 
normal baseline value by day 21, in time for the next course of treatment. 
After multiple courses of NOVANTRONE*. white blood cell and platelet 
nadirs show no further decrease beyond those observed in the first few 
cycles, indicating no cumulative or permanent effects of NOVANTRONE* 
on marrow reserves.
Cardiotoxicity
Adverse cardiac experiences have been infrequent. In contrast, doxoru­
bicin has been reported to produce chronic cardiomyopathy and irre­
versible congestive heart failure in up to 11 % of patients given nine or 
more courses o f that drug at the usual dose schedule (60 mg/m2 every 
three weeks). Whether or not related to NOVANTRONE*. only 119 cardiac- 
related episodes have been reported from a total data-base of more than 
3,200 treated patients, including only 29 (0.9%) reports o f  clinical con­
gestive heart failure, o f which only one had no other known predispos­
ing factors. The risk of cardiotoxicity is increased with prior anti- 
neoplastic drug or radiation therapy. In patients without predisposing 
factors, development o f congestive heart failure with NOVANTRONE* 
therapy is rare.
Clinical experience suggests there is no need to lower the dose for pa­
tients with existing renal or hepatic disease.
In summary, NOVANTRONE* is well tolerated and provides a better 
quality of life for patients with breast cancer, compared with doxorubicin 
and yet shows comparable efficacy.
NOVANTRONE* has been used alone or in combination in patients with 
or without prior chemotherapy, as well as in those who have received 
prior adjuvant therapy. It is less cardiotoxic than anthracyclines such as 
doxorubicin and thus represents a clear therapeutic advance over cur­
rently available compounds.
SYMPTOMS AND TREATM ENT O F OVERDOSAGE
There is no known specific antidote for NOVANTRONE. As would be 
expected from the pharmacological actions of the drug, haematopoietic, 
gastrointestinal, hepatic and renal toxicity may be seen, depending on 
the dosage given and the physical condition of the patient. The manage­
ment of overdosage is symptomatic and supportive and patients should 
be monitored closely. (See also the sections “ WARNINGS” , “ PRE­
CAUTIONS”  and “ ADVERSE REACTIONS")
DOSAGE
The recommended initial dosage for use as a single agent is 14 mg/m2 of 
body surface area, given as a single intravenous dose, which may be 
repeated at 2 1 -day intervals. A lower initial dose (12 mg/m2 or less) is 
recommended in patients with inadequate marrow reserves due to prior 
therapy or poor general condition.
Dosage modification and timing of subsequent dosing should be deter­
mined by clinical judgement depending on the degree and duration of 
myelosuppression. If 2 1 day white blood cell and platelet counts have 
returned to adequate levels, prior doses can usually be repeated. The 
following Table indicates a guide todosing based on myelosuppression.
WBC AND 
PLATELET NADIR
TIME TO 
RECOVERY
SUBSEQUENT
DOSING
IF WBC NADIR RECOVERY REPEAT PRIOR DOSE OR
>1 500 <21 DAYS INCREASE BY 2mq/m! IF
AND MYELOSUPPRESSION NOT
PLATELET NADIR CONSIDERED ADEQUATE.
>50 000
IF WBC NADIR RECOVERY WITHHOLD UNTIL
>1 500 >21 DAYS RECOVERY THEN
AND REPEAT PRIOR DOSE.
PLATELET NADIR 
>50 000
IF WBC NADIR ANY DURATION DECREASE BY 2mq/m2
<1 500 FROM PRIOR DOSE AFTER
OR RECOVERY.
PLATELET NADIR 
<50 000
IF WBC NADIR ANY DURATION DECREASE BY 4 mg/m2
<1 000 FROM PRIOR DOSE AFTER
OR RECOVERY.
PLATELET NADIR 
<25 000
While no unforeseen problems have been encountered when NOVAN­
TRONE* is used in combination with other antineoplastic therapy, data 
are limited; therefore, NOVANTRONE* in combination therapy should 
be used with caution until wider experience is obtained.
As a guide, when used in combination chemotherapy with another 
myelosuppressive agent, the initial dose of NOVANTRONE* should be 
reduced by 2-4 mg/m2 below the doses recommended above for single 
agent usage; subsequent dosing, as outlined above, depends on the de­
gree and duration of myelosuppression.
ADMINISTRATION O F  SOLUTION
NOVANTRONE* solution should be diluted to at least 50 mL with either 
Sodium Chloride for Injection (U.S.P.) or 5% Dextrose for Injection 
(U.S. P.). This solution should be introduced slowly into the tubing of a 
freely-running intravenous infusion of Sodium Chloride for Injection 
(U.S.P.) or 5% Dextrose for Injection (U.S.P.) administered over not 
less than three to five minutes intravenously. If extravasation occurs, 
the administration should be stopped immediately and restarted in an­
other vein. However, serious local reactions have not been reported 
following extravasation.
NOVANTRONE* should be administered by individuals experiencedig, 
the use of antineoplastic therapy.
Caution in the handling and preparation of NOVANTRONE* solutions 
must be exercised and the use of protective eyeglasses, gloves and adttr^ 
protective clothing is recommended. (See "SA FE HANDLING BY 
HOSPITAL PERSONNEL" section).
STORAGE DIRECTIONS 4  <
NOVANTRONE* should be stored at room temperature — DO NOT 
FREEZE. With recommended storage. NOVANTRONE* remains stable 
for two (2) years. -i
Following preparation of the infusion, the diluted solution should be 
stored at room temperature and used within 24 hours. Any original 
solution which remains in the vial should be discarded. NOTE: LIKE 
THE ORIGINAL SOLUTIONS, THE DILUTIONS SHOULD ALSO 
NOT BE FROZEN.
DRUG COMPATIBILITY ^  *•
Until specific compatibility data are available, it is recommended that 
NOVANTRONE* not be mixed in the same infusion with other drugs. . 
GUIDELINES FOR SAFE USE BY HOSPITAL PER SO N N EL^
Handling:
1. Preparation o f antineoplastic solutions should be done in a v e rn a l - 
laminar flow hood (Biological Safety Cabinet — Class II).
2. Personnel preparing NOVANTRONE* solutions should wear PVC 
gloves, safety glasses and protective clothing such as disposable 
gowns and masks.
3. Personnel regularly involved in the preparation and handling of 
antineoplastics should have bi-annual blood examinations. ■* «,
Disposal:
1. Avoid contact with skin and inhalation of airborne particles by use 
of PVC gloves and disposable gowns and masks.
2. All needles, syringes, vials, ampoules and other materials which 
have come in contact with NOVANTRONE* should be segregated in 
plastic bags, sealed and marked as hazardous waste. In c in e ra ted J 
I000°C or higher. Sealed containers may explode if a tight seal 
exists.
3. If incineration is not available, mitoxantrone hydrochloride may \fk 
detoxified by adding 5.5 parts by weight of calcium hypochlorite to 
each 1 part by weight of mitoxantrone hydrochloride in 13 parts by 
weight o f water. + The calcium hypochlorite should be added GR*V* 
DUALLY and the procedure carried out with adequate ventilation 
since chlorine gas is liberated.
Vials: *  *
Prepare an adequate quantity of calcium hypochlorite solution (eg; Add 
43.5 g calcium hypochlorite to 100 mL of waterf). Withdraw any 
NOVANTRONE* remaining in the vial with the aid of a hypodermic syringe. 
Add to the prepared calcium hypochlorite solution slowly, preferably in 
chemical fume hood or biological safety cabinet — Class II. Add an 
appropriate quantity of the calcium hypochlorite solution to the vial to 
detoxify any remaining drug. Withdraw the solution and discard in the 
sewer system with running water. Dispose of the detoxified vials in a 
safe manner.
Needles, syringes, disposable and non-disposable equipment:
Rinse equipment with an appropriate quantity of calcium hypochloci'e . 
solution (43.5 g per 100 mL of water*). Discard the solution in the 
sewer system with running water and discard disposable equipment in a 
safe manner. Thoroughly wash non-disposable equipment in soap^ind^ 
water.
Spillage /Contamination:
Wear gloves, mask, protective clothing. Place spilled material in sp 
appropriate container (i.e. cardboard for broken glass) and then in a 
polyethylene bag; absorb remains with gauze pads or towels; wash area 
with water and absorb with gauze or towels again and place in bag;-scaj, 
double bag and mark as a hazardous waste. Dispose of waste by inciner­
ation or by other methods approved for hazardous materials. Personnel 
involved in cleanup should wash with soap and water. ^
t  Appropriate safety equipment such as goggles and gloves should be 
worn while working with calcium hypochlorite solution since it is 
corrosive. —r
AVAILABILITY
NOVANTRONE* mitoxantrone hydrochloride for injection is supplied as 
a sterile aqueous solution at a concentration equivalent to 2 mg mitoxaif- ' 
trone free base per mL. and is available in the following vial sizes:
lOmL/vial (20mg) Product C ode..............................................  9393-34
12.5mL/vials (25mg) Product C ode.......................................... 9393-7*
Identification:
Glass vials containing 10 and l2.5mL of a clear, dark blue solutio^ 
CHEM ISTRY
Composition
NOVANTRONE* mitoxantrone hydrochloride, a synthetic anthracenedi^ne.'* 
is a potent antineoplastic agent. Its molecular formula is C22H28N40 6 
.2HC1 and its molecular weight is 517.4. It is a hygroscopic dark blue 
solid supplied as a sterile, aqueous solution containing mitoxantronf 
hydrochloride equivalent to 2 mg/mL mitoxantrone free base, with so­
dium chloride, sodium acetate, and acetic acid as inactive ingredients. 
The product does not contain antibacterial preservatives. Its structural 
formula appears below.
H H
H O  O NCH.CH,NCH,CHjOH
HO O NCH,CH,NCH,CH,OH
H H '* ■
molecular formula: C 22H2gN40 6.2HCI molecular weight: 517.4. 
Chemical Name ^  J
1 .4-Dihydroxy-5.8-bis[[2-[(2-hydroxyethyl)amino]- 
ethyl] aminoj -9,10-anthracenedione dihydrochloridc
PAAB
CCPP
*Trade mark of American Cyanamid Company Cyanamid Canada Inc. 
Toronto Product monograph available on request.
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The Prone Position for Transurethral Resection of 
Anterior Bladder-Wall Tumours
Transurethral resection of tumours of the 
. » anterior bladder wall may be technically 
difficult. The resectoscope must be held 
► with an awkward upside-down grip and 
the surgeon assume an uncomfortable 
' " position, particularly as the bladder fills 
^nd causes the tumour to drift away 
from the surgeon. There is a risk of in- 
t traperitoneal perforation as the surgeon 
cuts more deeply to resect the tumour.
+ When the patient is in the prone position 
the tumour is more accessible. This 
» *■ allows it to be resected more easily, 
more thoroughly and more comfortably.
4 *The technique may be used in men as 
well as in women.
La resection transuretrale des tumeurs de 
la paroi anterieure de la vessie peut 
y  presenter des difficultes techniques. La 
prise du resectoscope est difficile et le 
■ v chirurgien conserve une position incon- 
fortable, particulierement quand la vessie 
v *se remplit, poussant la tumeur hors de la 
portee du chirurgien. Alors que le 
T chirurgien doit sonder plus profond6ment 
pour rSsequer la tumeur, il y a risque de 
perforation intrap£ritoneale. La tumeur 
r  ,  est plus facilement accessible quand le 
patient est couch6 sur le ventre. Ceci 
v- vpermet une resection plus facile, plus 
complete et plus confortable. La techni- 
y que s'applique aussi bien chez I'homme
que chez la femme. 
r
y Transurethral resection is an excellent 
method of treating patients with the com- 
Knon, superficial stage 0, A or B1 car­
cinoma of the bladder and as palliation 
->- for some patients with stage C or D 
tumours (Jewett classification1 with the 
*• Marshall modification2). The procedure 
is technically simple, the morbidity and 
*" mortality are low and bladder function is 
^ ^preserved. These benefits are related, to 
some extent, to the experience of the
. From the Department o f  Surgery
(Urology), University o f  Pittsburgh Medical 
Center, Pittsburgh, Pa.
T
I Accepted for publication Dec. 2, 1983
Reprint requests to: Dr. T.E. Hodgins, 684 
Belmont Ave., Kitchener, Ont. N2M 1N6
surgeon and to the fact that most blad­
der cancers are found near the ureteral 
orifices. Melicow3 noted that, in 70% of 
patients, the carcinomas are found on the 
posterior and lateral wall near the ureteral 
orifices, 20% are found on the trigone 
and in only 10% of patients do the 
tumours occur on the dome of the blad­
der. Cox and associates4 reported that 
44% of carcinomas are found on the 
lateral wall, 26% at the base of the blad­
der and only 13% are located on the 
dome. In 17% of the patients the lesions 
were multiple.4 Greene and associates5 
noted that more than 80% of carcinomas 
of the bladder are related anatomically to 
the ureteral orifice and only 9% are found 
on the anterior bladder wall (Table I).
The tum ours, which are found 
anteriorly near the 12 o’clock position, 
are often silent and thus more advanced 
when the diagnosis is made. A few are 
high-grade adenocarcinomas reflecting a 
urachal origin. Anterior bladder-wall 
tumours are technically more difficult to 
handle with a resectoscope because the in­
strument must be held in an awkward up­
side-down grip. Moreover, the surgeon 
often needs to assume an uncomfortable 
position and, as the bladder fills, the 
tumour drifts away from the resectionist, 
forcing him to “ reach” to continue to 
resect the tumour. In some cases, an assis­
tant must apply suprapubic pressure. 
There is the added risk of intraperitoneal 
perforation of the bladder as the surgeon 
resects more deeply to remove all the 
carcinoma.
Some years ago, the senior author 
(R.A.H.), faced with the problem of a 
carcinoma in the anterior wall of the blad­
der in a woman, suggested that the
T ab le  1—Lo cation  of B lad der T u m o u rs3
Lo catio n No. %
P o ste ro la te ra l to u retera l o r if ice s 5 5 4 6
La te ra l w a ll 2 6 2 2
B ase 14 12
Trigo ne 3 2
Dom e, an terio r w a ll 11 9
V e s ic a l neck 7 5
P o ste rio r w a ll 5 4
tumour could be resected more thorough­
ly, more easily and more comfortably 
with the patient in the prone position.6 
In this position, the anterior wall of the 
bladder has the same relation to the resec­
tionist as the trigone and posterior wall 
of the bladder have in the lithotomy 
position.
We would like to draw attention to this 
suggestion and extend its applicability to 
men. In men, an external perineal 
urethrotomy is needed with the urethro­
tomy as proximal in the perineal urethra 
as possible, so there will be a “ straight 
shot”  through the prostatic urethra into 
the bladder.
Surgical Technique
The procedure may be done with the 
patient under general or spinal anesthesia.
The patient is in the usual lithotomy 
position when the diagnostic cystoscopic 
examination is made. The resectoscope 
sheath is passed through the urethra in 
women or the urethrotomy in men. The 
foot section of the operating table, 
lowered for the cystoscopic examination, 
is elevated into place and the patient’s legs 
are lowered onto the foot section. The pa­
tient, with the resectoscope sheath in situ, 
is turned to the prone position, with the 
legs straight and together so that the 
resectoscope sheath is supported by the 
medial aspect of the thighs. The resec­
toscope sheath may be wrapped with a 
sterile towel and held by the surgeon. The 
patient is placed so that the abdomen lies 
on the middle section of the table, 
pushing the anterior bladder wall into a 
flattened and more accessible position for 
the resectionist. An arm board is secured 
to each side of the middle section of the 
surgical table in a slightly abducted posi­
tion and the legs are strapped to the arm 
boards. The foot section of the table is 
lowered completely to provide room for 
the resectionist. The operative site is 
prepared once more.
When the anterior lobe of the prostate 
is enlarged, a certain effort must be made 
to elevate the ocular end of the resec­
toscope so that the loop may bite deeply 
into the tumour. Sometimes the anterior
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lobe of the prostate must be resected. 
When the procedure is completed, a no. 
24 French Foley catheter is left in the 
bladder for 6 days. In men, the Foley 
catheter is introduced with the patient 
supine and traverses the entire urethra. 
The perineal incision is packed with 
iodoform gauze to control bleeding. 
Several catgut sutures in the skin hold the 
packing in place for 4 days.
Comment
The benefits of the prone position are 
several. The resectionist can use the resec- 
toscope in a comfortable and familiar 
fashion. The tumour does not drift away 
from the resectionist as the bladder fills. 
These advantages allow a more careful 
and thorough resection.
There is concern about implantation of
malignant cells in the tract of the exter­
nal perineal urethrostomy. We have not 
seen this. Experience in similar situations, 
transperineal or transrectal needle biop­
sy of the carcinomatous prostate,7 tran­
surethral resection of carcinoma of the 
prostate by way of an external perineal 
urethrostomy8 and transurethral resec­
tion of the prostate and bladder car­
cinoma at the same sitting,9 suggests that 
seeding is rare. We believe that the abili­
ty to resect tumours of the anterior blad­
der wall easily and thoroughly when the 
patient is in the prone position far 
outweighs the risk of planting carcinoma 
in the surgical tract.
We have found use of the prone posi­
tion an excellent modification when resec­
ting the sometimes difficult or almost 
impossible-to-reach tumours of the 
anterior bladder wall.
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Human Atrial Trabeculae: an Experimental Preparation f o r . . 
Studying Myocardial Response to Perioperative Manipulations
Trabeculae taken from discarded human 
right atrial specimens during cardiac 
surgery provide a useful preparation for 
studies in myocardial physiology and 
pharmacology. Three extrinsic 
measurements that have a marked effect 
on contraction of this preparation are 
temperature, stimulation frequency and 
calcium ion (Ca2 + ) concentration. There 
is a large decline in developed force 
below 30°C. The optimal stimulation fre­
quency (temperature 34°C , Ca2+ con­
centration 2 .5  mM) is 1 Hz. The Ca2 + 
level required to give half maximal force 
development is 2.0 mM. In a series of 
46 atrial trabeculae (approximately 1 mm 
in diameter) from 33 patients, the 
authors found a mean contraction ten­
sion of 1.37 ± 0.09 g/mm2 (±  standard 
error) (temperature 34°C , stimulation 
frequency 1 Hz, pH 7.4, Ca2+ concen­
tration 2.5 mM) at maximum force. The
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preparation appears to have great poten­
tial for the study of perioperative 
manipulation on myocardial function.
Les colonnes charnues prelevees sur les 
pieces d'oreillette humaine retirees au 
cours d'une chirurgie cardiaque offrent 
une preparation utile pour l'6tude de la 
physiologie et de la pharmacologie du 
myocarde. Trois facteurs extrinseques 
qui exercent un effet notable sur la con­
traction de cette preparation sont la 
temperature, la frequence de contraction 
et la concentration des ions calciques 
(Ca2 + ). On constate une baisse impor- 
tante de la tension dgveloppee sous les 
30°C. La frequence optimale de stimula­
tion (£ 34°C  et a une concentration de 
Ca2+ de 2.5 mM) est de 1 Hz. Le taux 
de Ca2+ necessaire pour assurer la 
moitie de la force maximale de 
developpement est de 2.0 mM. Dans 
une serie de 46 colonnes charnues 
auriculaires (d'environ 1 mm de 
diam&tre) provenant de 33 patients, les 
auteurs ont trouv§ une tension de con­
traction de 1.37 ± 0.09 g/mm2 (±  I'er- 
reur type) (S 34°C , frequence de 
stimulation de 1 Hz, pH de 7.4, concen­
tration de Ca2+ de 2.5 mM) & force 
maximum. Cette preparation semble of- 
frir de grandes possibilites pour I'etude 
des manipulations perioperatoires sur la 
fonction myocardique.
Myocardial tissue from human atria is f 
available on a regular basis in centre^ ■* ■ 
where open-heart surgery is performed. t 
This tissue is potentially valuable for'" y 
studying the mechanics of human 
myocardium. Further, it may be used to ’ ' 
study the effects of myocardial interven- j 
tions, including cardioactive drugs,
without the need to extrapolate from ,  1 
animal models. j
The effects of drugs on human atria!. 
tissue have been reported in the j
literature,1-9 but it is not easy to compare -* 
and evaluate the results. The difficulty i 
arises because preparations lack unifor- 
mity and the extrinsic variables such as \ 
stimulation rate and temperature differ. 
Variations in the state of the preparations^ , 
are perhaps an even more serious problem j
and this clearly should be evaluated in , 
each preparation. To do this, some stan- j 
dardized measure of contractile perfor- < 
mance is required to provide a criterion | 
for comparing and screening prepara- •" '  
tions. A reasonable number of measure­
ments under standardized conditions are'* 4 
needed so that acceptable limits may be , 
defined.
We have developed a standardized pro- > 
cedure for obtaining reasonably uniform 
preparations from human atria. In this ♦ J 
report we examine 46 such preparations. 
Maximum contraction tension is evalu-  ^ r 
ated under a defined set of conditions and
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the effects of the main extrinsic deter­
minants of myocardial contraction (tem­
perature, stimulation frequency, pH and 
calcium ion concentration) are surveyed.
Methods
Samples of right atrial appendages were 
yObtained from consenting patients at the 
time of cardiac surgery. Immediately after 
removal from the patient, the samples 
were immersed in oxygenated blood at 
4°C and transported to the laboratory.
The endocardial surface was examin­
ed for trabeculae approximately 1 mm in 
^diameter and 5 mm to 10 mm long. Two 
suitable trabeculae could usually be found 
in most atrial samples. The trabeculae 
were removed and held vertically. The 
lower end was held by a fixed plexiglass 
clip. The upper end was attached to a 
force transducer (model UC 2; Gould 
Inc., Oxnard, Calif.) through a second 
vclip. The position of the force transducer 
was measured by a Mercer micrometer 
gauge (model 252; St. Albans, England), 
with the zero reference length taken from 
the point at which the muscle clips 
touched.
The preparation was then immersed in
T a b le  1 - D a t a  fro m  H u m an  R ig n i m i . a l
T ra b e c u la e  (n = 4 6 )
V a r ia b le V a lu e
W e ig h t , m g 6 . 4 2  ±  0 . 3 5
L e n g th  a t  L mal, m m 7 .1 8  ±  0 . 2 4
C ro s s - s e c t io n a l a re a , m m 2 0 .8 7  ±  0 . 0 4
F o rce , g
R e s t in g 0 . 4 3  ±  0 . 0 6
D e ve lo p e d 1 .2 5  ±  0 . 0 8
T e n s io n , g /m m 2
R e s t in g 0 .4 7  ±  0 . 0 6
D e ve lo p e d 1 .3 7  ±  0 . 0 9
V a lu e s  p re s e n te d  a s  m ean ±  s ta n d a rd  e rro r .
A ll m e a su re d  a t  3 4 ° C ,  1 H z, C a 2 ’  2 .5  m M  and
pH  7 .4 .
a buffered Tyrode’s solution (mM: NaCl 
117, KC1 3.4, MgS04 3.1, KH2P 0 4 1.2, 
NaHC03 28, glucose 11 and CaCl2 2.5) 
in a 120 mL water-jacketed bath at 34°C. 
The bath was continuously aerated with 
a mixture of 95% oxygen and 5% carbon 
dioxide (pH 7.4).
Field stimulation was used to excite the 
preparation through platinum plate elec­
trodes on either side of the muscle. 
Stimulus pulses (5 ms) were generated by 
a Grass S88 stimulator through a Grass 
SIU-5 stimulus isolation unit (Grass In­
strument Co., Quincy, Mass.). Stimulus 
voltage was adjusted to a level 50% above 
the maximum response. Contractions 
were monitored on a Grass model 7 direct 
writing recorder from the force trans­
ducer.
After mounting, the trabeculae were 
allowed to equilibrate at 34°C for 20 
minutes at a stimulus frequency of 0.1 Hz 
with a light (0.2 g) preload. Stimulus fre­
quency was then increased to 1 Hz and 
length was increased until maximum force 
(Lraax) was developed. Muscles were 
allowed to stabilize for a further 20 
minutes and basal resting and active 
forces were measured.
This second equilibration period was 
used to screen out unacceptable prepara­
tions — those with contraction anomalies 
such as multiple peak contractions, those 
with spontaneous electrical activity and 
those with low contractile force. An ar­
bitrary cut-off value of 0.7 g was adopted 
on the basis of preliminary experiments.
About half of the preparations were re­
jected, mainly because of spontaneous ac­
tivity; 46 trabeculae remained. These 
preparations were taken from 33 patients 
(26 men, 7 women), between 20 and 68 
years of age. The operative diagnoses 
were coronary artery disease in 27, 
valvular disease in 4 and congenital heart 
disease in 2 patients.
The effect of one variable was studied 
in each of four groups of preparations. 
In group 1 (n = 14), five different 
stimulation frequencies were used (0.5, 
1.0, 1.5, 2.0 and 2.5 Hz). In group 2 (n 
= 8), force was monitored at three pH 
levels (6.7, 7.4 and 7.9). The pH of the 
Tyrode’s solution was adjusted to these 
values by titration with 0.1 M sodium 
hydroxide or 0.1 M hydrochloric acid. 
Group 3 (n = 12) was used to study the 
effect of different temperatures (20°, 25°, 
30°, 35° and 40°C). In group 4 (n = 12), 
different Ca2+ concentrations were used 
(1.5, 2.0, 2.5, 3.0, 3.5 and 4.0 mM). In 
all of the above interventions, changes 
were made in random order and after 
each change a stabilization period of 5 to 
15 minutes was allowed before the 
response was measured. Preliminary ex­
periments showed that the effects of 
changes in temperature, pH and frequen­
cy were reversible but that some residual 
effects remained after changes in Ca2+ 
concentration. To overcome this pro­
blem, the preparation was returned to a 
Ca2+ level of 2.5 mM after each change, 
and force with each concentration was ex­
pressed as a percentage of that in 2.5 mM 
Ca2+ immediately before each random 
change.
For comparative purposes the tension 
(g/mm2) was calculated by dividing the 
measured force (g) by the cross-sectional 
area (mm2). At the end of each experi­
ment, the trabecula between the two clips 
was removed, blotted dry, and weighed 
on a Roller-Smith torsion balance 
(Bethlehem, Penn.). The cross-sectional 
area (mm2) was then calculated by first 
converting the weight (mg) of the 
preparation into volume (mm3) with a 
density of 1.065 and then dividing the 
volume by the length (mm) of the muscle 
at Lmax, assuming the trabecula to be 
cylindrical.
<D>
CD► □
0.5  1.5 2.5
Stimulation Rate -  pulse/s
FIG. 1—Frequency-force relation; mean contractile force (circles) 
and standard error (vertical lines) for 14 trabeculae; pH 7.4, 34°C, 
Ca2+ concentration 2.5 mM.
Temperature -  °C
FIG. 2—Temperature-force relation; mean contractile force (circles) 
and standard error (vertical lines) for 12 trabeculae; pH 7.4, frequency 
1 Hz, Ca2+ concentration 2.5 mM.
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Results
During the first equilibrium period, 
while the muscle was stimulated at 0.1 
Hz, force increased slowly. It increased 
further when the rate changed to 1.0 Hz. 
A t Lmax, resting force was about one 
third of developed force (Table I). At 
greater lengths, resting force increased 
rapidly and developed force declined.
Group 1
The effect of stimulation frequency on 
developed force was examined over the 
range 0.5 to 2.5 Hz (pH 7.4, 34°C, Ca2+ 
concentration 2.5 mM). Maximum con­
tractile force was developed at a frequen­
cy of 1 Hz (Fig. 1) with a steady fall as 
frequency increased.
Group 2
When the effect of pH on developed 
force (1 Hz, 34°C, Ca2+ concentration
2.5 mM) was measured, maximum force 
was found to develop at pH 7.4 (1.04 ± 
0.18 g [ ± SEJ). At the other two pH levels 
used, force was smaller although the dif­
ference was not great (0.88 ± 0.26 g at 
pH 6.7 and 0.94 ± 0.18 g at pH 7.9).
Group 3
Below 30° C there was a notable and 
consistent decline in force (Fig. 2). The 
response at 35°C was greater than at 
either 30°C or 40°C but the variation was 
not large over this range.
Group 4
A fairly large increase in force was evi­
dent over the range of Ca2+ levels from
1.5 to 3.0 mM, half maximum force be­
ing reached at about 2.0 mM. Above 3.0 
mM a plateau was reached (Fig. 3) that 
approached a value about 25°7o higher 
than that in 2.5 mM Ca2+
Discussion
With the procedure described and the 
selection criteria outlined, it is possible to 
obtain reasonably consistent contractile 
responses from isolated human atrial 
trabeculae. It is not easy to compare the 
values we obtained with those of others 
using human myocardial tissue because a 
standardized procedure and standardiz­
ed measurement of contractile force are 
lacking. Only one study of human myo­
cardium out of 11 reports we surveyed ex­
pressed developed tension in normalized 
units (g/mm2) .10 Sonnenblick and 
colleagues10 had a value of 1.81 ± 1.19 
g/m m 2 (± SD) for human papillary 
muscle, which is about 30% higher than
the value we obtained for atrial muscle. 
Studies using human atria generally in­
volve large atrial samples1,2 or atrial 
strips.8 In such preparations the 
myocytes would not be parallel and align­
ed with the axis of force measurement so 
that maximum developed force would not 
be reached. Wagner and associates8 us­
ed atrial strips about 1 mm in diameter 
and reported values of 233 ± 30 g/g dry 
weight, which would correspond to about 
150 mg/mm2. Large atrial preparations, 
such as those used by Levy,1,2 with 
weights up to 160 mg appear to give mus­
cle forces of up to 2 g, which would corre­
spond to very low tensions expressed 
either on a g/g basis or as tension per unit 
area. Gristwood and associates7 used 
atrial trabeculae 1.0 ± 0.1 mm in 
diameter. They did not tabulate results 
but their figures indicated muscle forces 
of 0.3 to 1.0 g which are comparable, 
although lower, than those we measured.
Most of our samples were taken from 
patients with coronary artery disease. It 
is not possible to tell to what extent this 
might have affected the preparations, but 
we found no clear difference between 
these preparations and those taken from 
patients with other heart defects. The 
specimens seem preferable to those taken 
soon after death of noncardiac origin. 
Abraltis and Stropus11 took atrial strips, 
which varied in diameter from 1 to 2 mm 
post mortem. Their recordings indicated 
a developed force of about 100 mg which 
would correspond to about 4% of the ten­
sion we observed and are certainly much 
smaller than contractions observed with 
similar atrial strips taken during 
operation.8
It is not yet possible to define any 
theoretical expected value for normalized 
tension development of the myocardial 
contractile elements although Fabiato12 
obtained a maximum value for “ skin­
ned” rabbit myocytes fully saturated with 
calcium of 11.67 g/mm2. As he pointed 
out, only about 20% of this force may be 
mobilized in a single twitch, which is nor­
mally limited by both the Ca2+ concen­
tration and the duration of the twitch. 
The contractile force we recorded is thus 
at least of the order of magnitude ex­
pected from Fabiato’s observations.
We have found an optimal frequency 
of 1 Hz under the conditions used. This 
could, of course, be different with dif­
ferent external conditions (temperature 
Ca2+ concentration). The optimal fre­
quency appears similar to that observed 
by Levy,1 although he did not give a 
systematic tabulation of results.
The acute effect of pH changes over the 
range of 6.7 to 7.9 is relatively small. 
Possibly, the effects of metabolic acidosis 
would be greater over a longer period 
since the myocardium has a large in­
tracellular buffering capacity,13 so it
would require some time for an ex­
tracellular change to be converted into an 
intracellular pH shift.
The sharp decline in force at tem­
peratures below 30°C has not been 
reported previously. It seems surprising 
since we have not seen a similar fall in 
developed force in other species. This 
perhaps warrants further investigation. <
The increase in contractile force with 
increasing Ca2+ concentration is typical 
of the myocardial response seen in other 
species, such as the dog14 and rat.15 As in 
the case of dog myocardium, it appears 
that maximum contractile force is only 
developed at higher Ca2+ levels than are, 
normally found in plasma. Rat heart, on 
the other hand, has a lower Ca2+ re­
quirement with half maximum activation 
at about 0.4 mM Ca2+ compared with 
2.0 mM found for human atrial muscle 
under the conditions described in these 
experiments.
The conditions we chose for the second 
equilibration period (34°C, 1 Hz, pH 7.4, 
Ca2+ concentration 2.5 mM), on which 
normalized values are based, are close to 
those required for maximum force 
development, although a further ex­
ponential type of increase would be given 
by raising Ca2+ to a still higher level.
Isolated trabeculae from discarded 
surgical specimens appear to provide a 
useful preparation for study. Under the 
conditions described here, the expected 
range of tension development is 1.37 ± 
0.09 g/m m 2. The small size of the 
trabecular preparation has the additional 
advantage that diffusion distances are 
small so that the time required fo r '  
equilibrating the extracellular space with 
agents such as cardioactive drugs would 
be minimal. The preparation has great 
potential for the study of the myocardial 
response to perioperative events such as , 
perfusion, cardioplegia and phar­
macologic manipulations. *
We acknowledge the technical assistance of 
Mrs. R. Ravindra and Mrs. D. Ayres.
FIG. 3—Calcium concentration-force rela­
tion (force at 2.5 mM Ca2+ = 100%) and  ^
standard error (vertical lines) for 12 trabeculae; 
pH 7.4, frequency 1 Hz, 34°C.
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Prescribing Information 
CEFOBID*
(cefoperazone sodium) For Intravenous or Intramuscular Injection
Antibiotic
ACTION
In vitro studies indicate that the bactericidal action of CEFOBID (cefoperazone sodium) results from the 
inhibition of bacterial cell wall synthesis.
INDICATIONS AND CLINICAL USES
CEFOBID (cefoperazone sodium) may be indicated for the treatment of the following infections when 
caused by susceptible strains of the designated microorganisms:
LOWER RESPIRATORY TRACT INFECTIONS caused by Streptococcus pneumoniae, Haemophilus in ­
fluenzae. Staphylococcus aureus, Streptococcus pyogenes, Klebsiella species (including Klebsiella 
pneumoniae), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, indole-positive Proteus 
species and Enterobacter species.
URINARY TRACT INFECTIONS caused by Escherichia coli, Pseudomonas aeruginosa, Enterobacter 
species, Klebsiella species, Enterococcus, Proteus mirabilis, Staphylococcus aureus, Staphylococ­
cus epidermidis and indole-positive Proteus species 
Due to the nature of the underlying conditions which usually predispose patients to Pseudomonas 
infections of the lower respiratory and urinary tracts, a good clinical response accompanied by 
bacterial eradication may not be achieved despite evidence of in vitro sensitivity.
ACUTE BILIARY TRACT INFECTIONS ASSOCIATED WITH CHOLECYSTITIS OR CHOLANGITIS caused 
by Escherichia coli.
SEPTICEMIA caused by Staphylococcus aureus. Streptococcus pneumoniae, Streptococcus agalac- 
tiae, Escherichia coli and Klebsiella species.
WOUND INFECTIONS (SURGICAL AND TRAUMATIC) caused by Staphylococcus aureus, Streptococ­
cus pyogenes and Pseudomonas aeruginosa.
GYNECOLOGICAL INFECTIONS (SUCH AS PELVIC INFLAMMATORY DISEASE AND ENDOMETRITIS) 
caused by Streptococcus agalactiae, Neisseria gonorrhoeae, Escherichia coli, Bacteroides species 
(including Bacteroides fragilis), Peptococcus species and Peptostreptococcus species.
Specimens for bacteriologic culture should be obtained prior to therapy in order to identify the causative 
organism and to determine its susceptibility to CEFOBID (cefoperazone sodium). Therapy may be in­
stituted before results of susceptibility testing are known , however, modification of the treatment may be 
required once these results become available.
CONTRAINDICATIONS: CEFOBID (cefoperazone sodium) is contraindicated in patients with known 
allergy to the cephalosporin class of antibiotics.
WARNINGS: Before therapy with CEFOBID (cefoperazone sodium) is instituted, careful inquiry should be 
made to determine whether the patient has had previous hypersensitivity reactions to cephalosporins, 
penicillins or other drugs. CEFOBID (cefoperazone sodium) should be administered with caution to 
penicillin-sensitive patients or to any patient who has demonstrated some form of allergy, particularly to 
drugs. If an allergic reaction to CEFOBID (cefoperazone sodium) occurs, discontinue administration of 
the drug and treat the patient with the usual agents (e g. epinephrine, antihistamines, pressor amines or 
corticosteroids).
Pseudomembranous colitis has been reported to be associated with the use of CEFOBID (cefoperazone 
sodium). Therefore, in those patients administered CEFOBID (cefoperazone sodium) who develop diar­
rhea, it is important to consider such a diagnosis.
Treatment with broad-spectrum antibiotics, including CEFOBID (cefoperazone sodium), alters the 
normal flora of the colon and may permit overgrowth of Clostridia. Studies indicate that a toxin produced 
by Clostridium difficile is one primary cause of antibiotic-associated colitis 
Mild cases of colitis may respond to drug discontinuance alone. Moderate to severe cases should be 
managed with fluid, electrolyte, and protein supplementation as indicated. When the colitis is not reliev­
ed by the discontinuance of CEFOBID (cefoperazone sodium) or when it is severe, consideration should 
be given to the administration of oral vancomycin 
PRECAUTIONS
General: The concomitant administration of aminoglycosides and some cephalosporins has caused 
nephrotoxicity. Although transient elevations of BUN and serum creatinine have been observed, there is 
no evidence that CEFOBID (cefoperazone sodium) when administered alone causes significant 
nephrotoxicity. However, the effect of administering CEFOBID (cefoperazone sodium) concomitantly 
with aminoglycosides is not known
CEFOBID (cefoperazone sodium) is excreted in both the bile and urine. In normal volunteers, 19 to 
41 % of the dose is excreted in the urine, the remainder being excreted by the hepato-biliary system. The 
serum half-life of CEFOBID (cefoperazone sodium) is usually prolonged and urinary excretion of the drug 
increased in patients with hepatic disease and/or biliary obstruction. Serum concentrations of 
cefoperazone should be monitored in these patients treated w ith doses in excess of 2 grams daily and 
dosage should be adjusted as necessary.
Because renal excretion is not the main route of elimination of cefoperazone, adult patients with renal 
failure usually require no adjustment in dosage when daily doses of 2 to 4 grams (1 to 2 grams every 12 
hours) are administered If higher doses of CEFOBID (cefoperazone sodium) are used, serum concentra­
tions of cefoperazone should be monitored. If there is evidence of accumulation, dosage should be 
decreased accordingly
In one study in patients with chronic renal failure, the half-life of CEFOBID (cefoperazone sodium) was 
reduced from 4.17 to 1.67 hours during hemodialysis. Thus, dosing should be scheduled to follow a 
dialysis period.
In patients with both hepatic dysfunction and renal impairment, the initial dosage of CEFOBID 
(cefoperazone sodium) should not exceed 1 to 2 grams daily and serum concentrations of cefoperazone 
should be monitored closely.
Vitamin K deficiency has occurred in a few patients treated with CEFOBID (cefoperazone sodium). The 
mechanism is most probably related to the suppression of gut flora which normally synthesizes this 
vitamin. Those at risk include patients with poor diet or malabsorption states (e g. cystic fibrosis) and 
patients on prolonged intravenous alimentation regimens. Prothrombin time should be monitored in 
these patients and exogenous vitamin K administered as indicated 
A reaction characterized by flushing, sweating, headache, and tachycardia has been reported when 
alcohol is ingested during and as late as the fifth day after CEFOBID (cefoperazone sodium) administra­
tion. Patients should be cautioned concerning ingestion of alcoholic beverages in conjunction with ad­
ministration of CEFOBID (cefoperazone sodium). For patients requiring artificial feeding orally or 
parenterally, solutions containing ethanol should be avoided.
CEFOBID (cefoperazone sodium) should be administered with caution to individuals with a history of 
gastrointestinal disease, particularly colitis.
Overgrowth of nonsusceptible organisms may occur during prolonged use of CEFOBID (cefoperazone 
sodium). Patients should be observed carefully during treatment. If superinfection occurs, appropriate 
measures should be taken
Drug Laboratory Test Interactions
A false-positive reaction for glucose in the urine may occur with Benedict's or Fehling’s solution. ^  
Pregnancy: The safety of CEFOBID (cefoperazone sodium) in pregnancy has not been established. The 
use of CEFOBID (cefoperazone sodium) in pregnant women requires that the likely benefit from the drug 
be weighed against the possible risk to the mother and fetus ^
Reproduction studies have been performed in mice, rats and monkeys at doses up to 10 times the 
human dose and have revealed no evidence of impaired fertility or teratogenic effects due to 
cefoperazone sodium Animal reproduction studies, however, are not always predictive of humaf 
response
Nursing Mothers: Cefoperazone is excreted in low concentration (0.4 to 0.9 /ig /m L) in human milk 
Caution should be exercised when CEFOBID (cefoperazone sodium) is administered to a nursing mott^r. 
Children: The safety and efficacy of CEFOBID (cefoperazone sodium) in children have not b ee n ^ 
established. j
ADVERSE REACTIONS *
Hypersensitivity: Macuiopapular rash, urticaria, pruritis, eosinophilia, drug fever f
Hematology — Decreases in hemoglobin and/or hematocrit have occurred. Slight decreases in 
neutrophil count have been reported, and reversible neutropenia may occur with prolonged administra A 
tion. Transient eosinophilia has occurred. Hypoprothrombinemia has been observed. Some individuals 
have developed positive direct Coombs' test during treatment.
Liver — Transient elevations in SGOT, SGPT and alkaline phosphatase levels have been noted. One p #  * 
tient with a history of liver disease developed significantly elevated liver function enzymes during 
therapy with CEFOBID (cefoperazone sodium). Clinical signs and symptoms of nonspecific hepatitis ac- g  
companied these increases After CEFOBID (cefoperazone sodium) therapy was discontinued, the fa -  r  
tient’s enzymes returned to pre-treatment levels and the symptomatology resolved 
Kidney — Transient elevations of blood urea nitrogen and serum creatinine have been noted.
Gastrointestinal — Altered bowel habits (loose stools or diarrhea) have been reported. Most of these 
events have been mild or moderate, but some have been severe. In all cases, these symptoms respond­
ed to symptomatic therapy or ceased when cefoperazone therapy was stopped Nausea and vomiting^ . 
have been reported rarely
Pseudomembranous colitis has been reported rarely in patients administered CEFOBID (cefoperazone 
sodium). Symptoms of pseudomembranous colitis can appear during or for several weeks subsequent ta« 
antibiotic therapy. s
Disulfiram-like Reaction ;
Disulfiram-like reactions have been reported when alcohol was ingested during and as late as the fifttjr 
day after CEFOBID (cefoperazone sodium) administration. j
Central Nervous System — Headache and dizziness occur rarely
Local Reactions — CEFOBID (cefoperazone sodium) is well tolerated following intramuscular adminis^p- ^  
tion. Occasionally, transient pain may follow administration by this route. When CEFOBID (cefoperazone 
sodium) is administered by the intravenous route, some patients develop phlebitis at the site of ad­
ministration. .
Other — Diaphoresis/chills 1
SYMPTOMS AND TREATMENT OF OVERDOSAGE
Since no case of overdosage has been reported to date with CEFOBID (cefoperazone sodium), no* 
specific information on symptoms or treatment of overdosage is available. Treatment should be symp­
tomatic.
Hemodialysis is not effective in the removal of cefoperazone. ^  '*
DOSAGE AND ADMINISTRATION ~ r
DOSAGE
CEFOBID (cefoperazone sodium) may be administered intravenously or intramuscularly.
Dosage and route of administration should be determined by severity of infection, susceptibility of the* 
causative organism, and condition of the patient.
Adult
The recommended daily dose of CEFOBID (cefoperazone sodium) is 2 to 9 grams administered in equal-4 
ly divided doses every 8 to 12 hours (See table below). The usual duration of treatment is 7 to 14 days.
Adult Dosage
Type of Infection Daily Dose Frequency and Route-*
Mild to moderately severe 
infections such as pneumonia, 
acute urinary tract infection, 
wound infection
2 to 4 grams 1 to 2 grams 
every 12 hours 
I.M. or I V. -4
Severe infections or infections 
caused by less sensitive 
organisms
4 to 8 grams 2 to 4 grams
every 12 hours *
IV .
Infections commonly requiring 
antibiotics in higher dosage
9 grams 3 grams every .  
8 hours I.V.
(e.g. septicemia and life-
threatening infections) j
The maximum adult daily dose should not exceed 9 grams *
For infections caused by Streptococcus pyogenes, therapy should be continued for at least 10 days. 
Impaired Renal Function . .
Because renal excretion is not the main route of elimination of cefoperazone, adult patients with renal 
failure usually require no adjustment in dosage when daily doses of 2 to 4 grams (1 to 2 grams every 12 
hours) of CEFOBID (cefoperazone sodium) are administered. If higher doses of CEFOBID (cefoperazone* 
sodium) are used, serum concentrations of cefoperazone should be monitored If there is evidence of' ' 
accumulation, dosage should be decreased accordingly. For patients whose glomerular filtration rate is 
less than 18 mL/m in or whose serum creatinine level is greater than 3.5 mg/dL, the maximum* 
CEFOBID (cefoperazone sodium) dosage should be 4 grams per day ^
In patients undergoing hemodialysis, dosing should be scheduled to follow a dialysis period. j 
Hepatic Disease and Biliary Obstruction j
The serum half-life of cefoperazone is increased 2 to 4 fold in patients with hepatic disease and/o* 
biliary obstruction. Serum concentrations of cefoperazone should be monitored in patients treated with 
doses in excess of 2 grams daily and dosage should be adjusted as necessary. , ^
Hepatic Dysfunction and Renal Impairment ** f
In patients with both hepatic dysfunction and concomitant renal impairment, the initial dosage of 
CEFOBID (cefoperazone sodium) should not exceed 1 to 2 grams daily and serum concentrations of 
cefoperazone should be closely monitored.
Children
The safety and efficacy of CEFOBID (cefoperazone sodium) in children have not been established.
ReferencesADMINISTRATIONIntramuscular:
CEFOBID (cefoperazone sodium) should be administered by deep intramuscular injection into a large 
muscle mass such as the gluteus maximus or anterior thigh. The maximum dose of CEFOBID 
(cefoperazone sodium) should be two (2) grams.
Intravenous:
Direct Intravenous (bolus) Injection: The reconstituted solution should be injected slowly over a 
period of no less than three (3) minutes. The maximum dose of CEFOBID (cefoperazone sodium) 
should be two (2) grams.
Intermittent Intravenous Infusion The reconstituted solution may be infused over a period of 15 
minutes to 1 hour through the tubing of an administration set while any of the intravenous solutions 
(See Solutions for I.V. Infusion) are being infused. During infusion of the solution containing 
CEFOBID (cefoperazone sodium), it is desirable to temporarily discontinue administration of the other 
solution.
Continuous Intravenous Infusion: CEFOBID (cefoperazone sodium) may also be administered over a 
longer period of time.
Note: If therapy with CEFOBID (cefoperazone sodium) is carried out in combination with an 
aminoglycoside antibiotic, each should be administered at different sites because of a physical in­
compatibility. An aminoglycoside should not be mixed with CEFOBID (cefoperazone sodium) in the 
same container.
PHARMACEUTICAL INFORMATION
CHEMISTRY
Trade Name: CEFOBID
Proper Name: Cefoperazone sodium
Chemical Name:
Sodium (6R,7R)-7-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl) 
acetamido)-3 [[(1 -methyl-1 H-tetrazol-5-yl)thio]methyll-8-oxo-5-thia-1 -azabicyclo[4.2.0] 
oct-2-ene-2-carboxylate
Molecular Formula: C25H2sNg0gS2Na Molecular Weight: 667.65 
Description:
Cefoperazone sodium is a white powder, soluble in water, sparingly soluble in methanol, poorly soluble 
in ethanol, and insoluble in ethyl ether, acetone, chloroform, or n-hexane.
Composition:
CEFOBID vials contain cefoperazone sodium (expressed in terms of free acid). The sodium content of 
each gram of CEFOBID is approximately 34 mg (1.5 mEq sodium ion). The pH of a 25% (w /v ) solution 
is 4.5 to 6.5 and the solution is colorless to straw yellow depending on the concentration.
RECONSTITUTION 
For Intramuscular Use:
Solution for Reconstitution
Sterile Water for Injection 
or, if required
Bacteriostatic Water for Injection 
0.5% Lidocaine Hydrochloride Injection 
Reconstitute as follows:
Vial Size
Volume to be Approximate Approximate
Added to Vial Available Average Concentration
(g) (mL) Volume (mL) (mg/mL)
1.0 3.5 4.0 250
2.0 7.0 8.0 250
Shake well until dissolved. Solutions should be allowed to stand after reconstitution to allow any foam­
ing to dissipate in order to permit visual inspection for complete solubilization. Vigorous and prolonged
agitation may be necessary to solubilize CEFOBID (cefoperazone sodium).
For Intravenous Use:
Solutions for Reconstitution and Dilution
Sterile Water for Injection
or, if required
Bacteriostatic Water for Injection 
Reconstitute as follows:
Volume to be Approximate Approximate
Vial Size Added to Vial Available Average Concentration
(g) (mL) Volume (mL) (mg/mL)
1 9.5 10.0 100
2 19.0 20.0 100
Shake well until dissolved. The prepared solution may be further diluted to the desired volume with any 
of the solutions for I.V. infusion listed below.
For direct intravenous (bolus) injection: Reconstitute as directed above 
For intermittent intravenous infusion: Reconstitute as directed above
For continuous intravenous infusion: Reconstitute with Sterile Water for Injection. The-reconstituted 
solution may be added to an appropriate intravenous bottle/bag containing any of the solutions for I .V. 
infusion listed below:
Solution for I.V. Infusion 
5% Dextrose Injection (USP)
5% Dextrose and Lactated Ringer's Injection 
5% Dextrose and 0.9% Sodium 
Chloride Injection (USP)
5%Dextrose and 0.2% Sodium 
Chloride Injection (USP)
Stability of Solutions 
Storage:
Reconstituted solutions for intramuscular injection should be used within 24 hours if kept at room 
temperature, or 72 hours if stored under refrigeration (5°C).
Reconstituted solutions for I.V. injection or infusion should be used within 24 hours if kept at room 
temperature, or 72 hours if stored under refrigeration (5°C).
Incompatibility
CEFOBID (cefoperazone sodium) should not be added to blood products, protein hydrolyzates, or amino 
acids. CEFOBID (cefoperazone sodium) should not be mixed together with an aminoglycoside. 
DOSAGE FORMS 
Availability:
CEFOBID (cefoperazone sodium) is available as a lyophilized powder 
1,0g vial — cefoperazone 1 .0 g as sodium salt 
2.0g vial — cefoperazone 2.0 g as sodium salt 
Storage
CEFOBID (cefoperazone sodium) should be stored protected from light and refrigerated (2 to 8°C). 
References:
1. Official product monograph. ‘ Prepared by Pfizer Canada Inc. (R.U.)
2. Data on file. Pfizer Inc. TM Owner.
©  Pfizer Canada Inc. 1984
Rizer Canada Inc. 
Kirkland, Quebec H9J 2M5
PAAB
CCPP
10% Dextrose Injection (USP)
Lactated Ringer's Injection (USP)
0.9% Sodium Chloride Injection (USP) 
Normosol® M and 5% Dextrose Injection 
Normosol® R
1. LEVY JV : Force-frequency relationship o f hum an atrial 
m uscle in vitro: beta-adrenergic m echanisms. Arch Int 
Physiol 1968; 76: 680-92
2. Idem : C om parative actions o f  beta-adrenergic receptor 
blocking drugs on  the contractile and electrical p ro p er­
ties o f  isolated hum an atrial muscle. Cardiologia (Basel) 
1968; 53: 293-305
3. Nayler W G , Chipperfield  D, Low e TE: The 
negative inotropic effect o f  adrenergic beta-receptor 
blocking drugs on hum an heart muscle. Cardiovasc Res 
1969; 3: 30-6
4. P r a s a d  K: Transm em brane potential and force o f  con­
traction  o f  the normal and potassium -deficient hum an 
a trial tissue in vitro. Can J  Physiol Pharmacol 1969; 47: 
1015-24
5. Idem : Effect o f prednisolone on the electrom echanical 
activity o f  isolated hum an atrial muscle. Clin Pharmacol 
Ther 1974; 16: 1023-30
6. Ec k e l  L , G ristw oo d  RW , Na w r a t h  H , Ow en  DAA, 
Sa t t e r  P : Inotropic and electrophysiological effects o f  
histam ine on hum an ventricular heart muscle. J  Physiol 
(Lond) 1982; 330: 111-23
7. G r is t w o o d  RW , L in c o l n  JC R , O w en  D A A , Sm it h  
IR: H istam ine release from  hum an right a trium . Br J  
Pharmacol 1981; 74: 7-9
8. W a g n er  J, Sc h u m a n n  H J , Knorr  A , R o h m  N, Re id - 
m a s t e r  JC : Stim ulation by adrenaline and dopam ine 
b u t not by n o radrena line  o f  m yocard ial a lpha- 
adrenoreceptors m ediating positive inotropic effects in 
hum an atrial preparations. Naunyn Schmeidebergs Arch 
Pharmacol 1980; 312: 99-102
9. B r is t o w  M R, G in sb u r g  R, M in o b e  W , C u b ic c io t - 
t i RS, Sa g e m a n  w s , L u r ie  K, Bil l in g h a m  M E, 
H a r r is o n  DC , STINSON EB: Decreased catecholam ine 
sensitivity and /3-adrenergic-receptor density in failing 
hum an hearts. N  Engl J  Med  1982; 307: 205-11
10. SONNENBLICK EH, BRAUNWALD E, MORROW AG: The 
contractile properties o f hum an heart muscle: studies on 
m yocardial m echanics o f  surgically excised papillary 
muscles. J  Clin Invest 1965; 44 : 966-77
11. ABRAITIS RI, STROPUS RA: [Prospects for the studying 
o f  m yocardial contractility  in hum an autopsy m aterial.] 
Biull Eksp Biol Med 1981; 91: 6-7
12. F a b ia t o  A: M yoplasm ic free calcium concentration  
reached during the tw itch o f  an in tact isolated cardiac 
cell and during calcium-induced release o f  calcium from  
the sarcoplasmic reticulum o f  a skinned cardiac cell from  
the adult ra t o r  rabbit ventricle. J  Gen Physiol 1981; 78: 
457-97
13. La i YL, At teb ery  BA, Br ow n  EB j r : M echanisms o f  
cardiac muscle adjustm ent to  hypercalcem ia. Respir 
Physiol 1973; 19: 123-9
14. SEIFEN E, FLACKE W , ALPER M H: Effects o f  calcium  
on  isolated m am m alian heart. Am  J  Physiol 1964; 207: 
716-20
15. FORESTER GV, Ma in w o o d  GW: Interval dependent in­
otropic  effects in the ra t m yocardium  and  the effect o f  
calcium . Pfluegers Arch 1974; 352: 189-%
377
N i c h o l a s  M . N e w m a n , m d ;* J o h n  V . F o w l e s , m d , FRCSjCjf
1 4 '
A Case of “Trigger Toe”
"Triggering" of the toes, in which local 
tendon hypertrophy prevents the smooth 
movement of the tendon, has been 
described as a problem more theoretical 
than real and only three cases have been 
reported.
The authors report a case of partial 
tethering of the flexor hallucis longus 
tendon just distal to the medial malleolus 
in a 28-year-old jogger who had painful 
triggering of the great toe on plantar 
flexion of the ankle and great toe.
Division of the flexor hallucis longus 
tendon pulley distal and posterior to the 
medial malleolus cured the patient.
Le probleme des orteils a ressort a ete 
juge comme un probleme plus thgorique 
que reel. Le gros orteil est rarement 
affects.
Les auteurs dScrivent un cas d'orteil a 
ressort du a un blocage partiel du tendon 
du long fISchisseur du gros orteil, 
blocage distal 6 la mallSole interne. La 
patiente est agSe de 28 ans. Elle fait de 
la course a pied et souffre depuis 5 ans 
de symptomes progressifs et douloureux 
relics a I'orteil a ressort.
Une section chirurgicale de la poulie du 
tendon du long flechisseur du gros orteil 
distale et postSrieure a la mallSole in­
terne a resolu le probl&me de ressort.
Localized tendon  hypertrophy, usually of 
in flam m atory  o r traum atic  origin, can 
obstruct the sm ooth  gliding o f the tendon 
th ro u g h  its pulley , p roducing a  “ trigger­
ing”  sensation as the obstruction is over­
com e. Typically, the first annu lar com ­
p o n en t of th e  digital flexor sheath  in  the 
h a n d  is the site  o f  the obstruction . Only 
ra re ly  has “ triggering”  been reported  in
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the fo o t .1'3 W e report here the case o f  a 
patient with stenosing tenovaginitis o f the 
sheath  o f  the flexor hallucis longus.
Case Report
A 28-year-old woman, who daily jogged 2 
miles, noticed a painless snapping sensation in 
the left great toe over a 5-year period. One year 
previously she had sprained her left ankle while 
skiing, and after this she had intermittent pain 
distal and posterior to the medial malleolus 
associated with a snapping sensation at the first 
metatarsophalangeal joint. Persisting symp­
toms, including inability to jog, led the patient 
to seek medical advice 1 year after her skiing 
injury.
On physical examination there was no defor­
mity or tenderness, and passive movements of 
the toes, foot and ankle were normal and 
painless. Following active plantar flexion of the 
ankle and great toe, attempted active dorsiflex- 
ion of the great toe caused a clawing deformi­
ty with further interphalangeal joint flexion. 
This deformity could be overcome actively and 
produced an audible and palpable “ snapping” 
as the interphalangeal joint returned to neutral. 
The snapping could be felt along the course of 
the flexor hallucis longus tendon both distal 
to the medial malleolus and on the plantar 
aspect of the great toe. We made the clinical 
diagnosis of stenosing tenovaginitis of a pulley 
of the flexor hallucis longus. This tendon 
passes through two flexor sheaths, a proximal 
sheath behind the talus and berfeath the susten­
taculum tali and a distal one beneath the neck 
and head of the first metatarsal4 (Fig. 1).
The flexor hallucis longus was explored 
under local anesthesia to permit active trigger­
ing during operation. There was no abnormali-
FIG. 1—Path of flexor hallucis longus ten­
don and position of proximal and distal flex­
or tendon sheaths.
ty at the metatarsophalangeal level. Through'* < 
a second incision, distal and posterior to the 
medial malleolus, the proximal pulley was ap- 
proached by reflecting anteriorly the posterior 
tibial nerve while preserving its calcaneal bran- '* 
ches. A fusiform thickening of the flexor 
hallucis longus was observed just proximal to '  ' 
this pulley which was also very thick. There was 
no dislocation or obvious laceration of the ten-'' ~y 
don and the synovium was not hypertrophied. 
Longitudinal sectioning of this flexor sheath 4 
eliminated the triggering. Six months after 1 
operation the patient was free of pain and * 
symptoms.
A t
Discussion * t
The flexor hallucis longus muscle arises 
from  the inferior two th irds o f the 
posterio r surface o f the fibula and  from  : 
the interosseous m em brane.4 The posi- A 
tion  o f  its tendon is m aintained by tw o ! 
pulleys, a  proxim al one beneath the * 
sustentaculum  tali and a distal one 
beneath the first m etatarsal. The m uscle 4 v 
is particularly  im portan t fo r pusho ff in 
running and has a  function  analogous to  4 
the Achilles tendon fo r the ballet dancer 
en pointed
The triggering phenom enon is m ost A 
com m on in the hand at the level o f  the 
m etacarpal head. It m ay be congenital or-, 
related to  inflam m atory  disease, p a r­
tic u la r ly  rh e u m a to id  te n o sy n o v itis . < 
N onspecific tenosynovitis o r tendon  in ­
ju ry , o r partia l tendon rup tu re  causing * 
tendon irregularity as the rup tured  fibres |
re trac t, m ay also produce triggering.6 4 
W hile tendinitis o f the flexor hallucis,, x 
longus is well recognized, particularly  in 
ballet dancers, triggering is so rare th a t A 
only three cases have been reported , two 
o f them  in ballet dancers;1,3’5 Jahss7 even -. 
doubted  its existence. j
The site o f triggering in ou r patien t * 
could no t be determ ined preoperatively 
because the triggering snap was tran sm it-4 
ted along the whole length o f  the tendon. ^  
In  retrospect, exploration o f  the m etatar­
sophalangeal pulley was unnecessary. The >  
cause o f  the localized tendon enlargement 
was no t definitely identified, bu t since I 
there was no synovitis, partia l rup tu re  o f 
central fibres in the tendon as described *■ 
by Sam m arco and M iller3 seems likely.
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 ^ Amphojeloma: Antacid Impaction in a Critically III Patient
V ►
y Patients in the intensive care unit seldom 
have mechanical small-bowel obstruction, 
■ - and obstruction due to medication
bezoars is even less common. A 65-year- 
v r old woman, in the intensive care unit 
because of septic shock and acute renal 
failure, had a small-bowel obstruction 
 ^ due to Amphojel concretions. Obstruc­
tion from such a cause may be pre- 
i i  vented by including non-constipating 
antacids, stool softeners or sorbitol.
 ^ *■ Aggressive use of H2-antagonists to 
prevent gastrointestinal bleeding in 
septic patients will reduce the need for 
orally administered antacids. When 
obstruction occurs due to antacid con- 
cretions, it may be relieved by passing a 
long intestinal tube, by giving enemas 
v for colonic obstruction or by operation.
y -  ►
II est peut frequent qu'un patient soit ac- 
^ cueilli aux soins intensifs souffrant d'une 
obstruction m6canique du grele, et une 
► obstruction due d un bezoard d'origine 
medicamenteuse est encore plus rare. 
t- ► Une femme de 65 ans, admise aux soins 
intensifs en choc septique et en insuf- 
’’fisance renale aigue, a presente une 
obstruction de I’intestin grele due a des 
concretions d'Amphojel. Une obstruction 
r  de ce type peut etre prdvenue en don- 
nant des anti-acides qui ne provoquent 
r pas de constipation et en administrant 
une substance capable d'amollir les 
i- fselles ou du sorbitol. L'utilisation 
systematique des antagonistes des 
recepteurs H2 chez les patients septiques 
dans le but de prevenir les hdmorragies 
’ gastro-intestinales va rdduire le besoin 
d'anti-acides oraux. On peut corriger une 
obstruction intestinale due d des concrd- 
y ^tions d'anti-acides en passant un long
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tube intestinal, en donnant des 
lavements ou en procddant a une 
intervention chirurgicale.
Acute renal failure is a common accom­
paniment of multiple organ failure in 
critically ill septic patients.1 These pa­
tients are at risk o f a major gastroin­
testinal hemorrhage for a number of 
reasons, one o f which is believed to be 
prolonged exposure o f the gastric mucosa 
to unopposed gastric acidity.2 Aggressive 
medical management o f the acute renal 
failure and gastric acidity involves the use 
of both H2-antagonists and antacids. In 
this setting Amphojel, an aluminum- 
containing antacid, is ideal because of its 
high buffering capacity and phosphate­
binding characteristics. There are scat­
tered reports in the literature of complica­
tions resulting from the use o f aluminum- 
containing antacids in critically ill 
patients.3-6 We report a patient with 
overwhelming sepsis and acute renal 
failure who had a complete small-bowel 
obstruction as a result of hardened Am­
phojel concretions.
Case Report
A 65-year-old woman was known to suffer 
from alcoholism and long-standing insulin- 
dependent diabetes. Several operative pro­
cedures had been performed including a 
hysterectomy, bilateral oophorectomy and a 
cholecystectomy several years before. For 1 
year she had had chronic urinary tract 
infections.
The patient initially presented to a local 
hospital with a short history of fever, chills, 
anorexia and drowsiness. She was noted to 
have foul smelling urine. For 72 hours she had 
refractory, elevated blood sugar levels and 
episodes of hypotension and confusion. Fler 
renal function progressively declined so she was 
transferred to the Kingston General Hospital.
On admission, the patient was disoriented, 
confused and unable to provide a history. She 
was markedly obese and had extreme 
tenderness in the right flank. Vital signs were
as follows: temperature 40°C, blood pressure 
70/40 mm Hg, respiratory rate 24/min, heart 
rate 120 beats/min. Her hemoglobin level was 
70 g/L, leukocyte count 23 x 109/L, platelets 
105 x 109/L , serum sodium 131 mmol/L, 
potassium 6.3 mmol/L, chloride 100 mmol/L 
and carbon dioxide 15 mmol/L. Renal failure 
was present with a blood urea nitrogen level 
of 73.19 mmol/L urea and a serum creatinine 
level of 680 jimol/L. Arterial blood gas 
measurements made on a partial intake of ox­
ygen of 40% revealed a pH of 7.3, partial 
pressure of oxygen of 87.2 mm Hg, of carbon 
dioxide 27.9 mm Hg and a bicarbonate level 
of 13 mmol/L. Gram staining of the urine 
showed large numbers of leukocytes and gram­
negative bacteria. Subsequent cultures grew 
Escherichia coli from both urine and blood. 
The patient was stabilized after hemodynamic 
monitoring lines were placed and broad spec­
trum antibiotics including tobramycin, clin­
damycin and erythromycin were given. 
Dopamine in the range of 4 to 6 /tg/kg was 
given intravenously to support her blood 
pressure. Computerized tomography disclos­
ed an emphysematous right kidney. Hemodial­
ysis was instituted. This was followed by ap­
preciable upper gastrointestinal bleeding and 
the patient’s hemoglobin level dropped by 30 
g/L. Ulcerative esophagitis, antritis, gastritis 
and a chronic pyloric channel ulcer were seen 
at endoscopic examination, but no active 
bleeding was noted. The patient was given 
cimetidine 300 mg intravenously twice daily 
and Amphojel 30 mL every hour as necessary 
through the nasogastric tube to maintain a 
gastric pH greater than 4.5.
A right radical nephrectomy was carried out 
24 hours after admission. Microscopic ex­
amination of the specimen disclosed acute 
pyelonephritis with acute papillary necrosis and 
diffuse glomerulosclerosis. Two days after 
operation, the patient was returned to the 
operating room because of continued bleeding 
from the incision in the right flank. Frank 
blood was noted in the peritoneal cavity and 
a laparotomy was done. Three litres of blood 
were found in the peritoneal cavity but no ab­
dominal source of bleeding and no perforation 
were seen in either the stomach or duodenum. 
There were many dense adhesions and multi­
ple putty-like concretions in the small bowel. 
Due to the patient’s unstable condition these 
concretions were not removed; preoperative 
medications including Amphojel were 
restarted.
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Over the following week the patient con­
tinued to deteriorate. Her abdomen became 
grossly distended and markedly tender in all 
four quadrants. Clinically and radiologically, 
a small-bowel obstruction was diagnosed. Sep­
sis was also evident hemodynamically by de­
creased systemic vascular resistance and in­
creased cardiac output despite appropriate an­
tibiotics. Oliguria remained and the patient re­
quired frequent hemodialysis to control the 
renal failure.
The patient continued to deteriorate; 18 days 
after admission she was reexplored. There was 
no focus of infection. However, the small 
bowel from the ligament of Treitz to the 
sigmoid colon was filled with rock-hard con­
cretions. The small bowel was grossly dilated 
in several areas with early ischemia adjacent 
to the concretions. The adhesions were lysed 
and through an ileotomy the concretions were 
removed. An ileostomy and mucous fistula 
were then formed. The concretions were rock- 
hard balls of Amphojel mixed with bile. All 
elements were removed from the bowel. The 
spleen was incidentally traumatized during this 
procedure and was removed.
The patient remained in septic shock with 
an elevated leukocyte count despite adequate 
antibiotic coverage with amphotericin B. 
Cultures of the sputum, urine and spleen 
revealed a pure growth of Torulopsis glabrata. 
She continued to deteriorate and died 30 days 
after admission of widely disseminated fungal 
septicemia.
Discussion
Mechanical intestinal obstructions are 
common in clinical surgical practice. 
However, impaction of feces or, less com­
monly, medications, accounts for only 
1 % to 2% of patients with mechanical in­
testinal obstruction reviewed in large 
series.7 In the intensive care unit, 
paralytic ileus is more commonly seen due 
to prolonged sepsis, major trauma or 
drug administration. It is also recognized 
that in these patients gastrointesti­
nal hemorrhage can be a major con­
cern.2 Aggressive medical management 
with H2-antagonists such as cimetidine 
and antacids has been reported to decrease 
the incidence of gastrointestinal hemor­
rhage.810 If  the patient is also in renal 
failure, the dosage of the Hr antagonists 
is adjusted and the preferred ant­
acid is one that contains aluminum.1 
These antacids are, however, notoriously 
constipating although they are effective 
buffers and bind intestinal phosphates, 
thus reducing the risk of hyperphos­
phatemia in acute renal failure. Mag­
nesium-containing antacids are general­
ly not used because they may cause mag­
nesium intoxication leading to serious 
neurologic and cardiovascular effects. 
Calcium carbonate is also avoided be­
cause of the possibility of hypercal­
cemia." Patients in the intensive care 
unit receiving aluminum-containing an­
tacids for control of gastric acidity and
having episodes of prolonged paralytic il­
eus and major cardiovascular instability 
are at risk of medication impaction in the 
large bowel or, less frequently, the small 
bowel.
Antacid impaction or medication bezo- 
ars have been reported in patients on 
long-term renal dialysis and those who 
have undergone renal transplantation. 
The most complete review was by Welch 
and associates6 in which 10 cases of col­
onic impaction were recorded in 180 
transplant patients and those with chronic 
renal failure over a 6-year period. The im­
pactions were always in the colon. Three 
patients in their group died. Small-bowel 
obstruction due to Amphojeloma is ex­
ceedingly rare; only three cases have been 
reported. The mortality for small-bowel 
obstruction due to antacid impaction is 
about 50%.
To avoid antacid impaction in critical­
ly ill patients, there are several treatment 
possibilities. First, antacid regimens may 
be altered to include nonconstipating 
agents such as magnesium hydroxide, 
unless it is contraindicated. Second, the 
use of stool softeners such as Colace and 
the addition o f sorbitol may decrease the 
constipating effect of aluminum antacids. 
Gastric acidity may be controlled through 
the aggressive intravenous administration 
of Hr antagonists such as cimetidine; 
this permits a reduction in the frequency 
of oral antacid administration. The effec­
tiveness of this therapy in preventing 
gastrointestinal hemorrhages has been 
debated.12 Lastly, proper hydration may 
soften the mixture of Amphojel and 
secretions within the small bowel.
When the bowel is obstructed by multi­
ple small-bowel or colonic concretions 
formed by antacids, several options are 
available to relieve the obstruction. A 
long intestinal tube may be used for 
drainage as well as for the administration 
of softeners and for cathartics. If the col­
on is primarily involved, enemas may 
relieve the impaction. These enemas con­
tain various combinations of Colace, 
olive oil, trypsin and soap suds. The use 
of hyperosmolar enemas containing 
Hypaque have been successful in reliev­
ing colonic obstruction in a few patients 
after transplantation. If all conservative 
measures fail, operation may be required 
to decompress the bowel and remove all 
concretions. Anastomoses should be 
avoided in the unprepared colon or in the 
presence of contamination. The preferred 
procedure is an ileostomy and mucous 
fistula for right-sided or distal small- 
bowel impactions. The Hartmann pro­
cedure is advocated for more distal im­
pactions. If complications such as colonic 
perforation occur, the prognosis is par­
ticularly poor.
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post-operative pain in those critical the need for narcotic analgesics.3 
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Prescribing Information
Marcaine*
(bupivacaine hydrochloride injection U.S.P.).
Indications:
Peripheral nerve block including retrobulbar block, infiltration, sympa­
thetic blockade, caudal, epidural, and pudendal blocks.
Contraindications:
Bupivacaine is contraindicated in persons with known sensitivity to 
local anesthetics of the amide type.
The use of bupivacaine is contraindicated in the presence of sepsis 
near the site of proposed injection, in severe shock and in heart block.
Warnings:
Usage in Pregnancy: There are no adequate and well-controlled studies 
in pregnant women of the effect of bupivacaine on the developing 
fetus. Decreased pup survival in rats and an embryocidal effect in rab­
bits have been observed when bupivacaine hydrochloride was adminis­
tered to these species in doses comparable to nine and five times 
respectively the maximum recommended daily human dose (400 mg). 
Bupivacaine hydrochloride should be used during pregnancy only if the 
potential benefit justifies the potential risk to the fetus. This does not 
exclude the use of Marcaine 0.25% or 0.50% at term for obstetrical 
anesthesia or analgesia.
Obstetrics: The highest (0.75%) concentration is not recommended for 
obstetrical anesthesia. There have been reports of cardiac arrest with 
difficult resuscitation or death following its use for epidural anesthesia 
in obstetrical patients.
Due to the high risk to the fetus, paracervical block is no longer recom­
mended.
The obstetrician is warned that severe persistent hypertension may 
occur after administration of certain oxytocic drugs, if vasopressors 
have already been used during labor (e.g. in the local anesthetic solu­
tion or to correct hypotension).
Until further experience is gained in children younger than 12 years, 
administration of bupivacaine in this age group is not recommended.
Precautions:
Marcaine (bupivacaine) should be used cautiously in persons with 
known drug allergies or sensitivities, particularly to the amide-type local 
anesthetics.
Caution is advised in administration of repeat doses of bupivacaine to 
patients with severe liver disease.
The lowest dosage that gives effective anesthesia should be used, to 
avoid high plasma levels and serious systemic side effects. Injection ol 
repeated doses of bupivacaine may cause a significant increase in 
blood levels due to accumulation of the drug or its metabolites or slow 
metabolic degradation.
Tolerance varies with the status of the patient. Debilitated, elderly and 
acutely ill patients may require reduced doses commensurate with age 
and physical condition.
It should be remembered that solutions containing a vasopressor 
agent, e.g. epinephrine, should be used with caution, if at all, in patients 
who are receiving monoamine oxidase inhibitors or anti-depressants 
of the triptyline or imipramme type, because severe, prolonged hyper­
tension may result. Dose-related cardiac arrhythmias may occur if 
preparations containing epinephrine are employed in patients during or 
immediately following the administration of chloroform, halothane, 
cyclopropane, trichloroethylene or other related agents. In deciding 
whether to use these products concurrently in the same patient, 
the combined action of both agents upon the myocardium, the concen­
tration and volume of vasoconstrictor used, and the time since injec­
tion, when applicable, should be taken into account.
The decision to use a local anesthetic containing a vasoconstrictor in 
areas with a limited blood supply or in patients with peripheral vascular 
disease, will depend on the physician’s appraisal of the relative advan­
tages and risks.
Local anesthetics which contain preservatives, i.e. those supplied in mul­
tiple dose vials, should not be used for caudal or epidural anesthesia. 
Epidural Use: It is advised that a test dose, generally 2-3 mL of 0.5% 
bupivacaine (or other amide anesthetic) containing 1:200,000 epine­
phrine (10-15 micrograms) be administered to check that the spinal 
canal or a blood vessel has not been entered while locating the epidural 
needle or catheter.
In the event of spinal injection clinical signs of spinal block would 
become evident in a few minutes.
In the event of intravascular injection a transient increase in pulse rate 
and possibly momentary increase in systolic blood pressure are 
usually detectable with a monitor. The other symptoms and signs of 
“epinephrine response” are less dependable. The effects of other medi­
cation the patient has received may modify this response.
When reinforcing doses are required the test dose should be used 
again to check the catheter location.
Use in Ophthalmic Surgery: When Marcaine 0.75% is used for retrobul- 
bar block, complete corneal anesthesia usually precedes onset of clini­
cally acceptable external ocular muscle akinesia. Therefore, presence 
of akinesia rather than anesthesia alone should determine readiness of 
the patient for surgery.
Adverse Reactions:
Reactions to bupivacaine are characteristic of those associated with 
amide-type local anesthetics. A major cause of adverse reactions to 
this group of drugs is excessive plasma levels, which may be due to 
over-dosage, inadvertent intravascular injection, or slow metabolic 
degradation. Other causes of reactions to these local anesthetics may 
be hypersensitivity, idiosyncrasy, or diminished tolerance.
Excessive plasma levels cause systemic reactions involving the central
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nervous system and the cardiovascular system. The central nervous 
system effects are characterized by excitation or depression. The first 
manifestation may be nervousness, dizziness, blurred vision, or tre­
mors, followed by drowsiness, convulsions, unconsciousness, and pos­
sibly respiratory arrest. Since excitement may be transient or absent, 
the first manifestation may be drowsiness, sometimes merging into 
unconsciousness and respiratory arrest.
Other central nervous system effects may be nausea, vomiting, chills, 
constriction of the pupils, or tinnitus. The cardiovascular manifesta­
tions of excessive plasma levels may include depression of the myocar- 
dium, blood pressure changes (usually hypotension), and cardiac 
arrest. Recent clinical reports and animal studies suggest this may be 
more likely to occur with the long acting amide local anesthetics such 
as bupivacaine.
Allergic reactions are characterized by cutaneous lesions (e.g. urticaria, 
edema) and other manifestations of allergy.
Reactions following epidural or caudal anesthesia may include: high or 
total spinal block, urinary retention; fecal incontinence, loss of perineal 
sensation and sexual function; persistent analgesia, paresthesia, and 
paralysis of the lower extremities; headache and backache; and slow­
ing of labor and increased incidence of forceps delivery.
It should be noted that reactions due to systemic absorption may be 
slow or rapid in onset. Those of rapid onset include respiratory depres­
sion, cardiovascular collapse and cardiac arrest. This type of reaction 
necessitates a high degree of preparedness since it can occur with little 
warning.
In co-ordinated studies of 3200 procedures carried out by 15 investiga­
tors, there were 2 severe systemic reactions. Both patients experienced 
convulsions as a result of inadvertent vascular injection.
Fetal bradycardia has been observed with the use of bupivacaine. Most 
cases, including a few fatalities, occurred when the paracervical route 
was used (see “Warnings”).
In some subjects bupivacaine may produce marked peripheral vaso­
constriction in unanesthetized areas which may last for several hours.
Treatment of Overdose and Severe Reactions:
Toxic effects of local anesthetics require symptomatic treatment; there 
is no specific cure. The physician should be prepared to maintain an 
airway and to support ventilation with oxygen and assisted or con­
trolled respiration as required. Supportive treatment of the cardiovas­
cular system includes intravenous fluids and, when appropriate, vaso­
pressors (preferably those that stimulate the myocardium).
Convulsions may be controlled with oxygen and intravenous adminis­
tration, in small increments, of a barbiturate or muscle relaxant, as 
follows: preferably, an ultra short-acting barbiturate such as thiopental 
or thiamylal; if this is not available, a short-acting barbiturate (e.g. seco­
barbital or pentobarbital) or a short-acting muscle relaxant (succmyl- 
cholme). Intravenous muscle relaxants and barbiturates should only be 
administered by those familiar with their use.
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Dosage and Administration:
The duration of anesthesia with bupivacaine is such that, for most pro­
cedures, a single dose is sufficient. Maximum dosage limit must be indi­
vidualized in each case after evaluating the size and physical status of 
the patient, as well as the usual rate of systemic absorption from a par 
ticular injection site. Most experience to date is with single doses of 
bupivacaine up to 225 mg with epinephrine 1:200,000, and 175 mg 
without epinephrine; more or less drug may be used depending on indi­
vidualization of each case.
At present there is insufficient clinical evidence with multiple dosage or 
intermittent dose techniques to permit precise recommendations for 
such procedures to be given. However, limited clinical experience in this 
area of use indicates that bupivacaine may be repeated in 3 to 6 hours 
up to a maximum dose of 400 mg in 24 hours. In most cases the dura­
tion of anesthetic effect is prolonged by the addition of epinephrine.
The following doses have generally proved satisfactory for the average 
adult. They may require adjustment in relation to age and the physical 
condition of the patient.
Local infiltration: up to a maximum dosage of 0.25% solution.
Peripheral nerve block: 5 to 30 mL of 0.50% or 5 to 60 mL of 0.25% 
solution.
Sympathetic: 20 to 50 mL of a 0.25% solution.
Epidural: 10 to 20 mL of a 0.25%, 0.50%, or 0.75%t solution.
Caudal: 15 to 30 mL of a 0.25% or 0.50% solution. 
tO.75% not recommended for obstetric use.
Supplied:
Each 20 mL single dose vial contains: bupivacaine 0.25%, 0.50% or
0. 7 5 .  with or without epinephrine 1:200,000. Boxes of 5 vials.
Each 50 mL multiple dose vial contains: bupivacaine 0.25% or 0.50%. 
Boxes of 1 vial.
Note: Bupivacaine solutions without epinephrine may be autoclaved. 
Product Monograph available on request.
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Early Valve Replacement in Active Infective Endocarditis
► ►
Infective endocarditis is associated with 
v a high mortality, but previous studies 
have suggested that the major complica- 
r tions of the condition might be
prevented by early surgery. Of 50 pa- 
’ tients treated for infective endocarditis at 
the Montreal Heart Institute from 1977 
r  to 1982, 30 were treated nonsurgically 
 ^ and the remaining 20 underwent early 
valve replacement before preoperative 
4 antibiotic therapy was completed. Of 
these 20, 14 had native valve endocar-
> h ditis and 6 prosthetic valve endocarditis.
The organisms involved were Streptococ- 
k * cus sp in 11, Staphylococcus aureus in 
2, gram-negative organisms in 3 and 
Candida parapsilosis in 1. Blood cultures 
remained negative in three patients.
There were three early deaths (15%) 
following operation and one late death 
f (5%). Infection on implanted prostheses 
' v did not recur, but reoperation was 
required in one patient because of 
r  prosthetic dehiscence 7 months after in­
itial implantation. All resected valves 
displayed evidence of infection. Follow­
up was obtained in all survivors. After an 
average follow-up of 26 months, 12 pa- 
 ^ y. tients remained in functional class I and 
4 in class II (New York Heart Association
> y classification). Early valve replacement
has resulted in improved survival of pa- 
tients with infective endocarditis and is 
now associated with a low operative 
y mortality and morbidity.
L'endocardite infectieuse s'accompagne 
r |.d'une forte mortality. Des Etudes
anterieures ont indique que les complica- 
i ► tions majeures de cette maladie
pouvaient etre evitees par une chirurgie 
*■ precoce. Sur 50 patients trait6s pour 
endocardite infectieuse a I'lnstitut de
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cardiologie de Montreal entre 1977 et 
1982, 30 ont regu un traitement medical 
alors que les 20 autres subissaient un 
remplacement valvulaire precoce avant la 
fin d'un traitement antibiotique 
preoperatoire. De ces 20 malades, 14 
avaient une endocardite affectant les 
valvules cardiaques naturelles et 6 une 
infection de valvule prosthetique. Dans 
11 cas, le microorganisme responsable 
6tait le Streptococcus sp, dans 2 cas 
Staphylococcus aureus, des bact6ries 
gram negatif dans 3 et Candida parap­
silosis dans 1. Les h6mocultures sont 
demeurees negatives chez trois patients. 
On a enregistre trois dbces (15%) t6t 
apres I’operation et un d£ces tardif (5%). 
II n'y a pas eu de rgcidive d'infection de 
prothese, mais une deuxi&me operation 
s'avera necessaire chez un patient £ 
cause de la dehiscence d'une valvule 
prosthetique 7 mois apres la pose 
initiale. Toutes les valvules resequees 
ont montre des signes d'infection. Tous 
les survivants ont fait I'objet d'examens 
de controle. Apres une periode de 
surveillance moyenne de 26 mois, 12 
patients se maintenaient dans la classe 
fonctionnelle I et 4 dans la classe II 
(selon la classification de la New York 
Heart Association). Un remplacement 
valvulaire precoce a ameiiore la survie 
des patients atteints d'endocardite infec­
tieuse et cette operation est maintenant 
liee a un faible taux de mortalite et de 
morbidite peroperatoires.
Despite the availability o f many new and 
potent antimicrobial drugs, infective en­
docarditis still carries a high mortality, 
owing to the severe complications of this 
disease. Previous studies have shown that 
congestive heart failure and systemic em­
bolism occur frequently and are respon­
sible for more than 75% of the deaths.1,2 
Both complications might be prevented 
by earlier surgical treatment. Therefore, 
the proper timing of operation appears to 
be a major, and still unresolved, issue in 
the management of this condition. There 
has been reluctance to recommend early 
valve replacement in these patients 
because implantation of a prosthetic
device in a septic environment is against 
well-established surgical principles. 
However, the poor results from the classic 
treatment have stimulated interest 
towards a more aggressive attitude. This 
paper describes our experience with 20 pa­
tients who underwent valve replacement 
early during the active phase o f infective 
endocarditis.
Patients and Methods
From 1977 to 1982, 50 patients with in­
fective endocarditis were treated at the 
Montreal Heart Institute. There were 28 
cases o f native valve endocarditis (half 
were treated medically) and 22 cases of 
prosthetic valve endocarditis (16 treated 
medically). During the same period, 980 
patients underwent valve replacement. 
Among the 22 patients treated for en­
docarditis o f a prosthetic valve, 5 infec­
tions occurred early (within 2 months of 
valve implantation) and 17 late. O f the 
30 patients managed by medical treatment 
alone, 4 (13%) died. Three o f them had 
late prosthetic valve endocarditis. Among 
the 26 patients in whom the infection was 
successfully controlled by medical treat­
ment, 7 (23%) underwent delayed opera­
tion 2 to 11 months (mean 6 months) after 
onset o f the disease, because o f late 
hemodynamic complications following 
termination o f  antibiotic treatment. There 
were no deaths following delayed valve 
replacement.
Early valve replacement during the ac­
tive phase o f infective endocarditis was 
performed in 20 patients. There were 15 
men and 5 women aged 18 to 69 years 
(mean 46 years), 14 with native valve en­
docarditis and 6 with late prosthetic valve 
endocarditis. In the 14 patients with en­
docarditis o f a native valve, the preex­
isting valvulopathy was rheumatic in 8, 
myxoid degeneration in 4 and a bicuspid 
aortic valve in 2 patients. The aortic valve 
was involved in seven patients, the mitral 
in two and both valves in five cases. In 
the other six patients, a mitral prosthesis 
was infected in four, an aortic prosthesis 
in one and both aortic and mitral pro­
stheses in one patient. In 9 o f the 20 cases, 
the site o f entry of the infection was
VOLUME 27, NO. 4, JU LY 1984 /  THE CANADIAN JOURNAL OF SURGERY 383
unknown. A dental infection was respon­
sible for six cases, a urinary infection was 
the cause in three, and otitis and skin in­
fection were responsible in one patient 
each. There were no cases of infective en­
docarditis secondary to drug addiction in 
our series. Responsible microorganisms 
are shown in Table I. Active infection 
was evident on pathologic examination of 
resected natural or prosthetic valves in all 
patients, most frequently vegetations 
(Table II). Following surgery, the specific 
antimicrobial therapy was continued un­
til treatment had lasted for 6 weeks, in­
cluding preoperative treatment.
Findings
Preoperative Management
Preoperative investigation included 
echocardiography in 18 patients (vegeta­
tions were indicated in 5), gallium scan­
ning in 6 patients with two positive tests 
and cardiac catheterization in 5 patients. 
Indications for hemodynamic studies 
were double-valve involvement in three 
and a left-to-right shunt in one patient 
and for coronary angiography in one pa­
tient with previous angina. Antibiotics 
were selected according to in-vitro sen­
sitivity and administered intravenously. 
None of these patients completed a full 
6-week course of antibiotic therapy before 
they underwent operation. The duration 
of treatment preoperatively ranged from 
1 to 40 days (average 21 days) (Fig. 1). 
Early valve replacement was performed 
because of the sudden appearance or pro­
gression of congestive heart failure in 15 
patients, resistance to antibiotic treatment 
as evidenced by persisting fever after 3 
weeks of treatment in 3 and major sys­
temic embolism in 2 patients. Two of the 
patients were in septic shock preopera­
tively.
Postoperative Results and Follow-up
There were three early deaths (within 
30 days), from uncontrollable hemor­
rhage in two patients and from acute 
renal failure in one. Two patients (14%) 
in the native valve group died and one 
(17%) in the prosthetic valve group. 
There was one late death 2 months 
postoperatively from intractable ar­
rhythmias. All four deaths occurred in 
patients who underwent complex surgical 
procedures (double-valve replacement in 
two, aortic valve replacement and closure 
of ventricular septal defect in one and 
mitral valve replacement associated with 
coronary bypass grafting in one).
All 16 survivors were available for 
follow-up, 12 to 60 months after opera­
tion (mean 26 months). There were no 
cases of reinfection of implanted pros- 
theses in our series. One patient under­
went reoperation because of massive 
dehiscence of a mitral valve prosthesis 7 
months after initial implantation for 
fungal infective endocarditis. Antifungal 
treatment was started preoperatively; am­
photericin B was given intravenously for 
18 days and flucytosine given orally for 
4 days. Both drugs were discontinued on
the fourth postoperative day because of 
rapidly progressive renal failure. A loud 
mitral systolic murmur and severe con­
gestive heart failure developed. At < 
reoperation, the mitral prosthesis was 
found to be torn from the annulus at A 
three different sites but there was no 
evidence of reinfection. The prosthesis ^ 
was replaced after scrubbing the endocar- i  
dium with iodine solution. All cultures 
taken at reoperation were negative. The _ 
patient showed no signs of recurrent in­
fection following operation and he re- < 
mains well 36 months later. At last 
follow-up, 12 of the 16 patients were in *• ‘ 
the New York Heart Association func­
tional class I and 4 in class II. An aortic 
diastolic murmur was noted in 2 of 13 pa-
T a b le  I I— P a th o lo g ic  Findings on
R es ec ted  V a lves
P a th o lo g ic  fe a tu re N o.
V e g e ta tio n s 1 6
A bscess 6
L e a fle t p e rfo ra tio n 4
F is tu la  o f sinus o f V a lsa lv a 2
R u p tu red  ch o rd ae 1
T a b le  1 -O rg a n is m s  R esponsib le  fo r  In fe c tiv e  E ndocard itis  
in 2 0  P a tie n ts  T re a te d  S u rg ic a lly *
O rg an ism N o. %
Streptococcus 11 5 5
viridans group 9
faecalis 1
Peptostreptococcus 1
Staphylococcus aureus 2 1 0
G ra m -n e g a tiv e  organ ism s 3 1 5
Haemophilus influenzae 1
Acinetobacter calcoaceticus 1
A ctinobacillus actinomycetem-comitans 1
Fungus: Candida parapsilosis 1 5
* ln  3  p a tie n ts  (1 5 % )  no o rg an ism s w e re  cu ltu red .
Surgical Treatment
The aortic valve was replaced in seven 
patients (35%), the mitral valve in four 
(20%) and both valves were replaced in 
nine patients (45%). In addition, two pa­
tients underwent closure of a ventricular 
septal defect caused by a fistula from aor­
tic valve endocarditis and one patient had 
coronary bypass grafting in addition to 
mitral valve replacement. A bioprosthesis 
was implanted in 17 patients and a 
mechanical valve in 3. Cold potassium 
cardioplegia and pericardial irrigation 
were used to protect the myocardium dur­
ing operation in all patients. After opera­
tion, complete atrioventricular block 
developed in two patients and a perma­
nent pacemaker had to be implanted. FIG. 1—Duration of preoperative antibiotic treatment (mean 21 days, range from 1 to 40 y days) in 20 patients who underwent early valve replacement for infective endocarditis.
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tients with an aortic prosthesis, and a 
mitral systolic murmur in 1 of 10 patients 
with a mitral prosthesis. Although 
hemodynamic studies were not perform­
ed, none of these regurgitation murmurs 
appeared to be clinically important.
* Discussion
All patients who underwent surgical 
treatment in our series presented with 
definite infective endocarditis as defined 
<- in the classification of Pelletier and 
Petersdorf,3 since evidence of active 
^ valve infection was demonstrated on 
histologic examination in all cases. The 
indications for and timing of valve 
replacement in the treatment of infective 
endocarditis are not yet well defined. 
Y Before 1977, the mortality from infective 
endocarditis was high. Before 1970 at the 
^Montreal Heart Institute, only 67% of 
patients survived the acute phase of in­
fection and in a second series of patients 
treated between 1969 and 1977, the 
overall mortality was 44%, even though 
k more patients were treated surgically.1’2 
Since 1977, the mortality from this disease 
a has decreased markedly to 14% (13% in 
the nonsurgical group and 15% in the 
surgical group). Besides the im­
provements in antimicrobial drugs 
available and in the surgical and myocar­
dial protection techniques, earlier valve 
replacement during the course of the 
disease has played a major role in improv­
ing survival. Death results from a major 
t complication, which could have been 
prevented by earlier surgical treatment in 
75% to 90% of cases.1'3 Comparing the 
results of nonsurgical and surgical 
treatments of infective endocarditis, 
Richardson and associates4 found a 
y significant difference in the respective 
mortality rates; they were 44% and 14% 
r  for native valve endocarditis, and 75% 
and 43% for prosthetic valve endocar­
ditis. They therefore recommended early 
valve replacement when signs of pro­
gressive heart failure develop, particularly 
with aortic valve endocarditis, or if 
systemic embolization occurs.
Few series of early valve replacement 
during the active phase of infective en­
docarditis have been reported (Table 
III412). Among 431 patients collected 
from 10 studies (including the present 
one) since 1976, there has been a pro­
gressive decline in early mortality, which 
ranged from 18% to 37% between 1976 
and 1980 to 16% or less since 1981. In 
most series, prosthetic valve endocarditis 
resulted in a higher surgical mortality 
than native valve disease, but the dif­
ference was small in our patients.
Although inserting a prosthesis in a 
septic environment is against generally 
recognized surgical principles, our ex­
perience and that of others4'8,12 indicate 
that the risk of reinfection of the im­
planted prosthesis is minimal. We have 
had no case of recurrent infection of a 
prosthesis following operation and only 
one case of dehiscence; this required 
reoperation. Others reported similar 
results, with reoperation rates ranging 
from 5% to 14% (Table III). In only one 
small series was there a high reoperation 
rate — 33%.7
While the organism responsible for the 
endocarditis can be identified in most pa­
tients, the site of entry of infection re­
mains unknown in almost half. When it 
is known, dental and urinary tract infec­
tions or manipulations are most often in­
volved. Improved prophylactic treatment 
in patients at risk should decrease the in­
cidence of endocarditis secondary to these 
well-established causes. Contrary to the 
experience of most others, we have had 
no cases of right heart infective endocar­
ditis and none of our cases was related to 
drug addiction.
Echocardiography is a useful nonin- 
vasive method for detecting valvular 
vegetations.11’13,14 In our series, using 
either the M-mode or two-dimensional 
echocardiography, vegetations were 
shown in only 28% of the patients. Thus,
T a b le  I l l - R e s u l t s  o f  E a r ly  V a lv e  R e p la c e m e n t  f o r  In f e c t iv e  E n d o c a rd it is  
R e p o r te d  in  th e  L ite r a tu r e
A u th o rs
N o . o f  
p a t ie n t s
E a r ly  m o r t a l i t y ,  %
R e o p e ra t io n ,
%N V E P V E M e a n
S tin s o n  a n d  c o lle a g u e s , 1 9 7 6 5 4 4 3 0 2 4 2 7 -
B o y d  a n d  c o lle a g u e s , 1 9 7 7 6 5 4 1 3 5 7 1 9 5
R ic h a rd s o n  a n d  c o lle a g u e s , 1 9 7 8 4 1 1 6 1 4 4 3 2 2 11
W ils o n  a n d  c o lle a g u e s , 1 9 7 8 7 1 1 1 8 - 1 8 3 3
Y o u n g  a n d  c o lle a g u e s , 1 9 7 9 s 3 0 3 7 3 7 5
L a u  a n d  c o lle a g u e s , 1 9 8 1 9 2 6 1 3 1 3 1 2
P ra g e r  a n d  c o lle a g u e s , 1 9 8 1 10 1 4 0 0 1 4
L e w is  a n d  c o lle a g u e s , 1 9 8 2 " 9 4 1 4 3 3 1 6 6
S y m b a s  a n d  c o lle a g u e s , 1 9 8 2 12 2 2 9 - 9 5
P re s e n t  s tu d y 2 0 1 4 1 7 1 5 5
T o t a l /m e a n ,  1 9 7 6 - 8 3 4 3 1 1 7 3 5 1 9 1 1
N V E  =  n a t iv e  v a lv e  e n d o c a rd it is , P V E  =  p r o s th e t ic  v a lv e  e n d o c a r d it is .
►
a diagnosis of infective endocarditis can­
not be excluded on the basis of a negative 
echocardiogram. Cardiac catheterization 
is not helpful for diagnosis and is seldom 
indicated in these patients, except when 
involvement of more than one valve is 
suspected or when coronary angiography 
is necessary to investigate concomitant 
coronary artery disease.
Our results are similar to those of 
Richardson and associates4 and confirm 
their conclusion that patients with infec­
tive endocarditis should undergo valve 
replacement early during the course of 
treatment if congestive heart failure pro­
gresses or systemic embolization occurs, 
regardless of the infective state. This more 
aggressive attitude has resulted in a 
marked decline in mortality. However, 
early prosthetic valve endocarditis still 
carries a high mortality whether treated 
surgically or nonsurgically.4,15 In the 
present study, five patients were con­
sidered to have had early prosthetic valve 
endocarditis (0.5% of all patients who 
had valve replacement between 1977 and 
1982). All responded to medical treat­
ment. Prevention of this catastrophic 
complication is the major consideration 
and the prophylactic regimen used in our 
patients, which includes skin cleansing 
with chlorhexidine 0.05% solution and in­
travenous administration of ampicillin 
and cloxacillin 1 g every 6 hours for 4 
days, starting just before operation, ap­
pears to be effective. In addition, special 
care is given to detection of dental pro­
blems or of any active infection pre- 
operatively.
The late results also justify our present 
attitude, since after an average follow-up 
of more than 2 years there has been no 
late prosthetic reinfection and only one 
valve dehiscence. At follow-up, prosthetic 
regurgitation murmurs were found in 
three other patients, but in only one of 
these was the murmur greater than grade 
2/6, and all three patients remained 
asymptomatic with no evidence of a 
hemodynamically important regurgita­
tion. However, these patients must be 
followed up carefully for at least 2 years 
following operation to detect signs of 
reinfection or of substantial paravalvular 
leak. Lau and colleagues9 have stressed 
the importance of carrying out complete 
debridement of the annulus and of re­
moving all necrotic tissue at operation; if 
the remaining annulus is friable, stitches 
reinforced with Teflon pledgets should be 
used. Postoperatively, the antibiotic 
regimen is determined by the in-vitro sen­
sitivity of the organism involved and is 
maintained for a minimum of 2 weeks 
and up to 6 weeks.
Conclusions
Our results lead us to recommend ear-
VOLUME 27, NO. 4, JULY 1984 /  THE CANADIAN JOURNAL OF SURGERY 385
ly valve replacement during the treatment 
o f infective endocarditis if congestive 
heart failure progresses, major systemic 
embolization occurs or if the patient does 
not respond to medical treatment. Opera­
tion should not be postponed in order to 
complete the antibiotic treatment, since 
in our experience late complications due 
to prosthetic reinfection or dehiscence are 
uncommon and do not justify the greater 
risk of major systemic complications 
from delaying definitive surgical treat­
ment.
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Management of Gangrene in Diabetic Extremities
4
*  ,< 
*  l
The long-term complications of diabetes 
mellitus occur despite insulin therapy.
One of these complications is gangrene 
of an extremity which is a prime cause 
of morbidity and mortality in diabetic 
patients. Peripheral occlusive vascular 
disease frequently underlies the gangrene 
and this challenges the surgeon to revas­
cularize the limb and to limit the amputa­
tion to the gangrenous tissue. The 
author describes six diabetic patients 
with gangrene of an extremity treated at 
the Riverside Hospital in Ottawa to illus­
trate how this condition may be mana­
ged by revascularization with no amputa­
tion or with conservative amputation and 
debridement. Major amputation was 
avoided in all six patients.
Les complications a long terme du dia- 
bete sucre surviennent malgre I'insulino- 
therapie. La gangrene d'un membre 
represente une de ces complications; elle 
est une cause importante de morbidite et 
de mortality chez le patient diabetique.
La maladie vasculaire obliterante periphe- 
rique est souvent sous-jacente a cette 
gangrene et ceci incite le chirurgien a
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revasculariser le membre et 6 limiter 
I'amputation au tissu gangreneux. L'au- 
teur decrit six cas de gangrene des mem- 
bres chez des patients diabetiques qui 
ont ete traites a I'Hopital Riverside d'Ot- 
tawa afin d'illustrer comment cette mala­
die peut etre traitee par revascularisation 
sans amputation ou avec une amputation 
conservatrice et debridement. Une ampu­
tation majeure a ete evitee chez les six 
patients.
Gangrene is a major complication of 
diabetes mellitus and contributes ap­
preciably to the morbidity and mortality 
and to the health-care costs o f these 
patients.1 The diabetic extremity is 
susceptible to infection, neuropathy and 
arterial occlusive disease, which poten­
tiate each other and cause gangrene.2 
Because accelerated atherosclerosis of 
medium and large vessels is more impor­
tant than microvascular disease in the 
etiology of gangrene,3 surgeons are now 
able to revascularize and salvage the limbs 
of many diabetic patients. Often clini­
cians do not consider revascularization of 
diabetic extremities with gangrene and 
even refer these patients to orthopedic 
surgeons for major amputation or to 
plastic surgeons for radical debridement 
rather than to a surgeon who can 
revascularize the extremity and limit the 
tissue loss to that which is already dead. 
A recent major textbook of medicine1
fails to mention revascularization in its v 
discussion of gangrene in diabetics.
Between March 1981 and March 1983, 4
six diabetic patients with gangrene of an 
extremity were referred to me at the - 
Riverside Hospital in Ottawa. In all six 
patients major amputation was avoided ’ 
by revascularization with or without con­
servative amputation. \
A 76-year-old man with insulin-dependent ! 
diabetes mellitus had painful gangrene of his < 
entire right fifth toe with erythema and edema 
of the adjacent foot. The rest of the foot was ■* 
warm and pain-free with normal sensation; he 
had no history of claudication or rest pain. The A 
popliteal pulse was present but the pedal pulses 
were absent. Doppler blood pressure in the  ^
posterior tibial artery was 100 mm Fig systolic 
and the brachial blood pressure was 180 mm < 
Hg systolic. Transmetatarsal amputation of the 
fifth toe failed to heal and the gangrene spread ■* 
to involve the fourth and third toes. 
Angiograms showed a large patent posterior -* 
tibial artery with proximal occlusion (Fig. 1).
An autogenous reversed saphenous vein graft * A 
was inserted from the superficial femoral artery 
to the posterior tibial artery (Fig. 2). The third f  
and fourth toes were amputated at the 
transmetatarsal level and the foot healed. The A 
patient had no further trouble with his foot.
It was pain-free and fully weight bearing until f  
his death 18 months later.
Comment.— Angiography should be done V 
before any major am putation. If the
Case Reports
Case 1
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revascularization of the posterior tibial artery 
had been done before the initial amputation, 
the patient would have lost only one toe and 
A would have been out of hospital 2 months 
earlier.
* -
Case 2
►
While vacationing in Florida, a 70-year-old 
V ► insulin-dependent diabetic man had a callus 
pared. Gangrene resulted, involving his left 
-  third, fourth and fifth toes and adjacent foot. 
One year previously, an ulcer of the same foot 
i>- had healed with conservative treatment. Pedal 
pulses were absent but he did not have 
* claudication or rest pain. On this admission, 
the pedal pulses were absent to palpation and 
► *- the Doppler blood pressure in the posterior 
tibial artery was the same as the brachial 
- v pressure. The popliteal pulse was present and 
angiography showed a tight stenosis of the 
y  posterior tibial artery, which was the only one 
supplying the foot. Percutaneous transluminal 
■ angioplasty of the posterior tibial artery was 
done and a palpable pulse was restored at the 
y r  ankle; a transmetatarsal amputation of the 
third, fourth and fifth toes he ied  with delayed 
* skin grafting. He was fully weight bearing with 
a minimal limp postoperatively.
5 Four months after the initial amputation, 
rest pain, ulceration and breakdown of the skin
i ».
FIG. 1—Case 1. Large patent distal posterior 
' '  tibial artery fed by collaterals. Peroneal and 
anterior tibial arteries cannot be seen.
grafts developed with necrosis of the second 
toe. The posterior tibial pulse was absent and 
angiography showed reocclusion of the 
posterior tibial artery. A popliteal posterior 
tibial saphenous vein graft was successful 
although the second toe had to be amputated. 
He was pain free and fully weight bearing with 
a patent saphenous vein graft 18 months after 
the initial amputation, when he died of 
esophageal varices.
Comment.—Adequate collateral circulation 
did not develop after the angioplasty and the 
patient lost another toe when the artery became 
occluded a second time. In the light of our pre­
sent knowledge of angioplasty of the tibial 
arteries, bypass grafting should have been done 
initially rather than angioplasty.
Case 3
A 58-year-old man was seen in the emergen­
cy department with gangrene along the lateral 
edge of his right foot. The rest of the foot was 
swollen, painful and warm. Pedal pulses were 
absent but the popliteal pulse was present. 
Although diabetes mellitus had not been 
diagnosed previously, his blood glucose level 
was 21.1 mmol/L. He had no history of 
claudication or rest pain in his extremities.
Angiography showed diffuse disease in the 
proximal tibial and peroneal arteries with a pa-
FIG. 2—Case 1. Operative arteriogram 
demonstrates saphenous vein graft filling 
posterior tibial artery.
tent distal posterior tibial artery supplying the 
foot. An autogenous reversed saphenous vein 
graft was inserted from the popliteal to the 
tibial arteries and the fifth toe and gangrenous 
tissue were amputated. Further debridement 
was done 1 week later. After 3 weeks of dress­
ing changes to the open amputation site, the 
area was granulating, so skin grafting was 
done. At present, the saphenous vein graft has 
been patent for 1V4 years and he is fully weight 
bearing with a healed amputation site.
Comment.—High skin temperature and 
erythema may not indicate adequate perfusion 
because a hyperdynamic circulation accom­
panies the inflammatory response to infection 
and gangrene. Revascularization should be 
done as early as possible after gangrene 
develops.
Case 4
A 48-year-old insulin-dependent diabetic 
man had gangrene of his left fifth toe and ad­
jacent foot. The foot was edematous and warm 
without pedal pulses. No Doppler signal was 
audible in either pedal artery; the popliteal 
pulse was present. He had had no symptoms 
of vascular insufficiency in the past.
Angiograms showed disease of the peroneal 
and tibial vessels in the calf with the foot sup­
plied by the terminal anterior tibial artery (Fig. 
3).
Because his own saphenous vein was throm­
bosed, an umbilical vein graft was inserted 
from the popliteal to the anterior tibial artery 
and the fourth and fifth toes were amputated. 
Delayed skin grafting was done after the open
FIG. 3—Case 4. Patent posterior tibial 
artery that makes minimal contribution to 
blood supply of foot. Collateral with critical 
stenosis (arrow) supplies large patent distal 
anterior tibial artery, which is main vessel sup­
plying foot.
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amputation site granulated with dressing 
changes.
The umbilical vein graft became infected and 
occluded after 4 months but the skin grafts had 
healed by that time and the umbilical vein graft 
was removed without adverse effect.
He is fully ambulatory and pain free 2 years 
after the initial amputation.
Comment.—The umbilical vein graft provid­
ed temporary revascularization while the 
gangrene was treated, the skin grafts healed 
and collaterals developed. Salvage rates are 
usually higher than graft patency rates for this 
group of patients. In retrospect, the saphenous 
vein thrombosis may have been due to the 
gangrene and the vein from the other leg may 
have been suitable for grafting.
Case 5
Gangrene o f  the tip of the right middle toe 
developed in a 61-year-old grossly obese 
insulin-dependent diabetic woman. The foot 
was warm and painful with erythema of the 
toe and foot adjacent to the gangrene. No 
pedal pulse was palpable and a faint signal was 
heard by Doppler in the dorsalis pedis artery. 
The popliteal pulse was not palpable but the 
femoral pulse was present. She had no history 
o f peripheral vascular insufficiency. The 
arteriogram showed a critical stenosis o f  the 
superficial femoral artery with some diffuse 
disease. The anterior tibial and peroneal 
arteries were thought by the radiologist to be 
occluded and there was no flow in the distal 
posterior tibial artery. Because of the lack of 
collaterals in the calf and the faint Doppler 
signal in the pedal arteries, the surgeon thought 
the problem was low flow rather than occlu­
sion. A femoropopliteal umbilical vein graft 
was inserted because her own saphenous vein 
was thrombosed; good flow returned to both 
pedal arteries. The tip of her toe autoam- 
putated and she is fully ambulatory and pain- 
free 1V4 years postoperatively.
Comment.—Angiograms need to be inter­
preted in the light o f the clinical findings and 
a positive Doppler signal may indicate a pa­
tent artery not visualized by angiography. An 
umbilical vein graft can be used as an arterial 
substitute when the patient’s saphenous vein 
is not suitable.
Case 6
A 68-year-old man with insulin-dependent 
diabetes mellitus had painful gangrene of the 
pulps of the left ring and fifth fingers. The 
pulses of the left upper extremity were absent 
and angiography showed occlusion of the left 
subclavian artery. An axilloaxillary saphenous 
vein graft revascularized the left upper extremi­
ty and the fingers have remained healed for 1 
year. No amputation or skin grafting was 
required.
Comment.—Diabetic gangrene may involve 
the upper as well as the lower extremity.
Discussion
Diabetic patients with gangrene maybe 
extremely ill initially due to infection ad­
jacent to the gangrene and to uncontrol- 
ed diabetes mellitus. Preoperatively, 
fluid, electrolyte, acid-base and blood- 
glucose abnormalities are corrected and
antibiotics (usually an aminoglycoside) 
are administered parenterally. The an­
tibiotics can be changed postoperatively 
as the culture results indicate. Roentge­
nograms may show associated bone 
destruction or gas in the soft tissues ad­
jacent to the gangrene. Drugs such as 
acetylsalicylic acid, dipyridamole4 and 
ibuprofen5 are more effective in prolong­
ing vein graft patency if they are begun 
preoperatively, and there is evidence that 
vitamin A6 and prostaglandins7 are 
beneficial although they are seldom us­
ed. Cessation of smoking is imperative 
and lipid abnormalities and obesity can 
be dealt with postoperatively.
Vascular disease may occur in both 
insulin-dependent and noninsulin-de­
pendent diabetic patients; the exact rela­
tion of the vascular lesions to the control 
of blood glucose remains debatable.8 
The large-vessel lesion in diabetes mellitus 
is similar pathologically to that seen in 
nondiabetic patients with atherosclerosis 
although the diabetic atherosclerotic 
lesions are more numerous and more 
often complicated by ulceration, calcifi­
cation and superimposed thrombosis.3 
Peripheral occlusive vascular disease is 
primarily due to atherosclerosis and is not 
related to medial calcification, which is 
also common in diabetic patients.1 The 
degree of narrowing of a vessel required 
to produce a detectable pressure gradient 
or reduction in blood flow is called the 
critical stenosis and this is present when 
the cross-sectional area of the lumen is 
reduced by 75% or the diameter by 
50% .9 The pressure drop across a 
stenosis varies with the flow which ex­
plains why unimportant stenoses at rest 
become important with the increased flow 
of exercise, and claudication pain results. 
The inflammatory response to an in­
fected, gangrenous extremity is a hyper­
dynamic circulation and this increased 
flow makes a stenosis more important. 
Arterial obstructions will be partially 
compensated for by collaterals that in­
crease as a result of the increased flow 
velocity through the normal collateral 
vessels or as a result of the abnormal 
pressure gradient across the collateral 
bed.10 The collaterals may look im­
pressive by arteriography but their 
resistance is always greater than that of 
an unobstructed vessel. If a collateral 
vessel is one-fourth the diameter of the 
main artery, 256 vessels are required to 
equal the resistance of the original 
artery.9
The blood supply to a diabetic limb 
with gangrene is difficult to assess clinical­
ly, especially when active infection is also, 
present and the inflammatory response to 
infection increases the skin temperature, 
causing erythema and edema that make 
pulses difficult to feel. The circulation 
may be hyperdynamic and cause arterial
stenoses to become more important. Dop­
pler studies and pedal artery blood 
pressures are useful and a positive Dop­
pler signal may indicate a patent artery < 
not visualized by angiography.11 The 
clinical assessment is probably the best A 
method of determining the need for 
revascularization; the surgeon should take A 
into consideration skin temperature, rest . 
pain, rubor, trophic changes and * 
palpability of pulses. Any diabetic patient „ 
with gangrene and absent pulses should 
be considered for arteriography and * 
possible vascular reconstruction. Occa­
sionally, infection and edema adjacent to * ‘ 
the gangrene will have spread to involve 
the operative site of revascularization and * ' 
it is usually prudent to delay the revascu­
larization in this situation because an- '  
tibiotics, elevation of the extremity and 
excision of the gangrenous area will usual­
ly clear the infection and edema from the . 
operative sites of revascularization. The 
angiographer should be informed that t i  
details of the distal arteries are required 
and that a hyperdynamic circulation may * 
alter the film sequence. He should also 
look for proximal disease which may be * 
occult.12 4
Although angiographic techniques can 
frequently be used as an aid or alternative A J 
to surgery,13 Johnston and associates14 ) 
have reported that percutaneous trans- 1 
luminal angioplasty of the tibial arteries ; 
is associated with a high incidence of oc­
clusion. However, angioplasty may be , 
useful for patients who are not candidates 
for major reconstructive surgery, as a 4 
temporizing measure while they are be- j 
ing prepared medically preoperatively, or -< -* 
for proximal lesions in larger arteries. ■ 
Hess and associates15 have reported 4 
arterial patency at 2 weeks in only 70 of ! 
136 patients after the use of intra-arterial ’ 
streptokinase and transluminal angio- y 
plasty.
The basic surgical principle in treating 7 ~r 
gangrene is to remove the dead tissue and I 
to preserve the remaining healthy tissue 
by preventing the spread of infection and „ 
necrosis. If the remaining tissue is 1 
ischemic, antibiotics will not prevent the 
spread of infection and gangrene and j| 
revascularization will be necessary. The 4 
revascularization procedure may chal- j! 
lenge the ingenuity of the surgeon; he may ’
have to insert an extra-anatomic bypass jj 
graft or a graft to a small artery such as 
the tibial, peroneal or pedal.16'20 ^
Autogenous saphenous vein is the prefer­
red material for grafting and sequential •< j 
grafts can be used from the femoral to the ■. 
popliteal and then to the tibial arteries if f- 
the superficial femoral and tibial arteries j 
are both involved. Because gangrene of 
a foot can cause thrombosis of the 
autogenous saphenous vein, a preoper­
ative venogram of the uninvolved leg  ^ . 
should be considered to assess saphenous
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vein patency because the vein from the 
unaffected leg may be required. Verta21 
has reported excellent results, grafting in-
I"> to arteries of the foot using saphenousvein and composite saphenous vein- >  polytetrafluoroethylene (PTFE) as se­
quential and nonsequential grafts. Poly- 
‘ ^ tetrafluoroethylene used as a noncom- 
 ^ . posite graft was not as successful. Reichle 
~ and associates22'24 established the value 
. of grafts from the common femoral 
artery to the tibial or peroneal arteries 
when the popliteal artery was occluded. 
Feldman and colleagues25 have recently 
1 reported patency in 7 of 11 grafts to the 
distal tibial from the popliteal or prox- 
’ K imal posterior tibial arteries. Umbilical 
vein grafts are superior to PTFE grafts 
' and should be used when the autogenous 
^ vein is not available.26’27 The Prolene 
mesh that now surrounds the umbilical 
i *- vein grafts is designed to prevent 
aneurysm formation that was a complica- 
y y tion of the unprotected grafts. En­
darterectomy is not recommended below 
* the knee although popliteal endarterec­
tomy is feasible.28 If more than one half 
of the sole of the foot has been destroyed, 
k the limb will never be suitable for weight 
bearing despite effective arterial 
i i reconstruction. Amputation should be the 
initial treatment.29 Revascularization oc­
casionally will allow a below-knee am­
putation rather than an above-knee am- 
*  putation. Failures of revascularization are 
usually due to an inadequate outflow and 
^ sympathectomy may be useful although 
diabetic patients often have reduced sym­
pathetic activity. Ideally, revasculariza- 
► ► tion should be done before any amputa­
tion because the earlier the blood supply 
 ^ can be restored to an extremity the less 
likelihood there is of further tissue loss. 
r Small areas of dry gangrene may be left 
to autoamputate if there is no associated 
‘ pain or infection; usually, however, con- 
r servative amputation and debridement of 
obviously nonviable tissue is required. 
Unless the gangrene is dry with no 
associated infection, delayed closure of 
► the wound is indicated and it may be 
several weeks before the site is suitable for 
r closure. Even with revascularization and 
after several weeks of open treatment, the 
* graft beds may not be ideal because of ir­
regularities, the presence of fascia, bone, 
residual infection and microvascular 
K diabetic changes. “ Postage stamp” split­
thickness skin grafts can be used to avoid 
r common causes of graft failure; these are 
hematoma under the grafts, motion of the 
' ► grafts and exudate from residual low- 
grade infection.
A Conclusions
The extremities of diabetic patients are 
 ^ prone to peripheral vascular occlusive 
disease and any resulting ischemia poten­
tiates infection and gangrene. Absent 
distal pulses in a diabetic extremity with 
gangrene should alert the clinician to the 
possibility of vascular reconstruction, 
which should be done as early as possi­
ble. The revascularization procedure, 
which may involve extra-anatomic or 
small-vessel grafting, will avoid a major 
amputation; it is surprising how much 
healing occurs when the blood supply has 
been restored.
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Bon Mots
Morals being what they are, it is not surprising that parts of the body that are 
well covered with skin, fat, hair and, formerly, by modesty, are now much 
more exposed — for example, the public tubercle.
Due to discoveries of a Canadian biochemist, Copp, we know now that the 
salmon is responsible for the production of a good amount of calcitonin. But 
what of the lowly herring? Is that species responsible for the production of 
heparing?
Pathologists, in particular, use foods to describe appearances of organs and 
tissues. The surgeons are following suit. That is why gastroplasty is sometimes 
followed by a dumpling syndrome.
Surgeons have described various types of rectal and anal repair in these pages 
as pre- and post-, but surely not postal!
I can understand the word psychiatric to describe a person, a therapy, a phi­
losophy or a discipline but what kind of person is a psychiatrick?
The other hospitals should drool with envy when I hear patients express a 
preference for the Salivation Army Hospital.
Joseph L. Shugar, md, frcsicj 
Senior Associate Editor
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Acute Dissection of the Descending Thoracic Aorta: *
Repair in an Unusual Case
Acute tamponade, although a rare 
manifestation of a descending thoracic 
aneurysm, was the dominant clinical 
feature of a classic type III dissecting 
aneurysm (arising distal to the left 
subclavian artery) in a 52-year-old man. 
High-quality aortography confirmed the 
diagnosis, ruling out any anomaly of the 
ascending aorta and the aortic arch. 
Surgical treatment was carried out 24 
hours after the initial episode without 
cardiopulmonary bypass. Through a left 
thoracotomy, a Gott shunt was inserted 
proximally at the apex of the left ventri­
cle and distally in the left femoral artery. 
Aortic repair with the interposition of a 
30-mm woven Dacron prosthesis was 
successful. Postoperative aortography 
showed complete restoration of aortic 
integrity.
La tamponnade cardiaque est une 
manifestation plutot inattendue d'une le­
sion aigue au niveau de I'aorte thoraci- 
que descendante. Nous I'avons observee 
comme manifestation principale d'une 
dissection aigue de type III. L'aorto- 
graphie thoracique a confirm^ ie 
diagnostic tout en eliminant la moindre 
anomalie au niveau de I'aorte ascendante 
et de la crosse aortique. La reparation 
chirurgicale a ete realisee par 
thoracotomie gauche avec la protection 
d'une derivation externe (shunt de Gott) 
inseree proximalement dans la pointe du 
ventricule gauche et distalement dans 
I'artere femorale gauche. Une interposi­
tion d'une prothese de Dacron tissee de 
30-mm a permis de retablir I'integrite 
aortique observable sur I'aortographie 
postoperatoire.
Cardiac tamponade is a well-known com­
plication o f  dissecting aneurysms 
originating in the ascending aorta (types
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I and III.1 It is also a rare but usually 
fatal outcome o f some dissecting 
aneurysms arising distal to the left subcla­
vian artery (type III).2 The mechanism, 
as observed at autopsy, is usually a 
retrograde dissection into the pericardium 
with or without a second rupture of the 
intrapericardial aorta. In our case, car­
diac tamponade was the dominant clinical 
picture in a type III dissecting aneurysm 
without retrograde dissection.
Case Report
A 52-year-old man with a history of un­
treated hypertension had sudden onset of chest 
pain followed rapidly by shock. The pain was 
localized to the interscapular area with radia­
tion to the anterior middle part of the chest. 
The patient complained of transient weakness 
of the left lower limb. Signs of cardiac tam­
ponade were obvious on examination. Blood 
pressure was 80/70 mm Hg and the central 
venous pressure was 26 cm H20 . The elec­
trocardiogram was normal, ruling out a car­
diac infarction, and the chest roentgenogram 
showed superior mediastinal widening and a 
double aortic knob contour (Fig. 1), suggesting 
a lesion at this level.
At pericardiocentesis, 200 mL of nonclot­
ting red blood were withdrawn. The patient im­
mediately improved and allowed us time to 
transfer him safely to the angiography 
department.
Aortography demonstrated a classic type III 
dissecting aneurysm (Fig. 2). Aneurysmal 
dilatation was present distal to the left subcla­
vian artery. The true lumen was irregular 
because of compression by the clotted false 
channel. The dissecting process extended to the 
diaphragm.
FIG. 1—Plain film  shows widened 
mediastinum and double aortic shadow at level 
of aortic knob.
FIG. 2—Type III dissecting aneurysm. Pre- *. 
operative aortogram showing irregular true 
lumen compresssed by clotted false channel, i 
Ascending aorta is normal. Pathologic process 
starts distal to left subclavian artery.
Soon after the dye injection, the cardiac tam­
ponade recurred, complicated by a supraven­
tricular tachycardia (160 beats/min). A blood 
pressure of 80/60 mm Hg was recorded 
through a right radial arterial line and the cen­
tral venous pressure was 30 cm H20 . Pericar­
diocentesis allowed aspiration of 300 mL of red 
blood and resulted in better and definitive heart 
decompression.
The blood pressure stabilized at 180/90 mm 
Hg and the central venous pressure at 15 cm 
H20 . Full digitalization was initiated and 
metabolic acidosis corrected. Nipride solution 
was administered intravenously to lower the 
blood pressure to between 100 and 120 mm Hg 
systolic. The hyperkinetic heart was controll­
ed with intravenous administration of 
propranolol.
The patient was operated on the following 
morning. Supraventricular tachycardia, which 
occurred upon induction of anesthesia, was 
easily controlled with an intravenous injection 
of propranolol.
Our standard procedure for lesions of the 
descending thoracic aorta was used.
Blood pressure and gas levels were record­
ed continuously through a right radial arterial 
line. A standard endotracheal tube is prefer­
red for full inflation of both lungs and max­
imum oxygenation during the period of aortic 
cross clamping. Autotransfusion is used. For 
minor losses from the intercostal arteries, the 
blood is saved in a reservoir primed with
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diluted heparin and is retransfused when nor­
mal aortic circulation is restored. During the 
period of aortic cross-clamping, the aortic flow 
is diverted through a Gott heparin-coated shunt 
(Sherwood Medical Industries, St. Louis, Mo.), 
placed between the ascending aorta proximal- 
ly and the descending aorta or left femoral 
artery distally. No systemic heparinization is 
required. This method of aortic shunting pro­
vides excellent proximal decompression of the 
brain and the heart and optimal distal perfu­
sion of all organs and of the spinal cord.
The lesion was approached through the bed 
of the resected fifth rib. There was 300 mL of 
free red blood in the left pleural cavity. All of 
the aortic arch and the descending thoracic aor­
ta had a reddish appearance; the adventitial 
and pleural layers were under extreme tension.
The pericardium was opened anterior to the
FIG. 3—Postoperative thoracic aortogram 
shows complete disappearance of false chan­
nel. True aortic lumen has more normal 
calibre.
FIG. 4—Postoperative abdominal aor­
togram shows normal origin of major aortic 
branches from true aortic lumen.
left phrenic nerve and 100 mL of old blood 
evacuated from the pericardial sac. No active 
bleeding was identified. The ascending aortic 
wall was normal to palpation but its surround­
ing adventitia was quite infiltrated in continuity 
with the mediastinal hematoma.
Because of its suspected friability, the 
ascending aorta was thought unsuitable for 
proximal cannulation and the apex of the left 
ventricle was used instead. The distal part of 
the Gott shunt was introduced into a 10-mm, 
side-branch, woven Dacron prosthesis 
anastomosed end-to-side to the left femoral 
artery.
Vascular clamps were applied on the aortic 
arch between the left carotid and the left 
subclavian arteries, on the descending aorta 
and on the left subclavian artery. The descend­
ing aorta, where an obvious aneurysmal dilata­
tion was noted, was incised distal to the left 
subclavian artery. The dissecting process in­
volved two thirds of the aortic circumference 
and the false lumen was full of fresh clots. No 
intimal tear was seen. Eight centimetres o f 
aneurysmal dilatation was resected. The 
dissected aorta was closed proximally and 
distally by incorporating a Teflon strip between 
the two separated medial layers. Then, a 
30-mm woven Dacron graft was sutured pro­
ximally and 8 cm distally to re-establish aortic 
continuity. The postoperative course was 
smooth and the patient was soon started on 
long-term antihypertensive drugs.
On the 10th postoperative day, controlled 
aortography was performed. The ascending 
aorta and aortic arch appeared normal in size 
and configuration (Fig. 3). The woven graft 
with proximal and distal anastomoses was well 
visualized and appeared normal. The descend­
ing thoracic aorta had assumed a more nor­
mal calibre, although it was slightly irregular. 
All the major abdominal arteries were perfus­
ed normally through the true aortic channel 
(Fig. 4).
Discussion
The source o f the cardiac tamponade 
was of concern in this case when emergen­
cy aortography showed a type III dissec­
ting aneurysm. Despite high-quality 
angiography, no secondary intimal rup­
ture could be identified in the in- 
trapericardial aorta. The patient would 
not have survived an intrapericardial 
hemorrhage coming from a retrograde 
dissection and a secondary intimal rup­
ture in the ascending aorta. Based on this 
clinical assertion, surgical repair was 
planned as for a standard type III dissec­
ting aneurysm.
The cardiac tamponade was explained 
on the basis o f extensive subadventitial 
dissection from the initial aortic wall rup­
ture in the descending aorta. Blood under 
pressure had separated the adventitial and 
pleural layers towards the pericardial 
reflection. Diffusion of blood under 
pressure through the pericardium is possi­
ble; this process may cause a hemothorax 
when blood diffuses through the pleura. 
A right hemothorax has been reported in 
type III dissecting aneurysm.3 This 
mechanism can also explain the hemo-
pericardium found in a few cases of 
traumatic rupture of the descending 
thoracic aorta without underlying cardiac 
injury.4 We recently treated a patient 
with a classic traumatic isthmic rupture 
of the descending thoracic aorta whose 
main clinical feature was cardiac 
tamponade.
Conclusions
Median sternotomy would have been 
disastrous in our patient if it had been 
taken for granted that the cardiac tam­
ponade was coming from dissection of the 
ascending aorta. This case emphasizes the 
need for complete, high-quality aorto­
graphy in all cases involving the thoracic 
aorta before an emergency surgical pro­
cedure is performed.
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NOTICES
Call for Abstracts: 
Stereotactic and 
Functional Neurosurgery
The 9th meeting of the World Society for 
Stereotactic and Functional Neurosurgery 
will be held July 4-7, 1985 at the Chelsea 
Hotel and the University o f Toronto, 
Toronto, Ont. It will be immediately fol­
lowed by the International Congress of 
Neurological Surgery.
Abstracts must be o f original work, not 
previously presented or published or 
accepted for publication, and they should 
be no longer than 250 words. The dead­
line for submission of abstracts is Sept. 
1, 1984. Proceedings of both meetings will 
be published in A pplied Neurophysiol­
ogy.
In order that presentations may be 
coordinated between the two meetings, all 
abstracts should be sent to: Dr. R.R. 
Tasker, Eaton Bldg. North 7-221, 
Toronto General Hospital, 101 College 
St., Toronto, Ont. M5G 1L7. For further 
information please write Mrs. Rae Ryan, 
Administrative Coordinator, Division of 
Neurosurgery, Eaton Bldg. North 7-221, 
Toronto General Hospital, 101 College 
St., Toronto, Ont. M5G 1L7 or call (416) 
595-3443.
continued on page 407
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Recent Research Suggests...
clindamycin concentrating in PMN lysosomes2.
4
«
•*
*  -
3. clindamycin-laden PMN moving 
toward the site of infection
Phosphate S.S.
enhances
HOST DEFENSE
Recent in-vitro research has shown that clindamycin concentrates within 
the PMN in amounts greater than are found outside of the PMN.1 The 
rates of chemotaxis, phagocytosis and killing of bacteria by PMNs are also 
enhanced by the presence of this antibiotic.2’3 These characteristics may 
help explain clindamycin’s outstanding record of clinical efficacy in both 
anaerobic and gram-positive aerobic infections.
Since host defense factors may be crucial in determining the outcome of 
an infection, selection of antibiotics based on host defense parameters 
may become a trend in infectious disease therapy.
1) Klempner MS, et al (Nov 1981) J Infect Dis 144(5)
2) Johnson JD, et al (March 1980) J Lab Clin Med 95(3)
3) Gemmell C, et al (1980) Current Chemotherapy and Infectious Disease 
(eds. J Nelson, C Grassi) Am Soc Microbiol Vol 2
5. phagocytosis of the bacterium 
by antibiotic-enhanced PMN
6. degranulation and killing 
of engulfed bacterium
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Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also 
by causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C  Phosphate (clindamycin phosphate) is indicated for the treatment of infec­
tions where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic 
bacteria, such as Bacteroides species, peptostreptococcus. anaerobic streptococci, Clostridium 
species and microaerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms 
(staphylococci, induding penicillinase-producing staphylococci, streptococci and pneumococci) when 
the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated 
in patients previously found to be hypersensitive to this compound, the parent com pound, clinda­
mycin, or clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) 
has not been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients 
who have demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, DalacinC Phosphate is not indicated in the newborn 
(infants below 30 days of age), or in pregnant women
Warnings: Some cases of severe and persistent diarrhea have been reported during  or after ther­
apy with Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally asso­
ciated with blood and m ucus in the stools and has at times resulted in acute colitis. When endos­
copy has been performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, if necessary, con­
tinued only with close observation. Significant diarrhea occurring up to several weeks post-therapy 
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes 
may respond to simple drug discontinuance. Moderate to severe cases, including those showing 
ulceration o r pseudomembrane formation, should be managed with fluid, electrolyte, and protein 
supplementation as indicated. Corticoid retention enemas and systemic corticoids may be of help 
in persistent cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes 
of colitis should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a princi­
pal cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this 
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco­
mycin were administered orally four times a day for 5 -1 0  or more days, there was a rapid observed 
disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
It should be  noted that serious relapses have occurred up to one month after apparently successful 
treatment. A  relatively pro longed period of continuing observation is therefore recommended.
Precautions: Dalacin C  Phosphate (clindamycin phosphate), like any drug, should be prescribed 
with caution in atopic individuals.
Dalacin C Phosphate must be diluted for intravenous administration. (See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms -  particularly 
yeasts. Should superinfections occur, appropriate measures should be taken as dictated by the clin­
ical situation.
As with all antibiotics, perform  culture and sensitivity studies in conjunction with d rug  therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, peri­
odic liver function tests should be performed during prolonged therapy. Blood counts should also 
be m onitored during extended therapy.
Dalacin C  Phosphate m ay be used in anuretic patients. Since the serum half-life of clindamycin in 
patients with impaired hepatic function is greater than that found in normal patients, the dose of 
Dalacin C  Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysis are 
not effective means of removing the compound from the blood. Periodic serum levels should be deter­
m ined in patients with severe hepatic and renal insufficiency.
Adverse Reactions: Local.
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin phosphate) 
intramuscularly (with a  solution containing 150 mg/mL), six (1.5%) demonstrated local reactions as 
follows: Two complained of pain at the injection site, two demonstrated induration at the injection site 
and two developed sterile abscesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion,
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and 
one patient developed both superficial and deep thrombophlebitis. The majority of these cases 
developed in conjunction with the use of indwelling I.V. catheters and it is difficult to know how much 
the d rug  contributed to  the irritation. Two patients developed localized erythema, swelling and pain 
at the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin 
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
Num ber o f Patients
R a s h ...................................................................................................................................................................7
U rtica ria ..............................................................................................................................................................1
P ru r itu s ..............................................................................................................................................................1
Fever, Leucocytosis...........................................................................................................................................1
Nausea, with or without vom iting ..................................................................................................................1
Diarrhea (See also under ‘W arnings”) ....................................................................................................... 4
H ypotension ...................................................................................................................................................... 1
H yp erten s io n ....................................................................................................................................................1
Shortness of Breath ........................................................................................................................................1
Superinfection*................................................................................................................................................. 4
Cardiac arrest’ * ................................................................................................................................................1
Bad or bitter taste in m o u th ........................................................................................................................... 5
'Superinfection is a  complication of antibiotic therapy in general and is not necessarily a true 
side effect of clindamycin phosphate.
**D ue to underlying myocarditis in this patient.
Phosphate S.S.
Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate 
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology, 
urinalysis and liver and kidney function tests. Some of these tests were abnormal initially and return­
ed to normal during therapy with Dalacin C Phosphate, while others were normal initially and became 
abnormal during therapy. Overall evaluation of clinical laboratory values in these patients does not 
indicate that Dalacin C Phosphate therapy has a  toxic effect on the hematopoietic, hepatic o r renal 
systems. Transient elevations of serum transaminases have occurred in some patients, but other liver 
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and 
there have not been clinical signs of drug-induced hepatic toxicity. « *
Symptoms and Treatment of Overdosage: No cases of overdosage have been reported. No 
specific antidote is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for 
five days have been given without adverse effects.
DOSAGE AND ADMINISTRATION
Adults
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2 ,3  or 4 equal doses. Intramuscular injections of more 
than 600 mg into a single site are not recommended.
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior 
to I.V. administration to a dilution of 300 mg in 50 ml of diluent (6 mg/ml) or more, and infused in not 
less than 10 minutes. Administration of more than 1200 mg in a single 1 hour infusion is not recom­
mended. Dalacin C Phosphate should not be injected intravenously undiluted as a bolus. 
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each 
infused over 20 minutes o r longer.
Severe infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused 
over 20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 mg/day by continuous 
drip or in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and infusion rates:
Dose Diluent Time
300 mg 50 ml 10 min.
600 mg 100 ml 20 min.
900 mg 150 ml 30 min.
1200 mg 200 ml 45 min.
Alternatively, drug may be administered in the form of a single rapid infusion of the first dose followed
by continuous I.V. infusion as follows:
To maintain serum Rapid Maintenance
clindamycin levels infusion rate infusion rate
Above 4 mcg/ml 10mg/min. for 30 min. 0.75mg/min.
Above 5 mcg/ml 15mg/min. for 30 min. 1.00mg/min.
Above 6 mcg/ml 20m g/m in. for 30 min. 1.25mg/min.
Children: (Over one month of age)
Intramuscular injection: 10 to 15mg/kg/day in 2 ,3  or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each 
infused over 20 minutes or longer. In severe infections, it is recommended that children be given no 
less than 300 mg/day regardless of body weight. (Dilute Dalacin C Phosphate Sterile Solution in the 
same manner as for adults.)
Dilution and Compatibility:
4 ml (600 mg) Dalacin C Phosphate when diluted with 1000 ml of the following commonly used in­
fusion solutions was found to be physically compatible and demonstrated no significant change in 
pH or antimicrobial potency over a  period of 24 hours:
Sodium chloride injection 
Dextrose 5%  in water 
Dextrose 5%  in saline 
Dextrose 5%  in Ringer's Solution
Dextrose 5%  in half-strength saline plus 40m Eq potassium chloride 
Dextrose 21/2%  in Lactated Ringer’s Solution (Hartmann's Solution).
Dalacin C Phosphate was not stable when added to Dextrose 5%  in water plus vitamins. Therefore 
it is not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B 
vitamins.
Supplied:
Dalacin C Phosphate contains the following per ml of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg 
Benzyl alcohol 5 mg 
Disodium edetate 0.5 mg 
Water for injection q.s.
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a 
pH range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 ml and 4 ml ampoules.
NOTE: Do not store below 15°C.
Product Monograph available upon request, c e  1377.1c
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Right Ventricular Size and Ventricular Septal Motion after 
Repair of Atrial Septal Defect in Children
An enlarged right ventricle and abnormal 
ventricular septal motion are 
characteristic echocardiographic features 
of atrial septal defect and often persist 
after the defect has been completely 
 ^ closed, even when the operation clinical­
ly is judged to be successful.
These features were examined 
retrospectively 15 to 21 months after 
operation in a group of children whose 
atrial septal defect had been closed be­
tween January 1976 and July 1979. 
Despite satisfactory postoperative results 
in all, about two thirds had an enlarged 
right ventricular dimension and about the 
same number had abnormal septal mo­
tion when examined echocardiographical- 
ly an average of 18 months after opera­
tion. The best operative strategy seems 
to be to operate while the right ven­
tricular end-diastolic dimension is still 
relatively small in echocardiographic 
*  terms.
L'augmentation des dimensions ventri- 
culaires droites et un mouvement septal 
anormal composent les elements 
gchocardiographiques qui caracterisent la 
communication interauriculaire. Cepen- 
r  dant ces signes persistent apr6s 
fermeture chirurgicale complete, et ce 
malgre un rgsuitat clinique satisfaisant.
Une revue des Etudes echocardio- 
graphiques fut conduite chez des enfants 
dont la communication interauriculaire 
fut r6paree entre janvier 1976 et 
*- juillet 1979. Les deux tiers des patients 
pr£sentent toujours une augmentation 
des dimensions ventriculaires droites en 
moyenne 18 mois aprfes chirurgie. Un 
nombre a peu pr6s identique presente un 
mouvement septal anormal. Ainsi, I'inter-
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vention devrait etre planifiee plus tot, 
alors que les dimensions ventriculaires 
droites sont dans les limites normales, a 
I'echocardiographie.
Increased right ventricular end-diastolic 
dimension (RVED) and abnormal ven­
tricular septal motion are the charac­
teristic echocardiographic features of 
atrial septal defect; they often persist even 
after clinically successful complete closure 
of the defect.1-4
Postoperative data on right ventricular 
performance have been reported recent­
ly for 51 children by Meyer and as­
sociates5 derived from serial echocar­
diograms taken 3 months to 5 years after 
closure of an atrial septal defect. The 
mean RVED of the group decreased max­
imally by 3 months with no further 
decreases up to 5 years; the mean RVED 
was always higher than that for 101 nor­
mal children of comparable age and size. 
Septal motion was normal in 55% by 3 
months after operation and in 89% of 
those examined at 5 years. The in­
vestigators suggested that the persistent 
enlargement of the right ventricle was due 
to chronic overload and that surgical 
closure in the first 3 years of life might 
prevent it.
This study complemented the serial 
echocardiographic study of Meyer and 
associates. Our focus was on pre- and 
postoperative echocardiographic findings 
in individual children, related to the nor­
mal range, and whether any preoperative 
factors suggest a better operative strategy.
Patients and Methods
This study used echocardiographic 
measurements in children whose secun­
dum atrial septal defect was repaired be­
tween Jan. 1, 1976 and June 30, 1979 in 
our hospital.
All echocardiographic tracings for 
these patients were reviewed. Only those 
for which a right ventricular cavity and 
septum could be identified were retained. 
Two copies were made of that portion, 
taken at or just below the level of the 
mitral valve tip.
Both copies of each tracing and a 
separate note identifying the child and 
date of the echocardiogram were assign­
ed a unique code number from a random 
number table. This code number was the 
sole identifier on the tracings, which were 
arranged in numerical order and furnish­
ed to two readers (S.N. and H .F.). The 
code was not broken until after all trac­
ings had been read, when clinical, cardiac 
catheterization and operative data that 
had been abstracted separately were 
merged with echocardiographic data.
The two readers measured RVED and 
classified septal motion as normal, flat or 
reversed, or noted that one or both were 
unmeasurable. Readings were reported 
separately by each reader to the data 
monitor (D.C.). If there was disagreement 
over whether a tracing could be read, if 
individual RVED measurements varied 
more than 10% from the mean of t^e two 
measurements or if judgement about the 
type of septal motion varied, the tracing 
was submitted to the head of our echocar­
diography service (W .J.D.) for arbitra­
tion.
We located 119 echocardiographic trac­
ings. Several otherwise acceptable tracings 
were rejected when matched to clinical 
data — two because the children had 
Down’s syndrome, one because the child 
had dextrocardia and one because the 
echocardiogram was taken immediately 
after operation for problems in the inten­
sive care unit rather than as a normal 
follow-up procedure. The final yield for 
study was 98 tracings in which both 
RVED and septal motion could be read: 
24 preoperative tracings (group 1), 18 
postoperative tracings (group 2) and 28 
pairs of pre- and postoperative tracings 
(group 3).
Echocardiographic Features
The right ventricular end-diastolic 
dimension was measured from the en­
docardium of the anterior wall of the 
right ventricle to the right side of the sep­
tum, at the level of the mitral valve, at 
the beginning of the QRS complex. Three 
complexes were measured on the majori-
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ty of tracings (93.9%), at the expiratory 
phase which appeared to have the least 
respiratory variation, and the average of 
these measurements was taken for each 
child.
In 44 of the 52 patients (84.6%) in 
groups 1 and 3, the preoperative echocar­
diograms were obtained within 1 week of 
cardiac catheterization and in the remain­
ing 8 patients (15.4%) from 2 to 46 
months (mean 19.9 months) before the 
catheterization.
Protocols in the Division of Cardiology 
call for an echocardiogram 18 months 
after repair of an atrial septal defect. Ex­
aminations in groups 2 and 3 took place 
from 0.2 to 51.1 months after operation 
(mean 20.5 months).
The normal range for RVED was de­
fined according to the criteria of Gutgesell 
and Paquet,6 which relate RVED to the 
cube root of weight.
Hemodynamic Features
All patients underwent right heart 
catheterization before operation (Tables 
I to III). Left-to-right shunt size was 
determined by the Fick principle and ex­
pressed as the pulmonary to systemic flow 
ratio (Qp:Qs). Right ventricular and 
pulmonary artery pressures were record­
ed in every case.
Intraoperative Measurements
The major and minor diameters of the 
defect were measured during operation 
for every child. Estimates were made of 
the defect area by assuming that all 
defects were elliptical.
Statistical Methods
Simple and multiple regression analyses 
were carried out to seek the best ex­
planatory variables for RVED and sep­
tal motion. This involved a step-up pro­
cedure to select the data that correlated 
most strongly with RVED or septal mo­
tion, or both. The relation of the change 
in RVED after operation to shunt size and 
right ventricular pressure at catheteriza­
tion, age of the child and size of defect 
at operation and length of follow-up was 
examined by linear regression to deter­
mine whether a particularly favourable 
operative strategy could be derived. 
P < 0.05 was considered significant.
Results (Tables I to III)
Preoperative (Tables I and III)
In all 52 children (groups 1 and 3) the 
RVED was enlarged above the normal 
99th percentile.6 All but nine had abnor­
mal septal motion; in about half of them, 
the septal motion was classified as 
reversed.
The right ventricular end-diastolic 
dimension correlated significantly 
(p < 0.05) with the child’s age, with body 
surface area and with a score for type of 
septal motion, but not with any of the
measurements obtained at cardiac ca­
theterization. The septal motion score 
(1 = normal, 2 = flat, 3 = reversed 
motion) correlated significantly only with 
the RVED and the shunt at catheteriza­
tion. There was no evidence that the type 
of septal motion, shunt size or pressures 
changed as the children aged; no child
Table 1-Group 1. Results
Preop echocardiographic
findings Catheterization
Age at 
operation,Patient
Age, mo
RVED, SM, Age, Shunt, RVP,
no. mm type mo ratio mm Hg mo
1 4.0 18 R 4.1 3.4 32 4.3
2 22.9 20 F 23.0 4.0 54 25.6
3 37.6 26 R 37.5 3.7 42 37.6
4 39.6 20 N 39.6 2.4 40 42.0
5 43.6 25 R 46.3 3.4 24 46.4
6 44 .8 20 N 56.8 2.3 41 90.0
7 48.3 21 F 60.3 1.8 29 65.1
8 52.5 24 F 52.2 3.7 30 54.4
9 53.3 19 F 7.3 2.5 36 56.9
10 53.9 23 N 53.9 2.8 24 57.4
11 57.2 24 R 57.2 2.2 33 57.3
12 61.6 28 N 61.6 2.9 26 61.7
13 61.9 23 F 61.9 2.1 32 62.0
14 62.0 24 R 62.0 2.7 44 62.1
15 70.8 21 N 70.8 1.8 33 73.3
16 74.7 32 R 74.8 2.2 35 76.6
17 75.8 23 F 31.3 2.1 25 78.7
18 82.0 26 R 82.0 4.0 61 82.0
19 89.1 20 F 89.3 1.6 30 90.7
20 108.6 37 R 104.4 4.0 33 108.7
21 111.1 33 R 111.1 5.0 37 111.2
22 146.1 32 F 146.2 2.0 35 162.8
23 148.2 29 N 148.2 2.4 28 148.3
24 176.9 34 F 176.9 2.4 29 177.0
RVED = right ventricular end-diastolic dimension, SM - septal motion, RVP -  right ventricular
pressure, N = normal, R = reversed, F -  flat.
Table 11-Group 2. Results
Patient
no.
Catheterization
Age at 
operation, 
mo
Postop echocardiographic 
findings
Age,
mo
Shunt,
ratio
RVP, 
mm Hg Age, mo
RVD,
mm
SM,
type
25 27.3 2.0 51 29.3 50.6 24 F
26 37.1 2.7 31 37.2 56.3 18 N
27 13.2 3.0 30 56.2 56.5 21 F
81.6 23 N
28 30.1 2.3 40 47.9 65.3 22 N
29 54.1 3.1 56 54.1 74.4 23 F
30 8.5 2.5 36 50.2 81.1 16 F
31 57.7 3.0 58 60.7 81.7 12 F
32 11.8 2.1 24 50.1 85.1 14 N
33 52.5 2.3 35 54.3 85.4 18 F
34 68.6 4.2 50 68.7 85.5 18 N
35 72.6 2.2 40 73.4 91.3 23 F
36 72.3 1.9 41 80.1 96.9 21 N
37 66.1 3.0 35 70.2 100.8 19 N
38 46 .3 1.8 30 94.0 110.0 19 F
39 98.5 3.1 20 100.5 139.6 13 N
40 111.9 2.6 36 112.0 152.7 27 F
41 168.3 1.9 45 173.0 192.1 29 F
42 192.6 2.1 25 201.2 219.4 22 F
RVED = right ventricular end-diastolic dimension, SM -  septal motion, RVP -  right ventricular 
pressure, N = normal, R = reversed, F = flat.
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had more than one preoperative catheter­
ization.
^  Postoperative (Tables II and III)
^  In approximately one third of the 46 
. y children (groups 2 and 3) who had 
postoperative echocardiograms, the
► I RVED was in the normal range. The same
proportion had normal septal motion; no 
*- child had reversed motion postopera- 
tively
Pre- and Postoperative (Table III)
^ ^ In the 28 group 3 children who had 
echocardiograms both before and after 
r r  operation, the RVED fell after operation 
in 25, remained the same in 1 but rose in
► 2. Before operation, all had RVED out­
side the 99th percentile of the Gutgesell
' and Paquet6 norms; after operation, 10 
 ^fell within the normal range at the first 
postoperative echocardiographic ex- 
y amination and 2 more fell within the nor­
mal range at a later examination. Septal 
-i motion was normal in 9 (8 had abnormal 
motion preoperatively), remained flat in 
i * 6 patients and turned flat from reversed 
motion in 12, but also turned flat in 2
k k
whose septal motion was normal preop­
eratively (Fig. 1).
The greatest fall in RVED was in those 
whose RVED had been largest before 
operation. However, because it was so 
markedly increased in these children, it 
was the patients with relatively minor
FIG. 1—Preoperative and postoperative 
right ventricular end-diastolic dimension 
(RVED) and septal motion (normal = white 
circles, flat = squares, reversed = black 
circles) related to body weight (shown on cube 
root scale) in 28 patients. Solid line = mean 
normal RVED, upper dotted line = 97.5th 
percentile, lower = 25th percentile.
preoperative increases in RVED who were 
most likely to be in the normal range after 
operation. There was little relation 
statistically between the time that had 
passed since operation and any decline in 
RVED (i.e., there was no evidence that 
a longer follow-up would produce more 
cases of normal RVED).
There were no significant differences in 
clinical factors between patients whose 
cardiac status returned to normal 
postoperatively and those whose status 
did not, other than the fact that grade 2 
murmurs were still heard (in 3 of 16 pa­
tients) only among those with an abnor­
mal RVED.
Regression analysis of the data on 
change in RVED did not pinpoint any 
preoperative strategy other than to 
operate on children while the RVED is 
still relatively small.
Discussion
Right ventricular end-diastolic dimen­
sion is usually measured from the en­
docardium of the anterior wall of the 
right ventricle to the right side of the 
septum,3,6'7 but the right ventricular wall 
can be poorly resolved on echocardio-
Table I l l-G ro u p  3 . Results
Patient
no.
Preop echocardiographic  
findings Catheterization
Age at 
operation, 
mo
Postop echocardiographic  
findings
Age, mo
RVED,
mm
S M ,
type
Age,
mo
Shunt,
ratio
RVP, 
mm Hg Age, mo
RVED,
mm
S M ,
typ e
4 3 3 3 .0 18 F 3 3 .0 3 .8 3 0 5 1 .6 6 9 .0 15 F
4 4 4 3 .2 2 3 N 4 3 .1 2 .0 3 0 4 8 .5 4 8 .8 2 0 N
7 3 .2 1 6 N
4 5 4 3 .7 3 0 R 4 3 .6 4 .0 4 2 4 3 .7 7 5 .8 13 F
4 6 5 2 .6 21 R 5 0 .6 2 .9 2 7 5 5 .0 7 5 .2 21 F
4 7 5 3 .8 2 4 R 5 3 .8 2 .6 3 0 5 8 .2 7 9 .9 2 2 F
4 8 5 7 .9 2 9 R 2 2 .0 2 .5 2 8 5 8 .0 8 5 .8 19 F
4 9 5 9 .7 2 6 F 5 9 .7 3 .3 4 3 5 9 .8 7 7 .7 1 8 F
5 0 5 9 .9 21 F 5 9 .9 1 .5 5 4 6 6 .0 83 .1 14 M
51 6 0 .2 2 6 R 6 0 .2 1 .8 5 0 6 0 .2 8 8 .5 21 F
5 2 61 .1 2 7 F 6 1 .1 2 .2 5 0 6 1 .2 8 1 .6 21 F
5 3 6 1 .7 2 2 F 6 1 .7 2 .8 5 5 6 6 .5 8 3 .2 17 N
5 4 6 2 .9 2 0 R 6 2 .9 2 .3 3 0 6 2 .9 81 .1 15 F
5 5 6 3 .4 2 9 R 6 3 .8 3 .6 4 8 6 3 .8 6 4 .0 19 F
5 6 6 4 .5 21 N 6 4 .4 2 .2 2 8 6 4 .5 8 0 .2 2 4 F
57 7 0 .5 2 0 F 7 0 .5 1 .5 3 0 7 0 .6 1 0 5 .0 15 N
5 8 7 2 .0 2 0 F 7 2 .0 2 .2 3 3 7 3 .6 9 1 .5 16 F
5 9 7 7 .1 2 6 R 7 7 .1 2 .5 3 5 8 3 .0 8 8 .5 17 N
6 0 8 3 .3 2 4 R 8 3 .3 2 .6 3 2 8 3 .4 1 0 2 .3 19 F
1 3 1 .8 17 N
61 8 3 .8 21 R 8 3 .8 2 .4 3 6 8 5 .7 1 3 6 .8 2 2 N
6 2 8 8 .5 2 5 N 8 8 .5 1 .8 2 3 1 0 2 .7 1 0 2 .9 16 F
6 3 1 2 4 .0 3 0 R 1 2 4 .0 3 .0 2 6 1 2 6 .3 1 4 6 .2 17 F
6 4 1 2 7 .5 2 8 R 1 2 7 .6 2 .3 3 8 1 3 1 .7 1 4 9 .8 14 N
6 5 1 6 5 .4 3 3 R 1 6 5 .4 3 .4 3 3 1 6 6 .7 1 9 1 .2 2 2 F
6 6 1 6 8 .6 4 0 R 1 6 9 .3 2 .4 3 5 1 7 1 .7 1 9 3 .3 2 4 F
6 7 1 7 5 .8 37 R 1 7 5 .9 4 .2 3 2 1 7 5 .9 1 7 6 .2 2 8 F
2 0 5 .7 2 4 N
6 8 1 9 9 .3 3 9 F 1 9 9 .2 2 .0 2 9 1 9 9 .3 2 2 0 .6 2 9 F
6 9 1 9 9 .7 3 9 R 1 9 9 .7 3 .4 2 5 1 9 9 .8 2 2 3 .7 2 6 F
7 0 2 0 3 .2 3 9 F 2 0 3 .2 1.7 2 8 2 0 7 .0 2 2 7 .3 3 4 F
RVED - right ventricular end-diastolic dimension, SIV -  septal motion, RVP -  right ventricular pressure, N -  norm al, R -  reversed, F -  f la t.
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Bactrim “Roche
Rx Summary 
Indications
The following infections when caused by susceptible 
pathogens:
■ upper and lower respiratory tract (particularly chronic 
bronchitis and including acute and chronic otitis 
media)
■ urinary tract: acute, recurrent and chronic
■ genital tract: uncomplicated gonococcal urethritis
■ gastrointestinal tract
■ skin and soft tissue
■ Pneumocystis carinii pneumonitis in infants and 
children.
Not indicated in infections due to Pseudomonas, 
Mycoplasma or viruses.
Contraindications
Evidence of marked liver damage or renal impairment 
where repeated serum assays cannot be carried out; 
blood dyscrasias; known hypersensitivity to trimethoprim 
or sulfonamides.
During pregnancy, and in newborn or premature infants 
during first few weeks of life.
Precautions
Benefit should be critically appraised against risk in 
patients with liver damage, renal damage, urinary 
obstruction, blood dyscrasias, allergies, or bronchial 
asthma. Reduce dosage in patients with renal impair­
ment. Do not administer if serum creatinine level is above 
2 mg%. Consider possible superinfection with a non­
sensitive organism.
Adverse reactions
Most frequent: nausea, vomiting, gastric intolerance, 
and rash.
Less frequent: diarrhea, constipation, flatulence, anore­
xia, pyrosis, gastritis, gastroenteritis, urticaria, head­
ache, and liver changes (abnormal elevations in alkaline 
phosphatase and serum transaminase).
Occasionally reported: glossitis, oliguria, hematuria, 
tremor, vertigo, alopecia, and elevated BUN, NPN, and 
serum creatinine.
Hematological changes: primarily, neutropenia and 
thrombocytopenia, and less frequently, leukopenia, 
aplastic or hemolytic anemia, purpura, agranulocytosis, 
and bone marrow depression; occur particularly in the 
elderly and mostly prove reversible on withdrawal
Dosage
Children: 6 mg trimethoprim/kg body weight per day, 
plus 30 mg sulfamethoxazole/kg body weight per day, 
divided into two equal doses.
Adults and children over 12 years of age:
Standard dosage:
1 'Bactrim' DS 'Roche' tablet or 2 adult tablets, twice 
daily.
Minimum dosage and dosage for long-term treatment:
'/2 Bactrim' DS 'Roche' tablet or 1 adult tablet, twice 
daily.
Maximum dosage (overwhelming infections):
1 Vi 'Bactrim' DS'Roche' tablets or 3 adult tablets, twice 
daily.
In acute infections treat for at least b days or until patient 
is asymptomatic for 48 hours; in urinary tract infections, 
until urine sterile.
Uncomplicated gonorrhea: 2 adult tablets or 
1 'Bactrim' DS Roche' tablet four times daily for 2 days. 
Pneumocystis carinii pneumonitis: 20 mg/kg/day tri­
methoprim and 100 mg/kg/day sulfamethoxazole in four 
divided doses for 14 days.
Supply
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with ROCHE C engraved on one face and BACTRIM and 
indented score on the other, each containing 80 mg tri­
methoprim and 400 mg sulfamethoxazole.
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DS tablets: White, capsule-shaped, biconvex tablet with 
ROCHE engraved on one face and BACTRIM DS and 
indented score on the other, each containing 160 mg 
trimethoprim and 800 mg sulfamethoxazole.
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200 mg sulfamethoxazole per 5 ml.
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containing 80 mg trimethoprim (16 mg/ml) and 400 mg 
sulfamethoxazole (80 mg/ml) for infusion with D5W,
Ringer’s solution or NaCI 0.9% solution. Packs of 
25 ampoules.
Product monograph available on request.
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graphy.7 In our study, only those with a 
clearly delineated right ventricular wall 
and ventricular septum were included.
Meyer8 provided normal RVED values 
for children arranged by age, weight and 
height. However, the resulting normal 
range is a series of flat steps with the same 
normal RVED over fairly broad age 
categories of several years. We preferred 
to adopt the standard of Gutgesell and 
Paquet,6 whose graph of RVED versus 
the cube root of body weight for 85 nor­
mal children gives a straight-line rela­
tionship.
All of our 52 children who had preop­
erative echocardiograms (groups 1 and 3) 
had an abnormal RVED but 9 had nor­
mal septal motion. Also, two with nor­
mal motion preoperatively developed flat 
motion after operation (in one the RVED 
was in the normal range postoperatively). 
Thus, normal septal motion does not 
always mean that the RVED is within 
normal limits nor does flat septal motion 
postoperatively always accompany an in­
creased RVED.
None of our postoperative echocar­
diograms showed reversed septal motion. 
In adults with an atrial septal defect, 
reversed motion postoperatively has been 
related to persistent right ventricular 
dilatation while reversion to normal mo­
tion was a feature of those with relative­
ly mild dilatation.9
The results obtained on evaluating sep­
tal motion may be ambiguous. In par­
ticular, calling the septal motion “ flat” 
may mean only that the motion is not 
clearly either normal or reversed. Our two 
readers did not agree about the type of 
septal motion in 28 (23.5%) tracings, 
which thus had to be submitted to arbitra­
tion: only 7 (5.9%) of the 119 tracings in­
volved one reader who believed motion 
was normal while the other thought it 
reversed. Similar proportions are found 
in studies of the reliability of clinical 
methods and judgement.10"12
Our data on diminished postoperative 
RVED are broadly consistent with the 
findings of Meyer and associates.5 Eigh­
teen months after operation, two thirds 
of our patients had an RVED outside the 
normal range. Use of the mean RVED to 
measure group change (as in Meyer’s 
study) could mask the benefits of opera­
tion in individual patients. We cannot ex­
plain the marked disparity in findings on 
septal motion (29% [8 of 28] of our pa­
tients reverted to normal motion against 
55% to 89% of theirs), but it is not clear 
whether our patients and classification 
criteria were sufficiently similar to permit 
direct comparison. Finally, the conclu­
sions of both groups about operative 
strategy have similar effects although 
grounded and phrased differently.
Our conclusions are based on single 
follow-up echocardiograms, which most
patients had. (Four patients had a second 
tracing sometime after operation; RVED 
continued to decrease in three, and in two j  
fell into the normal range on the later 
tracing.) Because our patients, by and ^ 
large, were seen between 15 and 21 
months after operation, the data are in- * 
sufficient to plot immediate or long-term 
postoperative changes. Future studies 1 < 
should include serial echocardiograms, or 
at least cross-sectional studies should use 
different follow-up intervals from the one 
used in this study.
Most of our patients were operated „ 
upon between 3 and 6 years of age. So 
far, we have not repaired an atrial septal < ■ 
defect at an earlier age unless the 
pulmonary-to-systemic flow ratio was V 
greater than 2.5:1. We found that the pa­
tients with less extreme preoperative in- 
creases in RVED were most likely to be 
in the normal range after operation. This ’ 
suggests that operative repair might best ^ , 
be carried out while the RVED, as 
measured by echocardiography, is still \ 
close to normal.
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* Omental Evisceration through an Abdominal Stab Wound: 
Is Exploratory Laparotomy Mandatory?
k The authors reviewed and analysed the 
records of 75 patients with omental and 
bowel evisceration as a result of 
abdominal stab wounds to discover 
whether omental prolapse makes 
laparotomy mandatory. Major intra­
abdominal injuries were found in 82.7%  
of the total group, 82.9%  in those with 
omental protrusion and 82.5%  in pa­
tients with bowel prolapse. The nature 
of the injuries and the incidence of multi­
ple organ trauma were similar in the two 
groups. Negative laparotomy did not 
cause important morbidity. The authors 
 ^ conclude that omental herniation after 
stab wounds of the abdomen should 
routinely prompt exploratory celiotomy.
Les auteurs passent en revue et ana- 
lysent les dossiers medicaux de 75 
patients victimes d'une Evisceration de 
I'intestin et de I'Epiploon a la suite d'un 
coup de couteau a I'abdomen, dans le 
v but de verifier si un prolapsus de I'Epi- 
ploon commande une laparotomie. Des 
blessures abdominales graves ont EtE 
constatees chez 82.7%  du groupe, chez 
82.9% du groupe ayant une protrusion 
de I'Epiploon et chez 82.5%  de ceux qui 
avaient un prolapsus intestinal. La nature 
des blessures et la frequence des trau- 
r matismes a de multiples organes etaient 
semblables dans les deux groupes. Une 
laparotomie negative n'entratne pas une 
morbidite importante. Les auteurs con- 
cluent qu'une hernie de I’Epiploon devrait 
entrainer systematiquement une laparoto­
mie exploratoire.
►
Selective exploration of patients with stab 
wounds of the abdomen, based on clinical 
observation,1-3 local wound exploration, 
peritoneal lavage4,5 or a combination of 
these methods,6'8 has gained wide 
popularity. At our institution, while we
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have adopted the policy of “ selective 
conservatism” ,4 omental or bowel 
evisceration through stab wounds has 
been a mandatory indication for 
laparotomy. We have analysed our ex­
perience to determine whether such a 
practice is justified. We could find only 
one other series9 in the English literature 
specifically addressing the issue of ab­
dominal stab wounds with evisceration.
Patients and Methods
We reviewed the records of all patients 
admitted to the Lincoln Medical and 
Mental Health Center between 1973 and 
1983 with omental or bowel evisceration 
as a result of knife wounds to the ab­
domen. We did not include patients with 
multiple stab wounds in addition to the 
one with evisceration. We also excluded 
three patients with inadequate documen­
tation and seven patients from earlier 
years of the study who were managed by 
amputation of the extruded omentum and 
clinical observation, because adequate 
follow-up could not be documented from 
their clinical records.
Seventy-five patients who satisfied the 
criteria for analysis constituted the study 
population. Seventy-two were men and 3 
were women. The age range was 17 to 59 
years. Five patients presented in shock 
(systolic blood pressure less than 70 mm 
Hg). The only other indication for 
laparotomy was evisceration of omentum 
(35 patients) and bowel (40 patients). All
patients were resuscitated initially with 
Ringer’s lactate and type-specific blood, 
if necessary, depending on hemodynamic 
status. Antibiotics (ampicillin, gen­
tamicin and clindamycin) were ad­
ministered preoperatively.
In the operating room the eviscerated 
bowel and omentum were copiously ir­
rigated with normal saline and the bowel 
was replaced. The extruded omentum was 
amputated. The type of operative repair 
of the injured organs followed standard 
surgical principles. Small-bowel injuries 
were treated by repair or resection of in­
volved bowel and anastomosis; colonic 
lacerations were managed by repair, col­
ostomy or repair and exteriorization; pan­
creatic lesions were repaired with 
drainage; splenic wounds were treated by 
splenectomy or splenorrhaphy and bile- 
duct or vascular injuries were repaired. 
The stab-wound site was routinely clos­
ed by fascial sutures to prevent the subse­
quent development of traumatic hernia.
For the purpose of this study, 
laparotomy was considered positive only 
if major visceral damage was found; 
small mesenteric and retroperitoneal 
hematomas were not considered signi­
ficant.
Results
Sixty-two of the 75 patients (82.7%) 
had serious intra-abdominal injury. The 
number of positive explorations was 
similar in the group with omental hernia-
T a b le  1 -Su m m a ry  of O rgan Injuries
N o. w ith No. w ith
Organ injured o m ental pro lap se bo w el pro lap se
Colon 8 10
Sm all bow el 1 0 2 4
S to m ach 3 4
Liver 7 5
Spleen 4 1
P an cre as 2 2
Kidney 0 1
M ajor blood vesse ls 6 5
D iaphragm 6 0
Extrah e p atic  bile d u cts 2 0
4 8 5 2
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(^ Mefoxin
ANTIBIOTIC
ACTION
In v itro  studies demonstrate that the 
bactericidal action of cefoxitin, a cephamycin 
derived from cephamycin C, results from the 
inhibition of bacterial cell wall synthesis. 
Evidence suggests that the methoxy group in 
the 7a position is responsible for the 
resistance of cefoxitin to degradation by 
bacterial beta-lactamases.
INDICATIONS AND CLINICAL USES
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - Intra-abdominal infections such as
peritonitis and intra-abdominal abscess
2 - Gynecological in fections such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and joint infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections 
Appropriate culture and susceptibility studies 
should be performed to determine the 
susceptibility of the causative organism(s) to 
MEFOXIN* Therapy may be started while 
awaiting the results of these tests, however, 
modification of the treatment may be required 
once these results become available. 
Organisms particularly appropriate for 
therapy with MEFOXIN* are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci 
Gram negative (beta-lactamase producing 
and non-producing strains)
E. coll
K le b s ie lla  species ( in c lu d in g  K. 
pneumoniae)
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides fragilis
MEFOXIN* may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria. 
Clinical experience has demonstrated that 
MEFOXIN* can be administered to patients 
who are also receiving carben ic illin , 
gentamicin, tobramycin, or amikacin (see 
PRECAUTIONS and ADMINISTRATION). 
Intravenous Administration 
The intravenous route is preferable for 
pa tien ts  w ith  bacterem ia, bac te ria l 
septicemia, or other severe or life-threatening 
infections, or for patients who may be poor 
risks because of lowered resistance resulting 
from  such de b ilita tin g  conditions as 
malnutrition, trauma, surgery, diabetes, heart 
failure, or malignancy, particularly if shock is 
present or impending.
PROPHYLACTIC USE
MEFOXIN* may be administered periopera- 
tively (preoperatively, intraoperatively and 
postoperatively) to patients undergoing 
vaginal or abdominal hysterectomy and 
abdominal surgery when there is a significant 
risk of postoperative infection or where the 
occurrence of postoperative infection is 
considered to be especially serious.
In patients undergoing cesarean section, 
intraoperative (after clamping the umbilical 
cord) and postoperative use of MEFOXIN* 
may reduce the incidence of surgery related 
postoperative infections.
Effective prophylactic use depends on the 
time of administration. MEFOXIN* usually 
should be given one-half to one hour before 
the operation. Prophylactic administration 
should usually be stopped within 12 hours. It 
has been generally reported that continuing 
administration of any antibiotic beyond
*®T rademark
24 hours following surgery increases the 
possibility of adverse reactions but, in the 
majority of surgical procedures, does not 
reduce the incidence of subsequent infection. 
If signs of postsurgical infection should 
appear, specimens for culture should be 
obtained for identification of the causative 
organism(s) so that appropriate therapy may 
be instituted.
CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics.
WARNINGS
Before therapy with MEFOXIN* is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
s e n s itiv ity  reac tions  to MEFOXIN*, 
cephalosporins, penicillins or other drugs. 
MEFOXIN* should be given with caution to 
penicillin-sensitive patients.
There is some clinical and laboratory evidence 
of partial cross-a llergenicity between 
cephamycins and the other beta-lactam 
antibiotics, penicillins and cephalosporins. 
Severe reactions (including anaphylaxis) have 
been reported with most beta-lactam 
antibiotics.
Pseudomembranous colitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed 
with caution in individuals with a history of 
gastrointestinal disease, particularly colitis. It 
is important to consider a diagnosis of 
pseudomembranous colitis in patients who 
develop diarrhea in association with antibiotic 
use. While studies indicate that a toxin 
produced by Clostridium difficile is one 
primary cause of antibiotic-associated colitis, 
other causes should also be considered.
Any patient who has demonstrated some form 
of allergy, particularly to drugs, should receive 
antibiotics including MEFOXIN* with caution. 
If an allergic reaction to MEFOXIN* occurs, 
adm inistration of the drug should be 
discontinued. Serious hypersensitivity 
reactions may require treatment with 
epinephrine and other emergency measures. 
PRECAUTIONS
The total daily dosage should be reduced 
when MEFOXIN* is administered to patients 
with transient or persistent reduction of 
urinary output due to renal insufficiency (see 
DOSAGE AND ADMINISTRATION) because 
high and prolonged serum an tib io tic  
concentrations can occur from usual doses.
In patients treated with MEFOXIN* a false­
positive reaction to glucose in the urine may 
occur with Benedict’s or Fehling’s solutions 
but not with the use of specific glucose 
oxidase methods.
Using the Jaffe Method, falsely high creatinine 
values in serum may occur if serum 
concentrations of cefoxitin exceed 100 pg/mL. 
Serum samples from patients treated with 
MEFOXIN* should not be analyzed for 
creatinine if withdrawn within two hours of 
drug administration.
Increased nephrotoxicity has been reported 
following concomitant administration of 
cepha losporins and am inoglycoside 
antibiotics.
The safety of MEFOXIN* in the treatment of 
infections during pregnancy has not been 
established. If the adm in istra tion of 
MEFOXIN* to pregnant patients is considered 
necessary, its use requires that the anticipated 
benefits be weighed against possible hazards 
to the fetus. Reproductive and teratogenic 
studies have been performed in mice and rats 
and have revealed no evidence of impaired 
fertility or harm to the fetus due to MEFOXIN*. 
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug.
Prolonged use of MEFOXIN* may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient’s condition 
is essential and if super-infection occurs 
during therapy, appropriate measures should 
be taken. Should an organism become 
resistant during antibiotic therapy, another 
antibiotic should be substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN* (100mg/kg/day and 
above) have been associated with an 
increased incidence of eosinophilia and 
elevated SGOT.
The safety and efficacy of MEFOXIN* for the 
treatment of infections in infants from birth to 
three months of age have not yet been 
established.
ADVERSE REACTIONS 4
MEFOXIN* is generally well tolerated. Adverse 
reactions rarely required cessation o f.  
treatment and usually have been mild and"’  
transient.
Local Reactions 4
T hrom bophleb itis  has occurred w ith 
intravenous administration. Some degree^f  ^
pain and tenderness is usually experienced 
after intramuscular injections using water. 
Induration has occasionally been reported. •* 
Allergic
Maculopapular rash, urticaria, pruritus,-! 
eosinophilia, fever and other allergic reactions 
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. - 
Nausea and vomiting have been reported 
rarely.
Blood 'T'
Trans ien t eos inoph ilia , leukopenia, 
neutropenia, hemolytic anemia, and thrombo- 4 
cytopenia have been reported. Some 
individuals, particularly those with azotemia, 
may develop positive direct Coombs tests 
during therapy with MEFOXIN*. j
Liver Function a >
Transient elevations in SGOT, SGPT, serum 
LDH, and serum alkaline phosphatase have* 
been reported. |
Kidney j
Elevations in serum creatinine and/or blood ^ 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failura 
has been reported rarely. The role of 
MEFOXIN* in changes in renal function tests 
is d if f ic u lt  to assess, since fac to id  * 
predisposing to prerenal azotemia or to 
impaired renal function have often been 
present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN* can be 
eliminated by dialysis in patients with renal '  
insufficiency. 4
DOSAGE AND ADMINISTRATION -<
TREATMENT DOSAGE j
MEFOXIN* may be administered intra*- > 
venously or intramuscularly when required. 
(See monograph for Preparation of Solution.)^ 
Adult Dosage
The usual adult dosage is 1g or 2g of 
MEFOXIN* every 6 to 8 hours. Dosage andy 
route of administration should be determined 
by severity of infection, susceptibility of the. . 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below. y —
Usual Adult Dosage
T y p e  of 
of infection
D aily
Dosage
Frequency 
and Route ^
U n c o m p l ic a t e d  
f o r m s *  o f  in ­
f e c t io n s  s u c h  a s  
p n e u m o n ia ,  
u r in a r y  t r a c t  
in f e c t io n ,  s o f t  
t is s u e  in f e c t io n
3 - 4  g 1 g  e v e r y  6 - 8  h
I .V .  o r l . M .  -v
M o d e r a t e ly  
s e v e r e  o r  s e v e r e  
in f e c t io n s
6 - 8  g 1 g  e v e r y  4  h
o r
2  g  e v e r y  6 - 8  h  I .V .  ^
In f e c t io n s  
c o m m o n ly  
n e e d in g  a n t i ­
b io t ic s  in  h ig h e r  
d o s a g e  (e .g .  g a s  
g a n g r e n e )
1 2  g 2  g  e v e r y  4  h  ^
o r
3  g  e v e r y  6  h  I .V .
j
’ Including patients 
absent or unlikely
in whomi bacteremia is
i
Therapy may be started while awaiting the 
results of susceptibility testing. *-
Antibiotic therapy for group A beta-hemolytic 
streptococcal infectionsshould be maintained? < 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving 
a collection of pus, surgical drainage should 
be carried out where indicated.
Dosage in Adult Patients with Impaired Renal 
Function
►
X
Y *
MEFOXIN* may be used in patients with 
reduced renal function but a reduced dosage 
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. 
A fte r a loading dose, the fo llow ing  
recommendations for maintenance dosage 
may be used as a guide:
RENAL CREATININE
FUNCTION
Mild
CLEARANCE
mL/min
DOSE
impairment
Moderate
50-30 1 -2  g
impairment
Severe
29-10 1-2 g
impairment
Essentially
9-5 0.5-1 g
no function <5 0.5-1 g
FREQUENCY
every 8-12 h 
every 12-24 h 
every 12-24 h 
every 24-48 h
'Y  In the patient undergoing hemodialysis, the 
loading dose of 1 - 2g should be given after 
each hemodialysis, and the maintenance dose 
v should be given as indicated in the Table 
above.
Infants and Children
The recommended dosage in children three 
months of age and oldens 80 to 160 mg/kg of 
u y- body weight per day divided into four to six 
equal doses. The higher dosages should be 
used for more severe or serious infections. 
*, The total daily dosage should not exceed 12g.
At this time no recommendation is made for 
children from birth to three months of age (see 
•A PRECAUTIONS).
At present there is insufficient data to 
j. recommend a specific dosage for children 
with impaired renal function."However, if the 
administration of MEFOXIN’ is deemed to be 
. » essential the dosage should be modified
y  consistent with the recommendations for 
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN is recommended as follows:
‘ y  Vaginal or abdominal hysterectomy and 
abdominal surgery
„  2 g adm in istered in tram uscu la rly  or
in travenous ly  ju s t p r io r to surgery 
(approximately one-half to one hour before 
K initial incision).
The second and third 2g doses should be 
administered at 2-6 hour intervals after the 
-- ► initial dose.
Cesarean Section
k . The first dose of 2 g should be administered 
intravenously as soon as the umbilical cord 
has been clamped. The second and third 
2g doses should be given intravenously or 
intramuscularly four hours and eight hours 
after the first dose.
 ^ AVAILABILITY
Sterile MEFOXIN* is a dry white to off-white 
powder supplied in vials containing cefoxitin 
'  sodium as follows:
No. 3356 1 g cefoxitin equivalent in boxes of 
>- 10 vials
No. 3357 2 g cefoxitin equivalent in boxes of 
y 10 vials.
PRODUCT MONOGRAPH AVAILABLE 
ON REQUEST
V
T 1. Quintiliani, R.: Overview of cephalosporin 
antib io tics in the 1980's, in "Con- 
siderations in the selection of anti­
microbial chemotherapy, a round-table 
discussion on treatment concepts”, Merck 
>  & Co. Inc., 1982, pp 6-25.
2. Trunkey, D.D.: Cephalosporin in the 
y management of trauma, Ibid, pp 44-52.
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tion (29 of 35 patients, 82.9°7o) and with 
bowel prolapse (33 of 40 patients, 
82.5%). The visceral injuries encountered 
are shown in Table I. Multiple organs 
were injured in 13 patients with omental 
herniation and in 12 with bowel 
evisceration.
There was one death. This patient had 
sustained a deep laceration of the right 
lobe of the liver and a near-total transec­
tion of the inferior vena cava. He died in- 
traoperatively of uncontrolled hemor­
rhage. Postoperative complications 
developed in 10 of the 74 survivors. Of 
the 13 patients who had no major organ 
injury at laparotomy, only 1 had a com­
plication of minor wound sepsis. Nine pa­
tients who were found to have organ in­
jury at laparotomy had the following 
complications postoperatively: atelectasis 
(three), pneumonia (two), wound infec­
tion (one), wound dehiscence (one), 
postoperative fever (one) and intestinal 
obstruction (one). Thus, the incidence of 
complications in the negative laparotomy 
group was 7.7% and in the positive group 
was 14.5%.
Discussion
Ever since the pioneering report of 
Shaftan in I960,1 selective operative 
treatment for stab wounds of the ab­
domen has gained wide popularity. 
Trauma centres have adopted their own 
screening techniques to delineate those 
victims of stabbing who require operative 
exploration. These methods include serial 
clinical observation of the patients for 
signs of peritoneal irritation, peritoneal 
lavage and local wound exploration, 
alone or in combination.2 8 This policy 
of “ selective conservatism” 4 has been 
supported by several large series of pa­
tients with stab wounds to  the 
abdomen.2"4
The m andatory  indications for 
celiotomy for knife wounds of the ab­
domen, as stressed by several authors,1'8 
include evidence of uncontrolled or con­
tinuing hemorrhage, signs of peritoneal 
irritation and clinical or radiologic con­
firmation of internal organ injury. 
Evisceration of bowel through a knife 
wound has also been mentioned frequent­
ly as an indication for mandatory 
exploration.2"4 The optimal management 
of patients with abdominal stab wounds 
and omental herniation, however, has not 
been adequately addressed in the 
literature. Shaftan1 described a case of 
omental extrusion through a knife wound 
of the abdomen; the omentum was ligated 
and excised and the wound debrided and 
the patient observed closely. Thompson 
and associates8 noted that all 17 of the 
300 patients with abdominal stab wounds 
who presented with omental herniation 
underwent laparotomy, with a 29% in­
cidence of negative exploration. Based on 
this experience, they challenged the con­
cept of mandatory celiotomy for all pa­
tients presenting with omental prolapse 
through knife wounds.
To our knowledge, the first report deal­
ing entirely with a series of patients with 
omental evisceration resulting from stab 
wounds to the abdomen was published by 
Granson and Donovan.9 In this study, 
100 consecutive patients were explored 
because of omental herniation. Sixty-nine 
percent were found to have major in- 
traperitoneal injury. The authors con­
cluded that exploration is clearly indicated 
under these circumstances.
Our experience lends support to this 
policy. Aside from the five patients who 
presented in shock, celiotomy was per­
formed on the sole indication of the 
presence of eviscerated omentum or 
bowel. The number of patients in whom 
no major organ injury was found was 
small and morbidity was minimal. The 
nature and incidence of major organ in­
jury and the frequency of multisystem in­
volvement were comparable in the pa­
tients with omental herniation and those 
with bowel prolapse. We conclude from 
our data that omental prolapse or bowel 
evisceration, or both, consequent to an 
abdominal stab wound constitute man­
datory indications for laparotomy.
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Assessing Cardiac Risk in Patients Who Undergo 
Noncardiac Surgical Procedures
To confirm the usefulness of the cardiac 
risk index published by Goldman and 
associates in 1977, the author did a 
separate, prospective study of 1140 
patients over the age of 40 years 
who underwent noncardiac surgical 
procedures. Four risk categories were 
defined (classes I to IV, low to high risk 
according to Goldman's point score). 
Percentages of postoperative cardiac 
events (life-threatening cardiac complica­
tions or cardiac death) were tabulated. 
The incidence of cardiac events for each 
risk category, classes I to IV, was 0.7% , 
3% , 15% and 30%, respectively. Com­
parisons with Goldman's original study 
demonstrate that the cardiac risk index is 
a reliable, objective and valid method of 
assessing cardiac risk in patients who 
undergo elective surgery.
Afin de confirmer Futility de I'indice de 
risque cardiaque public par Goldman et 
collaborateurs en 1977, I'auteur a realise 
une etude prospective independante por- 
tant sur 1140 patients de plus de 40 
ans, soumis & une intervention 
chirurgicale autre que cardiaque. Quatre 
classes de risque ont ete definies (les 
classes de I a IV correspondant a un ris­
que de faible a eleve selon le systfeme de 
cote de Goldman). Le pourcentage des 
incidents cardiaques postoperatoires (les 
complications cardiaques menaqant le 
pronostic vital ou entralnant la mort) a 
6t6 compile. La frequence des incidents 
cardiaques pour chacune des categories 
de risque a 6t6 de 0.7%, 3%, 15% et 
30%  pour chacune des classes de I & IV 
respectivement. La comparaison avec 
I'etude originate de Goldman ddmontre 
que I'index de risque cardiaque est une 
mdthode sure, objective et valable 
d'evaiuer le risque cardiaque chez les 
patients qui doivent subir une operation 
non urgente.
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In the past, preoperative assessment of 
surgical risk was formulated subjective­
ly, using the American Society of 
Anesthesiologists’ classification of 
physical status.1’3 In 1977, Goldman and 
associates4,5 reported a multifactorial ap­
proach to predict cardiac risk in noncar­
diac surgical procedures. They were able 
to compute objectively a cardiac risk in­
dex or score for each patient and classify 
that patient into an appropriate risk 
category, and then to observe the out­
come. The present study extends their 
work to a separate, prospective cohort. 
Its purpose is to classify patients accord­
ing to their cardiac risk index, observe 
their course and test the model as a 
predictor of postoperative cardiac 
outcome.
Patients and Methods
As a resident in surgery from July 1978 
to June 1982, I was able to study all pa­
tients under my direct care. Patients in­
cluded in the study sample are those for 
whom I was the operating surgeon or the 
first assistant, responsible for the pa­
tients’ pre- and postoperative care at
Table I— Computation of the Cardiac Risk 
Index after Goldman and Associates5
Risk factor Points
Age >  70 yr 5
Myocardial infarction
in previous 6 mo 10
S3 gallop or jugular venous 
distension 11
Important valvular aortic stenosis 3
Rhythm other than sinus or 
premature atrial contractions on 
last preoperative electrocardiogram 7
>  5 premature ventricular contrac- 
tions/min documented at any time 
before operation 7
Operation -  intraperitoneal, 
intrathoracic, aortic 3
Emergency procedure 4
General medical status (Po2 <  60
or Pco, >  50 mm Hg, K <  3.0 or 
H C0, <  20 mmol/L, BUN >  17.9 
mmol/L urea or Creat >  265 pmol/L, 
abnormal SGOT level, signs of 
chronic liver disease, bedridden 
from noncardiac causes) 3
Mount Sinai, Toronto East General, 
Toronto General and Toronto Western 
hospitals. Every patient over 40 years of 
age admitted to the general, vascular and 
thoracic (noncardiac) surgery services in 
which I worked was available for study. 
Only those patients who had general 
anesthesia were included; uncomplicated 
endoscopies were excluded. In all, 1140 
patients were studied. There were 870 pa­
tients with general surgical problems (ab­
dominal, pelvic, breast, head and neck, 
soft tissue), 185 patients with thoracic 
noncardiac problems and 85 patients with 
vascular disease (aortic, peripheral 
vascular). Women accounted for 54% 
and men for 46% of the study 
population.
The nine risk factors identified by 
Goldman and associates4 are listed in 
Table I as are the corresponding points 
they assigned to develop a cardiac risk in­
dex. Using the same criteria, I filled in a 
data sheet (Fig. 1) for each patient
CARDIAC RISK INDEX
Na“ » : _______________________  D ate:
ID ,: ___________  A tte n d in g  Su rgeon :
DATA BASE
1. Age, y r  [5]
2 . Has p a t i e n t  had MI w ith in  
l a s t  6 mo? ( 10 )
3. S3 g a l lo p  p r e s e n t?  ( I I ) *
4 . JVD s ig n i f i c a n t ?  ( 11)*
5. S i g n i f ic a n t  a o r t i c  s t e n o s is ?  (3)
6 .  L as t ECG rhythm ? (1 -  NSR,
2 ■ PA C 's, 3 ■ any o th e r )  (7)
7 . > 5  PV C 's/rain a t  any tim e?  (7)
8 .  T horacotom y o r  laparo tom y  or 
o th e r?  (3)
9 . I s  t h i s  an em ergency o p e ra t io n ?  (4)
* I f  both ite m s  p o s i t i v e ,  s c o re  11 p o in ts  o n ly  o n c e .
GENERAL MEDICAL DATA I s c o re  3 i f  any v a lu e s  abnorm al I
10. PC02 ( >  50 mm Hg)
11. P02 K  60 mm Hg)
12. B ic a rb o n a te  «  20 mmol/L)
13. P o tassiu m  «  3 mmol/L)
14. BUN ( >  1 7 .9  mmol/L u re a )
15. C r e a t in in e  (>  265 /im o l/L )
16. SGOT ( e le v a t e d )
17. C l in i c a l  e v id en c e  of l i v e r  
d is e a s e  ( y e s /n o )
18. B ed ridden  from  n o n c ard iac  
c au se s  ( y e s /n o )
TOTAL SCORE
C la s s  ( I  -  5 , I I  -  6- 12, I I I  -  13 -25 , IV -  2 6 -53 ) □
FIG. 1—Data sheet for computing risk score 
and category. MI = myocardial infarction, 
JVD = jugular venous distension, ECG = 
electrocardiographic, NSR = normal sinus 
rhythm, PAC’s = premature atrial contrac­
tions, PVC’s = premature ventricular 
contractions.
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preoperatively. Postoperatively, if a pa­
tient had any clinical evidence to suggest 
a cardiac problem, then a single elec­
trocardiogram or serial electrocardio­
grams were obtained. Similar criteria for 
interpreting the electrocardiogram were 
i used. Cardiac enzyme levels were deter­
mined if there was any suggestion of 
^ myocardial infarction. When the condi­
tion was not clear, medical or cardiologic 
consultations were obtained. Each patient 
was seen daily through the hospital stay. 
" The same definitions for postoperative 
cardiac events that Goldman used were 
k employed in this study.
Postoperative outcomes were classified 
as follows: (a) no or minor cardiac com- 
Y  plication or noncardiac death; (b) life- 
threatening cardiac complication and (c) 
cardiac death. The life-threatening car­
diac complications were cardiogenic 
pulmonary edema, myocardial infarction 
and witnessed ventricular tachycardia. A 
r cardiac death was diagnosed if the patient 
. died from an arrhythmia or refractory 
low-output state. Excluded were low 
x cardiac-output states associated with a 
primarily noncardiac condition such as 
A. sepsis or respiratory failure. A noncardiac 
death is one from a cause other than that 
t  causing a cardiac death. Total cardiac 
events are represented by the sum of items 
(b) and (c).
Proportional analysis was used to 
measure statistical significance between 
cardiac risk classes. With the use of the 
central limit theorem, the normal approx- 
► imation to the binomial distribution was 
obtained.
Results
The patients were classified into the
four risk categories, classes I to IV, ac­
cording to the point score from 
Goldman’s nine risk factors (Table I): 
class I patients scored 0 to 5; class II, 6 
to 12; class III, 13 to 25; and class IV, 
26 to 53.
Table II shows the categories and out­
come of the patients postoperatively. The 
percentage of cardiac events increased as 
the risk class increased. In class I patients, 
0.7% had some sort of cardiac event. For 
classes II, III and IV, the percentages rose 
to 3%, 15% and 30%, respectively. 
Overall, 35 (3%) of the 1140 patients suf­
fered a cardiac event.
The differences in incidence of cardiac 
events between risk classes in this study 
were significant (p < 0.02) for classes I 
and II and classes II and III. While there 
was a numerical difference between 
classes III and IV (15% v. 30%), the 
smaller numbers in each group made it 
difficult to attach significance to the dif­
ference. Closer study of the 23 class IV 
patients revealed that they accounted for 
7 (20%) of the 35 patients suffering a car­
diac event, and 6 of these were fatal com­
plications. Thus, 43% of the cardiac 
deaths were in class IV patients.
The outcome for patients in the series 
reported by Goldman and colleagues is 
reviewed in Table III.4 Both studies had 
a large and similar number of patients 
(1001 in Goldman’s study and 1140 in this 
study). It is quite evident that Goldman 
had far more class III patients (130 v. 74) 
but fewer class II patients (316 v. 453). 
The incidence of cardiac events in 
Goldman’s series was 0.9%, 6%, 14% 
and 78% for classes I to IV, respective­
ly. Overall, the percentage of cardiac 
events in Goldman’s study was 6% (58 of 
1001) compared with 3% in this study.
>
Table II—Cardiac Risk Index - Postoperative Outcome
Class No.
No, minor or 
noncardiac 
complication, no. (%)
Life-threatening 
complication, 
no. (%)
Cardiac death, 
no. (%)
1 590 586(99.31 3(0.5) 1 (0.2)
II 453 440 (97) 912) 4 (1 )
III 74 63(85) 8(11) 3 (4 )
IV 23 16(70) 1 (4) 6 (26 )
1140 1105(97) 21 (1.8) 14(1.2)
Table Ill-Cardiac Risk Index -  Postoperative Outcome in the Series of Goldman and Colleagues5
Class No.
No, minor or 
noncardiac 
complication, no. (%)
Life-threatening 
complication, 
no. (%)
Cardiac death, 
no. (%)
I 537 532(99.1) 4(0.7) 1 (0.2)
II 316 295(93) 16(5) 5 (2 )
III 130 112(86) 15(12) 3 (2 )
IV 18 4(22) 4(22) 10(56)
1001 943 (94.2) 39 (3.9) 19(1.9)
Discussion
This prospective study was designed to 
match that of Goldman and associates as 
closely as possible. In doing so its validi­
ty could be tested. Given the model 
Goldman proposed, one could study a 
new, separate patient population and 
observe the model’s value in predicting 
outcome for this new group.
Part of the difference between class IV 
patients in the two studies can be explain­
ed by the small number of patients in this 
class. Moreover, as a result of Goldman’s 
work, awareness of the high cardiac risk 
of class IV patients was increased and 
may have led to better pre- and post­
operative care, thus reducing the number 
of cardiac events in this group.
In reviewing the current status of car­
diac risk factor assessment in noncardiac 
surgical patients, Rose and associates6 
cited Goldman’s risk factors several 
times. Although none of his risk factors 
are disputed, some authors7-9 have in­
cluded risk factors that Goldman found 
were not significant. Goldman’s figures 
did not include autopsy data so the in­
cidence of postoperative cardiac death 
could, in fact, be higher. I used only 
Goldman’s risk factors as predictors but 
also used autopsy results when they were 
available.
Norman,10 in 1978, called for the 
assessment of tests of predictive indices 
in new, subsequent studies. My study has 
accomplished this. Norman also pointed 
out that bias may be introduced towards 
better patient care in assessing these risk 
factors. This may well be the reason for 
the lower incidence of postoperative car­
diac events in this series. Certainly the pa­
tients have benefited if such a bias existed.
Conclusions
Assessing cardiac risk using Goldman’s 
multifactorial index is a rapid and objec­
tive method of identifying the degree of 
risk in patients about to undergo noncar­
diac surgical procedures. The present 
study confirms the findings of Goldman 
and colleagues and demonstrates the 
validity of their study. The cardiac risk 
index can easily become part of the 
medical record for any noncardiac 
surgical patient over the age of 40 years.
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Editorial note.—Dr. Zeldin examines and reaf­
firms the usefulness of the Goldman cardiac 
risk index, originally published in 1977, by stu­
dying a number of patients who underwent 
noncardiac surgical procedures, assessing the 
cardiac risk factors, using Goldman’s multifac­
torial index. Although the results of this pro­
spective study are similar to those of 
Goldman’s original findings, Zeldin was unable 
to demonstrate that all four groups were 
statistically separate and distinct. His study 
shows that predictive tests such as Goldman’s
need to be assessed under different conditions.
It emphasizes the need to review carefully each 
patient’s cardiac history for possible complica­
tions so that appropriate precautions can be 
taken. The data collection sheet for estimating 
the cardiac risk index (Fig. 1) is informative 
should another centre wish to undergo a similar 
trial. Although Zeldin’s study may not be 
original, it is reliable, has scientific importance ^ 
and points the way towards assessment of one ^ 
facet of risk for patients who undergo elective 
surgery.
R .M . PRESHAW, MD, FRCS[C]
Seasonal Frequency of Testicular Torsion
The hypothesis that testicular torsion is 
more common in winter was examined in 
a retrospective survey of admissions to 
three Calgary hospitals. No seasonal 
peak in incidence of cases of torsion 
was identified from 1966 to 1982.
L'hypothfcse voulant qu'une torsion 
testiculaire soit plus frdquente en hiver a 
6t6 evaluee lors d'une enquete retrospec­
tive des hospitalisations dans trois 
etablissements de Calgary. Aucun pic 
saisonnier n'a 6t6 identifie dans la fre­
quence des torsions survenues entre 
1966 et 1982.
In a series of 46 cases of testicular tor­
sion in Dublin, Ireland, 40 occurred when 
the ambient temperature was less than 
2°C. This finding suggested to Shukla 
and associates1 that torsion of the testis 
was causally related to cold-induced con­
traction of the cremaster muscle. I have 
reviewed all cases of testicular torsion in 
Calgary, Alberta from 1966 to 1982, but 
found no evidence to support this 
hypothesis.
Patients and Results
Yearly diagnostic indices provided by 
the Professional Activity Study (Commis­
sion on Professional and Hospital Ac­
tivities, Ann Arbor, Mich.) for three 
Calgary hospitals were examined for the
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diagnostic coding “ testicular torsion” for 
1966 to 1982 inclusive and for the month 
of discharge from hospital. Actual patient 
records were reviewed at random to assess 
the accuracy of the diagnostic coding on 
discharge. Two hundred and seventy-two 
cases of testicular torsion were identified 
by the procedure outlined. Review of a 
random 26 patient records revealed 24 pa­
tients in whom the discharge diagnosis 
had been confirmed surgically. In two pa­
tients, no operation was done and there 
was doubt as to the accuracy of the 
diagnosis. This sample indicates an up­
per confidence limit of the error rate in 
the overall population of less than 25% 
(p = 0.05, binomial expansion), which 
might be expected after considering the 
acute presentation and most likely 
therapy for this condition.
FIG. 1— Monthly frequency of testicular tor­
sion for period 1966 to 1982 and mean daily 
temperature in Calgary, Alberta from 1961 to 
1979 inclusive.
The duration of hospital stay for these 
26 patients ranged from 4 to 29 days 
(mean 6 days), confirming that the month 
of discharge provides a reasonably ac­
curate estimate of the date the torsion 
occurred.
The month of discharge for the total 
group of 272 cases is shown graphically 
in Fig. 1, which also provides the mean 
daily temperature for each month for 
Calgary from 1941 to 1979.2 Using 
Hewitt’s rank-sum criterion of season­
ality,3 no significant difference in the 
frequency of torsion was found either for 
the 6 coldest months or any other sequen­
tial 6-month period (for November to 
April inclusive, rank sum 40, p = 0.5). 
No seasonal trend was apparent when the 
data were manipulated in other ways; in 
particular, separating adults from 
children (16 years or younger) caused no 
change in the pattern.
A
■ *
Discussion
Torsion of the testis is uncommon, but 
this has not restricted speculation as to 
its cause. Most authorities4'6 have con­
centrated on predisposing anatomical < 
variations, including abnormal reflection 
of the tunica vaginalis upon the testicle, 
complete tunica vaginalis investment of 
the testicle and cord (bell-clapper defor­
mity), an elongated mesorchium and 
separation of the epididymis from the 
testicle. On this basis it has been suggested .* 
that the other testicle is also at risk for 
torsion, presumably because of similar 
minor malformations. Torsion has been 
recorded as more likely in cryptorchid­
ism,7 especially when associated with 
malignant degeneration.8 Others have 
commented on an association between w 
torsion and violent exercise or even 
trauma to the testicle.9
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►In 1912, Uffreduzzi (quoted by Har­
rison5) suggested that one cause of tor­
sion was contraction of the cremaster 
muscle when subjected to a stimulus such 
as sudden cold. This idea was supported 
by an experimental study of the distribu­
tion of cremaster by Muschat,10 who 
showed a spiral insertion of the muscle 
which could conceivably contribute to 
rotation of the testis under some condi­
tions. A similar etiology was proposed by 
Donohue and Utley.11 Shukla and 
associates1 found evidence for a seasonal 
incidence of torsion in Dublin and related 
this to an ambient temperature of 2°C or 
lower. Two subsequent series, reported 
briefly from centres in the United 
Kingdom,12’13 offered support for a 
seasonal incidence of torsion.14
Because there are greater extremes of 
daily temperature in much of Canada 
than in the British Isles, it is appropriate 
to examine the frequency of testicular tor­
sion under such conditions. The hypo­
thesis for a peak incidence in cold weather 
might find even more support under ex­
tremes of climate. However, no evidence 
was found to support a seasonal frequen­
cy for torsion among a series of 272 cases 
identified retrospectively in Calgary, 
Alberta.
The reason for the difference between 
these results and those from the three 
series reported from the United Kingdom 
and Ireland is not clear. It seems unlike­
ly that using the hospital discharge date 
rather than the date of occurrence of tor­
sion would obscure any significant 
seasonal trend. A more important 
criticism of this kind of retrospective 
study would be the rate of error in the 
diagnosis at discharge. In testicular tor­
sion, the admission diagnosis might be ex­
pected to have a high rate of error 
(because of confusion with acute epididy­
mitis and other conditions) but it appears 
likely that physicians would provide a 
fairly accurate discharge diagnosis for this 
relatively simple disease state. This is sup­
ported by the finding in this series that 
in 24 of the 26 patient records examined 
at random, the diagnosis was confirmed 
at operation. Perhaps other series should 
be examined under different climatic con­
ditions before the seasonal hypothesis is 
rejected.
I thank the Directors of Surgery in Alberta 
Children’s Provincial General Hospital, 
Calgary General Hospital and Foothills 
Hospital, Calgary, for access to patient 
records.
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Acute Hemorrhagic Pancreatitis and Diabetes Mellitus 
following Endoscopic Retrograde Cholangiopancreatography
Endoscopic retrograde cholangiopan­
creatography (ERCP) is generally regard­
ed as a safe and useful investigation in 
the diagnosis and management of 
diseases of the pancreas and biliary tree. 
Asymptomatic hyperamylasemia is not 
uncommon following this procedure, but 
clinical pancreatitis is rare. The authors 
report on a 56-year-old man who suf­
fered life-threatening acute hemorrhagic 
pancreatitis 2 weeks after ERCP was 
performed for the investigation of ab­
dominal pain. He subsequently had insulin-
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dependent diabetes mellitus, which was 
not present at the time of ERCP.
La cholangiopancrgatographie endoscopi- 
que retrograde (CPER) est generalement 
consideree comme une procedure sure et 
utile pour le diagnostic et le traitement 
des maladies du pancreas et de I'arbre 
biliaire. Apres cette intervention, I'hy- 
peramylasemie n'est pas rare mais la 
pancrgatite tranche est rare. Les auteurs 
signalent le cas d'un homme de 56 ans 
qui a souffert d'une pancreatite hemorra- 
gique aigue ayant menace le pronostic 
vital, 2 semaines apres une CPER prati- 
qu6e pour diagnostiquer les causes d’une 
douleur abdominale. II a par la suite souf­
fert d'un diabbte insulino-dependant qui 
n'existait pas au moment de la CPER.
Endoscopic retrograde cholangiopan­
creatography (ERCP) is frequently used 
in the diagnosis and management of
diseases of the pancreas and biliary tree. 
Asymptomatic hyperamylasemia is a 
common sequela, but serious complica­
tions are considered to be rare.1-7 We 
recently encountered a case of life- 
threatening acute hemorrhagic pan­
creatitis following ERCP performed for 
the investigation of abdominal pain. The 
examination showed that the ducts were 
normal, but within days an acute ab­
domen developed, and hemorrhagic pan­
creatitis was present at laparotomy. The 
patient recovered but subsequently 
insulin-dependent diabetes mellitus 
developed.
Case Report
Nine years before the presenting illness, our 
patient, a 56-year-old white man, had 
undergone cholecystectomy for cholelithiasis, 
following which he had recurrent episodes of 
ascending cholangitis due to a bile-duct stric­
ture. Endoscopic retrograde cholangiopan­
creatography was performed; it showed a stric-
VOLUME 27, NO. 4, JU LY  1984 /  THE CANADIAN JOURNAL OF SURGERY 405
ture of the common bile duct at the level of 
the cystic duct, retained irregular stones in the 
distal common bile duct and normal-appearing 
pancreatic ducts. A choledochoenterostomy 
was performed. He remained afebrile and with 
no symptoms suggestive of common-duct 
obstruction for 8 years. Then he began to suf­
fer episodes of sharp epigastric pain, ag­
gravated within 30 minutes by food and re­
lieved by antacids and cimetidine. He had mild 
hypertension that was controlled by pro­
pranolol 40 mg twice daily. Because of the fre­
quent episodes of pain, a second ERCP was 
performed at the University of Alberta 
Hospital. The pancreatic duct was cannulated 
and visualized over approximately 21 cm; the 
main duct and the secondary radicals appeared 
normal and no areas of narrowing were seen. 
An attempt was made to cannulate the com­
mon bile duct, but only a small amount of dye 
was seen in the proximal 2 cm; this portion of 
the common duct appeared normal in calibre.
Following ERCP the patient returned home 
500 km away. He was well for 2 weeks after 
the ERCP but then he experienced epigastric 
and left upper quadrant pain. The pain was 
severe and became progressively worse; it was 
associated with distension but there was no 
vomiting. He was admitted to his local 
hospital. There his abdomen was noted to be 
tender, w ithout guarding or rebound 
tenderness. His oral temperature was 38°C. 
Plain abdominal roentgenograms indicated an 
ileus. He was treated by nasogastric suction and 
fluids, ampicillin and cimetidine given in­
travenously. Ascites was present and the 
amylase level o f the tapped fluid was increas­
ed to 135 U /L , when the serum amylase level 
was normal. The urinary amylase-creatinine 
ratio was 3:100. The hemoglobin value was 120 
g/L . A trace of blood was apparent in the 
nasogastric aspirate. Two units of blood were 
transfused. After initial improvement he rapid­
ly deteriorated and his pain, distension and 
ascites became worse. Twelve hours later he 
was transferred to the University of Alberta 
Hospital.
On admission he appeared acutely ill; the 
pulse rate was 88 beats/min, blood pressure 
140/80 mm Hg, respiratory rate 30/min and 
oral temperature 36.9°C. There was no jaun­
dice; his abdomen was distended and there was 
shifting dullness and hypoactive bowel sounds. 
There was marked, diffuse tenderness with 
guarding and rebound tenderness in all four 
quadrants. The nasogastric tube was draining 
bile-stained material but no blood. The 
leukocyte count was 14.6 x 109/L  with 30% 
polymorphonuclear band cells. The hemo­
globin level was 120 g/L, serum amylase level 
40 U/L and blood glucose 11.9 mmol/L. The 
blood glucose was previously normal and the 
hemoglobin 3 years previously was 170 g/L. 
The serum electrolyte values were normal; on 
room air the partial pressure of oxygen in 
venous blood was 57 mm Hg, and of carbon 
dioxide was 37 mm Hg, and the pH was 7.49. 
Abdominal ultrasonography demonstrated 
normal biliary ducts, but the pancreas could 
not be visualized because of overlying gas- 
containing bowel loops. A perforated viscus 
was suspected. At laparotomy, the abdomen 
contained 2 L of clotted and fresh blood. The 
pancreas was about three times the normal size. 
The diagnosis was hemorrhagic pancreatitis 
with bleeding into the peritoneal cavity. No ab­
normality was detected in the common bile 
duct. The blood was evacuated and the ab­
domen was lavaged with saline.
Recovery was slow. The blood glucose levels 
were persistently elevated and the patient re­
quired insulin, 10 units regular plus 12 units 
lente every morning. He is now able to eat 
without pain and his bowel habit has remain­
ed normal with no appearance or characteristic 
suggestive of steatorrhea.
Discussion
Complications following ERCP are 
few and usually mild. In one third of pa­
tients, benign hyperamylasemia or 
hyperamylasuria will develop 1 or 2 days 
following ERCP, but injection pan­
creatitis with pain, fever and leukocytosis 
is unusual.1-7 When this does occur, it 
usually is seen 24 to 36 hours following 
the ERCP, not 2 weeks later as occurred 
in our patient. Injection pancreatitis may 
occur more commonly in inexperienced
hands, but this was not true of our en­
doscopist. There was nothing unusual in 
the amount of dye used for the injection, 
the pressure applied or the rate of injec­
tion. Furthermore, the pancreatic ducts 
visualized by ERCP were normal.
There was no obvious cause of the 
hemorrhagic pancreatitis other than the 
ERCP. The only medication the patient 
had been taking was propranolol for 
hypertension. He had been under treat­
ment with this agent for 8 years; pro­
pranolol is not thought to be associated 
with the developm ent of severe 
pancreatitis.8 He had not been taking 
thiazides, and his serum lipid and calcium 
levels were not known to be elevated. No 
stones were detected in the common duct 
by ERCP or ultrasonography or at 
operation.
We thank Dr. A. Kenyon for referring the 
patient, Dr. S. Adams for reviewing the ERCP 
films and Mrs. Jackie Polovick for typing the 
manuscript.
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SESAP IV Critique
ITEM 17
The procedure depicted is a parietal cell vagotomy (proximal gastric vagotomy, super-selective vagotomy). Most 
surgeons who use it do so as a definitive operation for peptic ulcer disease, without pyloroplasty or bypass of the 
pylorus, which seems to be its chief advantage. It has not been associated with many of the postoperative complica­
tions of operative procedures that destroy or bypass the pylorus. Parietal cell vagotomy has not ordinarily been 
considered appropriate for patients with gastroesophageal reflux. Some investigators do use this procedure for pa­
tients with hemorrhage, obstruction, or perforation from peptic ulcer. Latarjet described the anatomy of the vagus 
nerves, on which this operation is based, some 60 years ago.
m
Reference
17/1. Wastell C: Proximal gastric vagotomy, in Nyhus LM, Wastell C (eds): Surgery of the Stomach and Duodenum, 
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Refresher Course in 
Genitourinary Radiology
The biannual Refresher Course in Geni- 
^ tourinary Radiology, offered by the Uni­
versity of Toronto, will be held Oct. 18 
and 19, 1984 at the Mount Sinai Hospi­
tal, Toronto, Ont. This course will deal 
with recent advances in genitourinary 
imaging and will review selected areas of 
general interest. Topics will include digi- 
^ tal subtraction angiography, computed 
tomography, ultrasonography, nuclear 
magnetic resonance, nuclear imaging, 
interventional techniques and the inves­
tigation of impotence.
For further information contact Dr. 
Robin R. Gray, Course Director, Depart­
ment of Radiology, The Wellesley Hos­
pital, 160 Wellesley St. E, Toronto, Ont. 
M4Y 1J3 or call (416) 966-6810.
Practical Hand Surgery
The 14th annual meeting of the Ameri­
can Association for Hand Surgery will be 
held in conjunction with the Mexican 
Society for Surgery of the Hand and the 
Caribbean Society for Hand Surgery, 
Nov. 25-28, 1984 at the Acapulco Prin­
cess Hotel, Acapulco, Mexico.
The theme for this year’s meeting will 
be the management of practical problems 
of hand surgery. Emphasis will be on cost 
effectiveness of accurate, quality, hand 
surgery care.
For further information contact Dr. 
Robert J. Demuth, Central Office, Ame­
rican Association for Hand Surgery, 2564 
Branch St., Middleton, Wise. 53562, 
USA.
international Meeting on 
Vascular Pathology
The 14th International Meeting on Vas­
cular Pathology will he held Oct. 22-24, 
1984 at the Auditorium of the University 
of Coimbra, Coimbra, Portugal. It has 
been organized by the Department of Sur­
gical Pathology, University of Coimbra, 
and sponsored by the International Union 
of Angiology.
For further information contact Mario 
Blanco Peres, Rua Gonqalo Cristovao, 
116-3°, 4000 Porto, Portugal.
CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The 
deadline is 1 month before issue date. Regular classified rates (for each insertion): $35.00 for the first 40 words or less, additio­
nal words 35C each (additional $13.00 for frame). Special Display under 75 words, 2 1/4" X 2" $85.00. $5.00 charge (first inser­
tion only) for CJS box numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
St. Joseph’s Health Centre, located in Toronto’s west end, an 830-bed active-chronic 
treatment and teaching hospital, affiliated with the University of Toronto, has an 
immediate opening for a:
Chief, Department of Surgery
The person appointed will supervise the activi­
ties of the Services of General Surgery, Plastic 
Surgery, Orthopedic Surgery, Vascular Surgery,
Thoracic Surgery and Dental Surgery in accor­
dance with the Departmental policies and the 
By-Laws of the Health Centre.
Candidates must be eligible for Active Staff 
Appointment, and have demonstrated teaching 
abilities, and excellent clinical skills, together
Mr. J.J. Ruffo
Chairman—Search Committee 
c/o Medical Director’s Office 
St. Joseph’s Health Centre 
30 The Queensway 
Toronto, Ontario M6R 1B5
with a flair for administration and proven leader­
ship qualities.
Applicants are invited to submit an up-to-date 
curriculum vitae, which should include an aca­
demic history, published articles and any other 
relevant information.
Appropriate documents should be addressed to:
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GENERAL SURGEON
BC
Required immediately by a busy community in the 
Cariboo region of British Columbia.
Fully accredited 60 acute and 40 extended care bed 
hospital. A 14.5 million dollar building project, including 
three ORs scheduled to start in 1985. Practice draws 
from city population of approximately 10 000 and catch­
ment area of 25 000. Current medical staff includes 16 
general practitioners, a general surgeon and ENT, and 
internist specialists.
Excellent recreational facilities and opportunities 
available. For further information call:
Mr. T.L. Thomas, Administrator 
(604) 992-2181
or write: G.R. Baker Memorial Hospital 
543 Front St.
Quesnel, BC V2J 2K7 -S84-021
GENERAL SURGEON 
&
OTORHINOLARYNGOLOGIST
NB
Required for 
accredited 90-bed 
general hospital 
McGill affiliation.
St. Joseph's Hospital 
Dalhousie, NB 
EOK 1B0
-S84-015
GENERAL SURGEON: ON — required in a group 
practice in northwestern Ontario. Duties would in­
clude general practice in a modern clinic that ac­
commodates four practitioners w ho alternate call at 
the area's 44-bed hospital. Community has a stable 
economic base and is located on a large lake — 
recreational facilities are excellent. Underserviced 
Area Grant available. Contact: Dr. V.W. Aniol, PO 
Box 311, Red Lake, ON P0V 2M0, (807) 727-2751.
-S 84-020
CERTIFIED GENERAL SURGEON: YT -  Re­
quired to  join 10 fam ily physicians/1 obstetrician- 
gynecologist group for an extended period. 
Emergency orthopedic experience a definite asset. 
Located in Whitehorse, Yukon Territory, servicing a 
population of 23 000 people and 26 doctors. Ex­
cellent location fo r someone w ho  enjoys the out­
doors. Remuneration to  be negotiated. Early oppor­
tunity fo r partnership. Please write, giving complete 
resume, or tel: J.L. Pollock, Clinic Ad­
ministrator, 406 Lambert St., Whitehorse, YT 
Y1A 1Z7, (403) 667-4421.
— S83-034
CRITICAL CARE FELLOWSHIP -  Surgical Inten­
sive Care Unit, University Hospital, University of 
Saskatchewan, Saskatoon, Saskatchewan. One 
year, renewable once, fo r physicians w ho are eligi­
ble fo r the Royal College certification examination in 
general surgery or anesthesia. Experience offered 
in: surgical critical care multidisciplinary unit in 
multiple trauma, open heart surgery, major com­
plications fo llow ing general surgical procedures, 
neurosurgical post-op care and infections in critical­
ly ill patients. Competitive salary. Opportunities for 
clinical research available. Position open from  July 
1, 1984. Send curriculum vitae to : Jaime C. Pinilla, 
MD, FRCS(C), Director, Surgical Intensive Care 
Unit, Department of Surgery, University 
Hospital, Saskatoon. SK S7N 0W0.
◄
— S84-019
C A N A D IA N  J O U R N A L  OF SU RG ERY
Publication and deadline 
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insertion): $35.00 for the first 40 words or
less, additional words 35b each, to
maximum of 150 words (additional $13.00 
for frame). Special Display under 75 
words, 2V4”  x 2” , $85.00. $5.00 charge 
(first insertion only) for CJS box numbers.
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Classified Advertising
Canadian Journal of Surgery
PO Box 8650 
Ottawa, ON K1G 0G8
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PREPARING A
CLASSIFIED ADVERTISEMENT?
Use this checklist to ensure that your ad is 
complete.
Specialty
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Location - size of city or town 
Job description and remuneration 
Amenities - sports, social, schools, etc.
Starting date 
Complete reply address 
(or request box number) *-
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Offers Significant Advantages Over Admixing 
H2-Receptor Antagonists from Ampuls and Vials
Safety
Provides bold two- 
colour labelling, 
assured concentration, 
guaranteed sterility 
and 18 month stability.
Economy
Eliminates cost of 
admixing materials. 
Reduces labour costs 
and wastage.
Efficiency
Frees staff for other 
clinical duties.
Tagamet leads the way in the treatment of 
acid-related disorders.
Manufactured and distributed for 
Smith Kline & French Canada Ltd. by 
Travenol Canada Inc.
VIAFLEX is a registered trademark of Baxter Travenol Laboratories Inc.. U.S.A
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Davis +  Geek Introduces
FTGIT
Surgical Chromic Suture
Something 
you’re used to 
without 
the problems 
you’re used to
You told us that you liked using catgut but you didn’t like its 
problems. So we took catgut and made it
• soft and supple
• easy to tie
• less likely to curl, “pigtail” and tangle
• easy to handle and control
Cyanamid Canada Inc. Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5
‘ Trademark American Cyanamid Company
